Sentence,class,file
"U.S.A., 2000 ,97(7), 3631-3636. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2012 ,28(6), 911-918. http://dx.doi.org/10.1007/  s00381-012-1747-3  [250] Rogawski, M.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Biochem., 2006 ,18(4-5), 287-294. http://dx.doi.org/10.1159/  000097675  [253] Gauthier, J.; Siddiqui, T.J.; Huashan, P.; Yokomaku, D.; Hamdan,  F.F.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2011 ,130(4), 563-73. http://dx.doi.org/10.1007/s00439- 011-0975-z  [254] Sato, D.; Lionel, A.C.; Leblond C.S.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2013 ,78(1), 8-27. http://dx.doi.org/  10.1016/j.neuron.2013.03.016  [256] Etherton, M.R.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2009 , 42(1), 45-55. http://dx.doi.org/10.1016/j.mcn.2009.05.004  [263] Budreck, E.C.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2011 ,31(38),  13500-13515. http://dx.doi.org/10.1523/JNEUROSCI.6439-10.2011  [269] Zeidan, A.; Ziv, N.E.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"http://dx.doi.org/10.1371/journal.pone.0042314  [270] Ripley, B.; Otto, S.; Tiglio, K.; Williams, M.E.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron , 2012 ,76(2), 309-16. http://dx.doi.org/10.1016/j.neuron.2012.07.024 [272] Budreck, E.C.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2010 ,30(6), 2115-2129.  http://dx.doi.org/10.1523/JNEUROSCI.4517-09.2010  [276] Peixoto, R.T.; Kunz, P.A.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2012 ,76(2), 396-409.  http://dx.doi.org/10.1016/j.neuron.2012.07.006  [277] Boeckers, T.M.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
",2002 ,81(5), 903-910.  http://dx.doi.org/10.1046/j.1471-4159.2002.00931.x  [278] Arons, M.H.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Nature ,2012 , 486(7402), 261-265.  http://dx.doi.org/10.1038/nature11208  [281] Gong, X.; Jiang, Y.W.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neuron ,2000 ,28(2), 499-510. http://dx.doi.org/10.1016/S0896- 6273(00)00128-8  [286] Marsden, K. C.; Beattie, J.B.; Friedenthal, J.; Carroll, R.C.",OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
"Neurosci., 2007 ,27(52), 14326-14337.  http://dx.doi.org/10.1523/JNEUROSCI.4433-07.2007  [287] Ma, D.Q.",Non-OADS,/arxiv_data1/oa_pdf/15/51/CN-12-71.PMC3915351.pdf
Downloaded	 from	http://www.cdsco.nic.in/Report_of_Dr_Ranjit_ Roy.pdf	[Last	accessed	on	2013	Dec	5].,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
Downloaded	 from	http://www.iso.org/iso/home/ standards/certification.htm	[Last	accessed	on	2013	Dec	5].,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
Downloaded	 from	http://www.nap.edu/openbook.,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
Downloaded	 from	http://www.picronline.org/article.as p?issn=2229‑3485;year=2012;volume=3;issue=2;spage=80;epage=84;a ulast=Bairy	[Last	accessed	on	2013	Dec	6].,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/32/b4/PCR-5-1.PMC3915361.pdf
Available	 from:	http://www.edctp.org/fileadmin/ documents/EMEA_ICH‑GCP_Guidelines_July_2002.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.ich.org/fileadmin/ Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/Step4/ E6_R1__Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.kem.edu/wp‑content/ uploads/2013/03/SOP‑10.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.kem.edu/wp‑content/,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.kem.edu/wp‑content/uploads/2013/03/ SOP‑14.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://tmc.gov.in/research/ pdf/TMC‑HEC‑SOP.pdf.,OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.kem.edu/wp‑content/uploads/2013/03/ SOP‑15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	 http://www.fda.gov/downloads/Regulatoryinformation/Guidances/ ucm127073.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0a/9c/PCR-5-11.PMC3915362.pdf
Available	 from:	http://www.tbcindia.nic.in/RNTCP.,Non-OADS,/arxiv_data1/oa_pdf/93/59/PCR-5-16.PMC3915363.pdf
Available	 from:	 http://www.who.int/tb/publications/manual_for_participants_ pp51_98.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/59/PCR-5-16.PMC3915363.pdf
Available	 from:	http://www.who‑umc.org/Graphics/   24734.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/59/PCR-5-16.PMC3915363.pdf
Available	 from:	 http://www.artnscience.us/Med_Ethics/index.html	 [Last	accessed	 on	 2013	Sep	26].,Non-OADS,/arxiv_data1/oa_pdf/a1/d6/PCR-5-3.PMC3915366.pdf
Available	 from:	http://www.cdsco.nic.in/GSR%20 364Ejune13.pdf	[Last	accessed	on	2013	Sep	27].,Non-OADS,/arxiv_data1/oa_pdf/a1/d6/PCR-5-3.PMC3915366.pdf
Available	 from:	http://www.searo.who.int/ entity/antimicrobial_resistance/BCT_hlm‑407.pdf	 [Last	accessed	 on	 2013	Jun	24].,OADS,/arxiv_data1/oa_pdf/8b/12/PCR-5-32.PMC3915367.pdf
Available	 from:	http://www.apps.who.,Non-OADS,/arxiv_data1/oa_pdf/8b/12/PCR-5-32.PMC3915367.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/23761612.,Non-OADS,/arxiv_data1/oa_pdf/d1/e0/IJPVM-5-117.PMC3915464.pdf
Available from: http://medind.nic.in/jah/t12/ i2/jaht12i2c.shtml.,OADS,/arxiv_data1/oa_pdf/ee/3a/IJPVM-5-16.PMC3915468.pdf
Available from: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/chapters.htm.,OADS,/arxiv_data1/oa_pdf/c0/5f/IJPVM-5-69.PMC3915476.pdf
Available at: http://www.who.int/tobacco/ research/cessation/code_practice_en.pdf last accessed  on 2012  29 April 8.,Non-OADS,/arxiv_data1/oa_pdf/c0/5f/IJPVM-5-69.PMC3915476.pdf
Available  at http://www.mciindia.org/RulesandRegulations/GraduateMedicalEducationRegulations1997.aspx Last  accessed on 15 -May -2012 13.,Non-OADS,/arxiv_data1/oa_pdf/c0/5f/IJPVM-5-69.PMC3915476.pdf
Available  at http://www.tepp.org.,Non-OADS,/arxiv_data1/oa_pdf/c0/5f/IJPVM-5-69.PMC3915476.pdf
Available at http://www.prescriptionforhealth.org/downloads/ integration2001.pdf Last accessed on 2012  14 April.,Non-OADS,/arxiv_data1/oa_pdf/c0/5f/IJPVM-5-69.PMC3915476.pdf
Data were analyzed using ANOVA (R version 2.2.1/MAANOVA version 0.98-7) (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/a7/6b/srep03894.PMC3915549.pdf
Regulated genes were mapped to GO-slim categories according to the Gene Ontology Consortium: (http://www.geneontology.org/GO_slims/goslim_generic.obo).,OADS,/arxiv_data1/oa_pdf/a7/6b/srep03894.PMC3915549.pdf
"Off-line image analysis was performed using ImageJ (NIH, http://imagej.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/a7/6b/srep03894.PMC3915549.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/6b/srep03894.PMC3915549.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 3894 | DOI: 10.1038/srep03894 8",Non-OADS,/arxiv_data1/oa_pdf/a7/6b/srep03894.PMC3915549.pdf
"Oncogene 2013; PMID:23318445; http://dx.doi.org/10.1038/onc.2012.583Keywords:  Fanconi anemia, ROS, mito - chondria, oxidative stress, metabolic  disorders Abbreviations:  FA, Fanconi anemia;  ROS, reactive oxygen species; Δψm,  mitochondrial transmembrane potential;  ICL, interstrand cross-links; 2D-DIGE, two-dimensional differential in gel electrophoreses; MMC, mitomycin C; NAC, N-Acetyl-l-cysteine; HEK, human embryonic kidney Submitted: 02/04/13Accepted: 02/19/13Published Online: 03/01/13http://dx.doi.org/10.4161/rdis.24048 Citation: Lyakhovich A.",Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Blood 2012; 119:4142-51;  PMID:22408259; http://dx.doi.org/10.1182/blood- 2011-09-381970.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Biol Chem 2011; 392:625- 32 ; PMID :21619480 ; http://dx.doi.org/10.1515/ bc.2011.064.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Carcinogenesis 1993; 14:1115-20; PMID:8389671; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
J Cell Biol 2006; 175:225- 35; PMID:17060495; http://dx.doi.org/10.1083/ jcb.200607061.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Oncogene 2013; PMID:23318445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Carcinogenesis 1995; 16:735-41;  PMID:7728950; http://dx.doi.org/10.1093/car - cin/16.4.735.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Mutagenesis 2002; 17:25-30; PMID:11752230;  http://dx.doi.org/10.1093/mutage/17.1.25.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Cancer Res 2008; 68:9693-702; PMID:19047147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
J  Biol Chem 2004; 279:16805-12; PMID:14764578; http://dx.doi.org/10.1074/jbc.M313721200.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Mol Cancer Res 2010; 8:46-56; PMID :20068062 ; http://dx.doi.org/10.1158/1541- 7786.MCR-09-0373.References 1.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
N Engl J Med 2010;  362:1909-19; PMID:20484397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Nat Rev Cancer 2011; 11:467- 80; PMID:21701511; http://dx.doi.org/10.1038/ nrc3088.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Biol Chem 2012; 393:11- 21; PMID:22628295; http://dx.doi.org/10.1515/ BC-2011-227.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Hereditas  1977; 86:147-50; PMID:914646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Nature 1981; 290:142-3; PMID:7207594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
Hum Genet 1985; 69:62-5; PMID:3967890; http://dx.doi.org/10.1007/ BF00295530.,Non-OADS,/arxiv_data1/oa_pdf/bf/49/rdis-1-e24048.PMC3915560.pdf
"Brain 2012; 135:3551-66; PMID:23250879; http://dx.doi.org/10.1093/brain/aws299Keywords:  Charcot Marie Tooth dis - ease 1B (CMT1B), Unfolded Protein  Response (UPR), curcumin, myelin, peripheral nerve, genetics Submitted: 02/11/13Accepted: 02/19/13Published Online: 03/06/13http://dx.doi.org/10.4161/rdis.24049 Citation: Bai Y, Patzko A, Shy ME.",Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
5 More than 120 different disease- causing mutations in MPZ have been identified (http://www.molgen.ua.ac.be/CMTMutations/default.cfm).,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Brain 2012; 135:3551-66;  PMID:23250879; http://dx.doi.org/10.1093/brain/ aws299.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Clin Genet 1974;  6:98-118; PMID:44301 58; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Ann Neurol  2011; 69:22-33; PMID:21280073; http://dx.doi.org/10.1002/ana.22166.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Brain 2004; 127:371-84; PMID:14711881;  http://dx.doi.org/10.1093/brain/awh048.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Hum Mol Genet 2008; 17:1877-89;  PMID:18337304; http://dx.doi.org/10.1093/hmg/ ddn083.8.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Am J  Hum Genet 2005; 77:841-50; PMID:16252242;  http://dx.doi.org/10.1086/497541.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Brain 2012; 135:2032- 47; PMID:22689911; http://dx.doi.org/10.1093/ brain/aws140.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
J Neurosci 2006; 26:2358-68; PMID:16495463; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Science 2004; 304:600-2; PMID:15105504;  http://dx.doi.org/10.1126/science.1093941.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Br J Nutr 2010; 103:1545-57; PMID:20100380; http://dx.doi.org/10.1017/ S0007114509993667.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Am  J Hum Genet 2007; 81:438-53; PMID:17701891;  http://dx.doi.org/10.1086/519926.15.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Pharm Res 2009; 26:2438-45; PMID:19714451; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Nat Med 2012; 18:1130-5; PMID:22706386; http://dx.doi.org/10.1038/ nm.2833.,OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
J Neurosci 2009; 29:6094- 104; PMID:19439587; http://dx.doi.org/10.1523/ JNEUROSCI.0686-09.2009.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
J Chromatogr A  2001; 935:173-201; PMID:11762774; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
Brain 2012; 135:3527-8; PMID:23250878;  http://dx.doi.org/10.1093/brain/aws311.,Non-OADS,/arxiv_data1/oa_pdf/8d/9d/rdis-1-e24049.PMC3915562.pdf
"Nature Genetics 2012; 44:1375-81; PMID:23143598; http://dx.doi.org/10.1038/ng.2453Keywords:  IGSF1, macroorchidism, cen - tral hypothyroidism, prolactin, obesity Abbreviations:  BMI, body mass index;  CH-C, congenital central hypothyroid - ism; CNS, central nervous system; FSH,  follicle-stimulating hormone; FT4, free T4; GH, growth hormone; Ig, immuno - globulin; IgSF, immunoglobulin super - family; IGSF1, immunoglobulin super - family member 1; LH, luteinizing hor - mone; (N)CAM, (neural) cell adhesion molecules; NK cells, natural killer cells; TBG, thyroxine-binding globulin; TRH, thyrotropin-releasing hormone; TRHR, thyrotropin-releasing hormone receptor; TSH, thyroid-stimulating hormone Submitted: 03/14/13Revised: 04/15/13Accepted: 04/30/13Published Online: 05/13/13 Citation: Joustra SD, van Trotsenburg ASP , Sun Y,  Losekoot M, Bernard DJ, Biermasz NR, et al.",Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
"Rare Diseases 2013; 1:e24883; http://dx.doi.org/10.4161/rdis.24883*Correspondence to: Sjoerd D. Joustra; Email: S.D.Joustra@lumc.nl; A.S. Paul van Trotsenburg; Email: A.S.vanTrotsenburg@amc.uva.nl; Jan M. Wit; Email: J.M.Wit@lumc.nlA recently uncovered X-linked syn - drome, caused by loss-of-function  of IGSF1 , is characterized by congenital  central hypothyroidism and macroor - chidism, variable prolactin deficiency,  occasional growth hormone deficiency, delayed pubertal testosterone secre - tion and obesity.",Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Nat Genet 2012; 44:1375-81; PMID:23143598;  http://dx.doi.org/10.1038/ng.2453 2.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Genomics 1998; 48:157-62; PMID:9521868; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Gene 1998; 214:1-6; PMID:9729118; http://dx.doi.org/10.1016/S0378-1119(98)00253-4 4.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
J Biol Chem 2008; 283:36369- 76; PMID:18981173; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Mol Endocrinol  2001; 15:654-67; PMID:11266515; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Mol Cell  Endocrinol 2002; 196:79-93; PMID:12385827;  http://dx.doi.org/10.1016/S0303-7207(02)00227-77.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Mol Cell Biol 2003;  23:4882-91; PMID:12832474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Curr  Opin Cell Biol 2007; 19:543-50; PMID:17935964;  http://dx.doi.org/10.1016/j.ceb.2007.09.010 9.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Semin Immunol 2003; 15:215-23; PMID:14690046; http://dx.doi.org/10.1016/S1044- 5323(03)00047-2 10.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Cell Mol Immunol 2010; 7:11- 9; PMID:20081873; http://dx.doi.org/10.1038/ cmi.2009.108 11.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Biotechnol J  2008; 3:1564-80; PMID:19072911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Neuroscientist  2011; 18:452-66; PMID:21903634; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Pediatrics 2005; 116:168-73; PMID:15995048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
J Inherit Metab  Dis 2010; 33(Suppl 2):S225-33; PMID:20195902;  http://dx.doi.org/10.1007/s10545-010-9062-1 16.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
"J Neuroendocrinol 2008;  20:1-70; PMID:18081553; http://dx.doi.org/10.1111 /j.1365-2826,2007.01616 17.",Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Horm Res Paediatr  2011; 76:56-64; PMID:21464560; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Cell Tissue Res 2008; 334:283- 94; PMID:18795335; http://dx.doi.org/10.1007/ s00441-008-0680-y 29.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Reproduction 2003; 125:769-84; PMID:12773099; http://dx.doi.org/10.1530/ rep.0.1250769 30.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
J Exp Med 2011; 208:2545-60; PMID:22084409; http://dx.doi.org/10.1084/jem.2011085324.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Clin Dysmorphol 2005;  14:133-5; PMID:15930902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Cell Tissue Res 2005; 322:133-40; PMID:15856309; http://dx.doi.org/10.1007/ s00441-005-1082-z 26.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
J Pediatr Endocrinol Metab 1996; 9:617-22;  PMID:9004178; http://dx.doi.org/10.1515/ JPEM.1996.9.6.61720.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Endocr J 2013; 60:245- 9; PMID:23363888; http://dx.doi.org/10.1507/ endocrj.EJ13-0009 21.,OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Nature 1986; 320:488-9; PMID:3083267;  http://dx.doi.org/10.1038/320488a0 22.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Endocrinology 1998; 139:156-62; PMID:9421410; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
Am J Med Genet A  2003; 118A:49-51; PMID:12605440; http://dx.doi.org/10.1002/ajmg.a.10888,Non-OADS,/arxiv_data1/oa_pdf/c2/e2/rdis-1-e24883.PMC3915563.pdf
"1,2 Recently, the  gene that is mutated in GPS was identified The Nbeal2–/– mouse as a model for the gray platelet syndrome Carsten Deppermann1, Paquita Nurden1,2, Alan T Nurden2, Bernhard Nieswandt1,*, and David Stegner1,3,* 1University of Würzburg; Department of Experimental Biomedicine; University Hospital and Rudolf Virchow Center; DFG Research Center for Experimental  Biomedicine; Würzburg, Germany; 2Plateforme Technologique et d’Innovation Biomédicale; Hôpital Xavier Arnozan; Pessac, France; 3Department of Neurology;  University of Würzburg; Würzburg, Germany Keywords:  gray platelet syndrome,  NBEAL2, platelet, α -granule Abbreviations: ARM, armadillo-like domain; BEACH, Beige and Chediak-Higashi; ConA, concanavalin-A; ECM, extracellular matrix; GPS, gray platelet syndrome; MK, megakaryocyte; Nbeal2, Neurobeachin-like 2; PF4, platelet-factor 4; PH, Pleckstrin homology; VWF, von Willebrand factor *Correspondence to: David Stegner;   Email: stegner@virchow.uni-wuerzburg.de; Bernhard Nieswandt; Email: bernhard.nieswandt@virchow.uni-wuerzburg.deSubmitted: 08/26/2013 Revised: 09/20/2013Accepted: 09/20/2013Published Online: 10/15/2013http://dx.doi.org/10.4161/rdis.26561Citation: Deppermann C, Nurden P , Nurden A,  Nieswandt B, Stegner D. The Nbeal2 −/− mouse  as a model for the gray platelet syndrome.",Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
J Clin Invest 2013; 123:3331-42; PMID:23863626;  http://dx.doi.org/10.1172/JCI69210,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood 2010;  116:4990-5001;  PMID:20709904 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood Rev 2007; 21:21-36;  PMID:16442192 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
J Mol Med (Berl) 2011; 89:109- 21; PMID:21058007 ; http://dx.doi.org/10.1007/ s00109-010-0691-5 4.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood Rev  2009; 23:177-89;  PMID:19450911 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Nat Med 2011; 17:1423-36;  PMID:22064432 ; http://dx.doi.org/10.1038/ nm.2515 6.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Am J Med  1971; 51:818-28;  PMID:5129551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
J Clin Invest 1987; 80:1138- 46; PMID:2443536 ; http://dx.doi.org/10.1172/ JCI113171 9.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Nat Genet 2011; 43:735-7;  PMID:21765411 ; http://dx.doi.org/10.1038/ng.88510.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Nat Genet  2011; 43:732-4;  PMID:21765412 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
J Clin Invest 2013; 123:3331-42;  PMID:23863626 ; http://dx.doi.org/10.1172/ JCI69210 14.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood  2013;  PMID:23861251 ; http://dx.doi.org/10.1182/ blood-2013-04-499491 15.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood 2013; 121:4938-47; PMID:23584880 ;  http://dx.doi.org/10.1182/blood-2012-10-461459 17.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Haematologica 2013; 98:868- 74; PMID:23100277 ; http://dx.doi.org/10.3324/ haematol.2012.07586118.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Arterioscler Thromb Vasc Biol 2010; 30:2368-71; PMID:21071706 ; http://dx.doi.org/10.1161/ ATVBAHA.110.217281 19.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Curr Opin Hematol 2013; 20:445-50; PMID :23921514 ; http://dx.doi.org/10.1097/ MOH.0b013e3283642267 20.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood 2008; 111:4958- 64; PMID:18256319 ; http://dx.doi.org/10.1182/ blood-2007-11-123620 21.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Bioinformatics 2009; 25:1219- 22; PMID:19289442 ; http://dx.doi.org/10.1093/ bioinformatics/btp151 22.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Traffic  2013; 14:749-66;  PMID:23521701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood 2012; 120:5032- 40; PMID :23002115 ; http://dx.doi.org/10.1182/ blood-2012-05-431205 24.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
Blood 2010; 115:2649- 56; PMID:20118404 ; http://dx.doi.org/10.1182/ blood-2009-07-231886  of the hallmarks of GPS patients and can  therefore be used to study the in vivo con - sequences of α-granule deficiency as well  as studying potential therapeutic options in the treatment of GPS.,Non-OADS,/arxiv_data1/oa_pdf/72/3d/rdis-1-e26561.PMC3915564.pdf
LSDs are different from one disease to the next and each drug development program poses unique Correspondence to: Pol F Boudes; Email: boudesp@excite.com Submitted: 08/24/2013; Revised: 09/22/2013; Accepted: 10/03/2013; Published Online: 10/24/2013http://dx.doi.org/10.4161/rdis.26690Citation: Boudes PF.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Ther Adv Endocrinol Metab  2010; 1:177-88;  PMID:23148162 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Nat Rev Drug Discov 2011; 10:341- 9; PMID :21532564 ; http://dx.doi.org/10.1038/ nrd3445 4.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
JAMA 2011; 305:2320- 6; PMID:21642684 ; http://dx.doi.org/10.1001/ jama.2011.769 5.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Nat Rev Drug Discov 2010; 9:901-2; PMID:21119719 ; http://dx.doi.org/10.1038/ nrd3340 6.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Nat Rev Drug Discov 2012; 11:191-200;  PMID:22378269 ; http://dx.doi.org/10.1038/ nrd3681 7.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Available  from: http://www.rarediseases.org/docs/policy/ NORDstudyofFDAapprovaloforphandrugs.pdf 9.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Natl Cancer Inst 2011; 103:636-44; PMID:21422403 ;  http://dx.doi.org/10.1093/jnci/djr062 12.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Available from: http://www.ema.europa.eu/ema/ index.jsp?curl=pages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=WC0b01ac058001d125&sear chTab=searchByAuthType&alreadyLoaded=true&is NewQuery=true&status=Authorised&keyword=Enter+keywords&searchType=name&taxonomyPath= &treeNumber=&searchGenericType=ca&genericsK eywordSearch=Submit14.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Clin Pharmacol Ther 2010; 88:848-53; PMID:20962774 ;  http://dx.doi.org/10.1038/clpt.2010.207 15.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Clin Pharmacol Ther 2011; 89:503-12;  PMID:21326288 ; http://dx.doi.org/10.1038/ clpt.2011.10 16.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
N Engl J Med  2001; 345:915-9;  PMID :11565527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Mol Genet Metab 2009; 96:20-6; PMID:19013090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Ann Intern Med  1995; 122:33-9;  PMID:7985893 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Pediatr 2004; 144:581-8; PMID :15126990 ;  http://dx.doi.org/10.1016/j.jpeds.2004.01.046 22.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Neurology 2007; 68:99-109;  PMID:17151339 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
N Engl J Med 2001; 345:9-16; PMID:11439963 ; http://dx.doi.org/10.1056/ NEJM200107053450102 24.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Ann Intern Med 2007; 146:77-86;  PMID:17179052 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
N  Engl J Med 2010; 362:1396-406; PMID:20393176 ;  http://dx.doi.org/10.1056/NEJMoa0909859 26.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
BMJ 1995; 311:485; PMID:7647644 ; http://dx.doi.org/10.1136/ bmj.311.7003.485 27.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Comm Statist Theory Methods 1994; 23:499-531; http://dx.doi.org/10.1080/03610929408831269 28.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Clin Pharmacol Ther 2010; 88:774-8;  PMID:20944560 ; http://dx.doi.org/10.1038/ clpt.2010.233 29.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Available from: http://www.access - data.fda.gov/drugsatfda_docs/label/2012/203188lbl.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Hum Mutat 2011; 32:965-77; PMID :21598360 ;  http://dx.doi.org/10.1002/humu.21530 32.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
N Engl J Med  2001; 345:915-9;  PMID :11565527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Ann Intern Med  1996; 125:605-13;  PMID :8815760 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Ann Intern Med 1979; 90:85-91; PMID:217290 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Mol Genet Metab 2012; 106:395-402; PMID:22658917 ;  http://dx.doi.org/10.1016/j.ymgme.2012.05.003 37.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Genet Med 2009; 11:536-41; PMID:19521244 ; http://dx.doi.org/10.1097/ GIM.0b013e3181a87867 38.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Clin Genet  2004; 65:299-307;  PMID:15025723 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Mol Genet Metab 2010; 99:283-90;  PMID:19951842 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Orphanet J Rare Dis 2011; 6:79-89; PMID:22129361 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Biopharm Stat 2005; 15:575-91; PMID:16022164 ;  http://dx.doi.org/10.1081/BIP-200062277 44.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Biopharm Stat 2010;  20:1115-24;  PMID:21058107 ; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Am J Med 2002; 113:112-9;  PMID:12133749 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Mol Genet Metab 2011; 103:1- 11; PMID:21439876 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Lancet 2009; 374:1986-96; PMID:19959221 ;  http://dx.doi.org/10.1016/S0140-6736(09)61493-8 52.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Inherit Metab Dis 2013; 36:373-84; PMID:22127392 ; http://dx.doi.org/10.1007/ s10545-011-9410-9 53.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Med Genet  2006; 43:347-52;  PMID:16227523 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
J Med Genet 2009; 46:548-52; PMID:19473999 ;  http://dx.doi.org/10.1136/jmg.2008.065904 55.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Paediatr Drugs 2011; 13:33-47;  PMID:21162599 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Orphanet J Rare Dis 2011; 6:16;  PMID:21496291 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Available from: http://www.aamc.org/ research/irbreview/irbconf06rpt.pdf,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
N Engl J Med 2010; 363:1591- 3; PMID:20942660 ; http://dx.doi.org/10.1056/ NEJMp1005101 60.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Available from: http://www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/ SignificantAmendmentstotheFDCAct/FDASIA/ ucm341027.htm .,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Nat Rev Drug Discov 2012; 11:660- 1; PMID:22935791 ; http://dx.doi.org/10.1038/ nrd3843  63.,OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
Adv Exp Med Biol 2010;  686:211-22;  PMID:20824448 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/33/rdis-1-e26690.PMC3915565.pdf
"1  Subjects with CF display severe pulmonary and gastrointestinal dysfunctions and have a life expectancy of approximately 40 y.Since the cloning of the CFTR  gene 24  y ago, over 1900 mutations have been iden - tified 2 (http://www.genet.sickkids.on.ca).",Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
3 F508del is the most dominant  CFTR mutation (~67% of all mutant alleles worldwide) expressed by approxi - mately 90% of subjects with CF (http://www.genet.sickkids.on.ca/).,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
"In  addition, it is expected that other subject-specific factors impact the efficacy of the pharmacotherapy as observed for many Novel opportunities for CFTR-targeting drug development   using organoids Johanna F  Dekkers1,2, Cornelis K  van der Ent1, and Jeffrey M  Beekman1,2,* 1Department of Pediatric Pulmonology; University Medical Center Utrecht; Children’s Hospital; Utrecht, the Netherlands; 2Department of Immunology;  University Medical Center Utrecht; Children’s Hospital; Utrecht, the Netherlands Keywords:  cystic fibrosis, CFTR  function, intestinal organoids,  personalized medicine, correctors, potentiators, primary cell models *Correspondence to: Jeffrey M Beekman;   Email: j.beekman@umcutrecht.nl Submitted: 07/19/2013; Revised: 10/09/2013;   Accepted: 11/06/2013;  Published Online: 12/04/2013 http://dx.doi.org/10.4161/rdis.27112Citation: Dekkers JF, van der Ent CK,  Beekman JM.",Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Nat Med 2013; 19:939-45; PMID:23727931; http://dx.doi.org/10.1038/nm.3201,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
8-10 Results from a phase II clinical  trial with the corrector Lumacaftor (VX-809) and the potentiator Kalydeco (VX-770) indicated that absolute lung function significantly improved by 6.7% in sub - jects homozygous for CFTR-F508del (http://investors.vrtx.com/releasedetail.cfm?releaseid=687394).,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
N  Engl J Med 2005; 352:1992-2001; PMID:15888700 ;  http://dx.doi.org/10.1056/NEJMra043184 2.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Science 1989; 245:1066-73; PMID:2475911 ;  http://dx.doi.org/10.1126/science.2475911 3.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Respiration 2000; 67:117-33; PMID:10773783 ;  http://dx.doi.org/10.1159/000029497 4.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Trends Mol Med 2012; 18:81-91; PMID:22138491 ;  http://dx.doi.org/10.1016/j.molmed.2011.10.003 5.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Trends Mol Med  2001; 7:201-4;  PMID:11325631 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Proc Natl Acad Sci U S A 2009; 106:18825- 30; PMID:19846789 ; http://dx.doi.org/10.1073/ pnas.09047091067.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
N Engl J Med 2011; 365:1663-72;  PMID:22047557 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Thorax 2012; 67:12- 8; PMID:21825083 ; http://dx.doi.org/10.1136/ thoraxjnl-2011-200393 9.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
PLoS One 2011; 6:e24445; PMID:21909392 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Thorax 2010; 65:594-9; PMID :20627915 ;  http://dx.doi.org/10.1136/thx.2009.125088 13.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Methods Mol Biol  2011; 741:39-54;  PMID:21594777 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Nat Biotechnol 2012; 30:876-82;  PMID:22922672 ;  http://dx.doi.org/10.1038/nbt.2328 16.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Cell Stem Cell 2013; 13:149-59;  PMID:23910082 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Nat Med 2013; 19:939- 45; PMID:23727931 ; http://dx.doi.org/10.1038/ nm.3201 18.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Science 2013; 340:1190-4;  PMID:23744940 ; http://dx.doi.org/10.1126/ science.1234852 19.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Gastroenterology 2011; 141:1762-72;  PMID:21889923 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Am J Respir Crit Care Med  2007; 175:1036-43;  PMID:17332481 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Radiology 2009; 253:813- 21; PMID:19952026 ; http://dx.doi.org/10.1148/ radiol.2533090418 26.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
J Cyst Fibros 2011; 10:187- 92; PMID:21354377 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
Nat Chem Biol 2013; 9:444-54; PMID:23666117 ;  http://dx.doi.org/10.1038/nchembio.125328.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
J Cyst Fibros  2012; 11:237-45;  PMID:22293084 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
PLoS One  2013; 8:e57617;  PMID:23483918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
BMC Gastroenterol  2013; 13:91;  PMID:23688510 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/ba/rdis-1-e27112.PMC3915567.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.240 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):240-247PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Regurgitation and Gastroesophageal Reflux Disease in Six to Nine  Months Old Indonesian Infants Badriul Hegar, Debora Hindra I. Satari, Damayanti R. Sjarif and Yvan Vandenplas * Department of Child Health, Faculty of Medicine, Universi ty of Indonesia, Cipto Mangunkusumo Hospital, Jakarta,  Indonesia, *Universitair Kinderziekenhuis  Brussel, Vrije Universiteit  Brussel, Brussels, Belgium Purpose: Regurgitation is known to peak at the age of 3-4 mont hs, with a sharp decrease around the age of 6 months.",Non-OADS,/arxiv_data1/oa_pdf/a2/0b/pghn-16-240.PMC3915725.pdf
"Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Gastroesophageal reflux (GER) is a physiologic  phenomenon, and is defined as the involuntary movement of gastric content into esophagus and is a  common phenomenon in infants.",Non-OADS,/arxiv_data1/oa_pdf/a2/0b/pghn-16-240.PMC3915725.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.273 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):273-278PGHN Case Report  PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-  Sulfamethoxazole-induced Vanishing Bile Duct Syndrome Hyun Jeong Cho, Hye Jeong Jwa, Kyu Seon  Kim, Dae Yong Gang* and Jae Young Kim  Departments of Pediatrics and *Pathology, Chungnam Nati onal University School of Medicine, Daejeon, Korea We present a case of a 7-year-old boy who had choles tasis after trimethoprim-sulfamethoxazole combination  therapy.",Non-OADS,/arxiv_data1/oa_pdf/de/79/pghn-16-273.PMC3915726.pdf
"Tel: +82-42-280-7249, Fax: +82-42-255-3 158, E-mail: pedkim@cnuh.co.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Vanishing bile duct syndrome (VBDS) is a rare  cholestatic liver disease ch aracterized by progressive  disappearance of intrahepatic interlobular bile ducts  in the absence of underlying liver or biliary tract dis-ease [1,2].",Non-OADS,/arxiv_data1/oa_pdf/de/79/pghn-16-273.PMC3915726.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.225 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):225-232PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Abnormality on Liver Function Test  Ki-Soo Kang Department of Pediatrics, Jeju National University School of Medicine, Jeju, Korea Children with abnormal liver function can often be seen in outpatient clinics or inpatients wards.",Non-OADS,/arxiv_data1/oa_pdf/68/f3/pghn-16-225.PMC3915727.pdf
"Tel: +82-64-754-8146, Fax: +82-64-754-3114, E-mail: kskang @jejunu.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　We often see children with abnormal liver function  in pediatric outpatient clin ics [1].",Non-OADS,/arxiv_data1/oa_pdf/68/f3/pghn-16-225.PMC3915727.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.261 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):261-268PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Clinical Characteristics of Failure to Thrive in Infant and  Toddler: Organic vs. Nonorganic Suk Dong Yoo, Eun-Ha Hwang, Yeoun Joo Lee and Jae Hong Park Department of Pediatrics, Pusan National Univ ersity School of Medicine, Yangsan, Korea Purpose: To investigate the clinical characteristics and outcomes among infants and toddlers with failure to thrive  (FTT).Methods: This retrospective study was done with 123 patients who had visited Pusan National University Children’s Hospital during their first two years of life and had received an FTT diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/9e/80/pghn-16-261.PMC3915728.pdf
"Tel: +82-55-360-2180, Fax: +82-55-360-2 181, E-mail:  jhongpark@pusan.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Failure to thrive (FTT), a term that refers to infants  and toddlers whose weights or weight gaining rates  are strikingly lower than expected from children of the same ages, genders, and ethnicities, is used for  cases where there are no effects on the height and  head circumference or just slight influence is found  despite underweight.",Non-OADS,/arxiv_data1/oa_pdf/9e/80/pghn-16-261.PMC3915728.pdf
Available from: http://www.cdc.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/9e/80/pghn-16-261.PMC3915728.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.219 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):219-224PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Acute Abdominal Pain in Children  Joon Sung Kim Department of Pediatrics, Ulsan Univ ersity Hospital, University of Ulsa n College of Medicine, Ulsan, Korea Acute abdominal pain is a common complaint in childhood, an d it can be caused by a wide range of underlying surgical  and non-surgical conditions.",Non-OADS,/arxiv_data1/oa_pdf/ca/da/pghn-16-219.PMC3915729.pdf
"Tel: +82-52-250-7060, Fax: +82-52-250-8071, E-m ail: drkimjs@daum.net Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Acute abdominal pain is one of the most common  complaints in children, and it poses a diagnostic  challenge owing to the vari ety of underlying causes.",Non-OADS,/arxiv_data1/oa_pdf/ca/da/pghn-16-219.PMC3915729.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.254 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):254-260PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Subclinical Vitamin D Insufficiency in Korean School-aged  Children Sang Woo Han, Ha Ra Kang , Han Gyum Kim *, Joo Hyun Kim *, Ji Hyun Uhm and Ji Young Seo Department of Pediatrics, Eulji General Hospital, Seoul, *Department of Medicine, Eulji University, Daejeon, Korea Purpose: Recently, vitamin D insufficiency has increased and has been correlated to growth and puberty in children.",Non-OADS,/arxiv_data1/oa_pdf/58/8a/pghn-16-254.PMC3915730.pdf
"ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Vitamin D plays an important role in the growth  and development of infants.",Non-OADS,/arxiv_data1/oa_pdf/58/8a/pghn-16-254.PMC3915730.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.233 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):233-239PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Poisoning in Korean Children and Adolescents  Jae Hyug Woo and Eell Ryoo* Departments of Emergency Medicine and *Pediatrics, Gil Medical Center, Gachon University Graduate School of  Medicine, Incheon, Korea Drug intoxication in children and adolescents is not uncommon in Korea.",Non-OADS,/arxiv_data1/oa_pdf/a6/de/pghn-16-233.PMC3915731.pdf
"Tel: +8 2-32-460-8905, Fax: +82-32-460-3224, E-mail: ryoo518@gilhospita l.com Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Younger children are vuln erable to unintentional  poisoning, whereas adolescence is critical age for in- toxication by intentional dr ug ingestion.",Non-OADS,/arxiv_data1/oa_pdf/a6/de/pghn-16-233.PMC3915731.pdf
Available from: http://www.kostat.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/a6/de/pghn-16-233.PMC3915731.pdf
Available from: http://www.poisoninfo.co.kr/ main.do.,Non-OADS,/arxiv_data1/oa_pdf/a6/de/pghn-16-233.PMC3915731.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.269 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):269-272PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Association between Celiac Dise ase and Intussusceptions in  Children: Two Case Report s and Literature Review Shahsanam Gheibi Department of Pediatric Gastroenterology , Maternal and Childhood Obesity Resear ch Center, Urmia University of Medica l Sciences, Urmia, Iran Association between celiac disease and intussusception has been reported in adult.",Non-OADS,/arxiv_data1/oa_pdf/e2/33/pghn-16-269.PMC3915732.pdf
"Tel:  +98-441-2226969, Fax: +98-441-2234125, E-mail: drgheibi@umsu.ac .ir Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Intussusception is not a wi dely recognized compli- cation of celiac disease.",Non-OADS,/arxiv_data1/oa_pdf/e2/33/pghn-16-269.PMC3915732.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.248 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):248-253PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Experiences with Endoscopic Interventions for Variceal  Bleeding in Children with Portal Hypertension: A Single Center Study Seung Jin Kim, Seak Hee Oh, Jin Min Jo and Kyung Mo Kim Department of Pediatrics, Asan Medical Center Children’s Ho spital, University of Ulsan College of Medicine, Seoul, Kore a Purpose: The aim of this study was to compare the efficacy and safety of band ligation and injection sclerotherapy  in the endoscopic treatment of children with variceal bleeding.Methods: The study population included 55 children, all of whom were treated at the time of endoscopic diagnosis  of esophageal varices at Asan Medical Center, Seoul, Korea, between January 1994 and January 2011.",Non-OADS,/arxiv_data1/oa_pdf/36/26/pghn-16-248.PMC3915733.pdf
"Key Words:  Esophageal gastric varices, Gastrointestinal endoscopy, Ligation, Sclerotherapy, Hyertension, Portal, Child Received：September 10, 2013, Revised：October 4, 2013, Accepted： October 8, 2013 Corresponding author: Kyung Mo Kim, Department of Pediatrics, Asan Medical Center Chi ldren’s Hospital, University of Ulsan College of  Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Kore a. Tel: +82-2-3010-3380; Fax: +82-2-473-3725; E-mail: kmkim@amc .seoul.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Esophageal varices, an im portant complication of  portal hypertension, are a major cause of mortality in both adults and children [1-3].",Non-OADS,/arxiv_data1/oa_pdf/36/26/pghn-16-248.PMC3915733.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.4.207 Pediatr Gastroenterol Hepatol Nutr 2013 December 16(4):207-218PGHN Invited Review PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Long Term Outcomes after Pe diatric Liver Transplantation Nada A. Yazigi MedStar Georgetown Transplant Institute, George town University Hospit al, Washington DC, USA Long term outcomes after liver transplantation are major determinants of quality of life and of the value of this heroic  treatment.",Non-OADS,/arxiv_data1/oa_pdf/1a/30/pghn-16-207.PMC3915734.pdf
"edu Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Liver transplantation is now a well-established  treatment for end stage liver disorders in pediatrics.",Non-OADS,/arxiv_data1/oa_pdf/1a/30/pghn-16-207.PMC3915734.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001106 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/73/ec/S0950268813001106a.PMC3915753.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813001106.476 C. Hogea and others,Non-OADS,/arxiv_data1/oa_pdf/73/ec/S0950268813001106a.PMC3915753.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001027 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/13/e3/S0950268813001027a.PMC3915754.pdf
SUPPLEMENTARY MATERIAL For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0950268813001027.,Non-OADS,/arxiv_data1/oa_pdf/13/e3/S0950268813001027a.PMC3915754.pdf
STI episodes seen in GUM clinics: annual data tables 2011 (http://www.hpa.org.uk/stiannualtables).,OADS,/arxiv_data1/oa_pdf/13/e3/S0950268813001027a.PMC3915754.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813001441 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a2/69/S0950268813001441a.PMC3915756.pdf
"To view a copy of this license, visit http://creative-commons.org/licenses/by-nc-sa/3.0",Non-OADS,/arxiv_data1/oa_pdf/54/50/cr2013138a.PMC3915903.pdf
http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html.,OADS,/arxiv_data1/oa_pdf/cb/27/cr20143a.PMC3915904.pdf
RReeffeerreenncceess 1. http://www.abbott.com/news-media/press-releases/2011Jan10.htm  2.,Non-OADS,/arxiv_data1/oa_pdf/f6/5b/PWKI-9-20451.PMC3915950.pdf
20. http://www.abbott.com/news-media/press-releases/abbott- announces-international-launch-of-the-absorb-bioresorbable- vascular-scaffold.htm Łukasz Rzeszutko et al.,Non-OADS,/arxiv_data1/oa_pdf/f6/5b/PWKI-9-20451.PMC3915950.pdf
16. http://www.cardiaq.com/newsreleases.html  17.,Non-OADS,/arxiv_data1/oa_pdf/39/58/PWKI-9-20890.PMC3915967.pdf
Available online: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.,OADS,/arxiv_data1/oa_pdf/14/5a/PWKI-9-21412.PMC3915998.pdf
"To view a copy of this license,  visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/41/cf/mt2013222a.PMC3916037.pdf
TNM Classification was adopted by Union for International Cancer Control (2009) http://www.uicc.org/node/7735.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/mt2013257a.PMC3916047.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Molecular Therapy vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/20/mt2013257a.PMC3916047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 201–216Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  201OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5024 8A randomized, double-blind study of the efficacy   and tolerability of extended-release quetiapine   fumarate (quetiapine Xr) monotherapy   in patients with major depressive disorder gang Wang1 alexander Mcintyre2 Willie r earley3 shane r raines3 hans eriksson4 1Beijing anding hospital, capital  Medical University, Beijing, People’s  republic of china; 2Department  of Psychiatry, Penticton regional  hospital, Penticton, Bc , canada;   3astraZeneca Pharmaceuticals,   Wilmington, De, Usa; 4astraZeneca  r&D, södertälje, sweden correspondence: gang Wang   Beijing anding hospital, 5 ankang   hutong, Xicheng, Beijing 100088,   People’s republic of china   Tel +86 10 583 03189   Fax +86 10 583 03182   email gangwangdoc@gmail.co mObjectives:  To evaluate the efficacy and tolerability of once-daily extended release quetiapine  fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD).",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Available from: http://www.astrazeneca.ca/ documents/ ProductPortfolio/SEROQUEL%20XR_PM_en.pd f. Accessed  July 21, 2011.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
Available from: http://www1.astrazeneca-australia.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00351169.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2009/09/WC500003526.pd f.  Accessed November 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Available from: http://www.frx.com/pi/lexapro_pi.pd f. Accessed  November 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
"Available from: http://www.fda.gov/cder/ drug/antidepressants/default.ht m. Accessed May 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/ndt-10-201.PMC3916085.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/0c/ndt-10-193.PMC3916086.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 193–200Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  193OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5549 0Predictors of repeated sick leave in the   workplace because of mental disorders Mitsuhiro sado1 Joichiro shirahase1 Kimio Y oshimura2 Yuki Miura1 Kazuhiro Yamamoto1 hajime Tabuchi1 Motoichiro Kato1 Masaru Mimura1 1Department of Neuropsychiatry,   Keio University school of  Medicine, shinjuku-ku, T okyo, Japan;   2Department of health Policy and  Management, Keio University school  of Medicine, shinjuku-ku, T okyo, Japan correspondence: Mitsuhiro sado   Department of Neuropsychiatry,  Keio University school of Medicine,  shinanomachi 35, shinjuku-ku,   Tokyo 160-8582, Japan   Tel +81 3 3353 1211 ext 62454   Fax +81 3 5379 0187   email mitsusado@z5.keio.j pIntroduction:  Mental disorders create a considerable burden to society.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/ndt-10-193.PMC3916086.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/ndt-10-193.PMC3916086.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/0c/ndt-10-193.PMC3916086.pdf
"Rare Diseases 2013; 1:e24932; http://dx.doi.org/10.4161/rdis.24932Introduction Xeroderma Pigmentosum (XP), Trichothiodystrophy (TTD)  and Cockayne Syndrome (CS) are rare, recessive disorders caused by mutational defects in the Nucleotide Excision Repair (NER) pathway and/or disruption of basic cellular DNA transcription.",Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
J Am Acad Dermatol 2005; 52:224- 32; PMID:15692466; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Arch Dermatol  2003; 139:1189-92; PMID:12975162; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Am J Med Genet A  2011; 155A:1081-95; PMID:21480477; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Hum Mol Genet  2001; 10:2539-47; PMID:11709541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Hum Mutat  2008; 29:1194-208; PMID:18470933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Neuroscience 2007; 145:1388-96; PMID:17276014; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
J Med Genet 2008; 45:609-21;  PMID:18603627; http://dx.doi.org/10.1136/ jmg.2008.058743 8.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
"J  Am Acad Dermatol 2001; 44:891-920, quiz 921- 4; PMID:11369901; http://dx.doi.org/10.1067/ mjd.2001.114294 9.",Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Hum Mol Genet  2002; 11:2919-28; PMID:12393803; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Nat Genet 2001; 27:299-303; PMID:11242112;  http://dx.doi.org/10.1038/85864,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
DNA Repair  (Amst) 2002; 1:1027-38; PMID:12531012; http://dx.doi.org/10.1016/S1568-7864(02)00166-015.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Ophthalmology 2011; 118:2335- 42; PMID:21959366; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Am J Hum Genet 2007; 80:457-66;  PMID:17273966; http://dx.doi.org/10.1086/512486 17.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Nucleic Acids Res 2009; 37:e31;  PMID:19179371; http://dx.doi.org/10.1093/nar/ gkp02311.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Hum  Mutat 1997; 9:519-25; PMID:9195225; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Mol  Cell 1998; 1:981-90; PMID:9651581; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
J Exp Med 2009; 206:3031-46; PMID:19934020; http://dx.doi.org/10.1084/jem.20091892 14.,Non-OADS,/arxiv_data1/oa_pdf/86/72/rdis-1-e24932.PMC3916142.pdf
Available: http://www.ivz.si/.,Non-OADS,/arxiv_data1/oa_pdf/18/cb/AIM-21-4-257.PMC3916158.pdf
"2012, http://www.mayoclinic.com/health/atrio-ventricu - lar-canal-defect/DS00745 3.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/AIM-21-4-293.PMC3916159.pdf
"2012, http://dx.doi.org/10.1017/S1047951112001400.",Non-OADS,/arxiv_data1/oa_pdf/fd/b7/AIM-21-4-293.PMC3916159.pdf
"New Zealand Ministry of Health,  2010. http://www.health.govt.nz/nz- health-statistics/national-collections-and- surveys/collections/national-minimum-dataset-hospital-events , Accessed 23 July  2011.",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/AIM-21-4-261.PMC3916160.pdf
"1999 http://www.cdc.gov/ nchs/data/ice/ice95v3/99ch19.pdf, Ac - cessed 17 May 2012.",OADS,/arxiv_data1/oa_pdf/c4/bd/AIM-21-4-261.PMC3916160.pdf
"Pro - ceedings of Statistics Canada Sym - posium, 2001.  http://www5.statcan.",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/AIM-21-4-261.PMC3916160.pdf
"World Health Organi - zation, Regional Office for the Western Pa - cific, 2003. http://www.wpro.who.int/pub - lications/docs/Improving_Data_Quality.pdf Accessed 28 December 2012.",Non-OADS,/arxiv_data1/oa_pdf/c4/bd/AIM-21-4-261.PMC3916160.pdf
8. http://www.researcherid.com/Home.action?SID=Q1P1MGAm1DfkE9%407b4f&returnCode=ROUTER.Success&SrcApp=CR&Init=Yes.,Non-OADS,/arxiv_data1/oa_pdf/20/fc/AIM-21-4-234.PMC3916174.pdf
http://www.telecare.,Non-OADS,/arxiv_data1/oa_pdf/c7/b0/AIM-21-4-241.PMC3916175.pdf
[http://www.auditcommission.gov.uk/SiteCollectionDocuments/Au - ditCommissionReports/National - Studies/NationalReport_FINAL.pdf].,Non-OADS,/arxiv_data1/oa_pdf/c7/b0/AIM-21-4-241.PMC3916175.pdf
"[Accessed May 2009], Available online form: http://mitdocs.sbu.ac.ir/2-MIT/Dr.%20L.Nazarimanesh/Lec - ture%20 Notes/03-01.pdf.",Non-OADS,/arxiv_data1/oa_pdf/c7/b0/AIM-21-4-241.PMC3916175.pdf
"Part III, Sec 4. pp  3-4 available online at http://www.dciindia.",Non-OADS,/arxiv_data1/oa_pdf/5a/f5/AIM-21-4-288.PMC3916189.pdf
Journal of Indian Society of Pedodontics and Preventive Dentistry homepage available at  http://www.jisppd.com/aboutus.asp.,Non-OADS,/arxiv_data1/oa_pdf/5a/f5/AIM-21-4-288.PMC3916189.pdf
"At the same time, the European  Commission (EC) was launching a Public Consultation on Open Re - search Data in view of the new EU framework programme for research and innovation , Horizon 2020 (http://ec.europa.eu/research/horizon2020/index_en.cfm), that will be running from 2014 to implement the “Inno - vation Union” and secure Europe’s global competitiveness.",Non-OADS,/arxiv_data1/oa_pdf/79/73/AIM-21-4-291.PMC3916190.pdf
Available from: http://www.ease.org.uk/ease-events/triennial-confer - ence/editing-digital-world-tallinn/poster-abstracts/standardizing-citati 7.,Non-OADS,/arxiv_data1/oa_pdf/79/73/AIM-21-4-291.PMC3916190.pdf
"Chicago (USA), Septem - ber 8-10, 2013. http://www.peerreview - congress.org/2013/Poster-Session-Ab - stracts.pdf , p. 47",Non-OADS,/arxiv_data1/oa_pdf/79/73/AIM-21-4-291.PMC3916190.pdf
"OncoImmunology 2013; 2:e27254; http://dx.doi.org/10.4161/onci.27254The immune response in HPV+  oropharyngeal cancer emma V King1,2, Christian h  Ottensmeier1,3, Gareth J Thomas1,3,* 1Cancer s ciences u nit; u niversity of s outhampton; s outhampton, u K; 2Department of Otolaryngology; h ead and Neck s urgery; Poole N hs Foundation Trust; Poole, u K;  3NIhr  experimental Cancer Medicine Centre s outhampton; s outhampton, u K Keywords:  human papillomavirus, oropharyngeal cancer, prognosis, survival, tumor-infiltrating lymphocytes although human papillomavirus ( hPV)+ oropharyngeal cancers often present with metastasis, most patients have  excellent long-term survival.",Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
"Head and neck squamous  cell cancer and the human papillomavirus: summary  of a National Cancer Institute State of the Science  Meeting, November 9-10, 2008, Washington, D.C.  Head Neck 2009; 31:1393-422; PMID:19787782 ;  http://dx.doi.org/10.1002/hed.21269 2.",Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
N Engl J Med  2010; 363:24-35;  PMID:20530316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
Int J Cancer  2012; 131:E74-85;  PMID:22020783 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
Cancer Res 2012; 72:5004-13; PMID:22991304 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-3277 7.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
Immunol Lett 2002; 83:215-20; PMID:12095712 ; http://dx.doi.org/10.1016/ S0165-2478(02)00088-38.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
J Immunol 2009; 182:2124-30; PMID:19201865 ; http://dx.doi.org/10.4049/ jimmunol.0802271 9.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
Oncogene 2008; 27:1794-9; PMID:17828295 ;  http://dx.doi.org/10.1038/sj.onc.1210798 10.,Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
"Ashrafi GH, Haghshenas MR, Marchetti B, O’Brien  PM, Campo MS. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005; 113:276-83; PMID :15386416 ;  http://dx.doi.org/10.1002/ijc.20558",Non-OADS,/arxiv_data1/oa_pdf/e8/d2/onci-3-e27254.PMC3916354.pdf
"Communicative & Integrative Biology 2014; 7:e26466; http://dx.doi.org/10.4161/cib.26466 Addendum to: Kohda K, Kakegawa W, Matsuda S, Yamamoto T, Hirano H, Yuzaki M. The δ2 glutamate receptor gates long-term depres - sion by coordinating interactions between two AMPA receptor phosphorylation sites.",OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Nat Rev Neurosci 2002; 3:896-902;  http://dx.doi.org/10.1038/nrn962 ; PMID :12415297 2.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuron 2011; 70:43- 50; http://dx.doi.org/10.1016/j.neuron.2011.02.044 ;  PMID:21482355 3.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neural Netw  2013; 47:36-41; http://dx.doi.org/10.1016/j.neu - net.2012.07.001 ; PMID:22840919 4.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuron  2000; 25:649-62;  PMID:10774732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
EMBO J 2000; 19:2765-74; http://dx.doi.org/10.1093/emboj/19.12.2765 ; PMID:10856222 7.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Science 2003; 300:1751-5; http://dx.doi.org/10.1126/sci - ence.1082915 ; PMID:12805550 8.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neurosci Res 2003; 46:11-22; PMID:12725908 ;  http://dx.doi.org/10.1016/S0168-0102(03)00036-1 9.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuroscience 2001; 105:443-55;  PMID:11672610 ;  http://dx.doi.org/10.1016/S0306-4522(01)00193-211.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Cell  1995; 81:245-52;  PMID:7736576 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
J Neurosci 2008; 28:5920-30; http://dx.doi.org/10.1523/ JNEUROSCI.1030-08.2008 ; PMID:18524896 14.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Science 2010; 328:363-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Eur J Neurosci 2007;  25:1357-62; http://dx.doi.org/10.1111/j.1460- 9568.2007.05412.x ; PMID:17425562 16.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
J Neurosci  2008; 28:1460-8; http://dx.doi.org/10.1523/ JNEUROSCI.2553-07.2008 ; PMID:18256267 17.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
J Physiol 2007; 579:729-35; http://dx.doi.org/10.1113/jphysiol.2006.127100 ;  PMID:17255161 18.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
J Physiol 2007; 584:89-96; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuroscience 2009;  162:633-43; http://dx.doi.org/10.1016/j.neurosci - ence.2008.12.002 ; PMID:19124061 20.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuron 2008; 59:608-20; http://dx.doi.org/10.1016/j.neuron.2008.06.026 ;  PMID:18760697 21.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Eur J Neurosci 2007; 26:2269-78; http://dx.doi.org/10.1111/j.1460- 9568.2007.05829.x ; PMID:17953619 22.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Tyrosine phosphorylation of GluR2 is required  for insulin-stimulated AMPA receptor endocytosis  and LTD. EMBO J 2004; 23:1040-50; http://dx.doi.org/10.1038/sj.emboj.7600126 ; PMID:14976558 23.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
J Neurosci  2006; 26:2544-54; http://dx.doi.org/10.1523/ JNEUROSCI.4322-05.2006 ; PMID:16510732 24.,Non-OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
Neuron 2010; 66:768-80; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/46/cib-6-e26466.PMC3916355.pdf
"OncoImmunology 2013; 2:e27214; http://dx.doi.org/10.4161/onci.27214Acute myeloid leukemia therapeutics CARs in the driver’s seat armen Mardiros, Christine e Brown, L e lizabeth Budde, Xiuli w ang, and s tephen J Forman* Department of h ematology and h ematopoietic Cell Transplantation; City of h ope; Duarte, C a usa Keywords:  adoptive T cell therapy, AML, CD123, chimeric antigen receptor, immunotherapy, leukemia acute myeloid leukemia remains a difficult disease to cure and novel therapeutic approaches are needed.",Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Leukemia  2000; 14:1777-84;  PMID:11021753 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
J Immunother  2007 ; 30:607-13;  PMID:17667524 ; http://dx.doi.org/10.1097/ CJI.0b013e318053ed8e 4.,Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Cell Stem Cell  2009 ; 5:31-42; PMID:19570512 ;  http://dx.doi.org/10.1016/j.stem.2009.04.0185.,OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Blood   2013 ; 122:3138 -48; PMID:24030378 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Blood  2013 ; 121:1165 - 74; PMID:23243285 ; http://dx.doi.org/10.1182/ blood-2012-06-438002 7.,Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Clin  Cancer Res 2013 ; 19:3153 -64; PMID:23620405 ;  http://dx.doi.org/10.1158/1078-0432.CCR-13-03308.,Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
N Engl J Med  2013 ; 368:1509 -18; PMID:23527958 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
Blood   2013 ; 121:1077 -82; PMID:23243288 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e7/1a/onci-2-e27214.PMC3916356.pdf
"OncoImmunology 2013; 2:e27185; http://dx.doi.org/10.4161/onci.27185Combining NK cells and mAb9.2.27 to combat  NG2-dependent and anti-inflammatory signals   in glioblastoma Justyna Kmiecik1, andrea Gras Navarro1, aurelie Poli2, Jesús Planagumà,3 Jacques Zimmer2, and Martha Chekenya1,4,* 1university of Bergen; Institute for Biomedicine; Bergen, Norway; 2Laboratoire d’Immunogénétique- allergologie; C rP-santé, Luxembourg;   3Department of Neuroimmunology; h ospital Clinic (IDIB aPs); Barcelona, s pain; 4university of Bergen; Institute for Clinical Dentistry; Bergen, Norway Keywords:  CNS immunosurveillance, CSPG4, glioblastoma, NK cells, passive immunotherapy Glioblastoma is a deadly brain cancer with limited treatment options.",Non-OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009 ; http://dx.doi.org/10.1056/ NEJMoa043330 2.,OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
Neuro Oncol   2011 ; 13:830-45; PMID:21798846 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
Oncogene  2008 ; 27:5182 -94; PMID:18469852 ;  http://dx.doi.org/10.1038/onc.2008.157 5.,Non-OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
Acta Neuropathol  2011 ; 122:495- 510; PMID:21863242 ; http://dx.doi.org/10.1007/ s00401-011-0867-2 6.,Non-OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
J Neuroimmunol  2013 ; 264:71- 83; PMID:24045166 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
Oncoimmunology  2013 ; 2:e23401 ;  PMID:23802079 ; http://dx.doi.org/10.4161/ onci.23401 8.,Non-OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
Nat Med  2011 ; 17:64-70; PMID:21131957 ;  http://dx.doi.org/10.1038/nm.2266 10.,OADS,/arxiv_data1/oa_pdf/68/23/onci-3-e27185.PMC3916357.pdf
"14 A similarly distinct and  highly specialized host response to group A streptococci in the  Correspondence to: Steven M Opal; Email: steven_opal@brown.edu Submitted: 10/04/2013; Accepted: 10/14/2013http://dx.doi.org/10.4161/viru.26803The current understanding of sepsis   and research priorities for the future Steven M o pal infectious d isease d ivision; a lpert Medical School of Brown University; Pawtucket, ri US a Keywords:  sepsis, septic shock, innate immunity, bacterial toxins, endotoxin, host–pathogen interactions, clinical trials",Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
N Engl J Med 2013; 369:840-51;  PMID:23984731 ; http://dx.doi.org/10.1056/ NEJMra1208623 2.,OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:4-11; PMID:24335434;  http://dx.doi.org/10.4161/viru.27372 3.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:12- 9; PMID:24193307; http://dx.doi.org/10.4161/ viru.26982 4.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:20-6; PMID:24280933;  http://dx.doi.org/10.4161/viru.271355.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:27- 35; PMID:24184604; http://dx.doi.org/10.4161/ viru.26908 6.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Lancet  2013 ; 381:774- 5; PMID:23472921 ; http://dx.doi.org/10.1016/ S0140-6736(12)61815-7 7.,OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence   2014 ; 5:45-56; PMID: 24067565; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Lancet Infect Dis 2013 ; 13:260-8; PMID:23427891 ;  http://dx.doi.org/10.1016/S1473-3099(13)70001-X 10.,OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:57-65 ; PMID:24067507;  http://dx.doi.org/10.4161/viru.26514 11.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence   2014 ; 5:66-72 ; PMID:24185508; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence   2014 ; 5:73-9; PMID: 24067428; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:80-97 ;  PMID:24184742; http://dx.doi.org/10.4161/ viru.26913 14.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:98-126;   PMID:24104403; http://dx.doi.org/10.4161/ viru.26515 15.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence   2014 ; 5:127-38; PMID:24157731; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:137- 42; PMID:24253109; http://dx.doi.org/10.4161/ viru.27103 17.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence   2014 ; 5:143-53;  PMID:24022070 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Proc Natl Acad Sci U S A 2013 ; 110:3507 - 12; PMID:23401516 ; http://dx.doi.org/10.1073/ pnas.122287811019.,OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:170- 8; PMID:24185532; http://dx.doi.org/10.4161/ viru.26906 22.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:179-89;  PMID:24225404; http://dx.doi.org/10.4161/viru.27045 23.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:190- 9; PMID:24335487; http://dx.doi.org/10.4161/ viru.27409 24.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Crit Care Med 2013 ;  41:580-637; PMID:23353941 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014; 5:200- 5; PMID:23921249; http://dx.doi.org/10.4161/ viru.25855 26.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:206- 12; http://dx.doi.org/10.4161/viru.26210 27.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014 ; 5:213- 8; PMID:24193365; http://dx.doi.org/10.4161/ viru.27024 28.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
Virulence  2014; 5:219-24;  PMID:23974910;  http://dx.doi.org/10.4161/viru.25965 29.,Non-OADS,/arxiv_data1/oa_pdf/72/42/viru-5-1.PMC3916364.pdf
*Correspondence to: Irshad H Chaudry; Email: IChaudry@uabmc.edu Submitted: 07/30/2013; Revised: 10/25/2013; Accepted: 10/28/2013http://dx.doi.org/10.4161/viru.26982,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
JAMA 2013; 309:1154-62; PMID:23512062 ;  http://dx.doi.org/10.1001/jama.2013.2194 3.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Intensive Care Med  2013; 39:165-228;  PMID:23361625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Curr Top Med Chem 2008; 8:603-14; PMID:18473886 ;  http://dx.doi.org/10.2174/156802608783955601 5.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Curr Opin Pharmacol 2013; 13:576-81;  PMID :23731522 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Mini Rev Med Chem 2012; 12:1071-80;  PMID:22924485 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Autoimmun Rev  2012; 11:A377-85;  PMID:22100310 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Clin Dev Immunol 2012; 2012:610504;  PMID:22693524 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Autoimmunity  2012; 45:364-76;  PMID:22429183 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Clin Rev Allergy Immunol  2011; 40 :8-15;  PMID :19937157 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Autoimmun Rev 2007; 6:366- 72; PMID:17537382 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Domest Anim Endocrinol 1998; 15:345-52; PMID:9785038 ; http://dx.doi.org/10.1016/ S0739-7240(98)00028-9 14.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Nat Rev Endocrinol  2013; 9:56-62;  PMID:23183675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Immunol 2009 ; 183:7031 -8;  PMID:19890043 ; http://dx.doi.org/10.4049/ jimmunol.0802665 16.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Sci Signal 2010; 3:pe36;  PMID:20940425 ; http://dx.doi.org/10.1126/ scisignal.3143pe36 18.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
"Arch Surg 1999; 134:935-8, discussion 938-40;  PMID:10487586 ; http://dx.doi.org/10.1001/ archsurg.134.9.935 19.",Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Infect Dis  1975; 132:316-35;  PMID:1159333 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock  2004; 21:410-4;  PMID :15087816 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Crit  Care 2012; 16:R92; PMID:22617003 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Crit Care Med  2009; 37:1655-62;  PMID:19325487 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Arch Surg  1998; 133:1200-5;  PMID:9820351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Surg Infect (Larchmt) 2013; 14:62- 8; PMID:23461696 ; http://dx.doi.org/10.1089/ sur.2012.009 25.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Crit Care Med  1997; 25:106-10;  PMID:8989185 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Cytokine 2001; 14:162- 9; PMID:11396994 ; http://dx.doi.org/10.1006/ cyto.2001.0861 27.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Am Coll Surg 2002; 195:11-8; PMID:12113534 ; http://dx.doi.org/10.1016/ S1072-7515(02)01187-028.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Trauma 2000;  48:932-7;  PMID:10823539 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock  2007; 27:151-6 ;  PMID:17224789 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Interferon Cytokine Res 2006; 26:887- 92; PMID:17238831 ; http://dx.doi.org/10.1089/ jir.2006.26.887 31.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Crit Care 2013; 28:549-55;  PMID:23414982 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Cell  1995; 80:401-11;  PMID:7859282 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Neuroimmunomodulation  2011; 18:254-60;  PMID:21430397 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Surgery 2005; 138:85-92; PMID:16003321 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Ann Surg 2007; 245:297-304;  PMID:17245185 ; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Am J Physiol Heart Circ Physiol 2006;  290:H416-23;  PMID :16155096 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock 2001 ; 16:340 -3; PMID:11699070 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock 2000;  14:81-90;  PMID:10947147 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Orthop Trauma  2011; 25:511-5;  PMID:21738064 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
PLoS One 2012; 7:e51457;  PMID:23251540 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Blood 2011; 118:5918- 27; PMID:21911834 ; http://dx.doi.org/10.1182/ blood-2011-03-340281 44.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Biol Reprod 2008; 78:432- 7; PMID:18003947 ; http://dx.doi.org/10.1095/ biolreprod.107.063545 45.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Mol Cell Cardiol 2006; 40:205-12;  PMID:16427650 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Ann Surg 1998; 227:790-9;  PMID:9637542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock 2003; 20:144- 8; PMID:12865658 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Leukoc Biol 2008; 83:499-506; PMID:17895398 ;  http://dx.doi.org/10.1189/jlb.0607360 54.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock 2009; 31:227-37; PMID:18665049 ; http://dx.doi.org/10.1097/ SHK.0b013e31818347e7 55.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Mol Cell Cardiol 2009; 47:264- 74; PMID:19450605 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Arch Surg 1997; 132:1207-14; PMID:9366714 ; http://dx.doi.org/10.1001/ archsurg.1997.01430350057010 60.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Shock  1997; 8:242-8;  PMID:9329124 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Eur J Pharmacol 2012; 688:62- 7; PMID:22609231 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Arch Surg 1998; 133:1281-8; PMID:9865644 ;  http://dx.doi.org/10.1001/archsurg.133.12.1281 63.,OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Cytokine 1998; 11:443-50; http://dx.doi.org/10.1006/ cyto.1998.0458 64.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Crit Care Med 2005; 33:1779- 86; PMID:16096456 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Am J Physiol Gastrointest Liver Physiol 2006; 291:G260-6;  PMID:16574990 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
J Appl Physiol (1985) 2007; 102:933-41; PMID:17110508 ; http://dx.doi.org/10.1152/ japplphysiol.00919.2006 72.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Gut 2009; 58:929- 39; PMID:19136511 ; http://dx.doi.org/10.1136/ gut.2008.168534 75.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Am J Respir Crit Care Med 2010; 182:1047-57; PMID:20558630 ; http://dx.doi.org/10.1164/ rccm.201001-0010OC 77.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Nat Med  2009; 15:42-9;  PMID:19098906 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Surgery  2007 ; 142:215-21; PMID:17689688 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
Crit Care Med 2009; 37(Suppl):S30-7;  PMID:19104223 ; http://dx.doi.org/10.1097/ CCM.0b013e3181922bd3,Non-OADS,/arxiv_data1/oa_pdf/73/10/viru-5-12.PMC3916365.pdf
"9,10 M1T1 clones can be distinguished from related sero - type M1 isolates by the presence of the phage-encoded virulence *Correspondence to: Shiranee Sriskandan;  Email: s.sriskandan@imperial.ac.ukSubmitted: 07/25/2013; Revised: 09/06/2013; Accepted: 09/06/2013http://dx.doi.org/10.4161/viru.26400The contribution of group A streptococcal  virulence determinants to the pathogenesis   of sepsis Mark  Reglinski and Shiranee  Sriskandan* Department of i nfectious Disease and i mmunity; i mperial College London; London, UK Keywords:  group A streptococcus, sepsis, toxic shock syndrome, superantigen, STSS Abbreviations: GAS, group A streptococcus; TSST-1, toxic shock syndrome toxin 1; STSS, streptococcal toxic shock syndrome;  TLR, toll like receptor; SAg, superantigen; ABD, antigen binding domain; TCR, T-cell receptor; DIC, disseminated intravascular  coagulation; TF, tissue factor Streptococcus pyogenes  (group A streptococcus, GAS) is  responsible for a wide range of pathologies ranging from mild  pharyngitis and impetigo to severe invasive soft tissue infec - tions.",Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Intensive Care Med  2003; 29:530-8;  PMID:12664219 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Intensive Care Med  2013; 39:165-228;  PMID:23361625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
JAMA 1993; 269:390-1;  PMID:8418347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Clin  Microbiol 2008; 46:2359-67; PMID:18463210 ;  http://dx.doi.org/10.1128/JCM.00422-087.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Clin  Microbiol 2009; 47:1155-65; PMID :19158266 ;  http://dx.doi.org/10.1128/JCM.02155-08 9.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nat Rev Microbiol 2011; 9:724-36; PMID:21921933 ;  http://dx.doi.org/10.1038/nrmicro2648 11.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
PLoS Pathog 2006; 2:e5;  PMID:16446783 ; http://dx.doi.org/10.1371/ journal.ppat.0020005 12.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Infect Dis  2005; 192:771-82;  PMID:16088826 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Eur J Clin Microbiol Infect Dis  2012; 31:859-65;  PMID:21877175 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
FEMS Immunol Med Microbiol  2008; 54:236-44;  PMID:18754783 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Proc Natl Acad Sci U S A 2002;  99:13855-60;  PMID:12370433 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Infect Immun 2009; 77:3141- 9; PMID:19451242 ; http://dx.doi.org/10.1128/ IAI.01560-08 18.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
"J Infect Dis 2009; 200:555-63;  PMID :19591574 ; http://dx.doi.org/10.1086/603541importance of conducting such experiments in study groups con - trolled carefully for gender.113 Whether such sexual dimorphism  influences the incidence and outcome of STSS is unclear from  existing human epidemiological studies, and may be offset by the generally enhanced male predisposition to acquisition of bacte - rial infection.",Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Mol Microbiol  2010; 76:1387-97;  PMID:20158613 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Mol Microbiol  1998; 30:209-19;  PMID:9786197 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Proc Natl Acad Sci U S A  2010; 107:888-93;  PMID:20080771 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Exp Med 1996; 184:665- 73; PMID:8760820 ; http://dx.doi.org/10.1084/ jem.184.2.665 24.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Proc Natl Acad Sci U S A 1993; 90:7676- 80; PMID:7689226 ; http://dx.doi.org/10.1073/ pnas.90.16.7676 25.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Innate Immun  2010; 2:596-606;  PMID:20814186 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
PLoS Pathog 2010; 6:e1000832;  PMID:20368967 ; http://dx.doi.org/10.1371/jour - nal.ppat.1000832 27.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Semin Immunopathol  2012; 34:31-41;  PMID:21858560 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Curr Top Microbiol Immunol 2013;  368:189-205;  PMID:23224709 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Top Companion Anim Med 2012; 27:40-5;  PMID:23031454 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Microbiology 2007; 153:2458- 64; PMID:17660410 ; http://dx.doi.org/10.1099/ mic.0.2006/003285-0 31.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Clin Invest 1998; 102:550-60;  PMID:9691092 ; http://dx.doi.org/10.1172/JCI3065 32.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Intensive Care Med 1997; 23:379-85;  PMID:9142575 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Blood  2002; 100:4470-7;  PMID:12393652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Science 2002; 297:1176-9;  PMID:12183630 ; http://dx.doi.org/10.1126/ science.107355 36.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Blood 2006; 107:3537-45;  PMID:16449527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Mol Microbiol  2007; 65:1147-57;  PMID:17662041 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nature 2011; 472:64-8; PMID:21475196 ;  http://dx.doi.org/10.1038/nature09967 39.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Cell 2004; 116:367-79; PMID:15016372 ; http://dx.doi.org/10.1016/ S0092-8674(04)00057-1 40.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Crit Care Med 1997;  25:1820-6;  PMID:9366764 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Blood Coagul Fibrinolysis 2007; 18:179-86; PMID:17287636 ; http://dx.doi.org/10.1097/ MBC.0b013e328040bf9a 44.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Infect Immun 2003; 71:1903-10; PMID:12654807 ; http://dx.doi.org/10.1128/ IAI.71.4.1903-1910.2003 45.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Cell Microbiol  2012; 14:107-19;  PMID:21951918 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Blood Coagul Fibrinolysis 2011; 22:451- 6; PMID:21597365 ; http://dx.doi.org/10.1097/ MBC.0b013e328346ef3f47.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Pharmacol Rev 2005; 57:27-77; PMID:15734727 ; http://dx.doi.org/10.1124/ pr.57.1.2 48.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Innate Immun 2009; 1:18-28;  PMID:20375563 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Crit Care Med 2000;  28:3684-91;  PMID:11098974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Invest Dermatol  2010; 130:1365-72;  PMID:20107486 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Exp  Immunol 2003; 133:299-306; PMID:12930353 ;  http://dx.doi.org/10.1046/j.1365-2249.2003.02203.x 55.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
N Engl J Med 1996; 334:240- 5; PMID:8532002 ; http://dx.doi.org/10.1056/ NEJM199601253340407 57.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Infect Dis  2009; 49:1369-76;  PMID:19788359 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
PLoS Biol  2011; 9:e1001149;  PMID :21931534 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Immunol Rev 2008;  225:226-43;  PMID:18837785 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Immunity 2001; 14:93-104;  PMID:11163233 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Biol Chem 2006; 281:25356-64;  PMID:16829512 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Protein Sci 2004; 13:2285-90;  PMID :15295110 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nat Struct Biol 1997; 4:635- 43; PMID:9253413 ; http://dx.doi.org/10.1038/ nsb0897-635 64.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Infect Immun 2003; 71:1548-50; PMID:12595474 ; http://dx.doi.org/10.1128/ IAI.71.3.1548-1550.2003 65.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Biol Chem 2003; 278:9885-95;  PMID:12473669 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Microbiol Rev 2000; 13:470-511; PMID:10885988 ; http://dx.doi.org/10.1128/ CMR.13.3.470-511.2000 67.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Early expression of cytokines in lymph  nodes after treatment in vivo with Staphylococcus  enterotoxin B. J Immunol Methods 1994;  175:47-58;  PMID:7930639 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Med Microbiol 2008; 57:1238-46; PMID:18809552 ;  http://dx.doi.org/10.1099/jmm.0.2008/001156-0 70.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Exp Med  1970; 131:611-22;  PMID:4905084 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Blood 2005; 105:3655- 62; PMID:15644417 ; http://dx.doi.org/10.1182/ blood-2004-07-2523 72.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Crit Care Med 2008; 36:1267-76; PMID:18379254 ; http://dx.doi.org/10.1097/ CCM.0b013e31816a0a78 73.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Semin  Immunopathol 2008; 30:29-40;  PMID:18071706 ;  http://dx.doi.org/10.1007/s00281-007-0101-4 74.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nat Rev Immunol 2004; 4:499-511; PMID :15229469 ;  http://dx.doi.org/10.1038/nri139175.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Shock  2004; 22:403-9;  PMID:15489631 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Exp Immunol 2004;  136:312-9;  PMID:15086396 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
FEBS J 2011;  278:4649-67;   PMID :21535475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Biochemistry 2008; 47:12995-3003;  PMID:19012411 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Infect Immun 2005;  73:2164-74;  PMID :15784559 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Mol Microbiol 1999; 33:778-90; PMID:10447887 ;  http://dx.doi.org/10.1046/j.1365-2958.1999.01525.x 84.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Infect Immun 2002; 70:2805- 11; PMID:12010966 ; http://dx.doi.org/10.1128/ IAI.70.6.2805-2811.2002 85.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Infect Dis 1996; 173:1399- 407; PMID:8648212 ; http://dx.doi.org/10.1093/ infdis/173.6.1399 87.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Infect Dis 2001; 184:166-73;  PMID:11424013 ; http://dx.doi.org/10.1086/32201888.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Pyrogenicity and  cytokine-inducing properties of Streptococcus pyo - genes superantigens: comparative study of strepto - coccal mitogenic exotoxin Z and pyrogenic exotoxin  A. Infect Immun 2001; 69:4141-5; PMID:11349089 ;  http://dx.doi.org/10.1128/IAI.69.6.4141-4145.2001 89.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Infect Dis 2010; 202:20-8;  PMID:20497047 ; http://dx.doi.org/10.1086/653082 90.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Exp Med 2000;  191:1765-76;  PMID:10811869 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Exp Immunol 1994; 98:140-4;  PMID:7923873 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Infect Dis 2001; 184:853-60;  PMID:11509997 ; http://dx.doi.org/10.1086/323443 96.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Infect Dis 1998; 26:1448-58; PMID:9636878 ;  http://dx.doi.org/10.1086/516376 99.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
N Engl J Med 1980; 303:1429-35;  PMID:7432401 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Cell Host Microbe 2008; 4:170- 8; PMID:18692776 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Antimicrob Chemother 2006; 58:117-24;  PMID:16670109 ; http://dx.doi.org/10.1093/jac/ dkl173106.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Eur J Immunol  2002; 32:2570-7;  PMID:12207341 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nat Med 2002; 8:1398- 404; PMID:12436116 ; http://dx.doi.org/10.1038/ nm1202-800 108.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Clin Infect Dis 2005; 41(Suppl  7):S445-8;  PMID:16237645 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nature 1994; 368:711-8; PMID :8152483 ;  http://dx.doi.org/10.1038/368711a0111.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Nat Struct Biol 1999; 6:123-9; PMID:10048922 ; http://dx.doi.org/10.1038/5809 112.,OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
J Immunol 2011; 186:3156-63;  PMID:21282506 ; http://dx.doi.org/10.4049/ jimmunol.1002057 113.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Am J Respir Crit Care Med 2007; 176:473-82; PMID:17575097 ;  http://dx.doi.org/10.1164/rccm.200611-1712OC 114.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
Emerg Infect Dis  2009; 15:1304-7;  PMID:19751599 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/d5/viru-5-127.PMC3916366.pdf
"19 It was recently shown that endothelial cells are  the center of innate immune cell recruitment and early cytokine *Correspondence to: Diana F Florescu; Email: dflorescu@unmc.edu Submitted: 08/08/2013; Revised: 11/05/2013; Accepted: 11/06/2013http://dx.doi.org/10.4161/viru.27103The complex link between influenza   and severe sepsis Diana F Florescu* and Andre C Kalil infectious Diseases Division; i nternal Medicine Department; University of Nebraska Medical Center; Omaha, N e USA Keywords:  infection, influenza, sepsis, viral, severe sepsis Severe sepsis is traditionally associated with bacterial  diseases.",Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Infect Disord Drug Targets 2011;  11:354-64;  PMID:21679146 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
N Engl J Med 2003 ; 348:138- 50; PMID:12519925 ; http://dx.doi.org/10.1056/ NEJMra021333 3.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Front Biosci   2004 ; 9:1201 -17; PMID:14977537 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Virus Res  2011 ; 162:12-8; PMID:22027189 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Cell 2011 ; 146:980-91;  PMID:21925319 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Antiviral Res  2012 ; 93:2- 15; PMID:22068147 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis 2010 ; 202:991-1001 ;  PMID:20731583 ; http://dx.doi.org/10.1086/6560449.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Antiviral Res  2013 ; 99:113- 8; PMID:23685311 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Arch Med Res 2009 ; 40:655- 61; PMID:20304252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet  2007 ; 370:1106 - 8; PMID:17905148 ; http://dx.doi.org/10.1016/ S0140-6736(07)61490-1 13.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Emerg  Infect Dis 2007 ; 13:708-12; PMID:17553248 ;  http://dx.doi.org/10.3201/eid1305.060572 14.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Infect Dis 2006 ; 43:132-40; PMID:16779738 ;  http://dx.doi.org/10.1086/505122 15.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Nature  2006 ;  440:435-6; PMID:16554799 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Curr Opin Immunol 2011 ; 23:481- 6; PMID:21840185 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Nature  2006 ;  444:378-82; PMID:17108965 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Virol 2010 ; 84:7569 - 80; PMID:20504924 ; http://dx.doi.org/10.1128/ JVI.00291-10 20.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Am J Respir Cell Mol Biol 2011 ; 45:1036 - 44; PMID :21562316 ; http://dx.doi.org/10.1165/ rcmb.2010-0349OC 21.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Gen Virol 2004 ; 85:2347 -56;  PMID :15269376 ; http://dx.doi.org/10.1099/ vir.0.79958-0 24.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Biochem  Pharmacol  2009 ; 78:539-52; PMID:19413999 ;  http://dx.doi.org/10.1016/j.bcp.2009.04.029 25.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Cell 2008 ; 133:235- 49; PMID:18423196 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Eur  J Pharmacol  2006 ; 533:240-52; PMID:16464450 ;  http://dx.doi.org/10.1016/j.ejphar.2005.12.057 27.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet  2002 ; 360:1831 -7; PMID:12480361 ;  http://dx.doi.org/10.1016/S0140-6736(02)11772-7 28.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis 2013 ;  207:1576 -84; PMID:23420903 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Nat Cell Biol  2006 ; 8:1223 -34; PMID:17060906 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Cell Sci 2008 ; 121:2115 - 22; PMID:18565824 ; http://dx.doi.org/10.1242/ jcs.017897 31.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Nat Cell Biol  2009 ; 11:1325 -31; PMID:19855388 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Sci Transl Med 2010 ; 2:23ra19 ; PMID:20375003 ;  http://dx.doi.org/10.1126/scitranslmed.3000678 34.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Leukoc Biol  2012 ; 92:11-20; PMID:22442495 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect 2011 ; 63:308- 16; PMID:21781987 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Gen Virol 2011 ; 92:1428 -34;  PMID:21367984 ; http://dx.doi.org/10.1099/ vir.0.030346-0 37.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Mucosal Immunol  2010 ; 3:29-39; PMID:19865078 ;  http://dx.doi.org/10.1038/mi.2009.120 39.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Nature  2013 ;  497:498-502; PMID:23636320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Virol J 2012 ; 9:270; PMID :23151015 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Immunol  2006 ; 119:188- 94; PMID:16517210 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Med Virol 2012 ; 84:1353 -9; PMID:22825813 ;  http://dx.doi.org/10.1002/jmv.23271 43.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Eur J Biochem  1998 ; 258:37-43; PMID:9851689 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis  2012 ; 205:458-65; PMID :22158564 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet Infect Dis  2006 ; 6:303-12; PMID :16631551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Infect Dis 2010 ; 50:175-83; PMID:20014948 ;  http://dx.doi.org/10.1086/649208 52.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
BMC Infect Dis 2006 ; 6:58; PMID:16549029 ;  http://dx.doi.org/10.1186/1471-2334-6-58 53.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet  1958 ; 2:1141- 3; PMID:13612141 ; http://dx.doi.org/10.1016/ S0140-6736(58)92404-8 54.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis  2002 ; 186:341-50; PMID:12134230 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Microb Pathog   1999 ; 26:111-9; PMID:10090858 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Crit Care Med 2013 ; 41:224- 36; PMID:23222256 ; http://dx.doi.org/10.1097/ CCM.0b013e318267633c 65.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Int J Med Microbiol 2011 ; 301:97- 104; PMID:20940105 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Infect Dis 2012 ; 54:1221 - 9; PMID:22437239 ; http://dx.doi.org/10.1093/cid/ cis197 67.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Immunity  2012 ; 37:158-70;  PMID:22705104 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
JAMA  2003 ; 289:179- 86; PMID:12517228 ; http://dx.doi.org/10.1001/ jama.289.2.179 69.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet Infect Dis 2012 ; 12:687- 95; PMID:22738893 ; http://dx.doi.org/10.1016/ S1473-3099(12)70121-4 71.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis 1998 ; 178:53-60;  PMID:9652423 ; http://dx.doi.org/10.1086/51561674.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Infect Dis Clin North Am 2004 ;  18:141-55; PMID :15081510 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis  2007 ; 195:1018 -28; PMID:17330793 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Rev Med Virol 2000 ; 10:119- 33; PMID:10713598 ; http://dx.doi.org/10.1002/ (SICI)1099-1654(200003/04)10:2<119::AID-RMV272>3.0.CO;2-O 78.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
JAMA  2009 ; 302:1880 - 7; PMID:19822626 ; http://dx.doi.org/10.1001/ jama.2009.1536 79.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
N Engl J Med  2009 ; 361:1935 -44; PMID:19815859 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
JAMA  2009 ;  302:1896 -902; PMID:19887665 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis 2011 ; 203:1739 -47;  PMID:21606532 ; http://dx.doi.org/10.1093/infdis/ jir187 83.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Intensive Care Med  2010 ; 36:1015 - 22; PMID:20237757 ; http://dx.doi.org/10.1007/ s00134-010-1853-184.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
J Infect Dis  2010 ; 202:681-9; PMID:20670171 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet  2009 ; 374:605- 7; PMID:19700000 ; http://dx.doi.org/10.1016/ S0140-6736(09)61512-9 86.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Int J Obes (Lond) 2013 ;  37:333-40; PMID:22546772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Enferm Infecc  Microbiol Clin  2012 ; 30:608-12; PMID:22459686 ;  http://dx.doi.org/10.1016/j.eimc.2012.02.007 89.,OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Pediatr  Crit Care Med 2012 ; 13:e140 -4; PMID:21760562 ;  http://dx.doi.org/10.1097/PCC.0b013e318228845f 90.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Infect Dis 2007 ; 45:1568 -75;  PMID:18190317 ; http://dx.doi.org/10.1086/523584 91.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
PLoS One  2011 ; 6:e26050 ; PMID:22022504 ;  http://dx.doi.org/10.1371/journal.pone.0026050 93.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Clin Infect Dis  2011 ; 53:326-33; PMID:21810744 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Am J Respir Crit Care Med  2011 ; 183:1200 -6; PMID:21471082 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
Lancet Infect Dis 2012 ; 12:364- 5; PMID:22541628 ; http://dx.doi.org/10.1016/ S1473-3099(12)70079-8,Non-OADS,/arxiv_data1/oa_pdf/64/38/viru-5-137.PMC3916367.pdf
"2 Since then, approximately 60 phase  2 (P2) or phase 3 (P3) randomized controlled clinical trials of  Correspondence to: Mitchell P Fink; Email: finkmp@gmail.com Submitted: 06/25/2013; Revised: 08/06/2013; Accepted: 08/07/2013http://dx.doi.org/10.4161/viru.26083Sepsis remains a common, serious, and heterogeneous  clinical entity that is difficult to define adequately.",Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Surg Res 1990; 49:186-96;  PMID:2199735; http://dx.doi.org/10.1016/0022- 4804(90)90260-9 2.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med  1982; 307:1225-30; PMID:6752708; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 1992; 326:1153- 7; PMID:1552919; http://dx.doi.org/10.1056/NEJM199204233261711 4.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA  1993; 269:2221-7; PMID:8474201; http://dx.doi.org/10.1001/jama.1993.03500170051033 5.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Ann Intern Med 1994; 121:1-5;  PMID:8198341; http://dx.doi.org/10.7326/0003- 4819-121-1-199407010-00001 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA  1994; 271:1836-43; PMID:8196140; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2004; 32:332-41; PMID:14758145; http://dx.doi.org/10.1097/01.CCM.0000108867.87890.6D 12.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2013; 41:706- 16; PMID:23425819; http://dx.doi.org/10.1097/ CCM.0b013e318274155113.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Agennix AG halts phase II/III oasis trial in severe sepsis [Internet] 2012 [cited 2012 Feb 2] Available from:http://agennix.com/index.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 2001; 344:699- 709; PMID:11236773; http://dx.doi.org/10.1056/NEJM200103083441001 15.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med  2005; 353:1332-41; PMID:16192478; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Lancet 2007; 369:836-43;  PMID:17350452; http://dx.doi.org/10.1016/S0140- 6736(07)60411-5 17.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 2012; 366:2055-64; PMID:22616830;  http://dx.doi.org/10.1056/NEJMoa1202290 18.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 2002; 288:862- 71; PMID:12186604; http://dx.doi.org/10.1001/jama.288.7.862,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Antimicrob Agents Chemother 1995; 39:1336- 40; PMID:7574526; http://dx.doi.org/10.1128/ AAC.39.6.1336 53.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Am J Physiol Lung Cell Mol Physiol 2005; 288:L633-40; PMID:15579629; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock  2003; 19:61-5; PMID:12558146; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock 2006; 26:41- 9; PMID:16783197; http://dx.doi.org/10.1097/01.shk.0000209562.00070.1a 56.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2001; 29:1303-10; PMID:11445675; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Kidney Int 2003; 64:1620-31; PMID:14531793;  http://dx.doi.org/10.1046/j.1523-1755.2003.00268.x 58.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Leukoc Biol 2009; 86:219-27; PMID:19369639;  http://dx.doi.org/10.1189/jlb.1008615 59.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Infect Dis  1998; 177:668-76; PMID:9498446; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 2003; 290:238-47; PMID:12851279;  http://dx.doi.org/10.1001/jama.290.2.238 61.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2001; 29:2081-9; PMID:11700399; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
"Surgery 1995; 118:406-10, discussion  410-1; PMID:7638758; http://dx.doi.org/10.1016/ S0039-6060(05)80352-6 41.",Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 1993; 328:1457-60; PMID:8479465; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Infect Dis 2010; 201:223-32;  PMID:20001600; http://dx.doi.org/10.1086/649557 44.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Leukoc Biol 2009; 86:229-35; PMID:19395472;  http://dx.doi.org/10.1189/jlb.1208742 45.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Nat Med 2013; 19:379;  PMID:23558605; http://dx.doi.org/10.1038/nm.3163 47.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Proc Natl Acad Sci U S A  2002; 99:12351-6; PMID:12209006; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Am J Respir Crit Care Med  2001; 164:891-5; PMID:11549551; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med  2008; 358:111-24; PMID:18184957; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med  1996; 334:1697-702; PMID:8637514; http://dx.doi.org/10.1056/NEJM199606273342603 21.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2004; 32:21-30;  PMID:14707556; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Kidney Int 2008; 74:991-3; PMID:18827799;  http://dx.doi.org/10.1038/ki.2008.442 25.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock 2005; 24(Suppl 1):19-23;  PMID:16374368; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock 1998;  9:1-11; PMID:9466467; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J  Clin Invest 2009; 119:2868-78; PMID:19805915;  http://dx.doi.org/10.1172/JCI39421 28.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2009; 37(Suppl):S30-7;  PMID:19104223; http://dx.doi.org/10.1097/CCM.0b013e3181922bd3 29.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
"Crit Care Clin 2009; 25:703-19,  vii-viii; PMID:19892248; http://dx.doi.org/10.1016/j.ccc.2009.08.005 30.",OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Invest Surg 2001; 14:195- 212; PMID:11680530; http://dx.doi.org/10.1080/089419301750420232 31. van der Poll T. Preclinical sepsis models.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit  Rev Immunol 2011; 31:379-446; PMID:22142165; http://dx.doi.org/10.1615/CritRevImmunol.v31.i5.20 33.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Adv Exp Med Biol  2010; 667:59-68; PMID:20665200; http://dx.doi.org/10.1007/978-1-4419-1603-7_6 34.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care  Med 1993; 21:318-27; PMID:8440099; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  1998; 26:1963-71; PMID:9875905; http://dx.doi.org/10.1097/00003246-199812000-00021 85.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2000;  28:638-42; PMID:10752807; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock 1996; 5:313-9; PMID:9156785; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Shock  2000; 14:421-8; PMID:11049104; http://dx.doi.org/10.1097/00024382-200014040-00001 89.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2010; 38:1685-94; PMID:20562702;  http://dx.doi.org/10.1097/CCM.0b013e3181e7c5c9 90.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2010; 38:72- 83; PMID:19661804; http://dx.doi.org/10.1097/ CCM.0b013e3181b07b78 91.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 2013; 309:1154-62; PMID:23512062;  http://dx.doi.org/10.1001/jama.2013.219473.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA  1997; 277:1531-8; PMID:9153367; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2001; 29:503-10; PMID:11373411; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 1995; 273:934- 41; PMID:7884952; http://dx.doi.org/10.1001/ jama.1995.03520360048038 76.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 1996; 24:1431-40; PMID:8797612;  http://dx.doi.org/10.1097/00003246-199609000- 00002 77.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2006; 34:2271-81; PMID:16810105; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 1996; 24:733-42; PMID:8706447; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2001; 29:765-9; PMID:11373466;  http://dx.doi.org/10.1097/00003246-200104000- 00015 81.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  1995; 23:1461-9; PMID:7664546; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Am J Respir Crit Care Med 2011; 183:1561- 8; PMID:21297074; http://dx.doi.org/10.1164/ rccm.201007-1167OC 63.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Clin Sci (Lond) 2000; 98:193-200; PMID:10657275;  http://dx.doi.org/10.1042/CS19990143 65.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Ann  Surg 1981; 194:51-6; PMID:7018430; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2001; 29:13-7; PMID:11176151; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 1991; 324:429- 36; PMID:1988827; http://dx.doi.org/10.1056/ NEJM199102143240701 68.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 1991; 266:1097- 102; PMID:1865542; http://dx.doi.org/10.1001/jama.1991.03470080067031 69.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  1995; 23:994-1006; PMID:7774238; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA  2000; 283:1723-30; PMID:10755499; http://dx.doi.org/10.1001/jama.283.13.1723 71.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med  2003; 31:419-27; PMID:12576946; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Lancet 2000; 356:961-7; PMID:11041396; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2004; 32:1- 12; PMID:14707554; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Exp Med 1991; 173:1029- 32; PMID:1826127; http://dx.doi.org/10.1084/ jem.173.4.1029 115.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
J Clin Invest  1992; 89:1551-7; PMID:1533231; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Br J Pharmacol 1990; 99:499-502; PMID:2110016; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Br J Pharmacol 1996;  118:1223-31; PMID:8818347; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Br J Pharmacol 2009; 157:1250-62; PMID:19563534;  http://dx.doi.org/10.1111/j.1476-5381.2009.00297.x 122.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Eur J Pharmacol  2007; 571:231-9; PMID:17632100; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
N Engl J Med 1987; 317:653- 8; PMID:3306374; http://dx.doi.org/10.1056/ NEJM198709103171101 103.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care  Med 1998; 26:645-50; PMID:9559600; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2005; 33:2457-64; PMID:16276166; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
CMAJ 2010; 182:1971- 7; PMID:21059778; http://dx.doi.org/10.1503/ cmaj.090707 106.,OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit  Care Med 1999; 27:723-32; PMID:10321661; http://dx.doi.org/10.1097/00003246-199904000-00025 107.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2003; 31:367- 73; PMID:12576938; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Am J Respir Crit Care Med  2002; 166:138-43; PMID:12119223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Am J Respir Crit  Care Med 2009; 180:640-8; PMID:19590022; http://dx.doi.org/10.1164/rccm.200903-0363OC 111.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2009; 37:1185- 96; PMID:19242322; http://dx.doi.org/10.1097/ CCM.0b013e31819c06bc 112.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Arch Surg 1998; 133:94- 100; PMID:9438767; http://dx.doi.org/10.1001/arch- surg.133.1.9492.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Crit Care Med 2009; 37:2929-38; PMID:19770753;  http://dx.doi.org/10.1097/CCM.0b013e3181b0266c 94.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Intensive Care Med 1994; 20:577-80; PMID:7706571;  http://dx.doi.org/10.1007/BF01705725 97.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Chest 1993; 104:882-8; PMID:8365305; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Intensive Care Med 1998; 24:663- 72; PMID:9722035; http://dx.doi.org/10.1007/ s001340050642 99.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
Intensive Care Med 1998; 24:336- 42; PMID:9609411; http://dx.doi.org/10.1007/ s001340050576 100.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
JAMA 2001; 286:1869- 78; PMID:11597289; http://dx.doi.org/10.1001/ jama.286.15.1869 101.,Non-OADS,/arxiv_data1/oa_pdf/a6/d7/viru-5-143.PMC3916368.pdf
"Prediction of infectious complication was insufficient after gastroesophageal cancer *Correspondence to: Konrad Reinhart;   Email: konrad.reinhart@med.uni-jena.deSubmitted: 08/28/2013; Revised: 11/29/2013; Accepted: 12/02/2013http://dx.doi.org/10.4161/viru.27393Rapid diagnosis of sepsis Frank Bloos and Konrad Reinhart* Department of Anesthesiology and i ntensive Care Medicine; Jena University Hospital; Jena, Germany Keywords:  sepsis, diagnosis, biomarker, cytokines, procalcitonin, PCR Abbreviations:  CRP, C-reactive protein; ICU, intensive care unit; IL, interleukin; LBP, lipopolysaccharide binding protein; MD2,  myeloid differentiation factor 2; PCR, polymerase chain reaction; PCT, procalcitonin; sTREM-1, soluble triggering receptor  expressed on myeloid cells 1; suPAR, soluble urokinase plasminogen activator receptor; TNF, tumor necrosis factor Fast and appropriate therapy is the cornerstone in the  therapy of sepsis.",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Lancet Infect Dis  2012; 12:919-24;  PMID:23103175 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
N Engl J Med 2003 ; 348:1546 - 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 3.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Hosp  Med 2013 ; 8:243-7; PMID:23401431 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med  2001 ; 29:1303 -10; PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med 1989 ;  17:389-93; PMID:2651003 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med   2013 ; 39:165-228; PMID:23361625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
JAMA  2008 ; 299:2294 -303;  PMID:18492971 ; http://dx.doi.org/10.1001/ jama.299.19.2294 9.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Am J Respir Crit Care Med 2009 ; 180:861- 6; PMID:19696442 ; http://dx.doi.org/10.1164/ rccm.200812-1912OC 10.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
JAMA  1995 ; 273:117- 23; PMID:7799491 ; http://dx.doi.org/10.1001/ jama.1995.03520260039030 12.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med 1997 ;  25:372-4; PMID:9034279 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med  2003 ; 31:1250 -6; PMID:12682500 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
N Engl J Med  1999 ; 340:448-54; PMID:9971870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
BMJ   2013 ; 346:f2450 ; PMID:23633005 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Ann Surg 2012 ; 256:245-50; PMID:22735714 ;  http://dx.doi.org/10.1097/SLA.0b013e31825b60f0 19.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Hepatobiliary Pancreat Sci  2012 ; 19:492-500; PMID:22038499 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Clin Infect Dis 2004 ; 39:206-17;  PMID:15307030 ; http://dx.doi.org/10.1086/421997 22.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
BMC Infect Dis  2012 ; 12:157; PMID:22809118 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit  Care  2006 ; 10:R1; PMID:16356205 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Infection  2008 ; 36:213-9;  PMID:18463788 ; http://dx.doi.org/10.1007/ s15010-007-7077-9 27.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
PLoS One  2013 ; 8:e65564 ;  PMID:23762396 ; http://dx.doi.org/10.1371/ journal.pone.0065564 28.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care   2011 ; 15:R169 ; PMID:21762483 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
PLoS One   2011 ; 6:e23615 ; PMID:21901123 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Crit Care 2011 ; 26:54-64; PMID:20646905 ;  http://dx.doi.org/10.1016/j.jcrc.2010.04.011 31.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2011 ;  15:R88; http://dx.doi.org/10.1186/cc10087 ;  PMID:21385367 33.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med   1998 ; 24:888-9; PMID:9757936 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Clin 2011 ; 27:253- 63; PMID:21440200 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Clin Infect Dis 2012 ; 55:651-62;  PMID:22573847 ; http://dx.doi.org/10.1093/cid/ cis464 40.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Diagn Microbiol Infect Dis 2013 ; 76:464- 9; PMID :23711529 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2010 ; 14:R205 ; PMID:21078153 ;  http://dx.doi.org/10.1186/cc9327 42.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2009 ; 13:R38; PMID:19291325 ;  http://dx.doi.org/10.1186/cc7751 43.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2013 ; 17:R115 ; PMID:23787145 ;  http://dx.doi.org/10.1186/cc12787 44.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Am J Respir Crit  Care Med 2006 ; 174:84-93; PMID:16603606 ;  http://dx.doi.org/10.1164/rccm.200512-1922OC 46.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med 2011 ; 39:1792 - 9; PMID:21358400 ; http://dx.doi.org/10.1097/ CCM.0b013e31821201a5 48.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Am J Respir Crit Care Med 2008 ; 177:498-505;  PMID:18096708 ; http://dx.doi.org/10.1164/ rccm.200708-1238OC 49.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med 2011 ;  39:2048 -58; PMID :21572328 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2006 ; 10:R145 ;  PMID:17038199 ; http://dx.doi.org/10.1186/cc506751.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Eur J Clin Invest  2010 ; 40:376-81; PMID:20192974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Clin Chem Lab Med 2013 ; 51:1477- 81; PMID:23314540 ; http://dx.doi.org/10.1515/ cclm-2012-0610 54.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
World J Surg 2009 ; 33 :558-66; PMID:19148699 ;  http://dx.doi.org/10.1007/s00268-008-9896-y 56.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med  2008 ; 36:2014 -22; PMID:18552695 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Am J Respir  Crit Care Med 2001 ; 164:396-402; PMID:11500339 ;  http://dx.doi.org/10.1164/ajrccm.164.3.2009052 59.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Emerg Med 2012 ; 43:97-106; PMID:22056545 ;  http://dx.doi.org/10.1016/j.jemermed.2011.05.072 60.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Scand J Infect Dis 2011 ; 43:883-90;  PMID:21892899 ; http://dx.doi.org/10.3109/003655 48.2011.600325 61.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Perinat Med  2010 ; 38:527-33; PMID:20443669 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Cytokine  2008 ; 43:160- 4; PMID:18565757 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
BMC Infect Dis 2008 ; 8:28; PMID:18321393 ;  http://dx.doi.org/10.1186/1471-2334-8-2864.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
"Diagnostic markers for neonatal  sepsis: comparing C-reactive protein, interleukin-6  and immunoglobulin M.  Scand J Immunol  2007 ; 65:171-5; PMID:17257222 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Pediatr Hematol Oncol  2012 ; 34:617-23; PMID :22983415 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Med Intensiva   2012 ; 36:556-62; PMID:22495097 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med  2002 ; 28:1220 -5;  PMID:12209268 ; http://dx.doi.org/10.1007/ s00134-002-1416-1 68.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Ann Intern Med  1993 ; 119:771-8; PMID:8379598 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
"J Trauma  1997 ; 42:446-54,  discussion 454-5 ; PMID:9095112 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Mediators Inflamm   1998 ; 7:347-53; PMID:9883970 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Transplant Proc   2006 ; 38:3012 -5; PMID:17112887 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Clin Microbiol Rev 2012 ; 25:609- 34; PMID:23034322 ; http://dx.doi.org/10.1128/ CMR.00016-12 74.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Nature  2001 ;  410:1103 -7; PMID:11323674 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Ann Intern Med 2004 ;  141:9-15; PMID :15238365 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med  2009 ; 35:587-95;  PMID:18936908 ; http://dx.doi.org/10.1007/ s00134-008-1333-z 78.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2012 ; 16:R229 ;  PMID:23194114 ; http://dx.doi.org/10.1186/cc11884 79.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care  2009 ; 13:R69;  PMID:19442309 ; http://dx.doi.org/10.1186/cc7876 80.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Cell Signal   2001 ; 13:85-94; PMID:11257452 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care   2003 ; 7:R154 -9; PMID:14624690 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Dis Markers  2009 ;  27:157-72; PMID:19893210 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med  2012 ; 38:1418 -28;  PMID:22706919 ; http://dx.doi.org/10.1007/ s00134-012-2613-1 87.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med   2013 ; 39:489-96; PMID:23100007 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Crit Care Med 2005 ; 33:1538 - 48; PMID:16003060 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med  2011 ; 37:1069 -76;  PMID :21573947 ; http://dx.doi.org/10.1007/ s00134-011-2245-x 91.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
PLoS One  2013 ; 8:e62323 ;  PMID:23734173 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Intensive Care Med   2010 ; 36:241-7; PMID:19924398 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
PLoS One   2012 ; 7:e46003 ; PMID:23029360 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J Crit  Care  2013 ; 28:2-8; PMID:22999484 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
J  Clin Microbiol  2011 ; 49:665-70; PMID:21106797 ;  http://dx.doi.org/10.1128/JCM.01602-10 97.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
Bone Marrow Transplant   2009 ; 43:553-61; PMID:19079316 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e4/b2/viru-5-154.PMC3916369.pdf
"6-8 Candida is the most frequent cause of fungal severe  sepsis or septic shock in ICU patients.9 In a cohort of 386 patients  with positive blood cultures and septic shock, candidemia *Correspondence to: Thierry Calandra; Email: Thierry.Calandra@chuv.ch Submitted: 07/28/2013; Revised: 08/11/2013; Accepted: 08/16/2013http://dx.doi.org/10.4161/viru.26187Invasive candidiasis as a cause of sepsis   in the critically ill patient Julie Delaloye and Thierry Calandra* infectious Diseases Service; Department of Medicine; Centre Hospitalier Universitaire v audois and University of Lausanne; Lausanne, Switzerland Keywords:  Candida albicans , sepsis, candidiasis, echinocandin, risk factors invasive fungal infections are an increasingly frequent  etiology of sepsis in critically ill patients causing substantial  morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis  2004; 38:311-20;  PMID:14727199 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin  Microbiol Rev 2007 ; 20:133-63; PMID:17223626 ;  http://dx.doi.org/10.1128/CMR.00029-06 3.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Ann N Y Acad Sci 2012 ;  1272 :31-9; PMID:23231712 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
JAMA  2009 ; 302:2323 - 9; PMID:19952319 ; http://dx.doi.org/10.1001/ jama.2009.1754 5.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care  2008 ; 12:204; PMID:18279532 ;  http://dx.doi.org/10.1186/cc6212 6.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 2004 ; 32(Suppl ):S495 -512;  PMID :15542958 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
JAMA  2013 ; 309:1154 -62; PMID:23512062 ;  http://dx.doi.org/10.1001/jama.2013.2194 8.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
N Engl J Med 2012 ; 366:2055 - 64; PMID:22616830 ; http://dx.doi.org/10.1056/ NEJMoa1202290 9.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2012 ; 54:1739 -46; PMID:22423135 ;  http://dx.doi.org/10.1093/cid/cis305 10.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med  2002 ; 30:1808 -14; PMID:12163798 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit  Care  2013 ; 17:R65; PMID :23561510 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Lancet Infect Dis  2003 ; 3:685-702; PMID:14592598 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Microbiol Infect  2006 ; 12:170-7; PMID:16441456 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Intensive Care Med  2009 ; 35:55- 62; PMID:18972101 ; http://dx.doi.org/10.1007/ s00134-008-1338-7 15.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 2009 ; 37:1612 - 8; PMID:19325476 ; http://dx.doi.org/10.1097/ CCM.0b013e31819efac0 16.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Eur  J Clin Microbiol Infect Dis 2006 ; 25:419-25;  PMID:16773391 ; http://dx.doi.org/10.1007/ s10096-006-0159-2 17.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin  Microbiol Infect 2011 ; 17:1061 -7; PMID:20825438 ;  http://dx.doi.org/10.1111/j.1469-0691.2010.03360.x 18.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Lancet   1989 ; 2:1437- 40; PMID:2574368 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2003 ; 37:1172 -7;  PMID:14557960 ; http://dx.doi.org/10.1086/378745 20.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Arch Intern Med  1988 ; 148:2642 -5; PMID:3196127 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Intensive Care Med  2003 ; 29:2162 -9;  PMID:13680110 ; http://dx.doi.org/10.1007/ s00134-003-2002-x23.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
J Crit  Care  2013 ; 28:2-8; PMID:22999484 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Eur J Clin Microbiol Infect Dis  2004 ; 23:323-30; PMID :15024623 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Curr Opin Crit Care 2010 ; 16:445- 52; PMID:20711075 ; http://dx.doi.org/10.1097/ MCC.0b013e32833e84d2 28 .,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 2008 ; 36:2034 - 9; PMID:18552700 ; http://dx.doi.org/10.1097/ CCM.0b013e3181760f42 29.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Int J  Antimicrob Agents  2009 ; 33:e1-7; PMID:19167196 ;  http://dx.doi.org/10.1016/j.ijantimicag.2008.10.035 30.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin  Microbiol Infect 2011 ; 17:1061 -7; PMID:20825438 ;  http://dx.doi.org/10.1111/j.1469-0691.2010.03360.x 31.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Ann Surg 1994 ;  220:751-8; PMID:7986142 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 2004 ; 32:2443 - 9; PMID :15599149 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Intensive Care Med   2005 ; 31:393-400; PMID :15711782 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Scand J Infect Dis 2008 ;  40:145-53; PMID:17852926 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Microbiol Infect  2004 ; 10:550-5; PMID :15191384 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Mycoses   2007 ; 50:302-10; PMID:17576324 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2004 ; 39:309-17; PMID :15306996 ;  http://dx.doi.org/10.1086/421946 39.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis  1999 ; 28:1071 -9; PMID:10452637 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Eur J Clin Microbiol Infect Dis 1996 ; 15:909- 12; PMID:9031872 ; http://dx.doi.org/10.1007/ BF01690507 42.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Microbiol Infect 2002 ;  8:405-12; PMID:12199850 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Medicine (Baltimore)  2002 ;  81:425-33; PMID:12441899 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Chest   2003 ; 124:2244 -55; PMID:14665507 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med  2006 ; 34:730-7; PMID:16505659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 2003 ; 31:752-7;  PMID:12626979 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Med Mycol  2005 ;  43:235-43; PMID:16010850 ; http://dx.doi.org/10.1 080/13693780410001731619 52.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Eur J Clin Microbiol Infect  Dis 2007 ; 26:271-6; PMID:17333081 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Chest  2011 ; 140:1177 - 83; PMID:21527510 ; http://dx.doi.org/10.1378/ chest.10-3035 54.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med  2006 ; 34:730-7; PMID:16505659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Ann Intensive Care  2011 ; 1:50; PMID:22128895 ;  http://dx.doi.org/10.1186/2110-5820-1-5056.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med  2006 ; 34:646-52; PMID:16505648 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Antimicrob Agents Chemother  2005 ; 49:3640 - 5; PMID:16127033 ; http://dx.doi.org/10.1128/ AAC.49.9.3640-3645.2005 58 .,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2013 ;  56:1284 -92; PMID:23315320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Ann Intern Med  1988 ; 108:88-100; PMID:3276268 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2012 ; 54:633-43;  PMID:22198786 ; http://dx.doi.org/10.1093/cid/ cir897 62.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis  2011 ; 52:750-70; PMID:21367728 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Intensive Care Med   2013 ; 39:165-228; PMID:23361625 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
FEMS  Microbiol Lett 2009 ; 296:1-10; PMID:19416355 ;  http://dx.doi.org/10.1111/j.1574-6968.2009.01575.x,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
J  Clin Microbiol  2011 ; 49:665-70; PMID:21106797 ;  http://dx.doi.org/10.1128/JCM.01602-10 69.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
J Clin Microbiol 2010 ; 48:3510 - 6; PMID:20720024 ; http://dx.doi.org/10.1128/ JCM.00147-10 70.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2012 ; 54:1240 -8; PMID:22431804 ;  http://dx.doi.org/10.1093/cid/cis200 71.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Sci Transl Med 2013 ; 5:182ra54 ;  PMID:23616121 ; http://dx.doi.org/10.1126/ scitranslmed.3005377  72.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Curr Opin Infect Dis 2008 ; 21:610- 9; PMID:18978529 ; http://dx.doi.org/10.1097/ QCO.0b013e3283177967 74.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 2009 ; 48:503-35; PMID:19191635 ;  http://dx.doi.org/10.1086/596757 75.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Crit Care Med 1999 ;  27:1066 -72; PMID:10397206 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Ann Intern Med 2008 ;  149:83-90; PMID:18626047 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
N Engl J Med 1994 ; 331:1325 - 30; PMID:7935701 ; http://dx.doi.org/10.1056/ NEJM199411173312001 81.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Lancet  2005 ;  366:1435 -42; PMID:16243088 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis  2007 ; 45:883-93; PMID:17806055 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
N Engl J Med 2007 ; 356:2472 -82;  PMID:17568028 ; http://dx.doi.org/10.1056/ NEJMoa066906 85.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Lancet  2007 ; 369:1519-27;  PMID:17482982 ; http://dx.doi.org/10.1016/ S0140-6736(07)60605-986.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Arch Intern Med  1995 ; 155:2429 -35; PMID:7503601 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis 1995 ; 21:994- 6; PMID:8645855 ; http://dx.doi.org/10.1093/ clinids/21.4.994 90.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Eur J Clin Microbiol Infect Dis  2000 ; 19:602-7; PMID:11014622 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Infect Dis  2010 ; 51:295-303; PMID:20578829 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
Clin Microbiol  Infect  2012 ; 18(Suppl 7 ):19-37; PMID:23137135 ;  http://dx.doi.org/10.1111/1469-0691.12039,Non-OADS,/arxiv_data1/oa_pdf/a7/f9/viru-5-161.PMC3916370.pdf
"18-20 Gram-negative bacteremia and sepsis are the most  common.14,15*Correspondence to: James K Padbury; Email: JPadbury@wihri.org Submitted: 07/03/2013; Revised: 10/21/2013; Accepted: 10/22/2013http://dx.doi.org/10.4161/viru.26906Neonatal sepsis An old problem with new insights Birju A Shah1 and James F Padbury2,* 1instructor of Pediatrics; Neonatal-Perinatal Medicine; w arren Alpert Medical School of Brown University; w omen & i nfants Hospital of Rhode i sland; Providence, R i USA;  2Pediatrician-in-Chief, Professor of Pediatrics; w arren Alpert Medical School of Brown University; w omen & i nfants Hospital of Rhode i sland; Providence, R i USA Keywords:  neonatal sepsis, epidemiology, microbiology, biomarkers, algorithms, newer tests, screening, group B streptococcus,  antibiotic prophylaxis Abbreviations:  CDC, Centers for Disease Control and Prevention; GBS, group B streptococcus; EOS, early-onset sepsis; IAIP,  inter alpha inhibitor protein(s); LOS, late-onset sepsis; NEC, necrotizing enterocolitis; NICHD, Eunice Kennedy Shriver National  Institute of Child Health and Human Development; NICU, neonatal intensive care unit; VLBW, very low birth weight Neonatal sepsis continues to be a common and significant  health care burden, especially in very-low-birth-weight infants  (VLB w <1500 g).",Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Clin North Am 2013; 60:367-89; PMID:23481106 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2005; 116:595-602;  PMID:16140698 ; http://dx.doi.org/10.1542/ peds.2005-0552 3.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Early Hum Dev 2012; 88(Suppl 2):S69- 74; PMID:22633519 ; http://dx.doi.org/10.1016/ S0378-3782(12)70019-1 4.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
"Pediatr Clin  North Am 2004; 51:939-59, viii-ix; PMID:15275982 ;  http://dx.doi.org/10.1016/j.pcl.2004.03.009 5.",OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis  J 1993; 12:111-4;  PMID:8426766 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr 1992; 121:428-33; PMID :1517922 ;  http://dx.doi.org/10.1016/S0022-3476(05)81801-3 10.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Int 2012;  54:486-90;  PMID:22299645 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Eur J Pediatr 2013; 172:501-8;  PMID:23271492 ; http://dx.doi.org/10.1007/ s00431-012-1910-6 12.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr Surg  2005; 40:371-6;  PMID:15750931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Surg Int 2005; 21:977-82; PMID:16211416 ;  http://dx.doi.org/10.1007/s00383-005-1539-x16.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
"J Pediatr 2012; 160:54,  e2; PMID:21840538 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr  2010; 157:757-61;  PMID:20955849 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr 1991; 119:630-8; PMID:1919897 ;  http://dx.doi.org/10.1016/S0022-3476(05)82418-7 19.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Clin Microbiol Rev  2004; 17:638-80;  PMID:15258097 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics  2002; 110:285-91;  PMID:12165580 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
N Engl J Med 2002; 347:240-7; PMID:12140299 ;  http://dx.doi.org/10.1056/NEJMoa012657 24.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics  2011; 127:817-26;  PMID :21518717 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics  2001; 108:1094-8;  PMID:11694686 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2000; 106:1387- 90; PMID:11099593 ; http://dx.doi.org/10.1542/ peds.106.6.138729.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2012; 130:e8- 15; PMID:22689869 ; http://dx.doi.org/10.1542/ peds.2011-3453 31.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
N Engl J Med 2002; 347:233- 9; PMID:12140298 ; http://dx.doi.org/10.1056/ NEJMoa020205 37.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2012;  129:1006-15;  PMID:22547779 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2011; 128:e1155-63;  PMID:22025590 ;  http://dx.doi.org/10.1542/peds.2010-3464 42.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Curr  Opin Pediatr 2013; 25:161-6; PMID:23407183 ;  http://dx.doi.org/10.1097/MOP.0b013e32835e1f96 43.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Crit Care Med 2005; 6:2-8;  PMID :15636651 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis J 2012; 31:799- 802; PMID:22531231 ; http://dx.doi.org/10.1097/ INF.0b013e318256905c 45.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis J 1997;  16:381-5;  PMID:9109140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Perinatol 2006; 26:688-92; PMID:17024143 ;  http://dx.doi.org/10.1038/sj.jp.7211597 47.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis  J 1987; 6:440-2; PMID:3601489 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis  1985; 4:242-5;  PMID:3889873 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect  Dis J 2012; 31:16-9; PMID:21860335 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr  1979; 95:89-98;  PMID:480023 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Perinatol 2008; 28:275-81; PMID:18200025 ;  http://dx.doi.org/10.1038/sj.jp.7211916 52.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Neonatology 2012; 102:25-36; PMID:22507868 ;  http://dx.doi.org/10.1159/000336629 53.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Acta Paediatr 1995; 84:10-3;  PMID:7734887 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics  1999; 104:447-53;  PMID:10469768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Arch Dis Child Fetal Neonatal Ed 2004; 89:F229- 35; PMID:15102726 ; http://dx.doi.org/10.1136/ adc.2002.023838 57.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Clin Perinatol  2010; 37:421-38;  PMID:20569816 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Clin  Endocrinol Metab 1994; 79:1605-8; PMID:7989463 ;  http://dx.doi.org/10.1210/jc.79.6.160559.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Clin Infect Dis 1998; 26:664-72;  PMID:9524841 ; http://dx.doi.org/10.1086/514576 60.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Ann Clin Biochem  2001; 38:483-93;  PMID :11587126 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Int J Infect Dis 2011; 15:e854-8; PMID:22019570 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr 1990; 117:961- 5; PMID:2246700 ; http://dx.doi.org/10.1016/ S0022-3476(05)80145-3 65.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis  J 2000; 19:879-87; PMID:11001114 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Perinat Med 2003; 31:60- 8; PMID:12661146 ; http://dx.doi.org/10.1515/ JPM.2003.009 67.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Arch Dis Child Fetal Neonatal Ed 2006; 91:F208-12;  PMID:16632649 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Matern Fetal Med 1999; 8:88- 94; PMID:10338061 ; http://dx.doi.org/10.1002/ (SICI)1520-6661(199905/06)8:3<88::AID-MFM4>3.0.CO;2-# 70.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Arch Dis Child Fetal Neonatal  Ed 1997; 77:F221-7;  PMID:9462194 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Clin Epidemiol 2001; 54:1251-7; PMID:11750194 ;  http://dx.doi.org/10.1016/S0895-4356(01)00400-073.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Res 1998; 44:469-77;  PMID:9773833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Acta Paediatr  1994; 83:696-9;  PMID:7949797 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Clin Invest 1989; 84:1045-9;  PMID:2677047 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Shock 1995; 3:196-203;  PMID:7773799 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2001; 108:E12;  PMID:11433091 ; http://dx.doi.org/10.1542/ peds.108.1.e12 81.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr  1998; 132:445-51;  PMID:9544899 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Res 2002;  51:296-303;  PMID:11861933 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
"J Pediatr 2000; 137:345- 50; PMID:10969258 ; http://dx.doi.org/10.1067/ mpd.2000.107846 84. de Haas M, Vossebeld PJ, von dem Borne AE, Roos D. Fc gamma receptors of phagocytes.",OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr  Res 1999; 45:871-6; PMID:10367781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Clin Exp Immunol  1997; 107:37-43;  PMID:9010254 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Infect Dis J 2012; 31:777- 81; PMID:22481422 ; http://dx.doi.org/10.1097/ INF.0b013e318256fb07 90.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Diagn Microbiol Infect Dis  2011; 69:153-60 ;  PMID :21251558 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Arch Dis Child Fetal Neonatal Ed  2003; 88:F209-13;  PMID:12719394 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Clin Invest 2010; 120:2989- 3000;  PMID:20592468 ; http://dx.doi.org/10.1172/ JCI40196 93.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Neonatology 2013;  103:268-73;  PMID:23485823 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatrics 2008; 121:129-34;  PMID:18166566 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Int J Biochem Cell Biol 2000;  32:125-37;  PMID:10687949 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Pediatr  2003; 143:11-5;  PMID :12915817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
"J Pediatr 2009; 154:620, e1;  PMID:19324226 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Crit Care Med 2002; 30:617-22;  PMID:11990925 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
J Infect Dis  2003; 188:919-26;  PMID:12964125 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
Pediatr Res 2010; 68:242- 7; PMID:20520583 ; http://dx.doi.org/10.1203/ PDR.0b013e3181e9fdf0,OADS,/arxiv_data1/oa_pdf/3e/0a/viru-5-170.PMC3916371.pdf
"6,7 One major difference in the definition of sepsis in children  vs. adults are the age-specific cutoffs for physiologic and organ *Correspondence to: Adrienne G Randolph;   Email: adrienne.randolph@childrens.harvard.eduSubmitted: 07/15/2013; Revised: 10/29/2013; Accepted: 11/01/2013http://dx.doi.org/10.4161/viru.27045Pediatric sepsis Important considerations for diagnosing and managing  severe infections in infants, children, and adolescents Adrienne G Randolph1,2,* and Russell J McCulloh3 1Harvard Medical School; Boston, MA USA; 2Department of Anesthesia, Perioperative and Pain Medicine; Boston Children’s Hospital; Boston, MA USA;   3Children’s Mercy Hospital; Kansas City, MO USA Keywords:  infants, children, pediatric, sepsis, septic shock, infection, innate immunity, review Sepsis is the leading cause of death in children worldwide.",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"106,107 Although there are a paucity of national-level data on pediat - ric sepsis outcomes from pre-developed countries,108 the World  Federation of Pediatric Intensive and Critical Care Societies (WFPICCS) is working to change this through their global sepsis initiative (http://www.wfpiccs.org).",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J 2009; 28(Suppl):S43-8; PMID:19106763 ;  http://dx.doi.org/10.1097/INF.0b013e31819588d7 2.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med 2005;  6(Suppl):S157-64;  PMID:15857551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Am J Respir Crit Care Med 2003; 167:695- 701; PMID:12433670 ; http://dx.doi.org/10.1164/ rccm.200207-682OC 4.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Epidemiol  2012; 4:319-25;  PMID:23226074 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Bull World Health Organ  2008; 86:408-16;  PMID:18545744 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med 2005; 6:2-8; PMID :15636651 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med  1992; 20:724-6;  PMID :1597021 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2010; 126:e1361- 99; PMID:20956434 ; http://dx.doi.org/10.1542/ peds.2010-2972D 9.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med 2013; 41:1761- 73; PMID:23685639 ; http://dx.doi.org/10.1097/ CCM.0b013e31828a2bbd 10.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2003; 112:793-9;  PMID:14523168 ;  http://dx.doi.org/10.1542/peds.112.4.793 11.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr  Emerg Care 2008; 24:810-5; PMID:19050666 ;  http://dx.doi.org/10.1097/PEC.0b013e31818e9f3a 12.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Acta Paediatr 2012;  101:120-7;  PMID:22003882 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
J Leukoc Biol 2004; 76:909-25; PMID :15292276 ;  http://dx.doi.org/10.1189/jlb.0604320 15.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Res 2009; 65:98R-105R;  PMID :19918215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Neonatology 2007; 92:145-57;  PMID:17476116 ;  http://dx.doi.org/10.1159/000102054 19.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Immunol 2006; 118:137-44;  PMID:16377252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
BMC Pediatr 2011; 11:29;  PMID:21492472 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Curr Opin Infect Dis 2006; 19:271-6;  PMID:16645489 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"Selected resources and guidelines for clinicians related to pediatric sepsis Resource Location Comments infectious Diseases Society of America http://www.idsociety.orgProvides links to clinical practice guidelines regarding the  treatment of multiple bacteria and viruses for children  including a guideline on management of pediatric  community acquired pneumonia Red Book aapredbook.aappublications.orgin-depth pediatric infectious diseases resource published by  the American Academy of Pediatrics world Health Organization Pocket book  of hospital care for children: guidelines  for the management of common  illnesses with limited resourceshttp://www.who.int/child-adolescent-health/ publications/CHiLD_HeALTH/PB.htmProvides diagnostic and treatment guidelines for managing  children suffering from various illnesses, including severe  infections and sepsis.",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"Centers for Disease Control Healthcare  infection Control Practices Advisory  Committee (HiCPAC)http://www.cdc.gov/hicpac/pubs.htmlPublishes guidelines for prevention, surveillance, and  treatment of nosocomial infections in multiple healthcare  settings UpToDate http://www.uptodate.comevidence-based clinician support at the point of care  electronic resource with many chapters devoted to pediatric  sepsis and pediatric infections.",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Surviving Sepsis Campaign Guidelines  for the Management of Sepsishttp://www.survivingsepsis.orgevidence-based guidelines for the management of sepsis in  adults and children.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Immunology  2004; 113:163-74;  PMID:15379976 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J  1999; 18:757-63;  PMID:10493334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Vaccine 2013; (Forthcoming)  PMID:23684824 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Microb Pathog  2013; 55:9-15;  PMID:23247146 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics  2007; 119:487-94;  PMID:17332201 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med 2013; 14:686- 93; PMID:23897242 ; http://dx.doi.org/10.1097/ PCC.0b013e3182917fad 30.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Clin North Am 2013; 60:367-89; PMID:23481106 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J 2000; 19:244-7;  PMID:10749468 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Infect Dis 2008; 47:328-38; PMID:18558873 ;  http://dx.doi.org/10.1086/589753 36.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med 2013; 14:356- 65; PMID:23548960 ; http://dx.doi.org/10.1097/ PCC.0b013e31828a70fe 37.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Lancet 2009; 374:903-11;  PMID:19748399 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J 1998;  17(Suppl):S132-6;  PMID:9781746 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Vaccine 2012; 30(Suppl 6):G32- 6; PMID:23228355 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Lancet 2000; 356:961-7; PMID:11041396 ;  http://dx.doi.org/10.1016/S0140-6736(00)02712-4 46.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Infect Dis 2011; 52:285-92; PMID:21217178 ;  http://dx.doi.org/10.1093/cid/cir034 47.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Epidemiol Infect  2011; 139:791-6;  PMID:20598212 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Eur J Clin Microbiol Infect Dis 2012; 31:2481- 90; PMID:22466969 ; http://dx.doi.org/10.1007/ s10096-012-1611-051.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Infect Control Hosp Epidemiol 2012; 33:1200-6;  PMID:23143356 ; http://dx.doi.org/10.1086/668425 52.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Am J Infect Control 2001; 29:152-7; PMID:11391276 ;  http://dx.doi.org/10.1067/mic.2001.115407 53.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N  Engl J Med 2005; 353:2559-67; PMID:16354892 ;  http://dx.doi.org/10.1056/NEJMoa051721 55.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Dev Pathol 2009; 12:211-6; PMID:19018665 ;  http://dx.doi.org/10.2350/07-02-0229.1 58.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Rev 2009; 30:386- 95; PMID:19797481 ; http://dx.doi.org/10.1542/ pir.30-10-386 60.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2006; 118:1774-93;  PMID:17015575 ;  http://dx.doi.org/10.1542/peds.2006-2223 61.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Respir Med 2002;  96(Suppl B):S1-7;  PMID:11996399 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2004; 113:701-7; PMID :15060215 ;  http://dx.doi.org/10.1542/peds.113.4.701 63.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2008; 122:805- 11; PMID:18829805 ; http://dx.doi.org/10.1542/ peds.2008-1336,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2011; 128:e1450-8; PMID:22065262 ;  http://dx.doi.org/10.1542/peds.2011-0774 65.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med 2013; 41:224- 36; PMID:23222256 ; http://dx.doi.org/10.1097/ CCM.0b013e318267633c 66.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J  2008; 27:241-5;  PMID:18277927 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Infect Dis 1994; 18:401- 7; PMID:8011823 ; http://dx.doi.org/10.1093/ clinids/18.3.401 71.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Blood Cancer 2008; 50:647-9; PMID:17278117 ; http://dx.doi.org/10.1002/ pbc.21120 72.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
J Pediatr (Rio J) 2007; 83(Suppl):S22-35;  PMID:17530136 ; http://dx.doi.org/10.2223/ JPED.1622 74.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J  1995; 14:136-40;  PMID:7746696 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Wien Med Wochenschr  2004; 154:242-5;  PMID:15244050 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Int J Infect  Dis 2002; 6:187-90; PMID:12718833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Infect Dis J 2012; 31:1203-5;  PMID:23073317 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Clin Rev Allergy Immunol 2008; 34:129-40; PMID:18330724 ; http://dx.doi.org/10.1007/ s12016-007-8041-2 81.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
J Allergy Clin Immunol  2010; 125(Suppl 2):S297-305; PMID:20042230 ;  http://dx.doi.org/10.1016/j.jaci.2009.08.043 82.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
AIDS Res Hum Retroviruses 2012; 28:282-8;  PMID:21902581 ;  http://dx.doi.org/10.1089/aid.2011.0057 83.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
JAMA 2006; 296:292- 300;  PMID:16849662 ; http://dx.doi.org/10.1001/ jama.296.3.292 85.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Am J Respir  Crit Care Med 2003; 167:1334-40; PMID:12615617 ;  http://dx.doi.org/10.1164/rccm.200210-1175OC 86.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med 2013; 41:580-637; PMID:23353941 ; http://dx.doi.org/10.1097/ CCM.0b013e31827e83af 87.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatrics 2010; 125:1217-23;  PMID:20478938 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"Arch Dis Child 2001; 85:386-90; PMID:11668100 ; http://dx.doi.org/10.1136/ adc.85.5.386 90. de Oliveira CF, de Oliveira DS, Gottschald AF, Moura  JD, Costa GA, Ventura AC, Fernandes JC, Vaz FA,  Carcillo JA, Rivers EP, et al.",OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N Engl J Med 2005; 353:877-89; PMID:16135832 ;  http://dx.doi.org/10.1056/NEJMoa044057 92.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N Engl J Med 2011; 364:2483-95; PMID :21615299 ;  http://dx.doi.org/10.1056/NEJMoa1101549 93.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
BMC  Med 2013; 11:68; PMID:23496872 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med 2012; 13:253- 8; PMID:21760565 ; http://dx.doi.org/10.1097/ PCC.0b013e31822882a3 96.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Res Pract 2011; 2011:854142; PMID:21687578 ;  http://dx.doi.org/10.1155/2011/854142 97.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Am  J Kidney Dis 2010; 55:316-25; PMID:20042260 ;  http://dx.doi.org/10.1053/j.ajkd.2009.10.048 98.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med 2012; 40:2883-9; PMID:22824936 ;  http://dx.doi.org/10.1097/CCM.0b013e31825bc54d 99.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Biomed Res Int 2013;  2013:928290;  PMID:23509808 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Arch Surg  1998; 133:1200-5;  PMID:9820351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Infect Control Hosp Epidemiol 2009; 30:636-44;  PMID:19496643 ; http://dx.doi.org/10.1086/597521 102.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Postgrad Med J 2011; 87:757-62;  PMID:21798969 ; http://dx.doi.org/10.1136/ pgmj.2010.116616,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Am J Respir Crit Care Med 2005; 171:348-53; PMID :15516535 ; http://dx.doi.org/10.1164/ rccm.200405-630OC 105.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Lancet 2007; 369:836-43;  PMID:17350452 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N Engl J Med  2001; 344:699-709;  PMID:11236773 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N Engl J Med 2012; 366:2055- 64; PMID:22616830 ; http://dx.doi.org/10.1056/ NEJMoa1202290108.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
J Glob Health  2012; 2:10404;  PMID:23198133 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Pediatr Crit Care Med  2012; 13:501-8;  PMID:22460772 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"Lancet 2012;  379:613-4, author reply 613-4; PMID:22340294 ;  http://dx.doi.org/10.1016/S0140-6736(12)60260-8 111.",Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Circulation 2010; 122(Suppl 3):S876-908;  PMID:20956230 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.110.971101112.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
Crit Care Med 2009; 37:666- 88; PMID:19325359 ; http://dx.doi.org/10.1097/ CCM.0b013e31819323c6 113.,Non-OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
N Engl J Med 2007; 356:1609-19; PMID:17442904 ;  http://dx.doi.org/10.1056/NEJMoa066240 114.,OADS,/arxiv_data1/oa_pdf/c4/d8/viru-5-179.PMC3916372.pdf
"Initial empiric anti-infec - tive therapy should be broad and target all likely pathogens and *Correspondence to: Christa A Schorr;   Email: Schorr-christa@cooperhealth.eduSubmitted: 08/26/2013; Revised: 11/22/2013; Accepted: 12/02/2013http://dx.doi.org/10.4161/viru.27409Severe sepsis and septic shock Management and performance improvement Christa A Schorr*, Sergio Zanotti, and R Phillip Dellinger Division of Critical Care Medicine; Department of Medicine; Cooper University Hospital; Camden, NJ USA Keywords:  guidelines, severe sepsis, sepsis bundles, resuscitation, performance improvement Morbidity and mortality from sepsis remains unaccept - ably high.",Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Online at http://www.survivingsepsis.org/SiteCollectionDocuments/ScreeningTool.pdf.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2003; 348:1546- 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 3.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Curr Infect Dis Rep 2006; 8:358-65; PMID:16934194 ; http://dx.doi.org/10.1007/ s11908-006-0046-0 4.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2004; 32:858-73;  PMID:15090974 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2008; 36:296-327; PMID :18158437 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2013; 41:580- 637; PMID:23353941 ; http://dx.doi.org/10.1097/ CCM.0b013e31827e83af 7.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2007; 35:1244- 50; PMID:17414736 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2001; 345:1368-77; PMID:11794169 ; http://dx.doi.org/10.1056/ NEJMoa010307 9.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2006; 34:943-9;  PMID:16484902 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Chest 2005; 127:1729- 43; PMID:15888853 ; http://dx.doi.org/10.1378/ chest.127.5.1729 12.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2006; 34:1025-32;  PMID:16484890 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2006; 34:2707-13;  PMID:16943733 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2007; 35:1105-12;  PMID:17334251 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Chest 2006; 129:225-32; PMID:16478835 ;  http://dx.doi.org/10.1378/chest.129.2.225 16.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2006; 34:2224- 7; PMID:16763509 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med  2005; 31:1066-71;  PMID :15973520 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2000; 28:2729-32;  PMID:10966242 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2001; 345:1368-77; PMID:11794169 ; http://dx.doi.org/10.1056/ NEJMoa010307 21.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 2010; 303:739-46; PMID:20179283 ;  http://dx.doi.org/10.1001/jama.2010.158 22.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Respir Crit Care Med 2010; 182:752-61;  PMID:20463176 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
"J Trauma 2009; 66:1539-46, dis - cussion 1546-7;  PMID:19509612 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
http://www.survivingsepsis.org/SiteCollectionDocuments/ScreeningTool.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Rev Infect Dis 1983;  5:35-53;  PMID:6828811 ; http://dx.doi.org/10.1093/ clinids/5.1.35 27.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Lancet 2003;  362:1011-6;  PMID:14522530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med  2009; 360:20-31;  PMID:19118302 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Antimicrob Agents Chemother 2005; 49:3640- 5; PMID:16127033 ; http://dx.doi.org/10.1128/ AAC.49.9.3640-3645.2005 33.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Surg Infect (Larchmt) 2005; 6:41- 54; PMID:15865550 ; http://dx.doi.org/10.1089/ sur.2005.6.41 34.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
J Intern Med 1998;  244:379-86;  PMID:9845853 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Chest 2000; 118:146-55; PMID:10893372 ; http://dx.doi.org/10.1378/ chest.118.1.146 36.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit  Care Med 2010; 38:367-74; PMID:20035219 ;  http://dx.doi.org/10.1097/CCM.0b013e3181cb0cdc,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Antimicrob Agents Chemother  2010; 54:1742-8;  PMID:20160050 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Antimicrob Agents Chemother  2009; 53:1386-94;  PMID:19164144 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit  Care Med 2010; 38(Suppl):e43-51; PMID:19935416 ;  http://dx.doi.org/10.1097/CCM.0b013e3181c85229 41.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2001; 27(Suppl 1):S49-62; PMID:11307370 ; http://dx.doi.org/10.1007/ PL00003797 42.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2009; 35:847- 53; PMID:19099288 ; http://dx.doi.org/10.1007/ s00134-008-1373-4 43.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2004; 350:2247-56; PMID :15163774 ; http://dx.doi.org/10.1056/ NEJMoa040232 44.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2012; 367:124-34; PMID:22738085 ; http://dx.doi.org/10.1056/ NEJMoa1204242 46.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2012; 367:1901- 11; PMID:23075127 ; http://dx.doi.org/10.1056/ NEJMoa1209759 47.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2011; 39:386-91; PMID:21248514 ;  http://dx.doi.org/10.1097/CCM.0b013e3181ffe217 48.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2000; 28:2758-65;  PMID:10966247 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2010; 362:779- 89; PMID:20200382 ; http://dx.doi.org/10.1056/ NEJMoa0907118 50.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2012; 40:725-30;  PMID:22036860 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Lancet 2007; 370:676-84; PMID:17720019 ;  http://dx.doi.org/10.1016/S0140-6736(07)61344-0 52.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med  2008; 34:2226-34;  PMID:18654759 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2008; 358:877-87;  PMID:18305265 ; http://dx.doi.org/10.1056/ NEJMoa067373 54.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Lancet 2000; 356:2139-43;  PMID:11191541 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA  2002; 288:862-71;  PMID:12186604 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2008; 358:111-24; PMID:18184957 ;  http://dx.doi.org/10.1056/NEJMoa071366 59.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 2009; 301:2362-75;  PMID:19509383 ; http://dx.doi.org/10.1001/ jama.2009.815 60.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Respirology 2011; 16:1088-95; PMID:21726354 ;  http://dx.doi.org/10.1111/j.1440-1843.2011.02018.x61.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med  2007; 33:730-3;  PMID:17325831 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Respir Crit Care Med 2003;  167:512-20;  PMID:12426230 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 1999; 340:409-17; PMID:9971864 ;  http://dx.doi.org/10.1056/NEJM199902113400601 64.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  1999; 27:2346-50;  PMID:10579246 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 2002; 288:2827-35; PMID:12472324 ; http://dx.doi.org/10.1001/ jama.288.22.2827 66.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care 2011; 15:R108;  PMID:21466676 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA  2001; 286:1869-78;  PMID:11597289 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2006; 34:285- 92; PMID:16424704 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Br J Haematol 2003; 122:10-23;  PMID:12823341 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med  1998; 338:347-54;  PMID:9449727 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 2008; 299:637- 45; PMID:18270352 ; http://dx.doi.org/10.1001/ jama.299.6.637 76.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med  2004; 351:327-36;  PMID:15269312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 2010; 303:865- 73; PMID:20197533 ; http://dx.doi.org/10.1001/ jama.2010.218 78.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Respir Crit Care Med 2008; 178:1156-63 ;  PMID :18776154 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Respir Crit Care Med 2006; 173:1233-9;  PMID:16556697 ; http://dx.doi.org/10.1164/ rccm.200503-353OC 81.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2006; 354:2564-75; PMID:16714767 ; http://dx.doi.org/10.1056/ NEJMoa06220083.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Lancet  2012; 379:229-35;  PMID:22166903 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Anesth Analg  1994; 78:772-4;  PMID:8135399 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Muscle Nerve 1998; 21:610- 7; PMID:9572240 ; http://dx.doi.org/10.1002/ (SICI)1097-4598(199805)21:5<610::AID-MUS7>3.0.CO;2-B 86.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2010;  363:1107-16;  PMID:20843245 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2009; 360:1283-97; PMID:19318384 ; http://dx.doi.org/10.1056/ NEJMoa0810625 88.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2012; 40:3251- 76; PMID:23164767 ; http://dx.doi.org/10.1097/ CCM.0b013e3182653269 89.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  2005; 33:2778-85;  PMID:16352960 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2008; 36:3062-6;  PMID :18824915 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive  Care Med 2002; 28:1411-8; PMID:12373465 ;  http://dx.doi.org/10.1007/s00134-002-1433-0 93.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2002; 28:29-37;  PMID:11818996 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Kidney Dis 2002; 40:875- 85; PMID:12407631 ; http://dx.doi.org/10.1053/ ajkd.2002.3631895.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Kidney Int  2001; 60:1154-63;  PMID:11532112 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Ann Intern Med 1990; 112:492-8;  PMID :2156475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med  1991; 19:1352-6;  PMID :1935152 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N  Engl J Med 1999; 341:793-800; PMID:10477777 ;  http://dx.doi.org/10.1056/NEJM199909093411103 101.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med 2011; 364:1305-14;  PMID:21417952 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Chest 2007; 131:507- 16; PMID:17296655 ; http://dx.doi.org/10.1378/ chest.06-1861 103.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
JAMA 1996; 275:308- 14; PMID:8544272 ; http://dx.doi.org/10.1001/ jama.1996.03530280060038,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2010; 38:1197- 205; PMID:20173630 ; http://dx.doi.org/10.1097/ CCM.0b013e3181d69ccf 107.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Nutrition 2004; 20:843- 8; PMID :15474870 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2004; 30:1666-71;  PMID :15185069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
N Engl J Med  2011; 365:506-17;  PMID:21714640 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 1999; 27:2799-805; PMID:10628629 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Clin Nutr  2003; 22:221-33;  PMID:12765660 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2008; 34:1980- 90; PMID:18626628 ; http://dx.doi.org/10.1007/ s00134-008-1213-6 115.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Am J Respir Crit Care Med 2010; 182:905- 9; PMID:20538959 ; http://dx.doi.org/10.1164/ rccm.201002-0262OC 116.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Intensive Care Med 2010; 36:1495-504;  PMID:20464541 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Chest 2011; 139:543- 54; PMID:21106660 ; http://dx.doi.org/10.1378/ chest.10-0595 118.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
"Crit Care Clin 2009; 25:857-67, x; PMID:19892257 ; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
"Clin Chest Med 2008; 29:721- 33, x;  PMID:18954706 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care  2005; 9:R764-70;  PMID:16356225 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
J Trauma  2010; 69:1282-7;  PMID:20134352 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2004; 32(Suppl):S595-7;  PMID :15542969 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2010; 38:668-78;  PMID:20029343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
Crit Care Med 2003; 31:1250-6;  PMID:12682500 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/74/viru-5-190.PMC3916373.pdf
"1,5,6 The  identification of various pro-inflammatory compounds, such as endotoxin, cytokines, products of arachidonic acid metabo - lism, coupled with the demonstration that a clinical syndrome resembling sepsis could be produced by injecting these molecules Correspondence to: Robert A Balk; Email: Robert_Balk@rush.edu Submitted: 07/30/2013; Revised: 11/07/2013; Accepted: 11/08/2013http://dx.doi.org/10.4161/viru.27135Systemic inflammatory response syndrome (SIRS) Where did it come from and is it still relevant today?",Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 1997; 25:1095-100;  PMID:9233726 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 1991; 266:1686- 91; PMID:1886193 ; http://dx.doi.org/10.1001/ jama.1991.03470120088038 7.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Chest 1997; 112(Suppl):321S-9S;  PMID:9400897 ; http://dx.doi.org/10.1378/ chest.112.6_Supplement.321S8.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
"Crit Care Clin 2000; 16:337-52,  vii; PMID:10768085 ; http://dx.doi.org/10.1016/ S0749-0704(05)70113-5 9.",OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 1993; 328:1471-7; PMID:8479467 ;  http://dx.doi.org/10.1056/NEJM199305203282008 10.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Arch Intern Med  1992 ; 152:1381-9;  PMID:1627018 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Chest 1991; 100:802- 8; PMID:1889276 ; http://dx.doi.org/10.1378/ chest.100.3.802 13.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
"Dear SIRS, I’m sorry to say  that I don’t like you.... Crit Care Med 1997;  25:372-4;  PMID:9034279 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Chest 2007;  132:1967-76;  PMID:18079230 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Chest 1992;  101:1656-62;  PMID:1600787 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 1995; 273:934- 41; PMID:7884952 ; http://dx.doi.org/10.1001/ jama.1995.03520360048038 18.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 1987; 317:653- 8; PMID:3306374 ; http://dx.doi.org/10.1056/ NEJM198709103171101 20.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 1989;  17:389-93;  PMID:2651003 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 1995; 273:117- 23; PMID:7799491 ; http://dx.doi.org/10.1001/ jama.1995.03520260039030 22.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med  2003; 31:1250-6;  PMID:12682500 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 2007; 35:1244- 50; PMID:17414736 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 2012; 40:754- 61; PMID:21963582 ; http://dx.doi.org/10.1097/ CCM.0b013e318232db65 26.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2001; 344:2051-9;  http://dx.doi.org/10.1056/NEJM200103083441001 28.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2012; 366:2055- 64; PMID:22616830 ; http://dx.doi.org/10.1056/ NEJMoa1202290 29.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2001; 345:1368-77; PMID:11794169 ; http://dx.doi.org/10.1056/ NEJMoa010307 30.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2004; 350:2247- 56; PMID :15163774 ; http://dx.doi.org/10.1056/ NEJMoa040232 31.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 2013; 41:580- 637; PMID:23353941 ; http://dx.doi.org/10.1097/ CCM.0b013e31827e83af 32.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Shock 2010; 33:375-80; PMID:19851126 ;  http://dx.doi.org/10.1097/SHK.0b013e3181c6ba6f 33.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2010; 362:779- 89; PMID:20200382 ; http://dx.doi.org/10.1056/ NEJMoa090711834.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 2006; 34:2707-13;  PMID:16943733 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Crit Care Med 2009; 37:2290- 8; PMID:19487943 ; http://dx.doi.org/10.1097/ CCM.0b013e3181a02afc 37.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 1991; 266:1686- 91; PMID:1886193 ; http://dx.doi.org/10.1001/ jama.1991.03470120088038 39.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Ann Intern Med  1994; 120:771-83;  PMID:8147551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 1996; 276:565-6;  PMID:8709407 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
N Engl J Med 2012; 366:2122-4;  PMID:22616829 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
JAMA 2011; 306:194- 9; PMID:21750297 ; http://dx.doi.org/10.1001/ jama.2011.909 43.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Lancet 2013; 381:774- 5; PMID:23472921 ; http://dx.doi.org/10.1016/ S0140-6736(12)61815-7 44.,OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
Am J Respir Crit Care Med 2012; 186:65-71; PMID:22538802 ;  http://dx.doi.org/10.1164/rccm.201201-0037OC,Non-OADS,/arxiv_data1/oa_pdf/60/a0/viru-5-20.PMC3916374.pdf
"Despite decades of investigation and the expenditure of billions of dollars, there is no specific treatment that is effective in the management of patients with  Correspondence to: Simon Finfer; Email: sfinfer@georgeinstitute.org.au Submitted: 06/17/2013; Revised: 07/22/2013; Accepted: 07/22/2013http://dx.doi.org/10.4161/viru.25855Severe sepsis with multiple organ dysfunction remains the  most common cause of death for patients treated in intensive care units.",Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med 2004; 30:536-55;  PMID:14997291; http://dx.doi.org/10.1007/s00134- 004-2210-z 2.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2001; 345:1368-77; PMID:11794169;  http://dx.doi.org/10.1056/NEJMoa0103073.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2004; 350:2247- 56; PMID:15163774; http://dx.doi.org/10.1056/ NEJMoa040232 4.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2004; 350:2294-6; PMID:15163781; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care  Med 2011; 37:86-96; PMID:20924555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Crit Care Med 2011; 39:386-91; PMID:21248514; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
PLoS Clin T rials 2006;  1:e21; PMID:16998584; http://dx.doi.org/10.1371/ journal.pctr.0010021 8.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med  2006; 354:449-61; PMID:16452557; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
J Am Coll Cardiol 1995; 26:57-65; PMID:7797776;  http://dx.doi.org/10.1016/0735-1097(95)00126-K 38.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Mayo Clin Proc 2005; 80:1546-8; PMID:16342646;  http://dx.doi.org/10.4065/80.12.1546 39.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Crit Care 2008; 12:R120;  PMID:18799004; http://dx.doi.org/10.1186/cc7017 42.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med  2009; 35:1738-48; PMID:19636533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2012; 367:1108-18; PMID:22992074;  http://dx.doi.org/10.1056/NEJMoa1204942 44.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Mayo Clin Proc 2010; 85:217- 24; PMID:20176928; http://dx.doi.org/10.4065/ mcp.2009.0394 45.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Crit Care Med  2009; 37:424-31; PMID:19114908; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Ann Intern Med 2011; 154:268-82;  PMID:21320942; http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00008 48.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Diabetes Care 2012;  35(Suppl 1):S11-63; PMID:22187469; http://dx.doi.org/10.2337/dc12-s01122.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med 2013; 39:811-22;  PMID:23430019; http://dx.doi.org/10.1007/s00134- 013-2863-6 23.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Crit Care 2012; 16:R94;  PMID:22624531; http://dx.doi.org/10.1186/cc11358 24.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med 2013; 39:165-228;  PMID:23361625; http://dx.doi.org/10.1007/s00134- 012-2769-8 25.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
JAMA 2012; 308:1566-72; PMID:23073953; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2006; 355:1903-11; PMID:17079764; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Mayo Clin Proc  2003; 78:1471-8; PMID:14661676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Stroke 2001; 32:2426-32; PMID:11588337;  http://dx.doi.org/10.1161/hs1001.096194 33.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Lancet 2000; 355:773-8;  PMID:10711923; http://dx.doi.org/10.1016/S0140- 6736(99)08415-9 34.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2001; 345:1359- 67; PMID:11794168; http://dx.doi.org/10.1056/ NEJMoa0113009.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2011; 364:2483- 95; PMID:21615299; http://dx.doi.org/10.1056/ NEJMoa1101549 10.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med  2008; 34:17-60; PMID:18058085; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2008; 358:125-39; PMID:18184958; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Crit Care  2010; 14:R185; PMID:20950434; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2012; 367:124-34; PMID:22738085;  http://dx.doi.org/10.1056/NEJMoa1204242 18.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
N Engl J Med 2012; 367:1901-11; PMID:23075127; http://dx.doi.org/10.1056/ NEJMoa1209759 19.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
Intensive Care Med 2013; 39:558-68;  PMID:23407978; http://dx.doi.org/10.1007/s00134- 013-2840-0 20.,Non-OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
JAMA 2013; 309:678-88; PMID:23423413;  http://dx.doi.org/10.1001/jama.2013.430 21.,OADS,/arxiv_data1/oa_pdf/28/43/viru-5-200.PMC3916375.pdf
"1 In this review we will address the epidemiology, mecha - nisms of resistance, impact on clinical outcomes, treatment and  *Correspondence to: Aurora Pop-Vicas;   Email: Aurora_Pop-Vicas@brown.eduSubmitted: 06/01/2013; Revised: 08/13/2013; Accepted: 08/19/2013http://dx.doi.org/10.4161/viru.26210Multi-antibiotic drug-resistant (MDR) gram-negative bacilli  are becoming a major threat to the standard care of septic patients.",Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect  Dis 2009; 48:1-12; PMID:19035777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
N Engl J Med  2009; 360:439-43; PMID:19179312; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Antimicrob Chemother 2006; 58:205- 10; PMID:16717055; http://dx.doi.org/10.1093/jac/ dkl1994.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2011; 53:60-7; PMID:21653305; http://dx.doi.org/10.1093/cid/ cir202,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Chest 2008; 134:281-7;  PMID:18682456; http://dx.doi.org/10.1378/chest.08- 1116 36.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother 2007; 51:1987- 94; PMID:17387156; http://dx.doi.org/10.1128/ AAC.01509-06 37.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Crit Care  Med 2008; 36:296-327; PMID:18158437; http://dx.doi.org/10.1097/01.CCM.0000298158.12101.41 40.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Crit Care Med  2006; 34:1589-96; PMID:16625125; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Crit Care Med 2010; 38:1773-85; PMID:20639750; http://dx.doi.org/10.1097/ CCM.0b013e3181eb3ccd 43.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
N Engl J Med 2010; 362:1804-13; PMID:20463340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Crit Care Med  2010; 38:1651-64; PMID:20562695; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Ann Intern Med 1991; 115:585-90; PMID:1892329;  http://dx.doi.org/10.7326/0003-4819-115-8-585 22.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother 2006; 50:3098- 101; PMID:16940107; http://dx.doi.org/10.1128/AAC.00438-06 23.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother  2007; 51:1553-5; PMID:17261621; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents  Chemother 2003; 47:1297-300; PMID:12654661;  http://dx.doi.org/10.1128/AAC.47.4.1297-1300.2003 25.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis  2012; 55:852-9; PMID:22700827; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2006; 43(Suppl 2):S49-56;  PMID:16894515; http://dx.doi.org/10.1086/504477 27.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Drugs 1999;  58(Suppl 2):11-8; PMID:10553699; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2007; 45:88-94;  PMID:17554708; http://dx.doi.org/10.1086/518605 29.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Eur J Clin Microbiol  Infect Dis 2010; 29:1349-53; PMID:20614151; http://dx.doi.org/10.1007/s10096-010-1004-1 30.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Antimicrob Chemother 2006; 58:387- 92; PMID:16751638; http://dx.doi.org/10.1093/jac/dkl239 33.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Microbiol Infect 2010; 16:102-11;  PMID:20085604; http://dx.doi.org/10.1111/j.1469- 0691.2009.03115.x 34.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother  2010; 54:3564-8; PMID:20547788; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Lancet Infect Dis 2011; 11:355-62; PMID:21478057; http://dx.doi.org/10.1016/S1473-3099(11)70059-7 9.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Reported in Times of India 11  March 2011. http://artciles.timesofindia.indiatimes/com/2011-03-11/delhi/28679651_1_djb-water-drink- ing-water-samples 10.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
BMC Infect Dis 2006; 6:130;  PMID:16914034; http://dx.doi.org/10.1186/1471- 2334-6-130 11.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Infect Control  Hosp Epidemiol 2010; 31:716-21; PMID:20486855;  http://dx.doi.org/10.1086/653201 12.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Emerg Infect  Dis 2007; 13:1121-3; PMID:18214201; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2008; 47:689-92;  PMID:18665816; http://dx.doi.org/10.1086/590941 14.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Antimicrob Chemother  2004; 54:735-43; PMID:15347638; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
N Engl J Med 2005; 352:380-91; PMID:15673804;  http://dx.doi.org/10.1056/NEJMra041359 16.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Curr Opin Microbiol 2009; 12:476- 81; PMID:19716760; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Int J Antimicrob Agents 2012; 39:283-94; PMID:22386741;  http://dx.doi.org/10.1016/j.ijantimicag.2011.12.012 18.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis  2010; 51:286-94; PMID:20572763; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Infect Dis 2013; 207:919-28; PMID:23288927;  http://dx.doi.org/10.1093/infdis/jis933 20.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Microbiol Rev 2009; 22:161-82;  PMID:19136439; http://dx.doi.org/10.1128/ CMR.00036-08,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2008; 46:567-70;  PMID:18199038; http://dx.doi.org/10.1086/526775 61.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Lancet Infect Dis 2010; 10:43-50;  PMID:20129148; http://dx.doi.org/10.1016/S1473-3099(09)70325-1 62.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Int J  Antimicrob Agents 2011; 37:415-9; PMID:21429716;  http://dx.doi.org/10.1016/j.ijantimicag.2011.01.012 63.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin  Microbiol Infect 2010; 16:184-6; PMID:19694767;  http://dx.doi.org/10.1111/j.1469-0691.2009.02921.x 64.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis  2013; 56:1685-94; PMID:23599308; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Int J  Antimicrob Agents 2008; 32:1-9; PMID:18550343;  http://dx.doi.org/10.1016/j.ijantimicag.2008.03.00253.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 1999; 28:1008-11; PMID:10452626; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Int J Antimicrob Agents  2010; 35:194-9; PMID:20006471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Antimicrob Chemother 2008; 61:417- 20; PMID:18174197; http://dx.doi.org/10.1093/jac/ dkm509 57.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis 2009; 48:1724-8;  PMID:19438394; http://dx.doi.org/10.1086/599225 58.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
J Infect  2009; 58:273-84; PMID:19344841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
"Diagn  Microbiol Infect Dis 2008; 61:358-9, author reply  360-1; PMID:18342476; http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother  2001; 45:3548-54; PMID:11709338; http://dx.doi.org/10.1128/AAC.45.12.3548-3554.2001 47.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Curr Infect Dis Rep  2011; 13:416-25; PMID:21800232; http://dx.doi.org/10.1007/s11908-011-0200-1 49.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Clin Infect Dis  2012; 55:943-50; PMID:22752516; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents  Chemother 2012; 56:2108-13; PMID:22252816; http://dx.doi.org/10.1128/AAC.06268-11 51.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
Antimicrob Agents Chemother 2012; 56:3395- 8; PMID:22430958; http://dx.doi.org/10.1128/ AAC.06364-11 52.,Non-OADS,/arxiv_data1/oa_pdf/90/9f/viru-5-206.PMC3916376.pdf
"19-21 The lipid A of  some human pathogens like Francisella  spp., Yersinia pestis , and Correspondence to: Girish Ramachandran;   Email: gramacha@medicine.umaryland.eduSubmitted: 08/21/2013; Revised: 10/28/2013; Accepted: 10/31/2013http://dx.doi.org/10.4161/viru.27024Gram-positive and gram-negative bacterial toxins  in sepsis A brief review Girish  Ramachandran Center for v accine Development; Department of Medicine; University of Maryland School of Medicine; Baltimore, MD USA Keywords:  sepsis, LPS, superantigens, TLR4, TNF α, cytokine storm Bacterial sepsis is a major cause of fatality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
"Clin Chest Med 2008; 29:735-47, x-xi;  PMID:18954707 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Cell  2007; 130:906-17;  PMID:17803912 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Infect Dis 2006;  193:634-44;  PMID:16453258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Ann Intern Med 1990; 113:227-42; PMID:2197912 ;  http://dx.doi.org/10.7326/0003-4819-113-3-227 7.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
N Engl J Med 2003; 348:1546- 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 8.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Clin Infect Dis 2003; 37:50-8; PMID:12830408 ; http://dx.doi.org/10.1086/375593 9.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Infect Dis 2004; 189:1734-42;  PMID :15116313 ; http://dx.doi.org/10.1086/383278 10.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature 2004;  430:250-6;  PMID :15241423 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Lancet Infect Dis 2008; 8:32-43; PMID:18063412 ; http://dx.doi.org/10.1016/ S1473-3099(07)70265-713.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Cell 2006; 124:783- 801; PMID:16497588 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Annu Rev Med 1987; 38:417-32;  PMID:3555304 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Annu Rev Biochem 2002; 71:635-700;  PMID:12045108 ; http://dx.doi.org/10.1146/ annurev.biochem.71.110601.135414 17.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Anal Biochem 2005; 345:336- 9; PMID:16118008 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Eur J Biochem 2000;  267:2008-13;  PMID:10727940 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Biol Chem 2003; 278:32552-60; PMID:12807870 ;  http://dx.doi.org/10.1074/jbc.M305536200 25.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nat Rev Microbiol  2005; 3:36-46; PMID:15608698 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature  1997; 388:394-7;  PMID:9237759 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science 1990; 249:1429-31; PMID:2402637 ;  http://dx.doi.org/10.1126/science.2402637 31.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1999; 189:1777-82;  PMID:10359581 ; http://dx.doi.org/10.1084/ jem.189.11.1777 33.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Proc Natl Acad Sci U S A  2004; 101:4186-91;  PMID :15010525 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
PLoS One 2012; 7:e32359;  PMID:22496731 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Cytokine 2008; 42:145- 51; PMID:18304834 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Biochem Biophys Res Commun 2002; 295:157- 62; PMID:12083783 ; http://dx.doi.org/10.1016/ S0006-291X(02)00638-1Conclusion Treatment of sepsis still remains a serious concern and chal - lenge in hospitals.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Blut 1987; 55:101- 8; PMID:3111564 ; http://dx.doi.org/10.1007/ BF00631779 40.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Microbes Infect  2001; 3:1327-34;  PMID:11755422 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Peptides 2012; 36:308-14; PMID:22659161 ;  http://dx.doi.org/10.1016/j.peptides.2012.05.014 43.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science 1997; 276:250- 3; PMID:9092473 ; http://dx.doi.org/10.1126/ science.276.5310.250 44.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Biol Chem 2004; 279:20044-8;  PMID:15014080 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Biol Chem 2001;  276:9083-92;  PMID:11108722 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
EMBO J 2000; 19:5071-80; PMID:11013210 ; http://dx.doi.org/10.1093/ emboj/19.19.5071 48.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Infect Immun 2000; 68:6139- 46; PMID:11035717 ; http://dx.doi.org/10.1128/ IAI.68.11.6139-6146.2000 50.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science  1985; 229:869-71;  PMID:3895437 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science  1986; 234:470-4;  PMID:3764421 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature  1987; 330:662-4;  PMID:3317066 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature 1993; 364:798-802;  PMID:8395024 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Proc Natl Acad Sci U S A 1990; 87:3629- 32; PMID:2333306 ; http://dx.doi.org/10.1073/ pnas.87.9.3629 63.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Proc Natl Acad Sci U  S A 1987; 84:4273-7; PMID:3108890 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med  1997; 186:1831-41;  PMID:9382882 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
JAMA 2013; 309:1154-62; PMID:23512062 ;  http://dx.doi.org/10.1001/jama.2013.219467.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
FEBS J 2011;  278:4649-67;  PMID :21535475 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Crit Rev Microbiol 1990; 17:251-72; PMID:2206394 ;  http://dx.doi.org/10.3109/10408419009105728 69.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Annu Rev Immunol  1991; 9:745-72;  PMID:1832875 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1989; 170:2011-22; PMID:2584933 ; http://dx.doi.org/10.1084/ jem.170.6.2011 72.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Proc Natl Acad Sci U S A 1989; 86:4210- 4; PMID:2542966 ; http://dx.doi.org/10.1073/ pnas.86.11.4210 74.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature 1989; 339:221-3;  PMID:2785644 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature 1990; 346:471-3;  PMID:2377208 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science 1989; 244:811- 3; PMID:2524876 ; http://dx.doi.org/10.1126/ science.2524876 77.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1996;  183:2675-80;  PMID:8676089 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med  1996; 183:2481-8;  PMID:8676068 ;  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
PLoS Biol  2011; 9:e1001149;  PMID :21931534 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1990; 171:455- 64; PMID:2303780 ; http://dx.doi.org/10.1084/ jem.171.2.455 83.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1992; 175:91-8; PMID:1730929 ;  http://dx.doi.org/10.1084/jem.175.1.91 84.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med 1998; 187:823-33; PMID:9500785 ; http://dx.doi.org/10.1084/ jem.187.6.823 85.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Infect Dis 1993; 168:232- 5; PMID:8515117 ; http://dx.doi.org/10.1093/ infdis/168.1.232 87.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Am J Infect Control 2005; 33(Suppl 1):S41-9;  PMID :15940115 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Crit Care Med  2009; 37:1777-86;  PMID:19325463 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Mol Microbiol 1997;  26:621-9;  PMID:9427393 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Int J Med Microbiol 2009; 299:161-76; PMID:18948059 ;  http://dx.doi.org/10.1016/j.ijmm.2008.08.003 92.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Rev Infect Dis 1983;  5(Suppl 4):S715-22;  PMID : 6415785 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Infect Immun 2012; 80:1626- 33; PMID:22354031 ; http://dx.doi.org/10.1128/ IAI.06061-11 97.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
JAMA  2002; 287:2236-52;  PMID:11980524 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Annu Rev Microbiol  2001; 55:647-71;  PMID :11544370 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Vaccine 1991; 9:533-9; PMID:1771966 ;  http://dx.doi.org/10.1016/0264-410X(91)90237-Z 101.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Ann Intern Med 2006;  144:270-80;  PMID:16490913 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Annu Rev  Cell Dev Biol 2003; 19:45-70; PMID:14570563 ;  http://dx.doi.org/10.1146/annurev.cellbio.19.111301.140655 103.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nature 2001; 414:229-33; PMID:11700563 ; http://dx.doi.org/10.1038/ n35101998 106.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Nat Rev Microbiol  2004; 2:721-6;  PMID:15372082 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Biochem Biophys Res Commun  1998; 248:706-11;  PMID:9703991 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Science 2002; 297:2048- 51; PMID:12202685 ; http://dx.doi.org/10.1126/ science.1073163110.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Toxins (Basel) 2011; 3:591-607;  PMID:22069727 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Infect Dis 2005; 192:837-45;  PMID:16088833 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Biochem Biophys  Res Commun 2005; 337:1249-56; PMID:16242117 ;  http://dx.doi.org/10.1016/j.bbrc.2005.09.180 114.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
J Exp Med  2005; 201:325-31;  PMID :15699068 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Infect Immun 2005; 73:8275- 81; PMID:16299324 ; http://dx.doi.org/10.1128/ IAI.73.12.8275-8281.2005 118.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Toxins (Basel)  2011; 3:660-71;  PMID:22069732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Cell Microbiol 2007; 9:924-9;  PMID:17087730 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Mol Aspects Med 2009; 30:456-66; PMID:19560486 ;  http://dx.doi.org/10.1016/j.mam.2009.06.002 122.,OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
Clin Infect Dis 2012; 54:1148-61;  PMID:22438345 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/85/98/viru-5-213.PMC3916377.pdf
"In data submitted to the CDC databases (National Healthcare Safety Network [NHSN], National Nosocomial Infections Surveillance [NNIS] systems), over the last decade the  Correspondence to: Alan S Cross; Email: across@medicine.umaryland.edu Submitted: 06/25/2013; Revised: 07/29/2013; Accepted: 07/30/2013http://dx.doi.org/10.4161/viru.25965Gram-negative bacterial (GNB) infections are a leading  cause of serious infections both in hospitals and the commu - nity.",Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis  1988; 158:291-300; PMID:3042871; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 1982; 307:1225-30; PMID:6752708; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Lancet 1985;  2:59-63; PMID:2861523; http://dx.doi.org/10.1016/ S0140-6736(85)90176-X 36.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis  1988; 158:312-9; PMID:3136210; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis  1992; 165:695-701; PMID:1552198; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Scand J Infect Dis 1989; 21:697-708; PMID:2617211;  http://dx.doi.org/10.3109/00365548909021700 40.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 1995; 274:172- 7; PMID:7596007; http://dx.doi.org/10.1001/ jama.1995.03530020090038 41.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Ann Surg  1993; 217:300-6; PMID:8452409; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Clin Invest 1983; 72:1874- 81; PMID:6358257; http://dx.doi.org/10.1172/JCI11115017.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Am J Med Sci  1970; 259:114-9; PMID:4905231; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Clin  Invest 1960; 39:82-8; PMID:14437724; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Vaccine  1995; 13:449-53; PMID:7639013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Clin Invest 1987; 80:51-6; PMID:3110215; http://dx.doi.org/10.1172/ JCI113062 22.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1994; 170:834-40; PMID:7523536;  http://dx.doi.org/10.1093/infdis/170.4.834 23.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Vaccine 1994; 12:1288- 94; PMID:7856293; http://dx.doi.org/10.1016/ S0264-410X(94)80054-4 24.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Clin Infect Dis 1996; 23:179- 81; PMID:8816151; http://dx.doi.org/10.1093/cli- nids/23.1.179 25.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1991; 163:1055-61; PMID:1902245;  http://dx.doi.org/10.1093/infdis/163.5.1055 26.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect  Dis 1996; 174:537-43; PMID:8769611; http://dx.doi.org/10.1093/infdis/174.3.537 27.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1989; 160:225- 36; PMID:2474616; http://dx.doi.org/10.1093/ infdis/160.2.225 29.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Clin Invest  1973; 52:3236-8; PMID:4584346; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
AMA Arch Intern Med 1951; 88:467- 88; PMID:14867954; http://dx.doi.org/10.1001/ archinte.1951.03810100051005 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Am Med Assoc 1959; 170:2188- 97; PMID:13822924; http://dx.doi.org/10.1001/ jama.1959.63010180008012 3.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 1959; 261:677- 83; PMID:14438354; http://dx.doi.org/10.1056/ NEJM195910012611401 4.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Infect Control Hosp Epidemiol  2013; 34:259-68; PMID:23388360; http://dx.doi.org/10.1086/669523 6.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 2009;  360:439-43; PMID:19179312; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2013;  309:1573-4; PMID:23592085; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 2013;  368:299-302; PMID:23343059; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Semin Arthritis Rheum  2012; 42:223-33; PMID:22748510; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 1991; 325:1453- 60; PMID:1944423; http://dx.doi.org/10.1056/NEJM199111213252101 12.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Annu Rev Microbiol 1967; 21:443-66; PMID:4860265; http://dx.doi.org/10.1146/annurev.mi.21.100167.002303 13.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Exp Med 1909; 11:241-56; PMID:19867246;  http://dx.doi.org/10.1084/jem.11.2.241 14.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Clin Microbiol Infect 2012; 18(Suppl 5):109-16;  PMID:22882709; http://dx.doi.org/10.1111/j.1469-0691.2012.03939.x 15.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Ann N Y Acad Sci 1966;  133:746-62; PMID:4164249; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Infect Immun  2000; 68:6202-8; PMID:11035726; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Biol Chem  2003; 278:25618-27; PMID:12716894; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Proc Natl Acad Sci U S A  2012; 109:20877-82; PMID:23184990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Leukoc Biol  2008; 83:483-8; PMID:18070981; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2010; 304:1787-94; PMID:20978258; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2010; 304:1833- 4; PMID:20978262; http://dx.doi.org/10.1001/jama.2010.1546 72.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2010; 303:2253-9; PMID:20530778; http://dx.doi.org/10.1001/ jama.2010.761 73.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2010; 304:1856; PMID:20978264; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 1997;  277:1058-63; PMID:9091694; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1994; 170:622- 9; PMID:8077720; http://dx.doi.org/10.1093/ infdis/170.3.622 54.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1989; 159:1073-82; PMID:2723454; http://dx.doi.org/10.1093/infdis/159.6.1073 55.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 1996; 173:1157-63; PMID:8627067;  http://dx.doi.org/10.1093/infdis/173.5.1157 56.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 2001; 183:1079-86; PMID:11237833;  http://dx.doi.org/10.1086/319297 58.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
J Infect Dis 2005; 192:2074-80;  PMID:16288370; http://dx.doi.org/10.1086/498167 59.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Lancet 1984; 1:981-3; PMID:6143965; http://dx.doi.org/10.1016/S0140-6736(84)92324-9 61.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
FEMS Immunol  Med Microbiol 1996; 16:21-30; PMID:8954349;  http://dx.doi.org/10.1016/S0928-8244(96)00065-X 62.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
FEMS Immunol Med Microbiol 2003; 37:59-67; PMID:12770761; http://dx.doi.org/10.1016/S0928- 8244(03)00104-443.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Crit Care Med  1991; 19:1104-13; PMID:1884609; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 1991; 324:429- 36; PMID:1988827; http://dx.doi.org/10.1056/ NEJM199102143240701 45.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 1991; 266:1097- 102; PMID:1865542; http://dx.doi.org/10.1001/jama.1991.03470080067031 46.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 1995; 273:934- 41; PMID:7884952; http://dx.doi.org/10.1001/ jama.1995.03520360048038 48.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med  1996; 334:1697-702; PMID:8637514; http://dx.doi.org/10.1056/NEJM199606273342603 49.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA  1994; 271:1836-43; PMID:8196140; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
N Engl J Med 2001; 344:699- 709; PMID:11236773; http://dx.doi.org/10.1056/ NEJM200103083441001 51.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
JAMA 2001; 286:1869- 78; PMID:11597289; http://dx.doi.org/10.1001/ jama.286.15.1869 52.,Non-OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
Lancet  2000; 356:961-7; PMID:11041396; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/29/viru-5-219.PMC3916378.pdf
"Because of the specificity of cellular target hosts, application of phages has been proposed  *Correspondence to: Xavier Wittebole;   Email: xavier.wittebole@uclouvain.beSubmitted: 06/27/2013; Revised: 07/30/2013; Accepted: 07/31/2013http://dx.doi.org/10.4161/viru.25991The seemingly inexorable spread of antibiotic resistance  genes among microbial pathogens now threatens the long- term viability of our current antimicrobial therapy to treat se - vere bacterial infections such as sepsis.",Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
"(for Phages for Human Application Group Europe; http://www.p-h-a-g-e.org), an international non-profit organiza - tion, with the aim to develop a specific framework for the use of bacteriophages.",Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Viruses  2012; 4:3162-78; PMID:23202520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Curr Opin Microbiol 2003; 6:417-24;  PMID:12941415; http://dx.doi.org/10.1016/S1369- 5274(03)00086-9 46.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Proc Natl Acad Sci U S A 2009; 106:4629- 34; PMID:19255432; http://dx.doi.org/10.1073/ pnas.0800442106 47.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Appl  Environ Microbiol 2012; 78:744-51; PMID:22113912; http://dx.doi.org/10.1128/AEM.05741-11 48.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Int J Antimicrob  Agents 2010; 36(Suppl 2):S50-4; PMID:21129924; http://dx.doi.org/10.1016/j.ijantimicag.2010.11.014 49.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
N Engl J Med  2009; 360:439-43; PMID:19179312; http://dx.doi.org/10.1056/NEJMp0804651 50.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
JAMA 2007; 298:1763-71; PMID:17940231; http://dx.doi.org/10.1001/jama.298.15.1763 51.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Expert Rev  Anti Infect Ther 2013; 11:297-308; PMID:23458769;  http://dx.doi.org/10.1586/eri.13.12 52.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Bioethics 2007; 21:218-29; PMID:17845480; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Nat Med 2012; 18:1318-20; PMID:22961150; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Drug Resist Updat 2011; 14:118- 24; PMID:21435939; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Curr Opin Microbiol 2011; 14:564-9; PMID:21873107;  http://dx.doi.org/10.1016/j.mib.2011.08.002 59.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Curr Opin Biotechnol 2011; 22:157-63;  PMID:21115341; http://dx.doi.org/10.1016/j.cop- bio.2010.10.00822.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Pathol Bacteriol 1933; 36:307-18;  http://dx.doi.org/10.1002/path.1700360212 23.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Naturwissenschaften 1940;  28:45-6; http://dx.doi.org/10.1007/BF01486931 26.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Lancet 2000;  355:1713-7; PMID:10905259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Proc Natl Acad Sci U S A 1942; 28:127- 130.1; PMID:16588529; http://dx.doi.org/10.1073/ pnas.28.4.127 28.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
"Adhya S, Black L, Friedman D, Hatfull G, Kreuzer K, Merril C, Oppenheim A, Rohwer F , Young R. 2004  ASM Conference on the New Phage Biology: the  ‘Phage Summit’.. Mol Microbiol 2005; 55:1300-14;  PMID:15720541; http://dx.doi.org/10.1111/j.1365-2958.2005.04509.x 33.",Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
BEG news  2000; 3:5 (http://phage.org/2000) 34.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Arch Virol 2012;  157:1843-9; PMID:22752841; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Viruses 2012; 4:3316- 35; PMID:23342361; http://dx.doi.org/10.3390/ v4123316 37.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Future Microbiol 2010; 5:1041-55; PMID:20632804;  http://dx.doi.org/10.2217/fmb.10.66 38.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Arch Virol 1996; 141:209-18; PMID:8634015; http://dx.doi.org/10.1007/ BF01718394 41.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Bacteriol 2002; 184:4529-35; PMID:12142423; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Arch Virol 2000; 145:197-203; PMID:10664418; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Bacteriophage  2011; 1:1-2; PMID:21687529; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
FEMS Microbiol Rev 2004; 28:127-81; PMID:15109783;  http://dx.doi.org/10.1016/j.femsre.2003.08.001 3.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Bacteriophage 2011;  1:66-85; PMID:22334863; http://dx.doi.org/10.4161/bact.1.2.15845 6.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Adv Virus Res 2012; 83:3-40; PMID:22748807; http://dx.doi.org/10.1016/B978-0- 12-394438-2.00001-3 7.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Am Med  Assoc 1934; 103:1769-76; http://dx.doi.org/10.1001/jama.1934.72750490003007 8.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Am Med  Assoc 1934; 103:1847-53; http://dx.doi.org/10.1001/ jama.1934.72750500003009 9.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Am Med  Assoc 1934; 103:1934-9; http://dx.doi.org/10.1001/ jama.1934.72750510005009 10.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
In the beginning… Bacteriophage 2011; 1:50-1; PMID:21687535; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Gen Physiol 1938; 21:335-66;  PMID:19873054; http://dx.doi.org/10.1085/ jgp.21.3.335 18.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Am Nat 1922; 56:32-50; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Studies in History and Phylosophy of Biological and Biomedical Sciences 2010; 41:367-75;  http://dx.doi.org/10.1016/j.shpsc.2010.10.012,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Res Microbiol 2007; 158:555-66; PMID:17889511;  http://dx.doi.org/10.1016/j.resmic.2007.07.006 90.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Curr  Pharm Biotechnol 2010; 11:15-27; PMID:20214605; http://dx.doi.org/10.2174/138920110790725348 91.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Appl Microbiol 2005; 98:7-13; PMID:15610412; http://dx.doi.org/10.1111/j.1365- 2672.2004.02422.x 92.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Science  2002; 295:2091-4; PMID:11896279; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
FEBS Lett  1986; 205:241-5; PMID:3527751; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
BMJ 2011; 342:d819; PMID:21300707; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Med Microbiol  1992; 37:258-61; PMID:1404324; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Proc Natl Acad Sci U S  A 1996; 93:3188-92; PMID:8622911; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents  Chemother 2005; 49:1220-1; PMID:15728933;  http://dx.doi.org/10.1128/AAC.49.3.1220-1221.2005 100.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents Chemother 2007; 51:446- 52; PMID:17116686; http://dx.doi.org/10.1128/ AAC.00635-06 101.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Indian J Pathol Microbiol 2008; 51:360-6; PMID:18723958; http://dx.doi.org/10.4103/0377- 4929.42511 102.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Infect Dis 2010; 201:1096-104; PMID:20196657; http://dx.doi.org/10.1086/651135 103.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Res Microbiol 2010; 161:854-60; PMID:20868746; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Curr Pharm Biotechnol  2008; 9:261-6; PMID:18691087; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Clin Exp Med 2009; 9:303-12; PMID:19350363;  http://dx.doi.org/10.1007/s10238-009-0044-2 77.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Adv Virus Res 2012; 83:73-121; PMID:22748809; http://dx.doi.org/10.1016/B978-0- 12-394438-2.00003-7 78.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
FEMS Immunol Med  Microbiol 2002; 34:135-8; PMID:12381464; http://dx.doi.org/10.1111/j.1574-695X.2002.tb00614.x 79.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Adv Virus  Res 2012; 83:41-71; PMID:22748808; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
PLoS One 2012; 7:e52709; PMID:23285164; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
PLoS One 2009; 4:e4944;  PMID:19300511; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Pharm Res 2011; 28:934- 7; PMID:21063753; http://dx.doi.org/10.1007/ s11095-010-0313-5 84.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Folia Microbiol (Praha) 2011; 56:191-200;  PMID:21625877; http://dx.doi.org/10.1007/s12223-011-0039-8 85.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Foodborne Pathog Dis 2005; 2:287-303; PMID:16366852; http://dx.doi.org/10.1089/ fpd.2005.2.287 86.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
FEMS  Microbiol Lett 2002; 214:153-7; PMID:12351223;  http://dx.doi.org/10.1111/j.1574-6968.2002.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Bacteriol 2007; 189:5608-16; PMID:17545290;  http://dx.doi.org/10.1128/JB.00619-0760.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Virol J 2012; 9:9;  PMID:22234269; http://dx.doi.org/10.1186/1743- 422X-9-9 61.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Microb Biotechnol 2009; 2:601-12;  PMID:21255295; http://dx.doi.org/10.1111/j.1751- 7915.2009.00089.x 62.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Clin Microbiol  2012; 50:1362-9; PMID:22278833; http://dx.doi.org/10.1128/JCM.06192-11 63.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Infect Dis  2003; 187:613-24; PMID:12599078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents Chemother  2004; 48:2558-69; PMID:15215109; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents Chemother 2005; 49:2874-8; PMID:15980363; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Virology  2012; 434:222-32; PMID:23102968; http://dx.doi.org/10.1016/j.virol.2012.09.002 71.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents  Chemother 2012; 56:3568-75; PMID:22491690;  http://dx.doi.org/10.1128/AAC.06330-11 72.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Infect 1998; 36:5-15; PMID:9515662; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Clin Otolaryngol 2009; 34:349-57; PMID:19673983; http://dx.doi.org/10.1111/j.1749- 4486.2009.01973.x 117.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
PLoS One 2009; 4:e4944; PMID:19300511; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Bacteriophage 2011;  1:66-85; PMID:22334863; http://dx.doi.org/10.4161/ bact.1.2.15845 111.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Chem Technol Biotechnol 2001; 76:689-99;  http://dx.doi.org/10.1002/jctb.438 113.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents Chemother 2001; 45:649- 59; PMID:11181338; http://dx.doi.org/10.1128/ AAC.45.3.649-659.2001 114.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Antimicrob Agents Chemother 2011; 55:1358- 65; PMID:21245450; http://dx.doi.org/10.1128/ AAC.01123-10 105.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
J Med Microbiol 2011; 60:205- 10; PMID:20965914; http://dx.doi.org/10.1099/ jmm.0.018580-0 106.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
PLoS One 2011; 6:e16963; PMID:21347240; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
Med Sci Monit  2011; 17:BR173-8; PMID:21709627; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
MBio 2012; 3:e00029- 12; PMID:22396480; http://dx.doi.org/10.1128/ mBio.00029-12,Non-OADS,/arxiv_data1/oa_pdf/20/81/viru-5-226.PMC3916379.pdf
"This biologic model of disease progression, and the recognition  that the cancer patients who were more likely to die were those with more locally extensive or disseminated disease inspired a  Correspondence to: John C Marshall; Email: marshallj@smh.ca Submitted: 07/24/2013; Revised: 10/21/2013; Accepted: 10/22/2013http://dx.doi.org/10.4161/viru.26908The PIRO (predisposition, insult, response,   organ dysfunction) model Toward a staging system for acute illness John C Marshall1,2,3 1Departments of Surgery and Critical Care Medicine; University of Toronto; Toronto, ON Canada; 2The Keenan Research Centre of the Li Ka Shing Knowledge i nstitute;   St. Michael’s Hospital; University of Toronto; Toronto, ON Canada; 3The i nterdepartmental Division of Critical Care Medicine; University of Toronto; Toronto, ON Canada Keywords:  sepsis, critical illness, staging, stratification, clinical trials, epidemiology Multimodal therapy for diseases like cancer has only become  practicable following the development of staging systems like  the TNM (tumor, nodes, metastases) system.",Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Ann Surg 1983; 197:495- 506; PMID:6342553 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Br J Surg  2009 ; 96:473-81; PMID:19358184 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Semin Surg Oncol 2003 ; 21:3- 7; PMID:12923909 ; http://dx.doi.org/10.1002/ ssu.10014 6.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med 2003 ; 349:247-57;  PMID:12867608 ; http://dx.doi.org/10.1056/ NEJMoa0222898.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Nat Med   2013 ; 19:619-25; PMID:23584089 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med 1995 ;  23:1638 -52; PMID:7587228 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Intensive Care Med   2003 ; 29:530-8; PMID:12664219 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med  1988 ; 318:727-32; PMID:3347221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Nat Rev Genet 2010 ; 11:17- 30; PMID:19953080 ; http://dx.doi.org/10.1038/ nrg2698 14.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Gene  2010 ; 467:1-12; PMID:20655368 ;  http://dx.doi.org/10.1016/j.gene.2010.07.008 15.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Nat Genet 2007 ; 39:523-8;  PMID:17322885 ; http://dx.doi.org/10.1038/ng1976 17.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med 2010 ; 362:2092 - 101; PMID:20484391 ; http://dx.doi.org/10.1056/ NEJMoa0905606 18.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
JAMA  1999 ; 282:561- 8; PMID:10450718 ; http://dx.doi.org/10.1001/ jama.282.6.561 19.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care  2011 ; 15:R254 ;  PMID:22026963 ; http://dx.doi.org/10.1186/ cc10515 20.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
J Immunol   2011 ; 186:2321 -8; PMID:21257964 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Ann Surg 2013 ; (Forthcoming );  PMID:23478521 ; http://dx.doi.org/10.1097/ SLA.0b013e31828538e8dysfunctions.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Ann Surg 2012 ; 255:147-57;  PMID:22167001 ; http://dx.doi.org/10.1097/ SL A.0b013e3182389515 23.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med 2003 ; 348:1546 - 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 25.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care  2013 ; 17:R50;  PMID:23506971 ; http://dx.doi.org/10.1186/ cc12570 26.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med 2007 ; 35:763-8;  PMID:17255870 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Gend Med 2010 ; 7:422- 37; PMID:21056869 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Lancet  2012 ; 379:1112 - 9; PMID:22353263 ; http://dx.doi.org/10.1016/ S0140-6736(11)61780-7 29.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med  1985 ; 13:818-29; PMID:3928249 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med 2011 ; 39:1174 - 89; PMID:21336127 ; http://dx.doi.org/10.1097/ CCM.0b013e31820eacf2 34.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
J Leukoc Biol 2010 ; 87:989- 99; PMID :20179153 ; http://dx.doi.org/10.1189/ jlb.120977535.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Proc Natl Acad Sci U S A 2013 ; 110:3507 - 12; PMID:23401516 ; http://dx.doi.org/10.1073/ pnas.1222878110 36.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
JAMA  1991 ;  266:1097 -102; PMID:1865542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
JAMA  2013 ; 309:1154 -62; PMID:23512062 ;  http://dx.doi.org/10.1001/jama.2013.2194 40.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care  2012 ; 16:R33; PMID:22373120 ;  http://dx.doi.org/10.1186/cc11211 41.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Intensive Care Med   2000 ; 26:716-21; PMID:10945388 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med 2009 ; 37:2290 - 8; PMID:19487943 ; http://dx.doi.org/10.1097/ CCM.0b013e3181a02afc 43.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Lancet  1985 ; 1:16-9; PMID:2856949 ;  http://dx.doi.org/10.1016/S0140-6736(85)90966-346.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N  Engl J Med 2005 ; 353:1659 -72; PMID:16236737 ;  http://dx.doi.org/10.1056/NEJMoa052306 47.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
World J Surg 1998 ; 22:158- 63; PMID:9451931 ; http://dx.doi.org/10.1007/ s002689900364 48.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Intensive  Care Med 2004 ; 30:1327 -33; PMID :15197443 ;  http://dx.doi.org/10.1007/s00134-004-2292-7 49.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med  2001 ; 344:699-709; PMID:11236773 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Intensive Care Med  2008 ; 34:496-504;  PMID:18060541 ; http://dx.doi.org/10.1007/ s00134-007-0943-1 51.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Chest  2008 ; 134:1208 - 16; PMID:18779186 ; http://dx.doi.org/10.1378/ chest.08-1106 52.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med  2009 ; 37:456-62; PMID:19114916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Crit Care Med 2009 ; 37:1329 - 35; PMID:19242329 ; http://dx.doi.org/10.1097/ CCM.0b013e31819d5db1 54.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
J Clin Oncol  2008 ; 26:380-5; PMID:18202413 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
N Engl J Med 2007 ; 357:874-84; PMID :17761591 ;  http://dx.doi.org/10.1056/NEJMoa067514 57.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Ann Rheum Dis  2013 ; 72:1375 -81; PMID:23233654 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Burns   1993 ; 19:124-7; PMID:8471144 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Ann Surg  1993 ; 218:769-76; PMID:8257227 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
PLoS One  2012 ; 7:e30275 ;  PMID:22272322 ; http://dx.doi.org/10.1371/ journal.pone.0030275 61.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
Am J Gastroenterol  2013 ; 108:1268 -76; PMID:23649185 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
J Burn Care Res  2006 ; 27:448-51; PMID:16819346 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3e/ed/viru-5-27.PMC3916380.pdf
6 As a  *Correspondence to: Willem Joost Wiersinga;  Email: w.j.wiersinga@amc.uva.nlSubmitted: 05/22/2013; Revised: 06/16/2013; Accepted: 06/17/2013http://dx.doi.org/10.4161/viru.25436The immune response to sepsis can be seen as a pattern  recognition receptor-mediated dysregulation of the immune system following pathogen invasion in which a careful balance  between inflammatory and anti-inflammatory responses is  vital.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Infect Dis 1991; 163:937- 45; PMID:2019770; http://dx.doi.org/10.1093/infdis/163.5.937 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Mol Med 2011; 17:2-3;  PMID:21246163; http://dx.doi.org/10.2119/mol-med.2010.00001.commentary 4.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Lancet 2013; 381:774-5;  PMID:23472921; http://dx.doi.org/10.1016/S0140- 6736(12)61815-7 5.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care Med 2013; 41:580- 637; PMID:23353941; http://dx.doi.org/10.1097/CCM.0b013e31827e83af 6.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
JAMA 2011; 306:2614- 5; PMID:22187284; http://dx.doi.org/10.1001/jama.2011.1853 7.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
"Intensive Care Med 2010; 36:222-31;  PMID:20069275; http://dx.doi.org/10.1007/s00134-009-1738-3 8. van der Poll T, Opal SM.",Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Lancet Infect Dis 2008; 8:32-43;  PMID:18063412; http://dx.doi.org/10.1016/S1473-3099(07)70265-79.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care Med  2001; 29:1303-10; PMID:11445675; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care Med  2013; 41:1167-74; PMID:23442987; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care Med 2012; 40:754-61; PMID:21963582;  http://dx.doi.org/10.1097/CCM.0b013e318232db65 12.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care 2007; 11:R40;  PMID:17378934; http://dx.doi.org/10.1186/cc5727 13.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care  Med 2008; 36:964-6; PMID:18431286; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Curr Opin Crit  Care 2011; 17:480-6; PMID:21900767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
N Engl J Med 2003; 348:1546-54; PMID:12700374; http://dx.doi.org/10.1056/ NEJMoa022139 16.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
JAMA  2009; 302:2323-9; PMID:19952319; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nature 2004; 430:250-6; PMID:15241423; http://dx.doi.org/10.1038/ nature02760 18.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Cell  2010; 140:821-32; PMID:20303873; http://dx.doi.org/10.1016/j.cell.2010.01.040 19.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Immunol 2010; 11:373-84; PMID:20404851; http://dx.doi.org/10.1038/ni.1863 20.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Clin Invest 2012; 122:2711-9; PMID:22850880; http://dx.doi.org/10.1172/ JCI62423 21.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Rev Immunol 2010; 10:826-37; PMID:21088683; http://dx.doi.org/10.1038/ nri2873 22.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Rev Immunol 2011; 11:213-20;  PMID:21350580; http://dx.doi.org/10.1038/nri2936 23.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Med  2007; 13:1042-9; PMID:17767165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Immunol 2010; 11:373-84; PMID:20404851;  http://dx.doi.org/10.1038/ni.1863 25.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Immunol 2005; 6:565-70;  PMID:15895089; http://dx.doi.org/10.1038/ni1207 26.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nature 2008; 452:234- 8; PMID:18305481; http://dx.doi.org/10.1038/ nature06726,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Clin Infect  Dis 2007; 44:1321-8; PMID:17443469; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
FASEB  J 2009; 23:2403-11; PMID:19346297; http://dx.doi.org/10.1096/fj.09-129445 59.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Biochim Biophys Acta 2010; 1799:149-56;  PMID:19948257; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Biol Chem 2004; 279:7370- 7; PMID:14660645; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Science 1999; 285:248- 51; PMID:10398600; http://dx.doi.org/10.1126/sci-ence.285.5425.248 64.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Med  2007; 13:1042-9; PMID:17767165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Leukoc Biol 2007;  81:1-5; PMID:17032697; http://dx.doi.org/10.1189/ jlb.0306164 66.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
PLoS Pathog 2012; 8:e1002987;  PMID:23133376; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Am J Respir Crit Care Med 2009; 180:1098- 106; PMID:19762566; http://dx.doi.org/10.1164/ rccm.200810-1552OC 68.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Immunol  2012; 189:2689-95; PMID:22956760; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Science 2004; 303:1532-5;  PMID:15001782; http://dx.doi.org/10.1126/sci-ence.1092385 70.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
PLoS Pathog 2009; 5:e1000639; PMID:19876394;  http://dx.doi.org/10.1371/journal.ppat.100063942.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Biotechnol 2010; 28:1057-68;  PMID:20944598; http://dx.doi.org/10.1038/nbt.1685 43.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Epigenetics  2011; 6:273-83; PMID:21048427; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Clin Invest 2009; 119:3502- 11; PMID:19955661; http://dx.doi.org/10.1172/ JCI40599 45.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Exp Med 2010; 207:1745- 55; PMID:20603313; http://dx.doi.org/10.1084/ jem.20100257 46.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Immunol  2011; 187:4890-9; PMID:21957143; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
"Am J Respir Crit Care Med 2008; 177:983-8; PMID:18263805; http://dx.doi.org/10.1164/ rccm.200703-418OC 48. de Jong HK, van der Poll T, Wiersinga WJ.",Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Innate Immun  2010; 2:381-94; PMID:20431282; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Exp Med  2011; 208:2581-90; PMID:22110166; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Annu Rev Immunol  2007; 25:821-52; PMID:17201677; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
FASEB J 2008; 22:2198-205;  PMID:18299333; http://dx.doi.org/10.1096/fj.07-105221 53.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nature 2001; 414:920-4; PMID:11780066; http://dx.doi.org/10.1038/414920a 54.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Med 2000; 6:164-70; PMID:10655104;  http://dx.doi.org/10.1038/72262 55.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
PLoS Negl T rop Dis 2010; 4:e605;  PMID:20169062; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Shock 2004; 22:309-13; PMID:15377884;  http://dx.doi.org/10.1097/01.shk.0000140305.01641.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
"Science 2012; 337:1111-5; PMID:22821982;  http://dx.doi.org/10.1126/science.1220363 28. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, et al.",OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Science 2008; 321:691-6;  PMID:18669862; http://dx.doi.org/10.1126/sci- ence.1158298 29.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Exp Med 2007; 204:2407- 22; PMID:17893200; http://dx.doi.org/10.1084/jem.20070628 30.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
JAMA 2013; 309:1154-62; PMID:23512062;  http://dx.doi.org/10.1001/jama.2013.2194 32.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care  Med 2010; 38:72-83; PMID:19661804; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Leukoc Biol  2013; 93:209-15; PMID:23108097; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Clin Invest  2013; 123:138-49; PMID:23241959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Exp Mol Med 2013; 45:e11; PMID:23429360;  http://dx.doi.org/10.1038/emm.2013.28 36.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Rev Immunol 2005; 5:446-58; PMID:15928677;  http://dx.doi.org/10.1038/nri1630 37.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Commun 2012;  3:707; PMID:22426228; http://dx.doi.org/10.1038/ ncomms1706 39.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Immunol 2006; 7:1074-81;  PMID:16964262; http://dx.doi.org/10.1038/ni1382 40.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Immunol 2011; 12:742-51;  PMID:21725320; http://dx.doi.org/10.1038/ni.2064 41.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Exp Med 2008; 205:451- 64; PMID:18268035; http://dx.doi.org/10.1084/jem.20071108,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Semin  Thromb Hemost 2010; 36:550-7; PMID:20632252;  http://dx.doi.org/10.1055/s-0030-1255449 94.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
JAMA  2001; 286:1869-78; PMID:11597289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
JAMA 2003; 290:238- 47; PMID:12851279; http://dx.doi.org/10.1001/jama.290.2.238 96.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
N  Engl J Med 2001; 344:699-709; PMID:11236773;  http://dx.doi.org/10.1056/NEJM200103083441001 97.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
N Engl J Med 2012; 366:2055- 64; PMID:22616830; http://dx.doi.org/10.1056/ NEJMoa1202290 98.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Lancet Infect Dis 2012; 12:678- 86; PMID:22809883; http://dx.doi.org/10.1016/ S1473-3099(12)70157-3 99.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
"Blood 2004; 103:4545-53; PMID:14988149;  http://dx.doi.org/10.1182/blood-2003-03-0713 85. de Jonge E, Dekkers PE, Creasey AA, Hack CE, Paulson SK, Karim A, et al.",OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care 2010; 14:236; PMID:21067540;  http://dx.doi.org/10.1186/cc9231 89.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Leukoc Biol 2008; 83:1309-22; PMID:18347074;  http://dx.doi.org/10.1189/jlb.0108001 91.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Endotoxemia and sepsis mortal- ity reduction by non-anticoagulant activated protein  C. J Exp Med 2007; 204:2439-48; PMID:17893198;  http://dx.doi.org/10.1084/jem.20070404 92.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Clin Invest 2010; 120:3167- 78; PMID:20714108; http://dx.doi.org/10.1172/ JCI4262971.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Curr Biol 2006; 16:401-7;  PMID:16488875; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Med 2007; 13:403-4; PMID:17415369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
PLoS One 2011; 6:e23637; PMID:21909403; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Clin Immunol 2012; 144:32-40; PMID:22659033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J Innate Immun 2010; 2:439-45; PMID:20588003; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nat Med 2008; 14:551-7;  PMID:18454156; http://dx.doi.org/10.1038/nm1753 79.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Nature  2007; 446:203-7; PMID:17322907; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Adv Exp Med Biol 2008; 632:61-9;  PMID:19025114; http://dx.doi.org/10.1007/978-0- 387-78952-1_5 81.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
Crit Care Med 2010; 38(Suppl):S26-34;  PMID:20083910; http://dx.doi.org/10.1097/ CCM.0b013e3181c98d21 82.,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
J  Thromb Haemost 2004; 2:1924-33; PMID:15550023;  http://dx.doi.org/10.1111/j.1538-7836.2004.00955.x,Non-OADS,/arxiv_data1/oa_pdf/a8/85/viru-5-36.PMC3916381.pdf
"*Correspondence to: Sachin Yende; Email: yendes@upmc.edu Submitted: 08/06/2013; Revised: 11/21/2013; Accepted: 11/27/2013http://dx.doi.org/10.4161/viru.27372Epidemiology of severe sepsis Florian B Mayr1,2,3, Sachin Yende1,2,*, and Derek C Angus1,2 1The Clinical Research, i nvestigation, and Systems Modeling of Acute i llness (CR iSMA) Center; University of Pittsburgh; Pittsburgh, PA USA;   2Department of Critical Care Medicine; University of Pittsburgh, Pittsburgh, PA USA; 3Department of Medicine; University of Pittsburgh; Pittsburgh, PA USA Keywords:  severe sepsis, epidemiology, risk factors, infection, organ dysfunction Severe sepsis is a leading cause of death in the United  States and the most common cause of death among critically ill  patients in non-coronary intensive care units ( iCU).",Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Available at: http://www.hcup-us.ahrq.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2003; 31:1250-6;  PMID:12682500 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  1998; 26:1793-800;  PMID:9824069 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
N Engl J Med 2003; 348:1546- 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 7.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Value Health 2002; 5:79-81; PMID:11918823 ;  http://dx.doi.org/10.1046/j.1524-4733.2002.52013.x8.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Chest 2011; 140:1223-31; PMID:21852297 ; http://dx.doi.org/10.1378/ chest.11-0352 9.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
JAMA 2012; 307:1405- 13; PMID:22474204 ; http://dx.doi.org/10.1001/ jama.2012.384 10.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care  2013; 17:R81;  PMID:23622086 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2010; 38:668-78;  PMID:20029343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
N Engl J Med 2013; 369:840-51;  PMID:23984731 ; http://dx.doi.org/10.1056/ NEJMra1208623 13.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir Crit Care Med 2013; 188:77-82;  PMID:23631750 ; http://dx.doi.org/10.1164/ rccm.201212-2199OC14.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2013; 41:1853- 62; PMID:23782964 ; http://dx.doi.org/10.1097/ CCM.0b013e31828a3994 15.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Scand J Infect Dis 2013; 45:577-83;  PMID:23596977 ; http://dx.doi.org/10.3109/003655 48.2013.786836 16.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2000; 28:1316-21;  PMID:10834672 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care 2004; 8:R153-62;  PMID :15312213 ; http://dx.doi.org/10.1186/cc2858 18.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care 2004; 8:222-6;  PMID:15312201 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Endocr  Metab Immune Disord Drug Targets 2006; 6:207-12;  PMID:16787296 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2007; 35:1284-9;  PMID:17414725 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Clin 1997; 13:389-407;  PMID :9107515 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2013; 41:1167-74;  PMID:23442987 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Intensive Care Med 2004; 30:589- 96; PMID:14963646 ; http://dx.doi.org/10.1007/ s00134-004-2157-0 24.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir  Crit Care Med 1996; 154:617-24; PMID:8810595 ;  http://dx.doi.org/10.1164/ajrccm.154.3.8810595 25.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2006; 34:344-53;  PMID:16424713 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  1998; 26:2078-86;  PMID:9875924 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Curr Opin Infect Dis 2004; 17:309-16;  PMID :15241074 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
J Infect  2003; 47:307-16;  PMID:14556755 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Arch Surg 1999; 134:1033-40;  PMID:10522842 ; http://dx.doi.org/10.1001/ archsurg.134.10.1033 31.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  1999; 27:1794-9;  PMID:10507600 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
JAMA 2009; 302:2323- 9; PMID:19952319 ; http://dx.doi.org/10.1001/ jama.2009.1754 33.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2004; 32:1510-26;  PMID :15241096 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
"Infect Dis Clin North Am 1999; 13:299-312, vii;  PMID:10340168 ; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2006; 34:2576-82;  PMID:16915108 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Clin Infect Dis 2005;  41(Suppl 7):S490-7;  PMID:16237652 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
JAMA 2010; 303:2495-503; PMID:20571016 ;  http://dx.doi.org/10.1001/jama.2010.851 38.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
N Engl J Med  1988; 318:727-32;  PMID:3347221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Expert Rev Respir Med 2010; 4:229-38;  PMID:20406089 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Proc Natl Acad Sci U S A 2007; 104:16645- 50; PMID:17925445 ; http://dx.doi.org/10.1073/ pnas.0704828104 43.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
"Crit  Care Med 2009; 37:192-201, e1-3; PMID:19050632 ;  http://dx.doi.org/10.1097/CCM.0b013e31819263d8 44.",Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2003; 31:2332-8;  PMID:14501964 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care 2012; 16:R132; PMID:22827924 ;  http://dx.doi.org/10.1186/cc11437 47.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Lancet Infect Dis 2006; 6:438-46; PMID:16790384 ;  http://dx.doi.org/10.1016/S1473-3099(06)70523-0 50.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care 2013; 17:R72; PMID:23594407 ;  http://dx.doi.org/10.1186/cc12680 51.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir Crit Care Med  2004; 169:557-61;  PMID:14982823 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Infection  2013; 41:545-51;  PMID:23264096 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
J Crit  Care 2012; 27:51-7; PMID:22033058 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care 2010 ; 14:R152 ;  PMID:20698966 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2001; 29:683-4;  PMID:11379540 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Pediatr Crit Care Med 2013; 14:686-93; PMID:23897242 ; http://dx.doi.org/10.1097/ PCC.0b013e3182917fad 58.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
N Engl J Med 2001; 345:1368-77; PMID:11794169 ; http://dx.doi.org/10.1056/ NEJMoa010307 59.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir Crit Care Med 2012; 186:1264-71;  PMID:23087028 ; http://dx.doi.org/10.1164/ rccm.201204-0713OC 60.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
J Crit Care 2010; 25:553- 62; PMID:20381301 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
"Crit Care 2013; 17:R50; PMID:23506971 ; http://dx.doi.org/10.1186/ cc12570 62. van Eijk LT, Dorresteijn MJ, Smits P, van der Hoeven  JG, Netea MG, Pickkers P. Gender differences in the innate immune response and vascular reactiv - ity following the administration of endotoxin to human volunteers.",Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2007; 35:1464- 9; PMID:17452928 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
"J Trauma 2006; 60:193-7, discussion 197- 8; PMID:16456455 ; http://dx.doi.org/10.1097/01.",Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir Crit Care Med 2008; 177:279-84; PMID:17975201 ;  http://dx.doi.org/10.1164/rccm.200703-480OC66.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2007; 35:763-8; PMID:17255870 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med 2008; 36:159-65;  PMID:18007272 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
J Thromb Haemost 2009; 7:634-40;  PMID:19187081 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Crit Care Med  2010; 38:759-65;  PMID:20009756 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
N Engl J Med 2004; 351:2611-8; PMID:15602021 ;  http://dx.doi.org/10.1056/NEJMoa04174771.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Lancet 2006; 367:1075-9; PMID:16581406 ;  http://dx.doi.org/10.1016/S0140-6736(06)68474-2 72.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Curr Infect Dis Rep 2007; 9:382-6;  PMID:17880848 ; http://dx.doi.org/10.1007/ s11908-007-0059-3 73.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
J Am Geriatr Soc  2012; 60:1070-7;  PMID:22642542 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
JAMA  2010; 304:1787-94;  PMID:20978258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
Am J Respir Crit Care Med  2008; 177:1242-7;  PMID:18369199 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c6/a0/viru-5-4.PMC3916382.pdf
"3,4,8,9*Correspondence to: Jonathan S Boomer; Email: jboomer@DOM.wustl.edu Submitted: 07/11/2013; Revised: 09/16/2013; Accepted: 09/17/2013http://dx.doi.org/10.4161/viru.26516The changing immune system in sepsis Is individualized immuno-modulatory therapy the answer?",Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2008; 36:296- 327; PMID :18158437 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Dis Mon 2004; 50:168-213; PMID:15133467 ;  http://dx.doi.org/10.1016/j.disamonth.2003.12.003 3.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Expert Rev Anti Infect Ther 2011; 9:1013-33;  PMID:22029521 ; http://dx.doi.org/10.1586/ eri.11.122 4.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Expert Rev Anti Infect Ther 2012; 10:369-80;  PMID:22397569 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Lancet Infect Dis 2008; 8:32-43; PMID:18063412 ; http://dx.doi.org/10.1016/ S1473-3099(07)70265-7 6.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Pathol 2012; 181:2-7; PMID:22642906 ;  http://dx.doi.org/10.1016/j.ajpath.2012.05.003 7.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Br J Surg 1997; 84:920-35; PMID:9240130 ; http://dx.doi.org/10.1002/ bjs.1800840707 8.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2009; 37:291- 304; PMID:19050640 ; http://dx.doi.org/10.1097/ CCM.0b013e31819267fb 9.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Clin 2000; 16:193- 213; PMID:10768079 ; http://dx.doi.org/10.1016/ S0749-0704(05)70107-X 10.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Semin Respir Crit Care Med 2011; 32:569-80; PMID:21989693 ;  http://dx.doi.org/10.1055/s-0031-1287865 11.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
JAMA 2011; 306:2614- 5; PMID:22187284 ; http://dx.doi.org/10.1001/ jama.2011.1853 12.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Lancet 2007; 369:836-43;  PMID:17350452 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Respir Crit Care Med 2013; 187:1041- 3; PMID:23675711 ; http://dx.doi.org/10.1164/ rccm.201303-0505ED 15.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Lancet Infect Dis 2013; 13:260-8; PMID:23427891 ;  http://dx.doi.org/10.1016/S1473-3099(13)70001-X 16.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Lancet Infect Dis 2012; 12:503- 5; PMID:22742624 ; http://dx.doi.org/10.1016/ S1473-3099(12)70136-6 17.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Clin Infect Dis 2002; 34:1084-93;  PMID:11914997 ; http://dx.doi.org/10.1086/339549 18.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
"Pediatr Clin North Am 2008; 55:647-68, xi; PMID:18501759 ;  http://dx.doi.org/10.1016/j.pcl.2008.02.009 19.",OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
N Engl J Med 2003; 348:138- 50; PMID:12519925 ; http://dx.doi.org/10.1056/ NEJMra021333 20.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Respir Crit Care Med 2001; 163:316-21;  PMID:11179099 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 1996;  24:1125-8;  PMID:8674323 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Emerg Med 2008; 26:711-5; PMID:18606328 ;  http://dx.doi.org/10.1016/j.ajem.2007.10.031 23.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J  Endotoxin Res 2006; 12:151-70; PMID:16719987 ;  http://dx.doi.org/10.1179/096805106X102246 24.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2010; 14:R237; PMID:21190579 ;  http://dx.doi.org/10.1186/cc9392 25.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Chest  2008; 134:281-7;  PMID:18682456 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care  2011; 15:R183 ;  PMID:21798063 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Med Mycol 2011; 49(Suppl  1):S17-23;  PMID:20718607 ; http://dx.doi.org/10.3 109/13693786.2010.509744 28.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2011; 15:R77; PMID:21362193 ;  http://dx.doi.org/10.1186/cc10069 29.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2008; 36:3145-50; PMID:18936696 ; http://dx.doi.org/10.1097/ CCM.0b013e31818f3fc4 30.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2009; 37:2350-8; PMID:19531944 ;  http://dx.doi.org/10.1097/CCM.0b013e3181a3aa43 31.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Ann Surg 1977;  186:241-50;  PMID:142452 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Nat Med 2009; 15:496- 7; PMID:19424209 ; http://dx.doi.org/10.1038/ nm0509-496 34.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
N Engl J Med  2010; 363:87-9;  PMID:20592301 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Leukoc Biol 2008; 83:523- 35; PMID:17913974 ; http://dx.doi.org/10.1189/ jlb.0607371 36.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Intensive Care Med  2009; 35:678-86;  PMID:18946659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Microbiol Immunol Infect 2012; (Forthcoming);  PMID:22921804 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Exp Med 2007;  204:1463-74;  PMID:17548519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2011; 15:231;  PMID:22017882 ; http://dx.doi.org/10.1186/ cc10333 40.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2002;  30(Supp):S18-26;  PMID:11891403 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Immunobiology  2007; 212:715-22;  PMID:18086373 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Immunol 2010;  184:6766-72;  PMID:20483771 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Leukoc Biol 2009; 86:219- 27; PMID:19369639 ; http://dx.doi.org/10.1189/ jlb.1008615 45.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2012; 16:R112;  PMID:22742734 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
JAMA 2011; 306:2594-605; PMID:22187279 ;  http://dx.doi.org/10.1001/jama.2011.1829 47.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med  1999; 27:1230-51;  PMID:10446814 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Shock 2010; 34:377- 83; PMID:20610943 ; http://dx.doi.org/10.1097/ SHK.0b013e3181dc0845 50.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
N Engl J Med 2009; 361:1570- 83; PMID:19828534 ; http://dx.doi.org/10.1056/ NEJMra0901217 52.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
EMBO J 2011; 30:3667- 83; PMID:21863020 ; http://dx.doi.org/10.1038/ emboj.2011.30753.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
FASEB J  2007; 21:708-19;  PMID:17307841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
PLoS Biol  2011; 9:e1001149;  PMID :21931534 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Mol Cell Biol  2002; 22:6034-45;  PMID:12167698 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Cold Spring Harb Perspect Biol 2010;  2:a002436;  PMID:20534709 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Nat Rev Immunol 2007; 7:803-15;  PMID:17893694 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Nat Rev Immunol 2002; 2:116-26; PMID:11910893 ;  http://dx.doi.org/10.1038/nri727 64.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Transplantation 2007; 83:774-82;  PMID:17414712 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Annu Rev Immunol 2012; 30:531-64; PMID:22224781 ; http://dx.doi.org/10.1146/ annurev.immunol.25.022106.141623 66.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Autoimmun  2009; 32:211-5;  PMID:19345068 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Lancet 1998; 351:950-3;  PMID:9734942 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Infect Dis 2000; 181:176-80;  PMID:10608764 ; http://dx.doi.org/10.1086/315214 70.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
N Engl J Med 2006; 354:1166-76;  PMID:16540617 ; http://dx.doi.org/10.1056/ NEJMra055446 71.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Cell  2010; 140:845-58;  PMID:20303875 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Clin Invest 1991; 88:1747-54;  PMID:1939659 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Clin  Vaccine Immunol 2008; 15:1851-8; PMID:18945879 ;  http://dx.doi.org/10.1128/CVI.00184-08 76.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Surgery 2000; 127:309-15; PMID :10715987 ; http://dx.doi.org/10.1067/ msy.2000.104118 77.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care  2012; 16:140;  PMID:22824381 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Immunology 2010; 129:474-81;  PMID:20201977 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Infect Immun  2006; 74:5227-35;  PMID:16926416 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Respir Crit Care Med 1997; 156:1105-13; PMID:9351609 ;  http://dx.doi.org/10.1164/ajrccm.156.4.9610002 81.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med  2001; 29:503-10;  PMID:11373411 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
JAMA  1994; 271:1836-43;  PMID:8196140 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med  1997; 25:1115-24;  PMID:9233735 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Intensive Care Med 2003; 29:1222-8; PMID:12830374 ; http://dx.doi.org/10.1007/ s00134-003-1796-x 88.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Am Soc Nephrol  2008; 19:1034-40;  PMID:18272842 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
JAMA 2013; 309:1154-62; PMID:23512062 ;  http://dx.doi.org/10.1001/jama.2013.2194 91.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
"Crit Care Clin 2000; 16:337-52,  vii; PMID:10768085 ; http://dx.doi.org/10.1016/ S0749-0704(05)70113-5 92.",OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med  2001; 29:1303-10;  PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Infect Immun 2010; 78:4714- 22; PMID:20823197 ; http://dx.doi.org/10.1128/ IAI.00456-10 94.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Mol Med  2008; 14:247-56;  PMID:18297128 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2011; 15:R58;  PMID:21310070 ; http://dx.doi.org/10.1186/ cc10031 96.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Clin Infect Dis 2007; 45:308-14;  PMID:17599307 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Intensive Care Med  2011; 37:525-32;  PMID:21153402 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Chest  2005; 127:2139-50;  PMID:15947332 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Scand  J Infect Dis 2010; 42:164-71; PMID:19958238 ;  http://dx.doi.org/10.3109/00365540903405768 100.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2008; 36:448-54;  PMID:18216600 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J  Infect Dis 1998; 178:1075-80; PMID:9806037 ;  http://dx.doi.org/10.1086/515694 102.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Infect Dis  2000; 182:970-3;  PMID:10950800 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med  2003; 31:367-73;  PMID:12576938 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Crit Care 1995; 10:21-6; PMID:7538851 ;  http://dx.doi.org/10.1016/0883-9441(95)90027-6 105.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Respir Crit Care Med 2009; 180:640- 8; PMID:19590022 ; http://dx.doi.org/10.1164/ rccm.200903-0363OC 106.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Surg 1992; 163:191-6; PMID:1739172 ;  http://dx.doi.org/10.1016/0002-9610(92)90099-D 107.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 1998;  26:434-9;  PMID:9504568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
"Arch Surg 1994; 129:1031- 41, discussion 1042; PMID:7944932 ; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Nat Med 1997; 3:678-81; PMID:9176497 ; http://dx.doi.org/10.1038/ nm0697-678 110.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Immunol 2010; 184:1401-9;  PMID:20026737 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Blood 2001; 97:14- 32; PMID:11133738 ; http://dx.doi.org/10.1182/ blood.V97.1.14 112.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Trends Pharmacol Sci 2012; 33:35-41; PMID:22032984 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Annu Rev Immunol 2006; 24:657-79; PMID:16551262 ; http://dx.doi.org/10.1146/ annurev.immunol.24.021605.090727 114.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Immunother 2006; 29:313-9;  PMID:16699374 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Clin Cancer Res  2010; 16:727-35;  PMID:20068111 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Semin Immunol  2012; 24:218-24;  PMID:22410365 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Clin Infect Dis  2012; 55:291-300;  PMID:22550117 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Infect Dis 2012; 206:606-16; PMID:22693226 ;  http://dx.doi.org/10.1093/infdis/jis383 120.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Immunol 2010; 184:3768- 79; PMID:20200277 ; http://dx.doi.org/10.4049/ jimmunol.0903151 121.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J  Immunol 2012; 189:5073-81;  PMID:23053510 ;  http://dx.doi.org/10.4049/jimmunol.1202062 122.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Target Oncol 2012; 7:55-68;  PMID:22383042 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Blood 2009; 113:6304-14; PMID:19380868 ; http://dx.doi.org/10.1182/ blood-2008-10-186601 125.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Immunol Rev 2008;  222:357-68;  PMID:18364014 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Annu Rev Immunol 2008; 26:677-704;  PMID:18173375 ; http://dx.doi.org/10.1146/ annurev.immunol.26.021607.090331 127.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Proc Natl Acad Sci U S A 2008; 105:2658-63;  PMID:18268348 ; http://dx.doi.org/10.1073/ pnas.0711918105 129.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Leukoc Biol  2010; 88:233-40;  PMID:20483923 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care 2010; 14:R220;  PMID:21118528 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 134.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Biol Chem 2005; 280:39553-61;  PMID:16169851 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Leukoc Biol  2012; 92:593-603;  PMID:22459947 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
BMB Rep 2011; 44:217-31;  PMID:21524346 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Cancer Res 2011;  71:3540-51;  PMID:21430066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Expert Opin Ther Targets 2011; 15:91-101; PMID:21142803 ; http://dx.doi.org/10.1517/147125 98.2011.540563 142.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Blood 2002;  100:4059-66;  PMID:12393655 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Am J Physiol  Regul Integr Comp Physiol 2007; 292:R1751- 9; PMID:17234957 ; http://dx.doi.org/10.1152/ ajpregu.00656.2006 144.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2002; 30:195-201;  PMID:11902262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Proc Natl Acad Sci U S A 1999; 96:14541-6;  PMID:10588741 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Clin Invest 2007; 117:1466-76;  PMID:17549249 ; http://dx.doi.org/10.1172/ JCI32446 148.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
J Clin Invest 2007; 117:1204-12; PMID:17476350 ;  http://dx.doi.org/10.1172/JCI31446 149.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2009; 37(Suppl):S30-7; PMID:19104223 ; http://dx.doi.org/10.1097/ CCM.0b013e3181922bd3 150.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Crit Care Med 2004;  32(Suppl):S219-22;  PMID :15118521 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
Proc Natl Acad Sci U S A 2013; 110:3507-12; PMID:23401516 ; http://dx.doi.org/10.1073/ pnas.1222878110 152.,OADS,/arxiv_data1/oa_pdf/86/2e/viru-5-45.PMC3916383.pdf
"The transmembrane *Correspondence to: Eirini Christaki; Email: eirini.christaki@gmail.com Submitted: 06/07/2013; Revised: 09/15/2013; Accepted: 09/17/2013http://dx.doi.org/10.4161/viru.26514The complex pathogenesis of bacteremia From antimicrobial clearance mechanisms   to the genetic background of the host eirini Christaki1,2,* and e vangelos J Giamarellos-Bourboulis3,4 1Third Department of i nternal Medicine; Aristotle University of Thessaloniki; Papageorgiou General Hospital; Thessaloniki, Greece; 2infectious Diseases Division;   warren Alpert Medical School of Brown University; Providence, R i USA; 3Fourth Department of i nternal Medicine; Medical School; University of Athens; Athens, Greece;  4integrated Research and Treatment Center; Center for Sepsis Control and Care; Jena University Hospital; Jena, Germany Keywords:  bacteremia, bloodstream infection, host defense, single nucleotide polymorphism Bacteremia develops when bacteria manage to escape the  host immune mechanisms or when the otherwise well-orches - trated immune response fails to control bacterial spread due  to inherent or acquired immune defects that are associated  with susceptibility to infection.",Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Ann Intern Med 2002; 137:791-7;  PMID :12435215 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Infect Dis 2002; 34:1431-9;  PMID :12015688 ; http://dx.doi.org/10.1086/339809 4.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Infect Dis 2011; 52:61-9; PMID:21148521 ; http://dx.doi.org/10.1093/cid/ ciq069 6.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Arch Intern Med 2007; 167:834-9; PMID:17452548 ;  http://dx.doi.org/10.1001/archinte.167.8.834 7.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Epidemiol Infect 2013; 141:174- 80; PMID:22417845 ; http://dx.doi.org/10.1017/ S0950268812000428 8.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
JAMA 2009; 302:2323- 9; PMID:19952319 ; http://dx.doi.org/10.1001/ jama.2009.1754 9.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Lancet Infect Dis  2010; 10:417-32;  PMID:20510282 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med  2013; 41:76-83;  PMID:23222266 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Chest  2003 ; 123:1615-24 ;  PMID:12740282 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Epidemiol Infect 2008;  136:108-14;  PMID:17335630 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Int J Med Microbiol 2007; 297:365-77; PMID:17452016 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Lancet Infect Dis 2008; 8:32-43;  PMID:18063412 ; http://dx.doi.org/10.1016/ S1473-3099(07)70265-7 17.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Int Immunol 2005; 17:1-14; PMID :15585605 ;  http://dx.doi.org/10.1093/intimm/dxh186 18.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med 2009; 37:291- 304; PMID:19050640 ; http://dx.doi.org/10.1097/ CCM.0b013e31819267fb 21.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Infect 2011; 63:407-19; PMID:21840338 ;  http://dx.doi.org/10.1016/j.jinf.2011.08.004 22.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care  2005; 9:485-9;  PMID:16277737 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med 2002;  30(Suppl):S18-26;  PMID:11782557 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Clin 2000; 16:193-213; PMID:10768079 ; http://dx.doi.org/10.1016/ S0749-0704(05)70107-X 25.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Am J Respir Crit Care Med 2011; 184:928- 38; PMID:21799073 ; http://dx.doi.org/10.1164/ rccm.201102-0271OC 26.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Nat  Rev Immunol 2004; 4:211-22; PMID :15039758 ;  http://dx.doi.org/10.1038/nri1310 28.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Med Microbiol 1992; 36:203-8;  PMID:1372362 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Emerg Infect Dis 2006 ; 12:1715-23 ;  PMID:17283622 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
JAMA 2007; 298:1763- 71; PMID:17940231 ; http://dx.doi.org/10.1001/ jama.298.15.1763 32.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Infect Dis 1999; 29:595-607; PMID:10530454 ;  http://dx.doi.org/10.1086/598640 33.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Curr Opin Microbiol 2012; 15:588- 95; PMID:23044073 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Lancet 2010; 375:1557- 68; PMID:20206987 ; http://dx.doi.org/10.1016/ S0140-6736(09)61999-1 35.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Control Hosp Epidemiol 2010; 31:584-91; PMID:20426656 ;  http://dx.doi.org/10.1086/652530 38.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Semin Immunopathol 2012; 34:261-80; PMID:22057887 ; http://dx.doi.org/10.1007/ s00281-011-0292-6 40.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Adv Dermatol  2008; 24:71-87;  PMID:19256306 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Invest Dermatol  2007; 127:2368-80;  PMID:17460726 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Invest Dermatol 2010; 130:2703- 6; PMID:21068735 ; http://dx.doi.org/10.1038/ jid.2010.294 43.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Invest  Dermatol 2011; 131:382-90; PMID:21048787 ;  http://dx.doi.org/10.1038/jid.2010.328 45.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Invest  Dermatol 2010; 130:2211-21;  PMID:20463690 ;  http://dx.doi.org/10.1038/jid.2010.123 46.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Annu  Rev Immunol 2005; 23:197-223; PMID :15771570 ;  http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
"Semin Immunopathol 2012; 34:237-59; PMID:22080185 ; http://dx.doi.org/10.1007/ s00281-011-0295-3 48. von Köckritz-Blickwede M, Nizet V. Innate immu - nity turned inside-out: antimicrobial defense by  phagocyte extracellular traps.",OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Mol Med (Berl)  2009; 87:775-83;  PMID:19444424 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Science  2004; 303:1532-5;  PMID :15001782 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Trends Immunol  2009; 30:513-21;  PMID:19699684 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Antimicrob Agents Chemother 2005; 49:269-75; PMID :15616305 ; http://dx.doi.org/10.1128/ AAC.49.1.269-275.2005 52.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Science 2008; 319:962-5;  PMID:18276893 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Immunol Res  2009; 43:25-61;  PMID:19066741 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Immun 2000;  68:6162-7;  PMID:11035720 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Biomed  Biotechnol 2011; 2011:986491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Dev  Immunol 2010; 2010:pii: 414650; http://dx.doi.org/10.1155/2010/414650 ; PMID:20953368 58.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care 2010; 14:R96; PMID:20504311 ;  http://dx.doi.org/10.1186/cc9031 59.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Immun 2008; 76:1434-44; PMID:18212072 ;  http://dx.doi.org/10.1128/IAI.01242-07 60.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Microbes Infect 1999; 1:633- 8; PMID:10611740 ; http://dx.doi.org/10.1016/ S1286-4579(99)80063-X 61.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Mol Immunol 2006; 43:78-85; PMID:16026838 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Microbiol Infect 2012; 18(Suppl 5):7-14;  PMID:22882668 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Ann Intern Med  1964; 60:759-76;  PMID:14156606 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Proc Natl Acad Sci U S A 2001;  98:14577-82;  PMID:11724962 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Immun 2010; 78:976- 83; PMID:20065024 ; http://dx.doi.org/10.1128/ IAI.01012-0969.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Mol Immunol 2007; 44:3850- 7; PMID:17768102 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Immun  2012; 80:3669-78;  PMID:22802341 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Immun 2012; 80:3399-409;  PMID:22825444 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
"Science 2010; 327:1098-102;  PMID:20185720 ;  http://dx.doi.org/10.1126/science.1178334 73. van de Veerdonk FL, Gresnigt MS, Kullberg BJ, van  der Meer JW, Joosten LA, Netea MG. Th17 responses  and host defense against microorganisms: an over - view.",OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
BMB Rep 2009; 42:776-87; PMID:20044948 ;  http://dx.doi.org/10.5483/BMBRep.2009.42.12.776 74.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Immunity 2011; 35:161- 8; PMID:21867926 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Annu Rev Med 1986; 37:49- 59; PMID:3518612 ; http://dx.doi.org/10.1146/ annurev.me.37.020186.000405 77.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med 1996; 24:584-9;  PMID:8612407 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care 2013; 17:R6;  PMID:23324310 ;  http://dx.doi.org/10.1186/ cc11930 82.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Clin Infect Dis 2009; 48(Suppl 4):S260-70; PMID:19374582 ; http://dx.doi.org/10.1086/598185,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Expert Opin Med Diagn 2012;  6:209-19; http://dx.doi.org/10.1517/17530059.2012 .667799 ; PMID:23480686 84.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Am J Physiol Lung Cell Mol Physiol 2012; 302:L1003-13;  PMID:22427530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Antimicrob Agents Chemother 2004; 48:93- 9; PMID:14693524 ; http://dx.doi.org/10.1128/ AAC.48.1.93-99.2004 86.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Antimicrob Agents Chemother 2004; 48:4713-7; PMID :15561848 ; http://dx.doi.org/10.1128/ AAC.48.12.4713-4717.2004 87.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Chest 2009; 136:832-40;  PMID:19433527 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Clin Microbiol  2009; 47:3308-12;  PMID:19675218 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Med Microbiol  2012; 61:1129-35;  PMID:22499777 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
J Clin Microbiol 2009; 47:1443- 51; PMID:19279177 ; http://dx.doi.org/10.1128/ JCM.01197-08 91.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
PLoS One  2010; 5:e14133;  PMID :21152436 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med 2010; 38:276-82;  PMID:19789454 ; http://dx.doi.org/10.1097/ CCM.0b013e3181b42af0 93.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Cytokine  2012; 59:358-63;  PMID:22609212 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Proc Natl Acad Sci U S A 2007; 104:16645- 50; PMID:17925445 ; http://dx.doi.org/10.1073/ pnas.070482810496.,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Transplant Proc 2012; 44:3026-8; PMID:23195019 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Crit Care Med 2011; 39:1388-93;  PMID:21317643 ; http://dx.doi.org/10.1097/ CCM.0b013e31820eda74 99.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Scand J Immunol  2008; 68:438-44;  PMID:18782274 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
Infect Genet Evol 2013; 16:386-91;  http://dx.doi.org/10.1016/j.meegid.2013.03.025 ;  PMID:23538333,OADS,/arxiv_data1/oa_pdf/62/98/viru-5-57.PMC3916384.pdf
"Mitochondria utilize approximately 98% Correspondence to: Mervyn Singer; Email: m.singer@ucl.ac.uk Submitted: 07/28/2013; Revised: 10/12/2013; Accepted: 10/22/2013http://dx.doi.org/10.4161/viru.26907The role of mitochondrial dysfunction   in sepsis-induced multi-organ failure Mervyn Singer Bloomsbury i nstitute of i ntensive Care Medicine; University College London; London, UK Keywords:  sepsis, mitochondria, multi-organ failure, nitric oxide, reactive oxygen species, biogenesis, mitophagy Abbreviations:  ADP, adenosine diphosphate; ANT, adenine nucleotide translocase; ATP, adenosine triphosphate; DAMP,  danger associated molecular pattern; FADH2, flavin adenine dinucleotide; MOF, multi-organ failure; NO, nitric oxide; NADH,  nicotinamide adenine dinucleotide; PGC-1 α, PPAR γ-coactivator-1 α; ROS, reactive oxygen species; UCP, uncoupling protein An important role for bioenergetic dysfunction is increas - ingly emerging to potentially explain the paradox of clinical  and biochemical organ failure in sepsis yet minimal cell death,  maintained tissue oxygenation and recovery in survivors.",Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
N Engl J Med 2003; 348:1546- 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 2.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2003; 31:2316-23;  PMID:14501962 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Respir Crit Care Med 2010; 182:183-91;  PMID:20299535 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
JAMA  2010; 304:1787-94;  PMID:20978258 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2007; 35:2408- 16; PMID:17948334 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med  1999; 27:1230-51;  PMID:10446814 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Respir Crit Care Med  2013; 187:509-17;  PMID:23348975 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care 2008; 12:R38;   PMID:18325092 ; http://dx.doi.org/10.1186/cc6823 9.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Shock 2013; 39:329-35;   PMID:23376953 ; http://dx.doi.org/10.1097/ SHK.0b013e318289376b 10.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Infection 1991; 19:317-23; PMID:1800370 ; http://dx.doi.org/10.1007/ BF01645355 11.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Intensive Care Med 2011; 37:1192-200; PMID:21533572 ; http://dx.doi.org/10.1007/ s00134-011-2227-z 13.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Curr Biol 2006;  16:R551-60;  PMID:16860735 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Cell 2006; 125:1241- 52; PMID:16814712 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Nat Rev Mol Cell  Biol 2012; 13:780-8; PMID:23175281 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Best Pract Res Clin Endocrinol Metab 2012; 26:711- 23; PMID:23168274 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Free Radic Biol Med  2012; 53:1919-28;  PMID:22989554 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Physiol Rev 2012; 92:791-896;  PMID:22535897 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care 2009; 13:220; PMID:19691819 ;  http://dx.doi.org/10.1186/cc7887 20.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Thyroid 2008; 18:145- 56; PMID :18279015 ; http://dx.doi.org/10.1089/ thy.2007.0250 21.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
IUBMB Life 2008; 60:210- 23; PMID:18344181 ; http://dx.doi.org/10.1002/ iub.37 22.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Endocr Dev 2008; 13:1-18;  PMID:18493130 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Biochim Biophys Acta 2012; 1823:1491-508;   PMID:22609301 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
N Engl J Med 2009; 361:1570-83; PMID:19828534 ; http://dx.doi.org/10.1056/ NEJMra0901217 25.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Cardiovasc Res 2008; 79:208-17;  PMID:18430751 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Science 2003; 299:896-9;  PMID:12574632 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Cardiovasc Res 2007; 75:283-90;  PMID:17466959 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Immunol Rev 2012;  249:158-75;  PMID:22889221 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Nature 2010; 464:104-7; PMID:20203610 ;  http://dx.doi.org/10.1038/nature0878033.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Inflamm Res 2011; 60:289-97; PMID:20976525 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Shock 2010; 34(Suppl  1):4-14;  PMID:20523270 ; http://dx.doi.org/10.1097/ SHK.0b013e3181e7e9ba 36.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care 2010; 14:231; PMID:20727232 ;  http://dx.doi.org/10.1186/cc9100 37.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Lancet 2005; 365:871-5; PMID:15752531 ;  http://dx.doi.org/10.1016/S0140-6736(05)71045-X 38.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2007; 35:1599- 608; PMID:17452940 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
N Engl J Med 2001; 345:588-95;   PMID :11529214 ; http://dx.doi.org/10.1056/ NEJMra002709 41.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Intensive Care Med 1998; 24:1209- 16; PMID:9876985 ; http://dx.doi.org/10.1007/ s001340050746 42.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Free Radic Biol Med  2012; 53:1252-63;  PMID:22841758 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Lancet  2002; 360:219-23;  PMID:12133657 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Physiol Regul Integr  Comp Physiol 2004; 286:R491-7; PMID:14604843 ;  http://dx.doi.org/10.1152/ajpregu.00432.2003 45.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
J Bioenerg Biomembr  2012; 44:243-52;  PMID:22426814 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Intensive Care Med 2005; 31:1356-61; PMID:16012806 ; http://dx.doi.org/10.1007/ s00134-005-2719-9 47.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care 2012; 16:R11;  PMID:22257427 ; http://dx.doi.org/10.1186/ cc11151,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Endocr Rev 2011; 32:670-93; PMID :21791567 ; http://dx.doi.org/10.1210/ er.2011-0007 49.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Respir Crit Care Med 2010; 182:745-51;   PMID:20538956 ; http://dx.doi.org/10.1164/ rccm.201003-0326OC 51.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Trends Biochem  Sci 2010; 35:145-9; PMID:20006513 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Biol Rev Camb Philos Soc 2004; 79:207-33; PMID :15005178 ; http://dx.doi.org/10.1017/ S1464793103006195 55.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Physiol Genomics  2013; 45:377-88;  PMID:23548685 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Circulation 2008; 117:103-14;   PMID:18172050 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.702993 57.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Lancet 2004; 364:545-8; PMID:15302200 ;  http://dx.doi.org/10.1016/S0140-6736(04)16815-3 58.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med  1993; 21:1012-9;  PMID:8319458 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
J Infect Dis 2012; 205:392-400;   PMID:22180620 ; http://dx.doi.org/10.1093/infdis/ jir764 61.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Respir  Crit Care Med 2007; 176:768-77; PMID:17600279 ;  http://dx.doi.org/10.1164/rccm.200701-161OC62.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
PLoS One  2012; 7:e47265;  PMID:23056618 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Circ Heart Fail 2013; 6:550- 62; PMID:23572494 ; http://dx.doi.org/10.1161/ CIRCHEARTFAILURE.112.000177 64.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med  2012; 40:1896-907;  PMID:22610192 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Circ Res  2012; 111:1208-21;  PMID:23065344 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Nature 2011; 469:221-5;  PMID :21124315 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2013; 41:182- 94; PMID:23222264 ; http://dx.doi.org/10.1097/ CCM.0b013e3182676657 68.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Cell Res 2013; 23:201- 12; PMID:23318584 ; http://dx.doi.org/10.1038/ cr.2013.6 69.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2006; 34:2439-46;   PMID:16791110 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care 2006; 10:228;  PMID:16953900 ; http://dx.doi.org/10.1186/ cc5014 71.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Immunol Rev 2012; 249:104-15; PMID:22889218 ;  http://dx.doi.org/10.1111/j.1600-065X.2012.01148.x 72.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
ScientificWorldJournal 2011; 11:2509- 29; PMID:22235182 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
FEBS J 2007; 274:2135-47; PMID :17371545 ;  http://dx.doi.org/10.1111/j.1742-4658.2007.05755.x 74.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Br J Anaesth  2013; 110:472-80;  PMID:23381720 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
N Engl J Med 2002; 346:557- 63; PMID:11856794 ; http://dx.doi.org/10.1056/ NEJMoa003289 77.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Lancet 2008; 371:1955-69; PMID:18539227 ;  http://dx.doi.org/10.1016/S0140-6736(08)60837-5 78.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Crit Care Med 2012; 40:919- 26; PMID:22036856 ; http://dx.doi.org/10.1097/ CCM.0b013e3182373174 79.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
J Pharmacol Exp Ther 2009; 329:641- 8; PMID:19190234 ; http://dx.doi.org/10.1124/ jpet.108.148049 80.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Science 2005; 308:518;  PMID:15845845 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Antioxid Redox Signal  2012; 17:11-21;  PMID:22221071 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
PLoS One 2013; 8:e63497;  PMID:23717435 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
J Biol Chem 2011; 286:16374-85; PMID:21454555 ;  http://dx.doi.org/10.1074/jbc.M110.207738 85.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Am J Respir  Crit Care Med 2012; 185:851-61; PMID:22312014 ;  http://dx.doi.org/10.1164/rccm.201106-1152OC 86.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Mitochondrion 2011; 11:108- 18; PMID:20727424 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
Acta Anaesthesiol Scand  2009; 53:717-23;  PMID:19388901 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/36/viru-5-66.PMC3916385.pdf
"24*Correspondence to: Daniel De Backer; Email: ddebacke@ulb.ac.be Submitted: 05/29/2013; Revised: 09/13/2013; Accepted: 09/13/2013http://dx.doi.org/10.4161/viru.26482Pathophysiology of microcirculatory dysfunction  and the pathogenesis of septic shock Daniel De Backer*, Diego Orbegozo Cortes, Katia Donadello, and Jean-Louis v incent Department of i ntensive Care; e rasme University Hospital; Université Libre de Bruxelles (ULB); Bruxelles, Belgium Keywords:  sepsis, microcirculatory blood flow, endothelium, organ failure, tissue PO2, tonometry, tissue PCO2 Multiple experimental and human trials have shown that  microcirculatory alterations are frequent in sepsis.",Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am J Respir Crit Care Med  2002; 166:98-104;  PMID:12091178 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2004; 32:1825-31;  PMID:15343008 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2013; 41:791-9; PMID:23318492 ;  http://dx.doi.org/10.1097/CCM.0b013e3182742e8b 4.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2010; 36:949- 55; PMID:20221744 ; http://dx.doi.org/10.1007/ s00134-010-1843-3 5.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2010; 14:R232; PMID:21182783 ; http://dx.doi.org/10.1186/cc9387 7.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2006 ; 10 :R15;  PMID:16420661 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive  Care Med 2010; 36:1928-34; PMID:20689935 ;  http://dx.doi.org/10.1007/s00134-010-1969-39.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2009; 37:2875-81;  PMID:19770750 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
J Surg  Res 1996; 61:190-6;  PMID:8769965 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Circ Res 2000; 86:774-8; PMID:10764411 ;  http://dx.doi.org/10.1161/01.RES.86.7.774 13.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Microcirculation  2007; 14:697-707;  PMID:17885995 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Clin Physiol Funct Imaging 2011; 31:151-8; PMID:21087397 ;  http://dx.doi.org/10.1111/j.1475-097X.2010.0094.x 15.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2012; 16:R83;  PMID:22587828 ; http://dx.doi.org/10.1186/ cc11341 16.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Nat Med 1999; 5:1209-12;  PMID:10502828 ; http://dx.doi.org/10.1038/13529 18.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2012; 40:1443-8; PMID:22430243 ; http://dx.doi.org/10.1097/ CCM.0b013e31823dae59 20.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am J Physiol Heart Circ Physiol 2006; 290:H2277- 85; PMID:16399873 ; http://dx.doi.org/10.1152/ ajpheart.00547.2005 22.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2011; 37:1534- 42; PMID:21695476 ; http://dx.doi.org/10.1007/ s00134-011-2267-4 23.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am J Physiol Gastrointest  Liver Physiol 2004; 286:G769-76; PMID :14715524 ;  http://dx.doi.org/10.1152/ajpgi.00275.2003 26.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2007; 11:R58;  PMID :17509156 ; http://dx.doi.org/10.1186/cc5920 27.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am  J Physiol Heart Circ Physiol 2007; 293:H1065- 71; PMID:17483235 ; http://dx.doi.org/10.1152/ ajpheart.01237.2006 28.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2011; 15:R223; PMID:21939529 ; http://dx.doi.org/10.1186/ cc10463 29.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2008; 34:2210- 7; PMID:18594793 ; http://dx.doi.org/10.1007/ s00134-008-1193-6 30.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am Heart  J 2004; 147:91-9; PMID:14691425 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Eur Heart J 2010; 31:3032- 9; PMID:20829210 ; http://dx.doi.org/10.1093/ eurheartj/ehq324 32.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2007; 33:1549- 56; PMID:17572876 ; http://dx.doi.org/10.1007/ s00134-007-0739-3 33.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Chest 2001; 120:923-7; PMID:11555530 ;  http://dx.doi.org/10.1378/chest.120.3.923 35.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med  2006; 32:516-23;  PMID:16485092 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Chest 2010; 138:1062-70;  PMID:20472858 ; http://dx.doi.org/10.1378/ chest.09-2690 37.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2003; 31:474-80; PMID:12576954 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2008; 36:535-42;  PMID:18216603 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Cerebrovasc Dis  2007; 23:140-7;  PMID:17124395 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
N Engl J Med 2011; 364:656-65;  PMID:21323543 ; http://dx.doi.org/10.1056/ NEJMra0910283 41.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2012; 40:2841-9; PMID:22890256 ;  http://dx.doi.org/10.1097/CCM.0b013e31825b916b 42.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med  2007; 35:2016-24;  PMID :17855815 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med  2006; 32:87-92;  PMID:16261341 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med  2005; 31:1661-8;  PMID:16205889 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med  2003; 29:1173-6;  PMID:12774160 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Shock 2007; 27:348-53;  PMID:17414414 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am J Respir Crit Care Med  1996; 153:191-5;  PMID :8542115 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
J Appl Physiol 2007; 102:2251-9; PMID:17347383 ; http://dx.doi.org/10.1152/ japplphysiol.01155.2006 56.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Curr Opin Anaesthesiol 2009; 22:150-4;  PMID:19390244 ;  http://dx.doi.org/10.1097/ACO.0b013e328328d1a1 57.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive  Care Med 2003; 29:1052-61; PMID:12802488 ;  http://dx.doi.org/10.1007/s00134-003-1783-2 58.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med  2000; 28:1865-70;  PMID:10890634 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med  2012; 38:1336-44;  PMID:22584795 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
J Cell Biol 2007; 176:231-41; PMID:17210947 ; http://dx.doi.org/10.1083/ jcb.200606027 61.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive  Care Med 2010; 36:1867-74; PMID:20725823 ;  http://dx.doi.org/10.1007/s00134-010-1966-6 62.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Anesthesiology 2002; 97:460-70;  PMID:12151938 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
J Crit Care 1997; 12:137- 41; PMID:9328853 ; http://dx.doi.org/10.1016/ S0883-9441(97)90043-5,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
"Crit Care Med 2005; 33:135-42, discussion 246-7;  PMID:15644660 ; http://dx.doi.org/10.1097/01.",Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2010; 36:1882- 9; PMID:20689910 ; http://dx.doi.org/10.1007/ s00134-010-2013-3 68.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive  Care Med 2007; 33:1557-62; PMID:17486316 ;  http://dx.doi.org/10.1007/s00134-007-0665-4 69.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2009; 13:R92; PMID:19534818 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2011; 15:R222; PMID:21936903 ; http://dx.doi.org/10.1186/ cc10462 71.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Lancet 2002; 360:1395- 6; PMID:12423989 ; http://dx.doi.org/10.1016/ S0140-6736(02)11393-6 72.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2010; 38:93- 100; PMID:19730258 ; http://dx.doi.org/10.1097/ CCM.0b013e3181b02fc174.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Intensive Care Med 2009; 35:1893-9; PMID:19639300 ;  http://dx.doi.org/10.1007/s00134-009-1591-4 75.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Shock  2011; 35:542-9;  PMID:21283060 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
BMC Anesthesiol  2011; 11:12;  PMID:21672227 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Am J Transplant  2006 ; 6 :1551-9;  PMID:16827855 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2008; 36:2355-62; PMID:18596627 ; http://dx.doi.org/10.1097/ CCM.0b013e31818024f6 82.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2012; 40:2833- 40; PMID:22846780 ; http://dx.doi.org/10.1097/ CCM.0b013e31825b88ba 83.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Biofactors 2009; 35:5-13; PMID:19319840 ;  http://dx.doi.org/10.1002/biof.784.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2007; 35:1966-71; PMID:17568327 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
J Am Soc Nephrol  2007; 18:860-7;  PMID:17301189 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2006; 34:1918- 24; PMID :16715034 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care Med 2002; 30:218-25;  PMID:11902265 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Shock  2009; 32:530-4;  PMID:19295478 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
Crit Care 2009; 13(Suppl 5):S12;  PMID:19951384 ; http://dx.doi.org/10.1186/cc8010,Non-OADS,/arxiv_data1/oa_pdf/8d/c8/viru-5-73.PMC3916386.pdf
"In this view, pro - gression of the syndrome (and a counter-inflammatory, “immu - noparalytic” phase of illness 16,17) will occur as a consequence of  inflammatory cellular signaling despite the rapid elimination of the pathogen through administration of cidal antimicrobial Correspondence to: Anand Kumar; Email address: akumar61@yahoo.com Submitted: 07/05/2013; Revised: 10/22/2013; Accepted: 10/22/2013http://dx.doi.org/10.4161/viru.26913An alternate pathophysiologic paradigm of sepsis  and septic shock Implications for optimizing antimicrobial therapy Anand Kumar Section of Critical Care Medicine; Section of i nfectious Diseases; Health Sciences Centre; w innipeg, MB Canada Keywords:  septic shock, antimicrobial, pharmacokinetics, sepsis, infection, antibiotic, life-threatening infection, combination  therapy, survival The advent of modern antimicrobial therapy following  the discovery of penicillin during the 1940s yielded remark - able improvements in case fatality rate of serious infections  including septic shock.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
JAMA 1959; 84:2188-97; http://dx.doi.org/10.1001/jama.1959.63010180008012 2.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Public Health 1976 ; 66:1180 - 4; PMID:1008114 ; http://dx.doi.org/10.2105/ AJPH.66.12.1180 3.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Med  1980 ; 68:344-55; PMID:6987871 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2003 ; 348:1546 - 54; PMID:12700374 ; http://dx.doi.org/10.1056/ NEJMoa022139 5.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2001 ; 29:1303 -10; PMID:11445675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
JAMA  1995 ; 274:968- 74; PMID:7674528 ; http://dx.doi.org/10.1001/ jama.1995.03530120060042 8.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Respir  Crit Care Med  2003 ; 168:165-72; PMID:12851245 ;  http://dx.doi.org/10.1164/rccm.2201087 9.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Inten - sive Care Med 2007 ; 33:396-9; PMID:17325833 ;  http://dx.doi.org/10.1007/s00134-007-0556-811.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Acta Anaesthesiol Scand  2006 ; 50:907-10; PMID:16923083 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2012 ; 366:2055 - 64; PMID:22616830 ; http://dx.doi.org/10.1056/ NEJMoa1202290 13.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Infect Dis Clin  North Am 1999 ; 13:413-26, ix ; PMID:10340175 ;  http://dx.doi.org/10.1016/S0891-5520(05)70083-0 15. van der Poll T. Coagulation and inflammation.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J  Endotoxin Res  2001 ; 7:301-4; PMID:11717589 ;  http://dx.doi.org/10.1177/09680519010070040301,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2003 ; 348:138- 50; PMID:12519925 ; http://dx.doi.org/10.1056/ NEJMra021333 17.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Pathol  2007 ; 170:1435 -44; PMID:17456750 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Lancet  2000 ; 356:961-7; PMID:11041396 ;  http://dx.doi.org/10.1016/S0140-6736(00)02712-4 19.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2001 ; 344:699- 709; PMID:11236773 ; http://dx.doi.org/10.1056/ NEJM200103083441001 21.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med 2008 ; 36:2973 - 9; PMID:18824906 ; http://dx.doi.org/10.1097/ CCM.0b013e31818b8c6b 22.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Scand J Infect Dis 2006 ; 38:7-14; PMID:16338832 ;  http://dx.doi.org/10.1080/00365540500372846 23.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch  Intern Med  2007 ; 167:1861 -7; PMID:17893307 ;  http://dx.doi.org/10.1001/archinte.167.17.1861 24.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect Dis  2003 ; 22:592-6 ; PMID:14513406 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Lancet  2005 ; 366:1435 -42;  PMID:16243088 ; http://dx.doi.org/10.1016/ S0140-6736(05)67490-9 26.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2007 ; 356:2472 -82; PMID:17568028 ;  http://dx.doi.org/10.1056/NEJMoa066906 27.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Intern Med 1991 ; 115:674-80; PMID:1929035 ;  http://dx.doi.org/10.7326/0003-4819-115-9-674 28.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Anesth Analg  2009 ; 108:1841 - 7; PMID:19448210 ; http://dx.doi.org/10.1213/ ane.0b013e318195e11d 29.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Circulation   2004 ; 109:1223 -5; PMID:15007008 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Lancet  1985 ; 2:578- 82; PMID:2863596 ; http://dx.doi.org/10.1016/ S0140-6736(85)90584-7 32.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med   2002 ; 28:1537-46; PMID:12583371 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Trauma  1993 ;  34:252-61; PMID:8459466 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest   2003 ; 123:1615 -24; PMID:12740282 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Trends Mol Med  2005 ; 11:56-63;  PMID :15694867 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Nat Med  2004 ; 10:124- 5; PMID:14760415 ; http://dx.doi.org/10.1038/ nm0204-124 37.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Shock  2011 ; 36:553- 9; PMID:22080961 ; http://dx.doi.org/10.1097/ SHK.0b013e318235331e 38.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect Dis  2006 ; 193:251-8; PMID:16362889 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Clin Microbiol  2004 ; 42:2980 -7; PMID:15243048 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest   2009 ; 136:832-40; PMID:19433527 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Medicine (Baltimore)   1969 ; 48:307-32; PMID:4897133 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Clin Microbiol  2006 ; 44:1342 -6; PMID:16597860 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2005 ; 41:594-8;  PMID:16080079 ; http://dx.doi.org/10.1086/432472 47.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Microbiol Infect  2007 ; 13:1077 -82; PMID:17727685 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med 2012 ; 40:2273 -80;  PMID:22809902 ; http://dx.doi.org/10.1097/ CCM.0b013e3182515190 51.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother  1987 ; 19:321-9; PMID:3106305 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Br Med J  1913 ; 2:353-9; PMID:20766753 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin  Infect Dis 2009 ; 49:997-1005 ; PMID:19719417 ;  http://dx.doi.org/10.1086/605555 54.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Scand J Infect Dis  2000 ; 32:27-30; PMID:10716073 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect  1997 ; 35:283-8; PMID:9459403 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Intern Med 1977 ; 86:456-71; PMID:403841 ;  http://dx.doi.org/10.7326/0003-4819-86-4-456 59.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med 1995 ; 155:2429 - 35; PMID:7503601 ; http://dx.doi.org/10.1001/ archinte.1995.00430220087009 61.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Intern Med  2001 ; 135:484-92; PMID :11578151 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest   2009 ; 136:1237 -48; PMID:19696123 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Scand J Infect Dis  2010 ; 42:185-92; PMID:20085422 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Interdiscip Perspect Infect Dis 2012 ;  2012 :765205 ; PMID:22919379 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   2010 ; 54:1742 -8; PMID:20160050 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis  2007 ; 45:329-37; PMID:17599310 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2008 ;  47(Suppl 1 ):S3-13; PMID:18713047 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   2010 ; 54:4851 -63; PMID:20733044 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest  2000 ; 118:146- 55; PMID:10893372 ; http://dx.doi.org/10.1378/ chest.118.1.146 71.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Intensive Care Med  2005 ; 20:296-301; PMID:16145220 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Clin Infect Dis 1999 ; 29:60-6, discussion 67-8 ;  PMID:10433566 ; http://dx.doi.org/10.1086/520182 74.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am  J Infect Control 2008 ; 36:283-90; PMID:18455049 ;  http://dx.doi.org/10.1016/j.ajic.2007.06.009 75.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Clin Microbiol 2012 ; 50:2066 -8;  PMID:22422850 ; http://dx.doi.org/10.1128/ JCM.06051-11 76.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 1998 ; 27:478-86;  PMID:9770144 ; http://dx.doi.org/10.1086/514686 77.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest   2006 ; 129:1210 -8; PMID:16685011 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Respir Crit Care Med  2000 ; 162:505-11; PMID:10934078 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med   2007 ; 33:1369 -78; PMID:17558493 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit  Care  2011 ; 15:R79; PMID:21366903 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  2008 ; 52:3188 - 94; PMID:18625778 ; http://dx.doi.org/10.1128/ AAC.01553-07 82.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother 2006 ; 57:511- 9; PMID:16443700 ; http://dx.doi.org/10.1093/jac/ dkl006 83.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Infection  2011 ; 39:519-26; PMID:22065426 ;  http://dx.doi.org/10.1007/s15010-011-0218-1 84.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother  2010 ; 65:1276 -85; PMID:20335186 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest  2003 ; 124:1798 - 804; PMID:14605051 ; http://dx.doi.org/10.1378/ chest.124.5.1798 86.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med 2001 ;  161:2099 -104; PMID :11570938 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Emerg Med  2009 ; 53:618-24; PMID:18723255 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Antimicrob Agents  2009 ; 34:575- 9; PMID:19740628 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Micro - biol Infect Dis 2006 ; 25:181-5; PMID:16505987 ;  http://dx.doi.org/10.1007/s10096-006-0096-0 93.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  2007 ; 51:3510 - 5; PMID:17646415 ; http://dx.doi.org/10.1128/ AAC.00338-07 94.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2003 ; 36:1418 -23; PMID:12766837 ;  http://dx.doi.org/10.1086/375057 95.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2003 ; 37:745-51;  PMID:12955633 ; http://dx.doi.org/10.1086/377200 96.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur Respir J  2012 ; 39:156-62; PMID:21828033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
JAMA   1997 ; 278:2080 -4; PMID:9403422 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect  Dis 1996 ; 15:286-90; PMID:8781878 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chest  2002 ; 122:262-8;  PMID:12114368 ; http://dx.doi.org/10.1378/ chest.122.1.262 101.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med  2002 ; 28:686- 91; PMID:12107671 ; http://dx.doi.org/10.1007/ s00134-002-1304-8 102.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med  2004 ; 164:637-44; PMID:15037492 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect  Dis 2006 ; 43:25-31; PMID:16758414 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Anti- microb Agents Chemother 2005 ; 49:3640 -5;  PMID:16127033 ; http://dx.doi.org/10.1128/ AAC.49.9.3640-3645.2005 105.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents  Chemother  2010 ; 54:184-90; PMID:19884371 ;  http://dx.doi.org/10.1128/AAC.00945-09 108.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med   2001 ; 27:513-20; PMID:11355119 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med 2010 ; 38:1045 -53; PMID:20048677 ;  http://dx.doi.org/10.1097/CCM.0b013e3181cc4824 111.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Surg Infect (Larchmt) 2005 ; 6:41- 54; PMID:15865550 ; http://dx.doi.org/10.1089/ sur.2005.6.41 112.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med 1985 ; 145:1621 -9;  PMID:3927867 ; http://dx.doi.org/10.1001/ archinte.1985.00360090089015 115.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect Dis 1998 ; 17:681- 4; PMID:9865979 ; http://dx.doi.org/10.1007/ s100960050160 117.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Br J Haematol 2011 ; 153:773-9; PMID :21517822 ;  http://dx.doi.org/10.1111/j.1365-2141.2011.08693.x 120.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Intern Med 1998 ; 129:862-9;  PMID:9867727 ; http://dx.doi.org/10.7326/0003- 4819-129-11_Part_1-199812010-00004 121.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Emerg Med 2001 ; 21:387-92; PMID:11728765 ;  http://dx.doi.org/10.1016/S0736-4679(01)00407-3 122.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med  2003 ; 29:1688 - 95; PMID :13680115 ; http://dx.doi.org/10.1007/ s00134-003-1957-y 123.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Transplant  2009 ; 9:1657 -65; PMID:19459798 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Ther 2010 ; 32:1285 - 93; PMID:20678676 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother 2012 ; 67:707-14;  PMID:22184469 ; http://dx.doi.org/10.1093/jac/ dkr511 126.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Respir Crit Care Med 2009 ; 180:861- 6; PMID:19696442 ; http://dx.doi.org/10.1164/ rccm.200812-1912OC,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med 2008 ; 36:296- 327; PMID :18158437 ; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Acta Anaes - thesiol Scand  2007 ; 51:1320 -6; PMID:17944634 ;  http://dx.doi.org/10.1111/j.1399-6576.2007.01439.x 129. de Sousa AG, Junior  CJF, Santos  GPD , Laselva  CR,  Polessi  J, Lisboa  LF, et al.",OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med  2008 ; 34:157- 62; PMID:17924093 ; http://dx.doi.org/10.1007/ s00134-007-0862-1 131.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med   2009 ; 35:871-81; PMID:19066848 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med 2009 ; 37:819- 24; PMID:19237883 ; http://dx.doi.org/10.1097/ CCM.0b013e318196206b 136.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2007 ; 35:1105 -12; PMID:17334251 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2010 ; 38:1036 -43; PMID:20154597 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Fr  Anesth Reanim  2010 ; 29:621-8; PMID:20634026 ;  http://dx.doi.org/10.1016/j.annfar.2010.04.007 140.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care  2010 ; 14:R83;  PMID:20459716 ; http://dx.doi.org/10.1186/cc9008 141.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
BMJ   2011 ; 342:d3245 ; PMID:21669950 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Pharmacother   2010 ; 44:1733 -8; PMID:20978215 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Trauma   2010 ; 69:1282 -7; PMID:20134352 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2010 ; 38:668-78; PMID:20029343 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Curr Pharm  Biotechnol  2011 ; 12:1996 -2001 ; PMID:21554218 ;  http://dx.doi.org/10.2174/138920111798808365 147.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Intensive Care Med   2007 ; 33:279-85; PMID:17165021 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  2012 ; 56:4241 - 9;  PMID :22615285 ; http://dx.doi.org/10.1128/ A AC.06426-11 150.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care  2010 ; 14:R126 ;  PMID:20594297 ; http://dx.doi.org/10.1186/cc9091 151.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care  2010 ; 14:R53;  PMID:20370907 ; http://dx.doi.org/10.1186/cc8945 152.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Anti - microb Agents  2012 ; 39:332-7; PMID:22333933 ;  http://dx.doi.org/10.1016/j.ijantimicag.2011.12.008 153.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect Dis  1984 ; 149:443-8; PMID : 6715900 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Inten - sive Care Med 2010 ; 36:979-83; PMID:20336279 ;  http://dx.doi.org/10.1007/s00134-010-1864-y 156. van Zanten  ARH , Polderman  KH, van Geijlswijk  IM,  van der Meer GYG , Schouten  MA, Girbes  ARJ.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Crit Care 2008 ; 23:422- 30; PMID:18725050 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother 2001 ;  47:246; PMID:11157921 ; http://dx.doi.org/10.1093/ jac/47.2.246 158.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents  Chemother  2009 ; 53:3430 -6; PMID:19433570 ;  http://dx.doi.org/10.1128/AAC.01361-08 160.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care  2009 ; 13:214;  PMID:19519961 ; http://dx.doi.org/10.1186/cc7774 161.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Clin Pharm Ther  1998 ; 23:185-90; PMID:9831969 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care  2012 ; 16:R218 ; PMID:23148736 ;  http://dx.doi.org/10.1186/cc11862 164.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2004 ; 39:1314 -20; PMID:15494908 ;  http://dx.doi.org/10.1086/425009 168.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother 2006 ; 58:1107 -17;  PMID:17040922 ; http://dx.doi.org/10.1093/jac/ dkl393 169.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2004 ; 38:864-70; PMID:14999632 ;  http://dx.doi.org/10.1086/381972 170.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Br Med J (Clin Res Ed) 1985 ; 291:636- 7; PMID:3928061 ; http://dx.doi.org/10.1136/ bmj.291.6496.636 172.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
South Med J  1985 ; 78:869-71; PMID:3892712 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Med 1981 ; 71:199-209; PMID:7020416 ;  http://dx.doi.org/10.1016/0002-9343(81)90106-6 175.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Clin Invest 1983 ; 71:411- 9; PMID:6826714 ; http://dx.doi.org/10.1172/ JCI110785 176.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Anti- microb Agents Chemother 2001 ; 45:2018 -22;  PMID:11408217 ; http://dx.doi.org/10.1128/ AAC.45.7.2018-2022.2001177.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med  1979 ; 139:1026 -31; PMID:475520 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Med  1985 ; 78:262-9; PMID:3881943 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med 2001 ; 345:1318 - 30; PMID :11794152 ; http://dx.doi.org/10.1056/ NEJMra010082 180.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Med 1987 ; 83:218-22; PMID:3303925 ;  http://dx.doi.org/10.1016/0002-9343(87)90688-7 181.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   2005 ; 49:4658 -66; PMID:16251309 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Infect  Dis 2005 ; 9:251-61; PMID:16099700 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2012 ;  54:1699 -709; PMID:22467668 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  1990 ; 34:1227 - 31; PMID:2393284 ; http://dx.doi.org/10.1128/ AAC.34.6.1227 188.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 1999 ; 29:1171-7; PMID:10524959 ;  http://dx.doi.org/10.1086/313440189.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J  Am Soc Nephrol 2012 ; 23:1551-9; PMID:22904350 ;  http://dx.doi.org/10.1681/ASN.2012010050 192.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2001 ; 32:402-12;  PMID:11170948 ; http://dx.doi.org/10.1086/318486 193.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect Dis 1999 ; 18:199- 202; PMID:10357054 ; http://dx.doi.org/10.1007/ s100960050258 194.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Respir Crit  Care Med 2000 ; 161:753-62; PMID:10712318 ;  http://dx.doi.org/10.1164/ajrccm.161.3.9904115 195.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med  2006 ; 355:653-65; PMID:16914701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Crit  Care Clin 2008 ; 24:349-63, ix-x ; PMID:18361950 ;  http://dx.doi.org/10.1016/j.ccc.2007.12.010 197.",OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Clin Infect Dis 1998 ; 26:1-10, quiz 11-2 ;  PMID:9455502 ; http://dx.doi.org/10.1086/516284 198.",Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Anti - microb Agents  2008 ; 31:345-51; PMID:18313273 ;  http://dx.doi.org/10.1016/j.ijantimicag.2007.12.009 200.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents  Chemother  2010 ; 54:1111-6; PMID:20038614 ;  http://dx.doi.org/10.1128/A AC.01183-09 201.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Antimicrob Agents  2006 ; 28:122- 7; PMID:16815689 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care   2012 ; 16:R113 ; PMID:22742765 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2007 ; 44:357-63;  PMID:17205441 ; http://dx.doi.org/10.1086/510590 205.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Pharmacother   2006 ; 40:219-23; PMID:16449546 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Ther  2007 ; 29:2433 -9; PMID :18158083 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Antimicrob Agents  2009 ; 33:464- 8; PMID :19150225 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2013 ; 56:236-44; PMID:23074313 ;  http://dx.doi.org/10.1093/cid/cis856 209.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  2003 ; 47:2749 - 55; PMID:12936969 ; http://dx.doi.org/10.1128/ AAC.47.9.2749-2755.2003 212.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Pharm Pract 2010 ; 23:6-18; PMID :21507788 ;  http://dx.doi.org/10.1177/0897190009356550 213.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Antimicrob Chemother 2003 ; 52:668-74;  PMID:12951354 ; http://dx.doi.org/10.1093/jac/ dkg403214.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Infect Dis  Clin North Am 2003 ; 17:529-43; PMID:14711075 ;  http://dx.doi.org/10.1016/S0891-5520(03)00061-8 215.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  1993 ; 37:1073 - 81; PMID:8517694 ; http://dx.doi.org/10.1128/ AAC.37.5.1073 216.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
JAMA  1998 ; 279:125- 9; PMID:9440662 ; http://dx.doi.org/10.1001/ jama.279.2.125 218.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect Dis 2004 ; 189:1590 -7;  PMID :15116294 ; http://dx.doi.org/10.1086/383320 219.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Clin Infect Dis 2011 ; 52:975-81;  PMID:21460309 ; http://dx.doi.org/10.1093/cid/ cir124 221.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Antimicrob Agents  2013 ; 41:255-60;  PMID:23312606 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chemotherapy  1978 ; 24:45-54; PMID:412648 ;  http://dx.doi.org/10.1159/000237759 226.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   1977 ; 11:956-64; PMID:406837 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect Dis  1977 ; 136:327-35; PMID:903671 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob  Agents Chemother  1978 ; 13:997-9; PMID:98109 ;  http://dx.doi.org/10.1128/AAC.13.6.997 230.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   1974 ; 6:442-6; PMID :4157342 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Chemotherapy  1998 ; 44:94-8; PMID:9551238 ;  http://dx.doi.org/10.1159/000007098 232.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Antimicrob Agents  2001 ; 17:103- 7; PMID:11165113 ; http://dx.doi.org/10.1016/ S0924-8579(00)00317-4 233.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Diagn Microbiol Infect Dis  1996 ; 26:29-33; PMID:8950526 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect Dis  1996 ; 15:688-93; PMID:8894583 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  2003 ; 47:1151- 3; PMID:12604560 ; http://dx.doi.org/10.1128/ A AC.47.3.1151-1153.2003 239.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
J Infect Chemother  2006 ;  12:172-6; PMID:16944253 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  1978 ; 13:849- 53; PMID:248271 ; http://dx.doi.org/10.1128/ AAC.13.5.849 243.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
N Engl J Med  1979 ; 301:126-31; PMID:449951 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Int J Anti - microb Agents  2011 ; 37:491-503; PMID:21292449 ;  http://dx.doi.org/10.1016/j.ijantimicag.2010.11.029 249.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Lancet Infect  Dis 2004 ; 4:519-27; PMID:15288826 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
BMJ  2004 ; 328:668- 79; PMID:14996699 ; http://dx.doi.org/10.1136/ bmj.38028.520995.63251.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
BMJ  2003 ; 326:1111- 8; PMID:12763980 ; http://dx.doi.org/10.1136/ bmj.326.7399.1111 252.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Arch Intern Med 2001 ;  161:1837 -42; PMID:11493124 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Respir Crit Care Med  2004 ; 170:440-4; PMID :15184200 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2007 ; 35:1493 -8; PMID:17452932 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Ann Intern Med  1991 ; 115:585-90; PMID:1892329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Am J Med 1989 ; 87:540- 6; PMID:2816969 ; http://dx.doi.org/10.1016/ S0002-9343(89)80611-4 258.,OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother  1992 ; 36:2639 - 44; PMID:1482131 ; http://dx.doi.org/10.1128/ AAC.36.12.2639259.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2010 ; 38:1651-64; PMID:20562695 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care Med  2010 ; 38:1773 -85; PMID:20639750 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Antimicrob Agents Chemother   2009 ; 53:1386 -94; PMID:19164144 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Eur J Clin Microbiol Infect Dis 2012 ; 31:2293 - 9; PMID:22350387 ; http://dx.doi.org/10.1007/ s10096-012-1568-z 264.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
Crit Care   2012 ; 16:R223 ; PMID :23158399 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ff/60/viru-5-80.PMC3916387.pdf
"Although several factors may contribute to the susceptibility of an individual to meningococcal disease, 3 the ability of an individual to mount a serum bactericidal  response against the challenge strain is probably the single most Correspondence to: Lisa A Lewis, Email: lisa.lewis@umassmed.edu;   Sanjay Ram, Email: sanjay.ram@umassmed.eduSubmitted: 06/19/2013; Revised: 09/16/2013; Accepted: 09/17/2013http://dx.doi.org/10.4161/viru.26515Meningococcal disease   and the complement system Lisa A Lewis and Sanjay Ram Division of i nfectious Diseases and i mmunology; University of Massachusetts Medical School; w orcester, MA USA Keywords:  Neisseria meningitidis, complement, meningococcus, sepsis, complement deficiency Despite considerable advances in the understanding of the  pathogenesis of meningococcal disease, this infection remains  a major cause of morbidity and mortality globally.",Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med  2001; 344:1378-88;  PMID:11333996 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vaccine  2009 ; 27(Suppl  2):B71-7; PMID:19477055 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Infect Dis 2012 ; 54:1162 -5;  PMID:22412064 ; http://dx.doi.org/10.1093/cid/ cis1206.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Nat Immunol  2010 ; 11:785- 97; PMID:20720586 ; http://dx.doi.org/10.1038/ ni.1923 7.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunobiology  2010 ; 215:1-11; PMID:19783065 ;  http://dx.doi.org/10.1016/j.imbio.2009.08.006 8.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Adv  Exp Med Biol 2009 ; 653:58-73; PMID:19799112 ;  http://dx.doi.org/10.1007/978-1-4419-0901-5_5 12.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunogenetics  1994 ; 40:37-44; PMID:8206524 ;  http://dx.doi.org/10.1007/BF00163962 13.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Immunol  2006 ; 43:86-96; PMID:16023210 ;  http://dx.doi.org/10.1016/j.molimm.2005.06.018 15.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Ann N Y Acad Sci  1983 ; 421:291-8; PMID:6586103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Springer Semin Immunopathol   1983 ; 6:361-71; PMID:6364431 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
C3b covalently bound to IgG demonstrates a reduced  rate of inactivation by factors H and I. J Exp Med  1984 ; 160:1640 -55; PMID:6239898 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun   2011 ; 79:724-31; PMID:21134964 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Immunol   2013 ; 190:6457 -67; PMID:23677468 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Immunol  2010 ; 185:507-16; PMID:20530262 ;  http://dx.doi.org/10.4049/jimmunol.0903598 28.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Nature   2006 ; 444:213-6; PMID:17051160 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Microbiol Rev  2010 ; 23:740-80; PMID:20930072 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Biol Chem 2011 ; 286:8297 -307;  PMID :21245150 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2002 ;  70:3752 -8; PMID:12065518 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Proc Natl Acad Sci U S  A 1983 ; 80:3461 -5; PMID:6222381 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Semin  Immunopathol  2012 ; 34:151-65; PMID:21811895 ;  http://dx.doi.org/10.1007/s00281-011-0280-x 43.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Biochem  J 1999 ; 344:167-75; PMID:10548547 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Biochemistry   1999 ; 38:7019 -31; PMID:10353813 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Mol Biol   2008 ; 375:80-101; PMID:18005991 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vox Sang  2007 ;  92:206-12; PMID:17348869 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Invest Ophthalmol Vis Sci 2009 ;  50:5818 -27; PMID:19661236 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunobiology   2012 ; 217:1034 -46; PMID:22964229 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Eur J Biochem 2002 ;  269:184-92; PMID:11784312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Biochim Biophys Acta  1983 ;  737:343-72; PMID:6349686 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Proc Natl Acad Sci U S A 1985 ;  82:4808 -12; PMID:3895225 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Biochemistry   1988 ; 27:4103 -9; PMID:2458130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Chim Acta 2006 ;  368:77-83; PMID:16460719 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Int J Biochem Cell Biol 1999 ; 31:539-44;  PMID:10399314 ; http://dx.doi.org/10.1016/ S1357-2725(99)00005-9 67.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 1987 ; 165:1095 -112; PMID:2951479 ;  http://dx.doi.org/10.1084/jem.165.4.1095 71.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Science  1953 ; 118:733- 7; PMID:13122009 ; http://dx.doi.org/10.1126/ science.118.3077.733 72.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Invest 1983 ; 71:236-47; PMID:6822663 ;  http://dx.doi.org/10.1172/JCI110764 75.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Invest 1989 ; 84:962- 70; PMID:2527255 ; http://dx.doi.org/10.1172/ JCI114259 76.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Immunol  2011 ;  48:2159 -69; PMID:21839519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 1908 ; 10:690- 733; PMID :19867159 ; http://dx.doi.org/10.1084/ jem.10.5.690 80.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 1969 ; 129:1307 - 26; PMID:4977280 ; http://dx.doi.org/10.1084/ jem.129.6.1307 81.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med  1969 ; 129:1327 -48; PMID:4977281 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 2000 ; 181:1172 -5;  PMID:10720549 ; http://dx.doi.org/10.1086/315352 83.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunol Res  1993 ; 12:295-311; PMID:8288947 ;  http://dx.doi.org/10.1007/BF02918259 84.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Vaccine Immunol  2007 ; 14:863-8; PMID:17494636 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
JAMA   1990 ; 264:1271 -5; PMID:2117679 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Epidemiol Infect  1994 ; 112:315- 28; PMID:8150006 ; http://dx.doi.org/10.1017/ S095026880005773388.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun   2009 ; 77:3588 -95; PMID:19528219 ;  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis  1987 ; 155:1266 -75; PMID:3106511 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Infect Dis 1999 ; 28:98-105;  PMID:10028078 ; http://dx.doi.org/10.1086/515075 92.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Nat Rev Immunol  2008 ; 8:34-47; PMID:18064051 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med  1980 ; 303:178-82; PMID:6966763 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 1994 ; 170:848-53; PMID:7930726 ;  http://dx.doi.org/10.1093/infdis/170.4.848 99.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Exp Immunol  1998 ; 111:97-101; PMID:9472667 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Scand  J Infect Dis 2006 ; 38:764-71; PMID:16938729 ;  http://dx.doi.org/10.1080/00365540600643203 102.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin  Infect Dis 2009 ; 48:587-94; PMID:19191644 ;  http://dx.doi.org/10.1086/596707 103.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
"Arch Dis Child 2002 ; 86:44- 6; PMID:11806883 ; http://dx.doi.org/10.1136/ adc.86.1.44 104. van Deuren  M, van der Ven-Jongekrijg J, Bartelink   AK, van Dalen R, Sauerwein  RW, van der Meer JW.",OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis  1995 ; 172:433-9; PMID:7622886 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 1989 ; 169:333- 8; PMID:2783334 ; http://dx.doi.org/10.1084/ jem.169.1.333 106.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 2005 ; 191:768-75;  PMID :15688294 ; http://dx.doi.org/10.1086/427514 107.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS Pathog  2009 ; 5:e1000396 ;  PMID:19390612 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 1989 ; 160:58- 65; PMID:2471750 ; http://dx.doi.org/10.1093/ infdis/160.1.58 110.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2004 ; 72:3344 -9; PMID :15155639 ;  http://dx.doi.org/10.1128/IAI.72.6.3344-3349.2004 111.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunology  2001 ;  102:365-72; PMID:11298837 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Eur J Pediatr 1995 ; 154:735 -8;  PMID:8582425 ; http://dx.doi.org/10.1007/ BF02276718 117.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Sex Transm  Dis 1987 ; 14:201-4; PMID:2830678 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med 1983 ;  308:913-6; PMID:6835295 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Arch Dis Child 2002 ; 86:215- 7; PMID:11861251 ; http://dx.doi.org/10.1136/ adc.86.3.215 121.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Pediatr Infect Dis J  1987 ; 6:75-6; PMID:3822623 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Pediatr  1989 ; 114:260- 4; PMID :2915285 ; http://dx.doi.org/10.1016/ S0022-3476(89)80793-0 123.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Scand J Infect  Dis 1989 ; 21:389-96; PMID:2511621 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Meningococcal disease in patients with late  complement component deficiency: studies  in the U.S.S.R. Medicine (Baltimore)  1993 ;  72:374-92; PMID:8231787 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Exp Immunol 1990 ; 81:423-7; PMID:2397612 ;  http://dx.doi.org/10.1111/j.1365-2249.1990.tb05350.x 127.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 1990 ; 161:932- 7; PMID:2109021 ; http://dx.doi.org/10.1093/ infdis/161.5.932 130.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Exp Immunol 2000 ;  119:305-10; PMID:10632667 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Pathol 1985 ; 38:309- 11; PMID:3973056 ; http://dx.doi.org/10.1136/ jcp.38.3.309 132.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Pediatr Surg  1986 ; 21:1084 -6; PMID:3794973 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Pediatr Surg 1986 ; 21:326- 30; PMID:3701550 ; http://dx.doi.org/10.1016/ S0022-3468(86)80195-6 134.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
JAMA  1981 ; 246:1119-20;  PMID:6790733 ; http://dx.doi.org/10.1001/ jama.1981.03320100055033 135.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Blood  2006 ; 107:4865 - 70; PMID:16527897 ; http://dx.doi.org/10.1182/ blood-2005-07-2820 140.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Lancet  1999 ; 354:1094 - 5; PMID:10509505 ; http://dx.doi.org/10.1016/ S0140-6736(99)02563-5 144.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Adv  Exp Med Biol 2003 ; 531:351-5; PMID:12916805 ;  http://dx.doi.org/10.1007/978-1-4615-0059-9_29 145.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Transpl Infect Dis  2007 ; 9:214-8; PMID:17692067 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Immunol  2006 ; 43:473-9; PMID:16337490 ;  http://dx.doi.org/10.1016/j.molimm.2005.02.017 147.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Lancet  1999 ; 353:1049 -53; PMID:10199352 ;  http://dx.doi.org/10.1016/S0140-6736(98)08350-0 148.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Scand J Immunol  1993 ; 37:468-70; PMID:8469930 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Pediatr Infect Dis J 2007 ; 26:243-6;  PMID:17484222 ; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Int  J Immunogenet  2012 ; 39:328-37; PMID:22296677 ;  http://dx.doi.org/10.1111/j.1744-313X.2012.01095.x 151.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunobiology  1998 ; 199:327- 39; PMID:9777416 ; http://dx.doi.org/10.1016/ S0171-2985(98)80037-5152.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Biochem Soc Trans 2003 ; 31:763- 7; PMID:12887299 ; http://dx.doi.org/10.1042/ BST0310763 153.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Arch Intern Med 1986 ; 146:1539 - 40; PMID:3729633 ; http://dx.doi.org/10.1001/ archinte.1986.00360200097016 154.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Pediatr Allergy Immunol  1993 ; 4:6-9; PMID:8348257 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Semin Arthritis Rheum 1990 ;  20:174-84; PMID:2287942 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Br  J Haematol 2013 ; 162:62-73; PMID:23617322 ;  http://dx.doi.org/10.1111/bjh.12347 161.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Am J Transplant 2013 ; 13:819-20;  PMID:23289494 ; http://dx.doi.org/10.1111/ ajt.12032 163.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Epidemiol Infect   2013 ; •••:1-4; PMID:23574798 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 2008 ; 205:1423 -34; PMID:18504306 ;  http://dx.doi.org/10.1084/jem.20072577 166.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Microb Pathog  1992 ; 13:219-24; PMID:1283998 ;  http://dx.doi.org/10.1016/0882-4010(92)90022-G 171.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2006 ; 74:2637 -50; PMID:16622200 ;  http://dx.doi.org/10.1128/IAI.74.5.2637-2650.2006 177.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2006 ;  74:4094 -103; PMID:16790783 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med  2005 ; 201:1637 -45; PMID:15897277 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Immunol  2012 ; 188:5063 -72; PMID:22504643 ;  http://dx.doi.org/10.4049/jimmunol.1103748 184.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Immunol  2009 ; 46:2808 - 17; PMID:19477524 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS Pathog  2010 ; 6:e1001027 ;  PMID:20686663 ; http://dx.doi.org/10.1371/ journal.ppat.1001027 187.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Microbiol Mol Biol Rev  2013 ; 77:234- 52; PMID:23699256 ; http://dx.doi.org/10.1128/ MMBR.00056-12 189.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 2003 ; 197:789- 99; PMID:12642606 ; http://dx.doi.org/10.1084/ jem.20021911 191.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2004 ;  72:2088 -100; PMID:15039331 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Biol Chem 2003 ; 278:24825 - 30; PMID:12716881 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun   2009 ; 77:764-9; PMID:19047406 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Proc Natl Acad Sci U S A  2002 ;  99:3417 -21; PMID:11891340 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS One   2012 ; 7:e45132 ; PMID:23028802 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Microbiol   2011 ; 82:1129 -49; PMID:22050461 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Science   2003 ; 301:373-5; PMID:12869763 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Biol Chem 1997 ; 272:20793 - 9; PMID:9252403 ; http://dx.doi.org/10.1074/ jbc.272.33.20793 205.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Lancet  1983 ; 2:355- 7; PMID:6135869 ; http://dx.doi.org/10.1016/ S0140-6736(83)90340-9 206.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin  Microbiol Rev 2004 ; 17:581-611; PMID :15258095 ;  http://dx.doi.org/10.1128/CMR.17.3.581-611.2004 208.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Microbiol  2011 ;  81:1136 -43; PMID:21812841 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Z Hyg  Infektionskr  1894 ; 17:355; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Science   2010 ; 328:508-12; PMID:20413503 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Invest 1993 ; 91:339- 43; PMID:8423230 ; http://dx.doi.org/10.1172/ JCI116190 217.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Invest 1943 ; 22:375-85; PMID:16695017 ;  http://dx.doi.org/10.1172/JCI101406 219.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect  Dis 1977 ; 136:733-9; PMID:925381 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vaccine   2005 ; 23:977-83; PMID:15620470 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Immunol  2000 ; 20:138-49; PMID:10821465 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Immunol  2011 ;  186:4881 -94; PMID:21402895 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Clin Invest 1985 ; 76:1765 - 72; PMID:3932472 ; http://dx.doi.org/10.1172/ JCI112167 227.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
APMIS   1996 ; 104:321-38; PMID:8703438 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun   2005 ; 73:6721 -6; PMID:16177349 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Med Microbiol  Immunol  2010 ; 199:173-83; PMID:20376486 ;  http://dx.doi.org/10.1007/s00430-010-0149-y 231.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Lancet   2002 ; 360:1741 ; PMID:12480427 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med  1969 ; 129:1385 -95; PMID:4977284 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vaccine   2000 ; 19:1129 -32; PMID:11137248 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
JAMA  1998 ; 280:1685 -9;  PMID:9832000 ; http://dx.doi.org/10.1001/ jama.280.19.1685236.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vaccine   2003 ; 21:734-7; PMID:12531351 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Pediatr Infect Dis J 2009 ; 28:385-90;  PMID:19384263 ; http://dx.doi.org/10.1097/ INF.0b013e318195205e 240.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
"Int J Epidemiol 2009 ; 38:413-8;  PMID:18988650 ; http://dx.doi.org/10.1093/ije/ dyn228 241. van de Waterbeemd B, Zomer  G, Kaaijk  P,  Ruiterkamp  N, Wijffels  RH, van den Dobbelsteen   GP , van der Pol LA.",OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS One  2013 ; 8:e65157 ;  PMID:23741478 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Science  2003 ; 302:602; PMID:14576423 ;  http://dx.doi.org/10.1126/science.1092329 243.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Proc Natl Acad Sci U S A 2006 ;  103:10834 -9; PMID:16825336 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Nature   2009 ; 458:890-3; PMID:19225461 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Immunol  2011 ; 186:3606 - 14; PMID:21325619 ; http://dx.doi.org/10.4049/ jimmunol.1003470 246.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS Pathog  2012 ; 8:e1002688 ;  PMID:22589720 ; http://dx.doi.org/10.1371/ journal.ppat.1002688 247.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis 1994 ; 170:449-53; PMID:8035035 ;  http://dx.doi.org/10.1093/infdis/170.2.449 249.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin  Exp Immunol  1995 ; 100:32-9; PMID:7697919 ;  http://dx.doi.org/10.1111/j.1365-2249.1995.tb03600.x 250.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med 2013 ; 368:2169 -81; PMID:23738544 ;  http://dx.doi.org/10.1056/NEJMoa1208981 252.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med 2011 ; 364:2561 -3; PMID:21612462 ;  http://dx.doi.org/10.1056/NEJMc1100859 253.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Exp Immunol  1998 ; 114:362-9; PMID:9844044 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Exp Immunol 2000 ;  119:311-6; PMID:10632668 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med  1971 ; 134:162-75; PMID:4254163 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
N Engl J Med 1979 ; 300:1124 - 9; PMID:431636 ; http://dx.doi.org/10.1056/ NEJM197905173002002 261.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Vaccine   2008 ; 26:451-9; PMID:18162264 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Vaccine  Immunol  2011 ; 18:1002 -14; PMID :21508163 ;  http://dx.doi.org/10.1128/CVI.00055-11 265.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Genome Res 2003 ; 13:391-8; PMID:12618369 ;  http://dx.doi.org/10.1101/gr.664303 266.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Infect Dis  1992 ; 166:1079 -88; PMID:1402019 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Cell Microbiol  2002 ;  4:585-98; PMID:12390351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2008 ; 76:339- 50; PMID:17984207 ; http://dx.doi.org/10.1128/ IAI.00613-07 272.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Immunobiology   1993 ; 187:382-402; PMID:8330904 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
J Exp Med 1988 ; 168:107- 26; PMID:2456365 ; http://dx.doi.org/10.1084/ jem.168.1.107 274.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2009 ; 77:2094 -103; PMID:19273554 ;  http://dx.doi.org/10.1128/IAI.01561-08276.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Infect Immun  2011 ; 79:3751 -9; PMID:21708990 ;  http://dx.doi.org/10.1128/IAI.05182-11 277.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
PLoS Pathog   2010 ; 6:e1000911 ; PMID:20502634 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Mol Microbiol  2013 ; 87:254- 68; PMID:23163582 ; http://dx.doi.org/10.1111/ mmi.12097 279.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Proc Natl Acad Sci U S A  2010 ; 107:3770 -5; PMID:20133713 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
Clin Microbiol Rev 2010 ;  23:740-80; http://dx.doi.org/10.1128/CMR.00048- 09; PMID:20930072,Non-OADS,/arxiv_data1/oa_pdf/0a/89/viru-5-98.PMC3916388.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/68/dddt-8-183.PMC3916431.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 183–195Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  183Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5157 7Qsar and docking studies on xanthone  derivatives for anticancer activity targeting   Dna topoisomerase ii α sarfaraz alam Feroz Khan Metabolic and structural Biology  Department, central institute of  Medicinal and aromatic Plants,   council of scientific and industrial  research, lucknow, Uttar Pradesh,   india correspondence: Feroz Khan   Metabolic and structural Biology   Department, central institute   of Medicinal and aromatic Plants, council   of Scientific and Industrial Research,   PO-ciMaP, Kukrail Picnic spot road,   lucknow-226015, Uttar Pradesh, india   Tel +91 522 271 7668   Fax +91 522 234 2666   email f.khan@cimap.res.i nAbstract:  Due to the high mortality rate in India, the identification of novel molecules is   important in the development of novel and potent anticancer drugs.",Non-OADS,/arxiv_data1/oa_pdf/18/68/dddt-8-183.PMC3916431.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/18/68/dddt-8-183.PMC3916431.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/68/dddt-8-183.PMC3916431.pdf
Available from http://www.cdc.gov/cancer/ dcpc/data/.,OADS,/arxiv_data1/oa_pdf/18/68/dddt-8-183.PMC3916431.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/0d/jpr-7-089.PMC3916436.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/f2/0d/jpr-7-089.PMC3916436.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/0d/jpr-7-089.PMC3916436.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/c9/ijn-9-745.PMC3916444.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 745–757International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  745OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5639 1enhanced antitumor activity of realgar   mediated by milling it to nanosize Ye Tian1 Xiaobo Wang1,2 ronggang Xi1,2 Weisan Pan1 shuang Jiang2 Zhao li1 Yu Zhao3 guanghui gao4 Dan liu2 1Department of Pharmaceutics,   shenyang Pharmaceutical University,   shenyang, 2Department of Pharmacy,   210th hospital of People’s liberation  army, Dalian,3Department of  Pharmaceutics, college of Pharmacy,   harbin Medical University, harbin,   4Department of laboratory Medicine,   liaoning Institute for Food and Drug  control, shenyang, People’s republic  of china correspondence: Xiaobo Wang   Department of Pharmaceutics,   shenyang Pharmaceutical University,   103 Wenhua road, shenyang,   liaoning 110016, People’s republic   of china   Tel/Fax +86 24 2398 6313   email wxbbenson0653@sina.co mAbstract:  Realgar is a poorly water-soluble compound that exhibits poor bioavailability.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/ijn-9-745.PMC3916444.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/de/c9/ijn-9-745.PMC3916444.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/c9/ijn-9-745.PMC3916444.pdf
"6: 611, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.611 ▣PREFACE",Non-OADS,/arxiv_data1/oa_pdf/25/23/kjp-51-611.PMC3916446.pdf
"6: 613-619, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.613 ▣MINI-REVIEW Comprehensive Review of Ocular Angiostrongyliasis with  Special Reference to Optic Neuritis Ying Feng1, Yukifumi Nawa2, Kittisak Sawanyavisuth3,4, Zhiyue Lv5,6 and Zhong-Dao Wu5,6,* 1Department of Histology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China; 2Research Affairs, Faculty of  Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 3Department of Internal Medicine, Faculty of Medicine, Khon Kaen University, Khon  Kaen 40002, Thailand; 4Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen  40002, Thailand; 5Key Laboratory of Tropical Disease Control (Sun Yat-Sen University), Ministry of Education, Guangzhou 510080, China;  6Department of Parasitology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China Abstract:  Angiostrongyliasis, caused by Angiostrongylus cantonensis  infection, is a food-borne parasitic disease.",Non-OADS,/arxiv_data1/oa_pdf/f9/d4/kjp-51-613.PMC3916447.pdf
"*Corresponding author (wuzhd@mail.sysu.edu.cn) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/d4/kjp-51-613.PMC3916447.pdf
"6: 621-627, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.621 ▣MINI-REVIEW Paragonimus  and Paragonimiasis in Vietnam: an Update Pham Ngoc Doanh1,*, Yoichiro Horii2 and Yukifumi Nawa3 1Institute of Ecology and Biological Resources, Vietnam Academy of Science and Technology, Hanoi, Viet Nam; 2Laboratory of Veterinary   Parasitic Diseases, Faculty of Agriculture, University of Miyazaki, Miyazaki, Japan; 3Research Affairs, Faculty of Medicine, Khon Kaen University,  Khon Kaen, Thailand Abstract:  Paragonimiasis is a food-borne parasitic zoonosis caused by infection with lung flukes of the genus Paragoni - mus.",Non-OADS,/arxiv_data1/oa_pdf/14/98/kjp-51-621.PMC3916448.pdf
"*Corresponding author (pndoanh@iebr.ac.vn) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/98/kjp-51-621.PMC3916448.pdf
"6: 629-632, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.629 ▣ORIGINAL ARTICLE Susceptibility of Laboratory Rodents to Trichinella papuae Lakkhana Sadaow1,2, Pewpan M. Intapan1,2, Thidarut Boonmars1, Nimit Morakote3 and Wanchai Maleewong1,2,* 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Research and Diagnostic Center for  Emerging Infectious Diseases, Khon Kaen University, Khon Kaen 40002, Thailand; 3Department of Parasitology, Faculty of Medicine,   Chiang Mai University, Chiang Mai 50200, Thailand Abstract:  Members of the genus Trichinella  are small nematodes that can infect a wide range of animal hosts.",Non-OADS,/arxiv_data1/oa_pdf/44/f1/kjp-51-629.PMC3916449.pdf
"*Corresponding author (wanch_ma@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/f1/kjp-51-629.PMC3916449.pdf
"6: 633-636, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.633 ▣ORIGINAL ARTICLE Angiostrongylus cantonensis : Scanning Electron  Microscopic Observations on the Cuticle of Moulting  Larvae Xin Zeng1,2, Jie Wei1,2, Juan Wang1,2, Feng Wu1,2, Feng Fung1,2, Xiaoying Wu3, Xi Sun1,2, Huanqing Zheng1,2,   Zhiyue Lv 1,2,* and Zhongdao Wu1,2,* 1Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China;   2Ministry of Education Key Laboratory of Control of Tropical Diseases, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China;.",Non-OADS,/arxiv_data1/oa_pdf/ad/50/kjp-51-633.PMC3916450.pdf
"*Corresponding authors (wuzhd@mail.sysu.edu.cn; lvzhiyue@mail.sysu.edu.cn) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/50/kjp-51-633.PMC3916450.pdf
"6: 637-644, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.637 ▣ORIGINAL ARTICLE Modulation of Antibody Responses against Gnathostoma  spinigerum  in Mice Immunized with Crude Antigen  Formulated in CpG Oligonucleotide and Montanide ISA720 Pewpan M. Intapan1,2,*, Chakrit Hirunpetcharat3, Churairat Kularbkaew4, Wiboonchai Yutanawiboonchai4,   Penchom Janwan1,2 and Wanchai Maleewong1,2 1Department of Parasitology and 2Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University,  Khon Kaen 40002, Thailand; 3Department of Microbiology, Faculty of Public Health, Mahidol University, Bangkok 10400, Thailand;   4Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  This study aimed to investigate the antibody responses in mice immunized with Gnathostoma spinigerum  crude  antigen (GsAg) incorporated with the combined adjuvant, a synthetic oligonucleotide containing unmethylated CpG motif  (CpG ODN 1826) and a stable water in oil emulsion (Montanide ISA720).",Non-OADS,/arxiv_data1/oa_pdf/ce/e3/kjp-51-637.PMC3916451.pdf
"*Corresponding author (pewpan@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/e3/kjp-51-637.PMC3916451.pdf
"6: 645-650, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.645 ▣ORIGINAL ARTICLE Rapid Detection and Identification of Wuchereria bancrofti ,  Brugia malayi , B. pahangi , and Dirofilaria immitis  in  Mosquito Vectors and Blood Samples by High Resolution  Melting Real-Time PCR Tongjit Thanchomnang1,2, Pewpan M. Intapan1,3, Chairat Tantrawatpan1,4, Viraphong Lulitanond1,5,   Sudchit Chungpivat6, Piyanan Taweethavonsawat6, Worasak Kaewkong1,7, Oranuch Sanpool1,3,   Penchom Janwan1,3, Wej Choochote8 and Wanchai Maleewong1,3,* 1Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;  2Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand; 3Department of Parasitology, Faculty of Medicine, Khon Kaen  University, Khon Kaen 40002, Thailand; 4Division of Cell Biology, Department of Preclinical Sciences, Faculty of Medicine, Thammasat University,  Rangsit Campus, Pathum Thani 12121, Thailand; 5Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002,  Thailand; 6Parasitology Unit, Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand;  7Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand; 8Department of Parasitology,   Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand Abstract:  A simple, rapid, and high-throughput method for detection and identification of Wuchereria bancrofti , Brugia  malayi , Brugia pahangi , and Dirofilaria immitis  in mosquito vectors and blood samples was developed using a real-time  PCR combined with high-resolution melting (HRM) analysis.",Non-OADS,/arxiv_data1/oa_pdf/eb/0e/kjp-51-645.PMC3916452.pdf
"*Corresponding author (wanch_ma@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/eb/0e/kjp-51-645.PMC3916452.pdf
"6: 651-656, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.651 ▣ORIGINAL ARTICLE Molecular Differentiation of Schistosoma japonicum  and  Schistosoma mekongi  by Real-Time PCR with High  Resolution Melting Analysis Amornmas Kongklieng1,2, Worasak Kaewkong2,3, Pewpan M. Intapan1,2, Oranuch Sanpool1,2,   Penchom Janwan1,2, Tongjit Thanchomnang2,4, Viraphong Lulitanond2,5, Pusadee Sri-Aroon6,   Yanin Limpanont6 and Wanchai Maleewong1,2,* 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Research and Diagnostic Center for  Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 3Department of Biochemistry, Faculty of  Medical Science, Naresuan University, Phitsanulok, 65000 Thailand; 4Faculty of Medicine, Mahasarakham University, Mahasarakham 44000,  Thailand; 5Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 6Applied Malacology Center,  Department of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand Abstract:  Human schistosomiasis caused by Schistosoma japonicum  and Schistosoma mekongi  is a chronic and debili - tating helminthic disease still prevalent in several countries of Asia.",Non-OADS,/arxiv_data1/oa_pdf/f5/73/kjp-51-651.PMC3916453.pdf
"*Corresponding author (wanch_ma@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/73/kjp-51-651.PMC3916453.pdf
"6: 657-662, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.657 ▣ORIGINAL ARTICLE Morphological and Molecular Characterization of  Lymnaeid Snails and Their Potential Role in Transmission  of Fasciola  spp.",Non-OADS,/arxiv_data1/oa_pdf/25/1a/kjp-51-657.PMC3916454.pdf
"*Corresponding author (dung_parasitologist@yahoo.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/1a/kjp-51-657.PMC3916454.pdf
Available from: http://www.megasoftware.net/.,Non-OADS,/arxiv_data1/oa_pdf/25/1a/kjp-51-657.PMC3916454.pdf
"6: 663-667, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.663 ▣ORIGINAL ARTICLE Zoonotic Echinostome Infections in Free-Grazing Ducks in  Thailand Weerachai Saijuntha1, Kunyarat Duenngai2 and Chairat Tantrawatpan3,4,* 1Walai Rukhavej Botanical Research Institute (WRBRI), Mahasarakham University, Maha Sarakham 44150, Thailand; 2Department of Public Health,  Faculty of Science and Technology, Phetchabun Rajabhat University, Phetchabun 67000, Thailand; 3Division of Cell Biology, Department of  Preclinical Sciences, Faculty of Medicine, Thammasat University, Rangsit Campus, Pathum Thani 12120, Thailand; 4Research and Diagnostic  Center for Emerging Infectious Diseases, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Free-grazing ducks play a major role in the rural economy of Eastern Asia in the form of egg and meat produc - tion.",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/kjp-51-663.PMC3916455.pdf
"*Corresponding author (talent3003@yahoo.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/6d/kjp-51-663.PMC3916455.pdf
"6: 669-676, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.669 ▣ORIGINAL ARTICLE Ultrastructure of Spermatogenesis in the Testis of  Paragonimus heterotremus Nongnut Uabundit1, Pipatphong Kanla1, Phongphithak Puthiwat1,2, Channarong Arunyanart1,   Kowit Chaiciwamongkol1, Wanchai Maleewong3,4, Pewpan M. Intapan3,4,  Sitthichai Iamsaard1 and Wiphawi Hipkaeo1,* 1Department of Anatomy, Faculty of Medicine, Khon Kaen University, Muang, Khon Kaen 40002, Thailand; 2Department of Anatomy, Faculty of  Medical Science, Naresuan University, Muang, Phitsanulok 65000, Thailand; 3Department of Parasitology, Faculty of Medicine, Khon Kaen  University, Muang, Khon Kaen 40002, Thailand; 4Research and Diagnostic Center for Emerging Infectious Diseases, Khon Kaen University, Muang,  Khon Kaen 40002, Thailand Abstract:  Lung fluke, Paragonimus heterotremus , is a flatworm causing pulmonary paragonimiasis in cats, dogs, and hu - mans in Southeast Asia.",Non-OADS,/arxiv_data1/oa_pdf/60/cb/kjp-51-669.PMC3916456.pdf
"*Corresponding author (wiphawi@kku.ac.th; hipkaeo1@hotmail.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/cb/kjp-51-669.PMC3916456.pdf
"6: 677-681, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.677 ▣ORIGINAL ARTICLE Molecular Variation in the Paragonimus heterotremus   Complex in Thailand and Myanmar Oranuch Sanpool1,2,4, Pewpan M. Intapan1,2,*, Tongjit Thanchomnang2,4, Penchom Janwan1,2,   Yukifumi Nawa3, David Blair5 and Wanchai Maleewong1,2 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Research and Diagnostic Center for  Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 3Research Division, Faculty of Medicine,  Khon Kaen University, Khon Kaen 40002, Thailand; 4Faculty of Medicine, Mahasarakham University, Mahasarakham 44150, Thailand;   5School of Marine and Tropical Biology, James Cook University, Queensland, Australia Abstract:  Paragonimiasis is an important food-borne parasitic zoonosis caused by infection with lung flukes of the genus  Paragonimus .",Non-OADS,/arxiv_data1/oa_pdf/90/8c/kjp-51-677.PMC3916457.pdf
"*Corresponding author (pewpan@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/8c/kjp-51-677.PMC3916457.pdf
"6: 683-687, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.683 ▣ORIGINAL ARTICLE Paragonimus paishuihoensis  Metacercariae in Freshwater  Crabs, Potamon lipkei , in Vientiane Province, Lao PDR Shigehisa Habe1, Pham Ngoc Doanh2, Shinichiro Yahiro3, Nanthasane Vannavong4, Hubert Barennes4,   Peter Odermatt5, Gilles Dreyfuss6, Yoichiro Horii7,* and Yukifumi Nawa8 1Department of Microbiology and Immunology, School of Medicine, Fukuoka University, Fukuoka, Japan; 2Institute of Ecology and Biological  Resources, Vietnam Academy of Science and Technology, Hanoi, Vietnam; 3Sigma Clinic, Fukuoka, Japan; 4Institut de la Francophonie pour la  Médecine Tropicale, Vientiane, Lao PDR; 5Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel,  Switzerland; 6 Faculties of Medicine and Pharmacy, Limoges, France; 7Laboratory of Veterinary Parasitic Diseases, Faculty of Agriculture, University  of Miyazaki, Miyazaki, Japan; 8Research Affairs, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand Abstract:  Among Paragonimus  species, P. paishuihoensis  is one of the most mysterious and poorly understood species.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/kjp-51-683.PMC3916458.pdf
"*Corresponding author (horii@cc.miyazaki-u.ac.jp) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/90/kjp-51-683.PMC3916458.pdf
"6: 689-694, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.689 ▣ORIGINAL ARTICLE Molecular Differentiation of Opisthorchis viverrini  and  Clonorchis sinensis  Eggs by Multiplex Real-Time PCR with  High Resolution Melting Analysis Worasak Kaewkong1,2, Pewpan M. Intapan1,3, Oranuch Sanpool1,3, Penchom Janwan1,3, Tongjit Thanchomnang1,4,  Porntip Laummaunwai1,3, Viraphong Lulitanond1,5, Pham Ngoc Doanh6 and Wanchai Maleewong1,3,* 1Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;  2Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand; 3Department of Parasitology, Faculty of  Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 4Faculty of Medicine, Mahasarakham University, Mahasarakham 44000, Thailand;  5Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 6Department of Parasitology, Institute of  Ecology and Biological Resources, Vietnam Academy of Science and Technology, Hanoi, Vietnam Abstract:  Opisthorchis viverrini  and Clonorchis sinensis  are parasites known to be carcinogenic and causative agents of  cholangiocarcinoma in Asia.",Non-OADS,/arxiv_data1/oa_pdf/d8/9c/kjp-51-689.PMC3916459.pdf
"*Corresponding author (wanch_ma@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/9c/kjp-51-689.PMC3916459.pdf
"6: 695-701, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.695 ▣ORIGINAL ARTICLE Curcumin Prevents Bile Canalicular Alterations in the Liver  of Hamsters Infected with Opisthorchis viverrini Prapaporn Jattujan1, Somchai Pinlaor2,3, Lakhanawan Charoensuk2,3, Channarong Arunyanart1,   Jariya Umka Welbat1 and Wunnee Chaijaroonkhanarak1,* 1Department of Anatomy, 2Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;   3Liver Fluke and Cholangiocarcinoma Research Center, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Opisthorchis viverrini  infection causes inflammation and liver injury leading to periductal fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/2e/0f/kjp-51-695.PMC3916460.pdf
"*Corresponding author (wunnee_chai@yahoo.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/0f/kjp-51-695.PMC3916460.pdf
"6: 703-710, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.703 ▣ORIGINAL ARTICLE Distribution and Abundance of Opisthorchis viverrini   Metacercariae in Cyprinid Fish in Northeastern Thailand Somchai Pinlaor1,2,*, Sudarat Onsurathum1,2, Thidarut Boonmars1,2, Porntip Pinlaor2,3,   Nuttanan Hongsrichan1,2, Apisit Chaidee1,2, Ornuma Haonon1,2, Wutipong Limviroj1, Smarn Tesana1,2,   Sasithorn Kaewkes1,2 and Paiboon Sithithaworn1,2 1Department of Parasitology and 2Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine; 3Centre for Research and  Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  To increase public health awareness for prevention of opisthorchiasis caused by eating raw freshwater fish, the  distribution and abundance of Opisthorchis viverrini  metacercariae (OV MC) was investigated in freshwater fish obtained  from 20 provinces in northeastern Thailand between April 2011 and February 2012.",Non-OADS,/arxiv_data1/oa_pdf/35/ab/kjp-51-703.PMC3916461.pdf
"*Corresponding author (psomec@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/ab/kjp-51-703.PMC3916461.pdf
"Fish were transferred on ice to the  laboratory of the Department of Parasitology, Faculty of Medi - cine, Khon Kaen University, Khon Kaen, Thailand, where they  were identified by comparison with the FishBase online at  http://www.fishbase.org/home.htm.",OADS,/arxiv_data1/oa_pdf/35/ab/kjp-51-703.PMC3916461.pdf
"6: 711-717, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.711 ▣ORIGINAL ARTICLE Establishment of an Allo-Transplantable Hamster  Cholangiocarcinoma Cell Line and Its Application for   In Vivo  Screening of Anti-Cancer Drugs Nattapong Puthdee1,5, Kulthida Vaeteewoottacharn1,5,7,*, Wunchana Seubwai2,5, Orasa Wonkchalee3,5,   Worasak Kaewkong6, Amornrat Juasook3,5, Somchai Pinlaor3,5, Chawalit Pairojkul4,5, Chaisiri Wongkham1,5,   Seiji Okada7, Thidarut Boonmars3,5 and Sopit Wongkham1,5 Departments of 1Biochemistry, 2Forensic Medicine, 3Parasitology, 4Pathology, 5Liver Fluke and Cholangiocarcinoma Research Center, Faculty of  Medicine, Khon Kaen University, Khon Kaen, Thailand; 6Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok,  Thailand; 7Division of Hematopoiesis, Center for AIDS Research, Kumamoto University, Japan Abstract:  Opisthorchis viverrini  (O. viverrini ) is a well-known causative agent of cholangiocarcinoma (CCA) in humans.",Non-OADS,/arxiv_data1/oa_pdf/78/69/kjp-51-711.PMC3916462.pdf
"*Corresponding author (kulthidava@kku.ac.th)  © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/69/kjp-51-711.PMC3916462.pdf
"6: 719-726, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.719 ▣ORIGINAL ARTICLE Complete Mitochondrial Genome of Haplorchis taichui   and Comparative Analysis with Other Trematodes Dongmin Lee1, Seongjun Choe1, Hansol Park1, Hyeong-Kyu Jeon1, Jong-Yil Chai2, Woon-Mok Sohn3,   Tai-Soon Yong4, Duk-Young Min5, Han-Jong Rim6 and Keeseon S. Eom1,* 1Department of Parasitology, Medical Research Institute and Parasite Resource Bank, Chungbuk National University School of Medicine,   Cheongju 361-763, Korea; 2Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799,  Korea; 3Department of Parasitology and Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-70-51, Korea;  4Department of Environmental Medical Biology, Institute of Tropical Medicine and Arthropods of Medical Importance Resource Bank, Yonsei  University College of Medicine, Seoul 120-752, Korea; 5Department of Immunology and Microbiology, Eulji University School of Medicine,   Daejeon 301-746, Korea; 6Department of Parasitology, Korea University College of Medicine, Seoul 136-705, Korea Abstract:  Mitochondrial genomes have been extensively studied for phylogenetic purposes and to investigate intra- and  interspecific genetic variations.",OADS,/arxiv_data1/oa_pdf/14/cb/kjp-51-719.PMC3916463.pdf
"*Corresponding author (kseom@chungbuk.ac.kr) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/cb/kjp-51-719.PMC3916463.pdf
Sequences were assembled manu - ally and aligned against the complete mt genome sequences of  our own Metagonimus yokogawai  sequence (will be published  elsewhere) and trematode parasites available in the GenBank  database (http://www.ncbi.nlm.nih.gov WebGenBank) using  BLAST searches.,OADS,/arxiv_data1/oa_pdf/14/cb/kjp-51-719.PMC3916463.pdf
"6: 727-734, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.727 ▣ORIGINAL ARTICLE A Cross-Sectional Study on Intestinal Parasitic Infections  in Rural Communities, Northeast Thailand Sirintip Boonjaraspinyo1, Thidarut Boonmars2,3,4,*, Butsara Kaewsamut4, Nuttapon Ekobol5,   Porntip Laummaunwai2,6, Ratchadawan Aukkanimart2,3, Nadchanan Wonkchalee2,3,   Amornrat Juasook2,7 and Pranee Sriraj2,3 1Departments of Community Medicine and 2Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002; Thailand;   3Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand;   4Northeast Animal Laboratory Center, Khon Kaen University, Khon Kaen 40002, Thailand; 5Namphong Hospital, Khon Kaen 40002, Thailand;  6Research and Diagnostic Center for Emerging Infectious Diseases, Khon Kaen University, Khon Kaen 40002, Thailand;   7Faculty of Veterinary Medicine, Mahasarakram University, Mahasarakram, Thailand Abstract:  Despite the existence of effective anthelmintics, parasitic infections remain a major public health problem in  Southeast Asia, including Thailand.",Non-OADS,/arxiv_data1/oa_pdf/72/52/kjp-51-727.PMC3916464.pdf
"*Corresponding author (bthida@kku.ac.th; boonmars@yahoo.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/52/kjp-51-727.PMC3916464.pdf
"6: 735-738, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.735 ▣CASE REPORT Clinical Manifestations of Eosinophilic Meningitis Due to  Infection with Angiostrongylus cantonensis  in Children Kittisak Sawanyawisuth1,4,*, Jarin Chindaprasirt1, Vichai Senthong1, Panita Limpawattana1, Narong Auvichayapat2,  Sompon Tassniyom2, Verajit Chotmongkol1, Wanchai Maleewong3,4 and Pewpan M. Intapan3,4 1Department of Medicine, 2Department of Paediatrics, 3Department of Parasitology, 4Researches and Diagnostic Center for Emerging Infectious  Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Eosinophilic meningitis, caused by the nematode Angiostrongylus cantonensis , is prevalent in northeastern  Thailand, most commonly in adults.",Non-OADS,/arxiv_data1/oa_pdf/d8/e6/kjp-51-735.PMC3916465.pdf
"*Corresponding author (kittisak@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d8/e6/kjp-51-735.PMC3916465.pdf
"6: 739-742, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.739 ▣CASE REPORT Sparganosis Presenting as Cauda Equina Syndrome with  Molecular Identification of the Parasite in Tissue Sections Adhiratha Boonyasiri1, Pornsuk Cheunsuchon2, Prajak Srirabheebhat3, Hiroshi Yamasaki4,   Wanchai Maleewong5,6 and Pewpan M. Intapan5,6,* 1Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok  10700, Thailand; 2Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand;   3Division of Neurosurgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand;   4Department of Parasitology, National Institute of Infectious Diseases, Tokyo, Japan; 5Department of Parasitology, Faculty of Medicine,   Khon Kaen University, Khon Kaen 40002, Thailand; 6Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine,   Khon Kaen University, Khon Kaen, 40002, Thailand Abstract:  A 52-year-old woman presented with lower back pain, progressive symmetrical paraparesis with sensory im - pairment, and sphincter disturbance.",Non-OADS,/arxiv_data1/oa_pdf/00/45/kjp-51-739.PMC3916466.pdf
"*Corresponding author (pewpan@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/45/kjp-51-739.PMC3916466.pdf
"6: 743-745, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.743 ▣BRIEF COMMUNICATION A Modified Formalin-Ether Concentration Technique for  Diagnosis of Human Strongyloidiasis Witthaya Anamnart1,*, Pewpan M. Intapan2 and Wanchai Maleewong2 1Department of Medical Technology, School of Allied Health Sciences and Public Health, Walailak University, Nakhon Si Thammarat;   2Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  We compared the efficacy and applicability of a modified formalin-ether concentration technique (M-FECT) to  the conventional FECT (C-FECT) and the agar plate culture (APC) method for the detection of Strongyloides stercoralis   larvae.",Non-OADS,/arxiv_data1/oa_pdf/df/5c/kjp-51-743.PMC3916467.pdf
"*Corresponding author (awitthay@wu.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/5c/kjp-51-743.PMC3916467.pdf
"6: 747-749, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.747 ▣BRIEF COMMUNICATION Molecular Detection of Ancylostoma duodenale ,  Ancylostoma ceylanicum , and Necator americanus  in  Humans in Northeastern and Southern Thailand Issarapong Phosuk1,2, Pewpan M. Intapan1,2,*, Tongjit Thanchomnang1,3, Oranuch Sanpool1,2, Penchom Janwan1,2,  Porntip Laummaunwai1,2, Witthaya Aamnart4, Nimit Morakote5 and Wanchai Maleewong1,2 1Department of Parasitology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 2Research and Diagnostic Center for  Emerging Infectious Diseases, Khon Kaen University, Khon Kaen 40002, Thailand; 3Department of Medicine, Mahasarakham University,  Mahasarakham 44150, Thailand; 4Department of Medical Technology, School of Allied Health Sciences and Public Health,   Walailak University, Thasala, Nakhon Si Thammarat 80160, Thailand; 5Department of Parasitology, Faculty of Medicine Chiang Mai University,   Chiang Mai 50200, Thailand Abstract:  The 2 principal species of hookworms infecting humans are Necator americanus  and Ancylostoma duodenale .",Non-OADS,/arxiv_data1/oa_pdf/57/95/kjp-51-747.PMC3916468.pdf
"*Corresponding author (pewpan@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/95/kjp-51-747.PMC3916468.pdf
"6: 751-754, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.751 ▣BRIEF COMMUNICATION A Recombinant Matrix Metalloproteinase Protein from  Gnathostoma spinigerum  for Serodiagnosis of  Neurognathostomiasis Penchom Janwan1,2, Pewpan M. Intapan1,2, Hiroshi Yamasaki3, Porntip Laummaunwai1,2,   Kittisak Sawanyawisuth1,4, Chaisiri Wongkham5, Chatchai Tayapiwatana6, Amnat Kitkhuandee7,   Viraphong Lulitanond1,8, Yukifumi Nawa9 and Wanchai Maleewong1,2,* 1Research and Diagnostic Center for Emerging Infectious Diseases, 2Department of Parasitology, Faculty of Medicine, Khon Kaen University,   Khon Kaen 40002, Thailand; 3Department of Parasitology, National Institute of Infectious Diseases, Tokyo, Japan; 4Department of Medicine,  5Department of Biochemistry, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand; 6Faculty of Associated Medical Sciences,  Chiang Mai University, Chiang Mai 50200, Thailand; 7Department of Surgery, 8Department of Microbiology,   9Research Division, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Neurognathostomiasis is a severe form of human gnathostomiasis which can lead to disease and death.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/kjp-51-751.PMC3916469.pdf
"*Corresponding author (wanch_ma@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/24/kjp-51-751.PMC3916469.pdf
"6: 755-757, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.755 ▣BRIEF COMMUNICATION Detection of Gnathostoma spinigerum  Antibodies in   Sera of Non-Traumatic Subarachnoid Hemorrhage  Patients in Thailand Amnat Kitkhuandee1, Waranon Munkong2, Kittisak Sawanyawisuth3,5,*, Penchom Janwan4,5,   Wanchai Maleewong4,5 and Pewpan M. Intapan4,5 1Division of Neurosurgery, Department of Surgery, 2Department of Radiology, 3Department of Medicine, 4Department of Parasitology;   5Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand Abstract:  Gnathostoma spinigerum  can cause subarachnoid hemorrhage (SAH).",Non-OADS,/arxiv_data1/oa_pdf/ba/42/kjp-51-755.PMC3916470.pdf
"*Corresponding author (kittisak@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/42/kjp-51-755.PMC3916470.pdf
"6: 759-761, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.759 ▣BRIEF COMMUNICATION Successful Treatment of Brugia pahangi  in Naturally  Infected Cats with Ivermectin Piyanan Taweethavonsawat * and Sudchit Chungpivat  Parasitology Unit, Department of Pathology, Faculty of Veterinary Science, Chulalongkorn University, Bangkok 10330, Thailand Abstract:  Lymphatic filariasis is a common parasitic disease of cats in tropical regions including Thailand.",Non-OADS,/arxiv_data1/oa_pdf/3d/7a/kjp-51-759.PMC3916471.pdf
"*Corresponding author (Piyanan.T@Chula.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/7a/kjp-51-759.PMC3916471.pdf
"6: 763-766, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.763 ▣BRIEF COMMUNICATION Evaluation of IgG4 Subclass Antibody Detection by  Peptide-Based ELISA for the Diagnosis of Human  Paragonimiasis Heterotrema Pewpan M. Intapan1,*, Oranuch Sanpool1, Penchom Janwan1, Porntip Laummaunwai1, Nimit Morakote2,   Yoon Kong3 and Wanchai Maleewong1 1Department of Parasitology and Research and Diagnostic Center for Emerging Infectious Diseases, Faculty of Medicine, Khon Kaen University,  Khon Kaen 40002, Thailand; 2Department of Parasitology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand;   3Department of Molecular Parasitology, Sungkyunkwan University School of Medicine and Center for Molecular Medicine,   Samsung Biomedical Research Institute, Suwon 440-746, Korea Abstract:  A synthetic peptide was prepared based on the antigenic region of Paragonimus westermani  pre-procathepsin  L, and its applicability for immunodiagnosis for human paragonimiasis (due to Paragonimus heterotremus ) was tested us - ing an ELISA to detect IgG4 antibodies in the sera of patients.",Non-OADS,/arxiv_data1/oa_pdf/4d/13/kjp-51-763.PMC3916472.pdf
"*Corresponding author (pewpan@kku.ac.th) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/13/kjp-51-763.PMC3916472.pdf
The amino acid sequence was subjected and  analyzed with software available online at http://tools.im - muneepitope.org/tools/bcell/iedb_input.,OADS,/arxiv_data1/oa_pdf/4d/13/kjp-51-763.PMC3916472.pdf
"6: 767-769, December 2013   http://dx.doi.org/ 10.3347/kjp.2013.51.6.767 ▣BRIEF COMMUNICATION High Prevalence of Haplorchiasis in Nan and Lampang  Provinces, Thailand, Proven by Adult Worm Recovery   from Suspected Opisthorchiasis Cases Adulsak Wijit1,*, Nimit Morakote2 and Jaewwaew Klinchid3 1Office of Disease Prevention & Control 10th, Chiang Mai 50000; 2Department of Parasitology, Faculty of Medicine, Chiang Mai University,   Chiang Mai 50200, Thailand; 3Chaehom Hospital, Lampang 52120, Thailand Abstract:  Opisthorchiasis, a risk factor for cholangiocarcinoma in humans, is of public health importance in Thailand.",Non-OADS,/arxiv_data1/oa_pdf/b5/4d/kjp-51-767.PMC3916473.pdf
"*Corresponding author (adulsak_w@hotmail.com) © 2013, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/4d/kjp-51-767.PMC3916473.pdf
"The Korean Academy of Conservative Dentistry.1This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Platelet rich fibrin - a novel acumen into regenerative endodontic therapy Research into regenerative dentistry has added impetus onto the field of molecular biology.",Non-OADS,/arxiv_data1/oa_pdf/7f/3a/rde-39-1.PMC3916499.pdf
"1Hotwani K, Department of  Pedodontics and Preventive Dentistry,  2Sharma K, Department  of Orthodontics and Dentofacial Orthopaedics, Sharad Pawar Dental College, Sawangi(M), Wardha, Maharashtra, India*Correspondence to Kavita Hotwani, MDS.Senior Lecturer, Department of Pedodontics and Preventive Dentistry, Sharad Pawar Dental College, Sawangi(M), Wardha, Maharashtra, IndiaTEL, +919975206525; E-mail, hotwani.kavita@gmail.comReview article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.1",Non-OADS,/arxiv_data1/oa_pdf/7f/3a/rde-39-1.PMC3916499.pdf
Available from: http://dx.doi.org/10.5402/2013/627367.,Non-OADS,/arxiv_data1/oa_pdf/7f/3a/rde-39-1.PMC3916499.pdf
"The Korean Academy of Conservative Dentistry.12This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Bond strength of self-adhesive resin cements to composite submitted to different surface pretreatments Objectives:  Extensively destroyed teeth are commonly restored with composite resin  before cavity preparation for indirect restorations.",Non-OADS,/arxiv_data1/oa_pdf/4e/57/rde-39-12.PMC3916500.pdf
"1Santos VH; Faria-e-Silva AL,  Department of Dentistry, Federal University of Sergipe, Aracaju, SE, Brazil 2Griza S, Department of Materials  Science and Engineering, Federal University of Sergipe, São Cristóvão, SE, Brazil 3Moraes RR, Department of  Restorative Dentistry, Federal University of Pelotas School of Dentistry, Pelotas, RS, Brazil*Correspondence to André Luis Faria-e-Silva, DDS, MD, PHD.Professor, Departamento de Odontologia, Campus da Saúde, Universidade Federal de Sergipe, Rua Cláudio Batista, s/n – Sanatório, Aracaju-SE, Brazil 49060-100TEL, +55-79-2105-1824; FAX, +55-79-2105-1822; E-mail, fariaesilva.andre@gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.12",Non-OADS,/arxiv_data1/oa_pdf/4e/57/rde-39-12.PMC3916500.pdf
"The Korean Academy of Conservative Dentistry.17This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Evaluation of softening ability of Xylene & Endosolv-R on three different epoxy resin based sealers within 1 to 2 minutes - an in vitro study Objectives:  This study evaluated the efficacy of Endosolv-R and Xylene in softening  epoxy resin based sealer after 1 to 2 min exposure.",Non-OADS,/arxiv_data1/oa_pdf/e2/1d/rde-39-17.PMC3916501.pdf
"Shenoi PR; Badole GP; Khode  RT, Department of Conservative Dentistry & Endodontics VSPM’s  Dental College & Research Center,  Nagpur, India *Correspondence to  Rajiv Tarachand Khode, BDS.Post Graduate Student, Department  of Conservative Dentistry &   Endodontics, VSPM’s Dental  College & Research Center, Nagpur,  Maharashtra, India 440019TEL, +919730271428; FAX, +91- 7104-306202; E-mail, rajiv.khode@ gmail.comResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.17",Non-OADS,/arxiv_data1/oa_pdf/e2/1d/rde-39-17.PMC3916501.pdf
Endodontic therapy November 2001;1-9. https://www.endoruddle.com/tc2pdf/12/NSRCTFailures_Nov2001.pdf (update 2013 May 22).,Non-OADS,/arxiv_data1/oa_pdf/e2/1d/rde-39-17.PMC3916501.pdf
Available from: http://www.osha.gov (update 2013 May 22).,OADS,/arxiv_data1/oa_pdf/e2/1d/rde-39-17.PMC3916501.pdf
Available from: http://www.septodont.ca/sites/default/files/Endosol%20E%20R.pdf (update 2013 May 22).,OADS,/arxiv_data1/oa_pdf/e2/1d/rde-39-17.PMC3916501.pdf
"The Korean Academy of Conservative Dentistry.24This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Micro-CT evaluation of internal adaptation in resin fillings with different dentin adhesives Objectives:  The purpose of present study was to evaluate the internal adaptation of  composite restorations using different adhesive systems.",Non-OADS,/arxiv_data1/oa_pdf/6d/21/rde-39-24.PMC3916502.pdf
"1Han SH, Department of  Conservative Dentistry, Kangbuk Samsung Hospital, Seoul, Korea 2Park SH, Department of  Conservative Dentistry, Oral Science Research Center, Yonsei University College of Dentistry, Seoul, Korea*Correspondence to Sung-Ho Park, DDS, PhD.Professor, Department of Conservative Dentistry, Oral Science Research Center, Yonsei University College of Dentistry, 50 Yonsei-ro, Seodaemun-gu, Seoul, Korea 120-752TEL,  +82-2-2228-3147; FAX, +82- 2-313-7575; E-mail, sunghopark@yuhs.acResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.24",Non-OADS,/arxiv_data1/oa_pdf/6d/21/rde-39-24.PMC3916502.pdf
"The Korean Academy of Conservative Dentistry.32This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Antibacterial effect of self-etching adhesive systems on Streptococcus mutans Objectives:  In this study, we evaluated the antibacterial activity of self-etching  adhesive systems against Streptococcus mutans using the agar diffusion method.",Non-OADS,/arxiv_data1/oa_pdf/7b/20/rde-39-32.PMC3916503.pdf
"Kim SR; Shin DH, Department of  Conservative Dentistry, Dankook  University College of Dentistry  and Institute of Dental Science,  Cheonan, Korea *Correspondence to  Dong-Hoon Shin, DDS, PhD.Professor, Department of  Conservative Dentistry, Dankook  University College of Dentistry and  Institute of Dental Science, San  7-1, Shinbu-dong, Dongnam-gu, Cheonan, Korea 330-716 TEL, +82-41-550-1965; FAX, +82- 41-553-1258; E-mail, donyshin@ dankook.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online) http://dx.doi.org/10.5395/rde.2014.39.1.32",Non-OADS,/arxiv_data1/oa_pdf/7b/20/rde-39-32.PMC3916503.pdf
"The Korean Academy of Conservative Dentistry.39This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cytotoxicity of newly developed pozzolan cement and other root-end filling materials on human periodontal ligament cell Objectives:  The purpose of this study was to evaluate in vitro cytotoxicity of the  pozzolan cement and other root-end filling materials using human periodontal ligament cell.",Non-OADS,/arxiv_data1/oa_pdf/4e/54/rde-39-39.PMC3916504.pdf
"TEL, +82-2-2228-8701; FAX, +82-2-313-7575; E-mail: andyendo@yuhs.acResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.39",Non-OADS,/arxiv_data1/oa_pdf/4e/54/rde-39-39.PMC3916504.pdf
"The Korean Academy of Conservative Dentistry.45This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Asymmetry in mesial root number and morphology in mandibular second molars: a case report Ambiguity in the root morphology of the mandibular second molars is quite common.",Non-OADS,/arxiv_data1/oa_pdf/eb/40/rde-39-45.PMC3916505.pdf
"Nayak G; Shetty S; Shekhar R, Department of Conservative Dentistry and Endodontics, Kanti  Devi Dental College and Hospital,  Mathura, Uttar Pradesh, India *Correspondence to  Gurudutt Nayak, BDS, MDS.Professor, Department of  Conservative Dentistry and  Endodontics, Kanti Devi Dental  College and Hospital, Mathura,  Uttar Pradesh, India 281006TEL, +91-9997259742; FAX, +91- 565-2825050; E-mail, gurudutt_ nayak@hotmail.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.45",Non-OADS,/arxiv_data1/oa_pdf/eb/40/rde-39-45.PMC3916505.pdf
"The Korean Academy of Conservative Dentistry.51This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical effectiveness of combining platelet rich fibrin with alloplastic bone substitute for the management of combined endodontic periodontal lesion The term ""endo-perio"" lesion has been proposed to describe the destructive lesion resulting from inflammatory products found in varying degrees in both the periodontium and the pulpal tissues.",Non-OADS,/arxiv_data1/oa_pdf/15/83/rde-39-51.PMC3916506.pdf
latagoyal83@gmail.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.51,Non-OADS,/arxiv_data1/oa_pdf/15/83/rde-39-51.PMC3916506.pdf
"The Korean Academy of Conservative Dentistry.56This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Diagnosis and treatment of teeth with primary endodontic lesions mimicking periodontal disease: three cases with long-term follow ups A tooth with primary endodontic disease that demonstrates a periodontal defect might be extracted because of misdiagnosis as severe periodontal disease or a vertical root fracture.",Non-OADS,/arxiv_data1/oa_pdf/f9/e1/rde-39-56.PMC3916507.pdf
"1Lim JH, Department of Oral  and Maxillofacial Surgery, Korea University Ansan Medical Hospital, Ansan, Korea 2Lee JH, Division of Biomaterials  and Bioengineering, Department of Preventive and Restorative Dental Sciences, University of California,  San Francisco, CA, USA 3Shin SJ, Department of  Conservative Dentistry, Yonsei  University College of Dentistry, Seoul, Korea*Correspondence to Su-Jung Shin, DDS, MS, PhD.Associate Professor, Department of Conservative Dentistry, Yonsei University, Gangnam Severance Dental Hospital, 211, Eonjuro, Gangnam-Gu, Seoul, Korea 135-270TEL, +82-2-2019-3572; FAX, +82-2-3463-4052; E-mail, shujungshin@yahoo.comCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.56",Non-OADS,/arxiv_data1/oa_pdf/f9/e1/rde-39-56.PMC3916507.pdf
"The Korean Academy of Conservative Dentistry.63This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Chronic maxillary sinusitis caused by root canal overfilling of Calcipex II This is a case report of chronic maxillary sinusitis caused by root canal overfilling of Calcipex II (Techno-Dent).",Non-OADS,/arxiv_data1/oa_pdf/8e/9b/rde-39-63.PMC3916508.pdf
"1Kim JW; Cho KM; Park SH; Park  SR, Department of Conservative Dentistry,  2Lee SS; Lee SK, Department of  Oral Pathology, Gangneung-Wonju National University College of Dentistry, Gangneung, Korea*Correspondence to Suk-Keun Lee, DDS, PhD.Department of Oral Pathology, Gangneung-Wonju National University College of Dentistry, Jukheon-gil 7, Gangneung, Gangwon-do, Korea 210-702TEL, +82-33-640-2228; FAX, +82-33-642-6410; E-mail, sklee@kangnung.ac.krCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.63",Non-OADS,/arxiv_data1/oa_pdf/8e/9b/rde-39-63.PMC3916508.pdf
"The Korean Academy of Conservative Dentistry.68This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Use of ultrasound Doppler to determine tooth vitality in a discolored tooth after traumatic injury: its prospects and limitations When a tooth shows discoloration and does not respond to the cold test or electric pulp test (EPT) after a traumatic injury, its diagnosis can be even more difficult due to the lack of proper diagnostic methods to evaluate its vitality.",Non-OADS,/arxiv_data1/oa_pdf/30/b4/rde-39-68.PMC3916509.pdf
"Professor, Department of Conservative Dentistry, Oral Science  Research Center, Yonsei University  College of Dentistry, 50 Yonsei-ro,  Seodaemun-gu, Seoul, Korea 120- 752TEL, +82-2-2228-3147; FAX, +82- 2-313-7575; E-mail, sunghopark@ yuhs.acCase report ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.68",Non-OADS,/arxiv_data1/oa_pdf/30/b4/rde-39-68.PMC3916509.pdf
"The Korean Academy of Conservative Dentistry.7This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A comparison of dimensional standard of several nickel-titanium rotary files Objectives:  The aim of this study was to compare the dimensional standard of several  nickel-titanium (Ni-Ti) rotary files and verify the size conformity.",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/rde-39-7.PMC3916510.pdf
"Professor, Department of Conservative Dentistry, Gangneung-Wonju National University College of Dentistry, Jukheon-gil 7, Gangneung, Gangwon-do, Korea 210-702TEL, +82-33-640-3189; FAX, +82-33-640-3103; E-mail, mendo7@gwnu.ac.krResearch article ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.7",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/rde-39-7.PMC3916510.pdf
"The Korean Academy of Conservative Dentistry.74This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Analysis of variance (ANOVA) comparing means of more than two groups Mean values obtained from different groups with different conditions are frequently  compared in clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/be/76/rde-39-74.PMC3916511.pdf
"The ‘SSW’ represents sum of squares within Hae-Young Kim  Department of Dental Laboratory Science and Engineering, College of Health Science & Department of Public Health Science, Graduate School & BK21+ Program in Public Health Sciences, Korea University, Seoul, Korea *Correspondence to Hae-Young Kim, DDS, PhD.Associate Professor,Department of Dental Laboratory Science & Engineering, Korea University College of Health Science, San 1 Jeongneung 3-dong, Seongbuk-gu, Seoul, Korea 136-703TEL, +82-2-940-2845; FAX, +82-2-909-3502, E-mail, kimhaey@korea.ac.krOpen lecture on statistics ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.74",Non-OADS,/arxiv_data1/oa_pdf/be/76/rde-39-74.PMC3916511.pdf
"The Korean Academy of Conservative Dentistry.78This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Setting time of MTAReaders' forum ISSN 2234-7658 (print) / ISSN 2234-7666 (online)http://dx.doi.org/10.5395/rde.2014.39.1.78 I have some difficulty in using MTA because of its slow setting time.",Non-OADS,/arxiv_data1/oa_pdf/bf/ed/rde-39-78.PMC3916512.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/78/b5/cia-9-243.PMC3916634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 243–248Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  243OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5207 724-weeks Pilates-aerobic and educative training to  improve body fat mass in elderly  serbian women Pedro Jesús ruiz-Montero1 Alfonso Castillo-rodriguez2 Milena Mikalački3 Čokorilo Nebojsa3 Darinka Korovljev3 1Department of Physical education  and sport, Faculty of Physical Activity  and sport, University of granada,   granada, spain; 2Faculty of sport,   University of Pablo de Olavide, seville,   spain; 3Faculty of sport and Physical  education, University of novi sad,   novi sad, serbia Correspondence: Pedro Jesus ruiz- Montero   Department of Physical education  and sport, school of sport sciences,  University of granada, Carretera de  Alfacar, s/n, CP 18071, granada, spain   email pedrorumo@ ugr.esBackground:  The purpose of this study was to examine the differences in anthropometric  measurements using an aerobic and Pilates exercise program which lasted 24 weeks.",Non-OADS,/arxiv_data1/oa_pdf/78/b5/cia-9-243.PMC3916634.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/78/b5/cia-9-243.PMC3916634.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/b5/cia-9-243.PMC3916634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 171–183International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  171OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5462 8Factors influencing the selection of delivery   with no one present in Northern Nigeria:   implications for policy and programs Bolaji Fapohunda1 nosakhare Orobaton1,2 1International Division, John snow   Inc, Rosslyn, VA, USA; 2Targeted   States High Impact Project (TSHIP),   Bauchi, Nigeria correspondence: Bolaji Fapohunda   International Division, John snow Inc,   1616 N Fort Myer Drive, 16th Floor,   Rosslyn, VA 22209, USA   Tel +1 973 746 0044   email bfapohunda@jsi.co mAbstract:  This paper examines the effects of demographic, socioeconomic, and women’ s  autonomy factors on the utilization of delivery assistance in Sokoto State, Nigeria.",Non-OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
Available  from: http://nigeria.unfpa.org/sokoto.html .,Non-OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
Avail - able from: http://databank.worldbank.org/data/views/ variableselection / selectvariables.aspx?sourc e=world-development-indicators.,OADS,/arxiv_data1/oa_pdf/1c/c3/ijwh-6-171.PMC3916635.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/2a/ijnrd-7-057.PMC3916636.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2014:7 57–67International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  57RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJNRD.S3788 7Renal manifestations of genetic mitochondrial  disease John F O’T oole Department of Internal Medicine,   Division of Nephrology,   MetroHealth Medical System,   Case western Reserve University  School of Medicine, Cleveland,   OH, USA Correspondence: John F O’Toole   Division of Nephrology, MetroHealth  Medical System, 2500 MetroHealth   Drive – Rammelkamp R460, Cleveland,  OH 44109-1998, USA   Tel +1 216 778 7141   Fax +1 216 778 4321   email jxo69@case.ed uAbstract:  Mitochondrial diseases can be related to mutations in either the nuclear or mitochon - drial genome.",Non-OADS,/arxiv_data1/oa_pdf/94/2a/ijnrd-7-057.PMC3916636.pdf
Publicly  available databases of mitochondrial DNA (mtDNA) variation  provide a useful resource for researchers and clinicians and  are easily accessible ( http://www.mitomap.org/MITOMA P7  and http://www.mtdb.igp.uu.s e8).,OADS,/arxiv_data1/oa_pdf/94/2a/ijnrd-7-057.PMC3916636.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/94/2a/ijnrd-7-057.PMC3916636.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/2a/ijnrd-7-057.PMC3916636.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bb/ff/ott-7-177.PMC3916637.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 177–186OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  177Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OTT .S4178 6Omacetaxine mepesuccinate in the treatment   of intrac table chronic myeloid leukemia Yaoyu Chen1 Shaoguang Li2 1Department of Oncology, Novartis  institutes for Biomedical Research,   Cambridge, 2Division of Hematology/ Oncology, Department of Medicine,   University of Massachusetts Medical  School, worcester, MA, USA Correspondence: Shaoguang Li   Department of Medicine, University   of Massachusetts Medical School,   364 Plantation Street, worcester,   MA 01605, USA   email shaoguang.li@umassmed.ed u    Yaoyu Chen   Department of Oncology, Novartis  institutes for Biomedical Research,   250 Mass Ave, Cambridge,   MA 02139, USA   email chenyaoyumaine@gmail.co mAbstract : In a significant proportion of patients with chronic myeloid leukemia, resistance to  BCR-ABL tyrosine kinase inhibitors develops due to acquisition of BCR-ABL  kinase domain  mutations and insensitivity of leukemia stem cells to tyrosine kinase inhibitors.",Non-OADS,/arxiv_data1/oa_pdf/bb/ff/ott-7-177.PMC3916637.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bb/ff/ott-7-177.PMC3916637.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/ff/ott-7-177.PMC3916637.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 159–169International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  159OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4557 9Irish midwives’ experiences of providing   maternity care to non-Irish women   seeking asylum carolyn l T obin1 Jo Murphy-lawless2 1Department of nursing, college  of Health and Human services,   University of new Hampshire,   Durham, nH, Usa; 2school of n ursing  and Midwifery, Trinity college, Dublin,   Ireland correspondence: carolyn l Tobin   Department of nursing, college of   Health and Human services, University   of new Hampshire, 4 library Way,   Durham, nH 03824, Usa   Tel +160 3862 4715   email carolyn.tobin@unh.ed uBackground:  Immigration and asylum seeking has been an important social and political phe - nomenon in Ireland since the mid 1990s.",Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
Available from: http://www.orac.ie/website/orac/oracwebsite.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
"Available from: http://www.esri.ie/__uuid/9495a3d4-7e97-4588-a1d3- c091fa1e7838/NPRS2012.pd f. Accessed November 21, 2013.",OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
Available from: https://www.google.co .nz/search?q =K PMG+Independent +Review+of+Maternity +%26+Gynaecology +Serv ices+in+the+Greater+Dublin+Area.+Dublin%2C +Ireland%3A +2008 &oq=KPMG+Independent +Review+of+Maternity +%26+Gynaecolo gy+Services+in+the+Greater+Dublin+Area.+Dublin%2C +Ireland%3 A+2008&aqs =chrome..69i57.1502j0j4&sourceid =chrome&espv =21 0&es_sm =93&ie=UTF-8.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
Available  from: http://www.whec.org.uk/wordpress/wp-content/uploads/   downloads/2012/05/ GuidanceCommissioningHealthServVulnMigran tWomen2012 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
"Available from: http://www.nice.org.uk/ nicemedia / live/13167/50817/50817.pd f. Accessed November 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
"Available from: http://www.democraticdialogue.org/ report14/r14omahony.ht m. Accessed November 16, 2006.",Non-OADS,/arxiv_data1/oa_pdf/33/56/ijwh-6-159.PMC3916638.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 69–79Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  69Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S5517 8exploring the concept of optimal functionality   in old age Samal Algilani1,* Lina Östlund-Lagerström1,2,* Annica Kihlgren1 Karin Blomberg1 Robert J Brummer1,2 ida Schoultz1,2 1Nutrition and Physical Activity  Research Centre, 2Nutrition Gut  Brain interactions Research Centre,   School of Health and Medicine,   Faculty of Medicine and Health,   Örebro University, Örebro, Sweden *These authors contributed equally  to this work Correspondence: ida Schoultz   Department of Medicine and Health  Sciences, Nutrition Gut Brain interactions  Research Centre, Fakultetsgatan 1,  Örebro University, 701 82 Örebro,  Sweden   Tel +46 19 30 32 09   email ida.schoultz@oru.s eBackground:  Aging is characterized by loss of function and represents a perspective that puts  the focus on the negative aspects of aging.",Non-OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
"Available from: http://www.census.gov/ prod/2009pubs/p95-09-1.pd f. Accessed November 12, 2012.",OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
Available from: http://www.scb.se/statistik/_publikationer/ LE0101_1980I05_BR_LE112SA0601.pdf .,OADS,/arxiv_data1/oa_pdf/94/a0/jmdh-7-069.PMC3916639.pdf
"Accepted on December 12, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.1  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.MICROBIOLOGY C. difficile  colonizes the large intestine of humans and do - mestic and wild mammals.",Non-OADS,/arxiv_data1/oa_pdf/81/5e/gnl-8-1.PMC3916678.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed/22574332.,OADS,/arxiv_data1/oa_pdf/81/5e/gnl-8-1.PMC3916678.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.102  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Pancreatic adenocarcinoma (PAC) is an extremely aggressive  tumor; as such, it is the fourth leading cause of cancer-related  death in the United States.1 In 2008, the estimated incidence in  the United States was 37,700 cases while an estimated 34,300  patients died of the disease.2 Worldwide, over 200,000 people  die annually of pancreatic cancer.3 Most patients with pancre - atic cancer present with locally advanced or metastatic disease  upon diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/22/8e/gnl-8-102.PMC3916679.pdf
"Accepted on June 26, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.109  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.CASE REPORT In June 2011, a 56-year-old male visited a local hospital  complaining of dyspepsia and back pain.",Non-OADS,/arxiv_data1/oa_pdf/c9/93/gnl-8-109.PMC3916680.pdf
"Accepted on May 27, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.113  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.values were recorded.",Non-OADS,/arxiv_data1/oa_pdf/5f/d5/gnl-8-113.PMC3916681.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.13 Il Yong Shin and Na Young Sung contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/40/93/gnl-8-13.PMC3916682.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Key Words:  Cathepsin D; Prognostic factors; Colorectal neo - plasms INTRODUCTION Traditional prognostic factors of colorectal cancer (CRCA)  include the tumor node metastasis (TNM) stage and ‘potential’  residual disease after initial surgery.1 Other features known to  be related to survival include vascular and perineural invasion,  tumor necrosis, character of invasive margin, and differentia - tion.2 Unfortunately, these factors are clearly not sufficient to  accurately assess individual risk and to possibly avoid adjuvant  systemic therapy.",Non-OADS,/arxiv_data1/oa_pdf/40/93/gnl-8-13.PMC3916682.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.24  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.B cells INTRODUCTION Dysregulation of the immune system has been suggested as a  pathogenesis of inflammatory bowel disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/a6/a9/gnl-8-24.PMC3916683.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.29  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.acterized by abundant infiltration of IgG4-positive plasma cells  and lymphocytes, dense fibrosis, and obliterative phlebitis in  the pancreas and is called lymphoplasmacytic sclerosing pan - creatitis (LPSP).2,3 This entity is associated with extrapancreatic  lesions showing histological features quite similar to those of  the pancreas, and is currently considered as a pancreatic mani - festation of IgG4-related systemic disease.3 Various organs are  involved in IgG4-related disease, such as IgG4-related sialad - enitis, IgG4-related dacryoadenitis, and IgG4-related retroperi - toneal fibrosis.3,4 Evidence suggests another type of AIP, which  has been designed idiopathic duct-centric chronic pancreatitis  (IDCP) and is histologically characterized by granulocytic epi - thelial lesions.5,6 IDCP shows a different clinical profile to LPSP,  with typical patients more than a decade younger and less likely  to show elevated serum IgG4 levels.5-7 Recently, LPSP has been  called type 1 AIP, and IDCP has been called type 2 AIP.8 Unlike  type 1 AIP, type 2 AIP is rarely associated sclerosing diseases  containing abundant IgG4-positive plasma cells, but is more  likely to occur concomitant with acute pancreatitis and ulcer - ative colitis (UC).5-8 Although infiltration of many IgG4-positive  plasma cells is occasionally detected in the colonic mucosa of  AIP patients,9,10 whether UC may represent an extrapancreatic  lesion of AIP is unknown.",Non-OADS,/arxiv_data1/oa_pdf/ad/0c/gnl-8-29.PMC3916684.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.35  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.the teeth lead to chronic periodontitis, which is characterized  by the irreversible loss of supporting connective tissue, alveolar  bone, and periodontal ligament.1 Chronic periodontitis is com - mon and severe in the American adult population, with at least  35% of dentate adults having periodontitis and 10% to 15%  having the severe forms of periodontitis.2 The presence and  progression of untreated chronic periodontitis jeopardizes the  intact dentition, leading to tooth loss and compromised patient- based outcomes such as esthetics, impaired oral functioning,  and other domains of oral-health-related quality of life.3,4 Pa- tients with chronic periodontitis require management such as  supportive periodontal care and surgery, including replacement  of their dentition.",Non-OADS,/arxiv_data1/oa_pdf/4b/28/gnl-8-35.PMC3916685.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.41  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.antibiotic-associated diarrhea (AAD) has increased rapidly due  to use of broad-spectrum antibiotics.1 In the preantibiotic era,  pseudomembranous colitis (PMC) was associated with ischemic  cardiovascular insufficiency, colonic obstructions, heavy metal  intoxication, sepsis, shock, or uremia.2 Since the 1970s, Clos- tridium difficile  has been responsible for 90% to 99% of PMC  cases.3 There has been a worldwide increase in the incidence  of C. difficile -associated diarrhea (CDAD).",Non-OADS,/arxiv_data1/oa_pdf/83/72/gnl-8-41.PMC3916686.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.49 Ji Hwan Lim and Joo-Hyun Kim contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/3a/e6/gnl-8-49.PMC3916687.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.damage models in rats.",Non-OADS,/arxiv_data1/oa_pdf/3a/e6/gnl-8-49.PMC3916687.pdf
"Published online on November 21, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.58  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.blastic tumor is a relatively rare disease characterized by chronic  infiltration of inflammatory cells and area of fibrosis.1 It is also  known as plasma cell granuloma due to the predominant infil - tration of plasma cells.2 Etiology of IPT remains uncertain al - though infectious condition, autoimmune phenomenon, or sys - temic inflammatory response syndrome has been suggested as  possible one.2-5 Nowadays, IPTs are more frequently recognized  due to increasing number of abdominal imaging performed in  clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/da/74/gnl-8-58.PMC3916688.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.64  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The aim of chronic hepatitis B (CHB) treatment is to improve  quality of life and prevent progression to cirrhosis, decompen - sated cirrhosis, hepatocellular carcinoma.1,2 Long-term anti- hepatitis B virus (HBV) nucleos(t)ide therapy is effective in pre - vention of progression of liver disease.",Non-OADS,/arxiv_data1/oa_pdf/25/17/gnl-8-64.PMC3916689.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.7  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Gastric cancer is prevalent among South Koreans and the  incidence of colon cancer is rapidly increasing due to more  frequent consumption of a Westernized diet.1 Therefore, upper  endoscopy and colonoscopy are often performed during health  check-ups.",Non-OADS,/arxiv_data1/oa_pdf/53/7a/gnl-8-7.PMC3916690.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.70  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION About 130 to 170 million people were infected with hepatitis  C virus (HCV) worldwide.1 Globally, 27% of liver cirrhosis (LC)  and 25% of hepatocellular carcinoma (HCC) were attributable to  HCV.2 About 50% to 80% of patients with HCV infection prog - ress to chronic infection which can lead to LC or HCC.3 Standard  treatment for hepatitis C infection is a combination therapy with  pegylated-interferon a and ribavirin but currently new standard  care was suggested with triple combination therapy includ - ing direct antiviral agents (i.e., boceprevir or telaprevir) aiming  to achieve sustained virologic response (SVR).4,5 Interestingly,  compared to Caucasian patients, Asian patients showed higher  rate of spontaneous clearance of HCV in acute hepatitis C,6 and  higher SVR rate after antiviral therapy in chronic hepatitis C,7  although the mechanism of this phenomenon was unclear.",Non-OADS,/arxiv_data1/oa_pdf/15/60/gnl-8-70.PMC3916691.pdf
"Accepted on October 29, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.79  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Hepatocellular carcinoma (HCC) is the sixth commonest  malignancy worldwide and is the third most common cause  of cancer-related death.",Non-OADS,/arxiv_data1/oa_pdf/53/85/gnl-8-79.PMC3916692.pdf
"Published online on August 14, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.88  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Stereotactic body radiation therapy (SBRT) allows for the  delivery of high radiation doses while minimizing toxicity on  adjacent organs.1,2 This technique demands high targeting accu - racy, taking into account respiratory and other involuntary mo - tion of the target lesion during radiation therapy.2 SBRT needs  fiducial markers for target localization and tracking.2 Fiducial  markers serve as reference points for computed tomography  (CT) planning and allow for simultaneous correction of target  motion.",Non-OADS,/arxiv_data1/oa_pdf/8f/1d/gnl-8-88.PMC3916693.pdf
"Published online on November 5, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl.2014.8.1.94  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Most of ampulla of Vater carcinomas (AVCs) can be classified  as intestinal type or pancreatobiliary type based on histologic  characteristics.1 Intestinal AVCs behave like their duodenal  counterparts, while pancreatobiliary ones are more aggressive  and behave like pancreatic adenocarcinomas.2 AVCs of differ - ent histologic types express different specific markers and have  different modes of tumor spread, extent of and interaction with  the extracellular matrix, and premalignant lesions.3 Patients  with intestinal AVCs have a much better prognosis than those  with pancreatobiliary AVCs.4 However, other studies have re - ported that histologic subgroup does not correlate with clinical  outcomes.5-7 The epithelial-mesenchymal transition (EMT) is a process in  which mature epithelial cells change in appearance and lose  cell-cell contacts and epithelial protein expression while at the  same time acquiring the phenotypic characteristics of mesen - chymal cells.8 Immunohistochemical (IHC) staining studies of  tissues from patients with AVCs have demonstrated that the loss  of epithelial markers and the gain of mesenchymal markers are  related to tumor progression.9-11 Loss of E-cadherin expression  in AVCs correlates with clinicopathologic features of tumor  progression, and predicts poor prognosis.9 Loss of membranous  b-catenin expression9 and gain of cytoplasmic or nuclear b- catenin expression in neoplastic glands is related to carcinogen - esis and tumor progression in gastrointestinal cancers.12 S100A4  promotes metastasis in several tumors.",Non-OADS,/arxiv_data1/oa_pdf/ce/0c/gnl-8-94.PMC3916694.pdf
Available at: http://www.british- thyroid-association.org/Guidelines .,Non-OADS,/arxiv_data1/oa_pdf/37/2f/423_2013_Article_1135.PMC3916707.pdf
Available from http://www.emea.europa.eu/ pdfs/human/ich/013595en.pdf.last accessed 7 May 2013.,Non-OADS,/arxiv_data1/oa_pdf/cd/16/UPS-119-025.PMC3916714.pdf
Available from http://www.archivesofpathology.org/doi/ abs/10.1043/0003-9985%282001%29125%3C0211% 3ATRBNHF%3E2.0.CO%3B2.Accessed 8 Aug 2013.,Non-OADS,/arxiv_data1/oa_pdf/bc/bc/UPS-119-055.PMC3916719.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.11.004 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/4f/ce/main.PMC3916753.pdf
We discardedCNVs that overlapped with CNVs in the parental ﬁbro- blasts or those that are documented in the Database of Genome Variation ( http://projects.tcag.ca/variation/ ) because these might represent common polymorphismsthat may preexist in the parental ﬁbroblasts.,Non-OADS,/arxiv_data1/oa_pdf/4f/ce/main.PMC3916753.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2013.11.004 .,Non-OADS,/arxiv_data1/oa_pdf/4f/ce/main.PMC3916753.pdf
"Stem Cell Reports Report Long-T erm Stability and Safety of T ransgenic Cultured Epidermal Stem Cells in Gene Therapy of Junctional Epidermolysis Bullosa Laura De Rosa,1,5Sonia Carulli,1,5Fabienne Cocchiarella,1Daniela Quaglino,2Elena Enzo,1 Eleonora Franchini,1Alberto Giannetti,3Giorgio De Santis,4Alessandra Recchia,1Graziella Pellegrini,1 and Michele De Luca1,* 1Center for Regenerative Medicine ‘‘Stefano Ferrari,’’ Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy 2Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy 3Emeritus of Dermatology, University of Modena and Reggio Emilia, 41125 Modena, Italy 4Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy 5These authors contributed equally to this work *Correspondence: michele.deluca@unimore.it http://dx.doi.org/10.1016/j.stemcr.2013.11.001 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2a/88/main.PMC3916757.pdf
None of these integrations belong to a comprehensive compilation of proto-oncogenes and genes associated with common insertion sites (CIS)in mouse tumors ( http://microb230.med.upenn.edu/ protocols/cancergenes.html ).,Non-OADS,/arxiv_data1/oa_pdf/2a/88/main.PMC3916757.pdf
"Sequences were map- ped onto the human genome by the BLAT genome browser (UCSC Human Genome Project Working Draft, Feb 2009, hg19;http://www.genome.ucsc.edu ).",OADS,/arxiv_data1/oa_pdf/2a/88/main.PMC3916757.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.12.002 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/main.PMC3916758.pdf
"ACCESSION NUMBERS The NCBI Gene Expression Omnibus accession number for the data reported in this paper is GSE52692.SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental ExperimentalProcedures, four ﬁgures, and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.",Non-OADS,/arxiv_data1/oa_pdf/ee/4f/main.PMC3916758.pdf
"Stem Cell Reports Report Simvastatin Promotes Adult Hippocampal Neurogenesis by Enhancing Wnt/ b-Catenin Signaling Nicholas C. Robin,1,2,3,4Zsuzsa Agoston,2,3,4Travis L. Biechele,1,2,3,4Richard G. James,2,3,4,5 Jason D. Berndt,2,3,4and Randall T. Moon1,2,3,4,* 1University of Washington Department of Pharmacology, Seattle, WA 98195, USA 2Institute for Stem Cell and Regenerative Medicine, Seattle, WA 98109, USA 3Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA 4University of Washington School of Medicine, Seattle, WA 98195, USA 5Center for Immunity and Immunotherapies, Seattle Children’s Research Institute, Seattle, WA 98101, USA *Correspondence: rtmoon@uw.edu http://dx.doi.org/10.1016/j.stemcr.2013.11.002 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/11/38/main.PMC3916759.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and four ﬁgures and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr.2013.11.002 .,Non-OADS,/arxiv_data1/oa_pdf/11/38/main.PMC3916759.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.11.009 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, whichpermits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/e7/69/main.PMC3916760.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and six ﬁgures and can be found with this article onlineathttp://dx.doi.org/10.1016/j.stemcr.2013.11.009 .,Non-OADS,/arxiv_data1/oa_pdf/e7/69/main.PMC3916760.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.11.006 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-No Derivative Works License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6e/62/main.PMC3916761.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes four ﬁgures and ﬁve tables andcan be found with this article online at http://dx.doi.org/10.1016/ j.stemcr.2013.11.006 .,Non-OADS,/arxiv_data1/oa_pdf/6e/62/main.PMC3916761.pdf
"Modelling .The density functional theory (DFT) calculations were performed on the two organic sensitizers by using the Amsterdam Density Functional package (ADF 2010.01) [ADF2010, SCM, Theoretical Chemistry, Vrije Universiteit, The Netherlands Amsterdam, http://www.scm.com (scientific computing and modellingaccessed 21-01-2014)] 32,33.",OADS,/arxiv_data1/oa_pdf/3a/70/srep04033.PMC3916786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4033 | DOI: 10.1038/srep04033 7",Non-OADS,/arxiv_data1/oa_pdf/3a/70/srep04033.PMC3916786.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4030 | DOI: 10.1038/srep04030 5",Non-OADS,/arxiv_data1/oa_pdf/70/41/srep04030.PMC3916788.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4020 | DOI: 10.1038/srep04020 5",Non-OADS,/arxiv_data1/oa_pdf/aa/fb/srep04020.PMC3916789.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4018 | DOI: 10.1038/srep04018 4",Non-OADS,/arxiv_data1/oa_pdf/c9/13/srep04018.PMC3916790.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications.,Non-OADS,/arxiv_data1/oa_pdf/6b/49/ncomms4143.PMC3916833.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Leeansyah, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/49/ncomms4143.PMC3916833.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4143 10 NATURE COMMUNICATIONS | 5:3143 | DOI: 10.1038/ncomms4143 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6b/49/ncomms4143.PMC3916833.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on European Journal of Clinical Nutrition website (http://www.nature.com/ejcn)Assessing energy expenditure and lean mass LPE Watson et al 240 European Journal of Clinical Nutrition (2014) 234 – 240 &2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c4/a2/ejcn2013237a.PMC3916834.pdf
Preprint at http://arxiv.org/abs/1309.5269 (2013).,Non-OADS,/arxiv_data1/oa_pdf/cc/7d/ncomms4225.PMC3916835.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/7d/ncomms4225.PMC3916835.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4225 ARTICLE NATURE COMMUNICATIONS | 5:3225 | DOI: 10.1038/ncomms4225 | www.nature.com/naturecommunications 5 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/cc/7d/ncomms4225.PMC3916835.pdf
"Advanced LIGO, http://www.advancedligo.mit.edu (2012).3.",Non-OADS,/arxiv_data1/oa_pdf/c1/58/ncomms4049.PMC3916837.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hudelist, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/c1/58/ncomms4049.PMC3916837.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4049 6 NATURE COMMUNICATIONS | 5:3049 | DOI: 10.1038/ncomms4049 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c1/58/ncomms4049.PMC3916837.pdf
Preprint at http://arxiv.org/abs/1308.0528 (2013).,Non-OADS,/arxiv_data1/oa_pdf/55/0f/ncomms4194.PMC3916840.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions How to cite this article: Scha¨fer, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/55/0f/ncomms4194.PMC3916840.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4194 6 NATURE COMMUNICATIONS | 5:3194 | DOI: 10.1038/ncomms4194 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/55/0f/ncomms4194.PMC3916840.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d8/e5/ncomms4108.PMC3916841.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhao, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/e5/ncomms4108.PMC3916841.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4108 ARTICLE NATURE COMMUNICATIONS | 5:3108 | DOI: 10.1038/ncomms4108 | www.nature.com/naturecommunications 11 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d8/e5/ncomms4108.PMC3916841.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ab/88/ncomms4095.PMC3916842.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ciobanasu, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/ab/88/ncomms4095.PMC3916842.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4095 10 NATURE COMMUNICATIONS | 5:3095 | DOI: 10.1038/ncomms4095 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ab/88/ncomms4095.PMC3916842.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Annese, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/ncomms4122.PMC3916843.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4122 ARTICLE NATURE COMMUNICATIONS | 5:3122 | DOI: 10.1038/ncomms4122 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/19/e5/ncomms4122.PMC3916843.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4019 | DOI: 10.1038/srep04019 6",Non-OADS,/arxiv_data1/oa_pdf/52/cf/srep04019.PMC3916872.pdf
http://www.agrobiomexico.org.,Non-OADS,/arxiv_data1/oa_pdf/7b/c3/srep04022.PMC3916873.pdf
"Genetic id Europe AG, http://www.genetic-id.de/en/products-and-services/gmo- testing/honey-testing.html, accessed September, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7b/c3/srep04022.PMC3916873.pdf
"http://www.siap.gob.mx/, accessed September, 2013.",Non-OADS,/arxiv_data1/oa_pdf/7b/c3/srep04022.PMC3916873.pdf
"FAOSTAT (2011) http://faostat.fao.org/site/535, accessed January 3, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7b/c3/srep04022.PMC3916873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4022 | DOI: 10.1038/srep04022 4",Non-OADS,/arxiv_data1/oa_pdf/7b/c3/srep04022.PMC3916873.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4036 | DOI: 10.1038/srep04036 6",Non-OADS,/arxiv_data1/oa_pdf/67/c9/srep04036.PMC3916891.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4023 | DOI: 10.1038/srep04023 7",Non-OADS,/arxiv_data1/oa_pdf/e2/f2/srep04023.PMC3916894.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/35/srep04031.PMC3916896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4031 | DOI: 10.1038/srep04031 8",Non-OADS,/arxiv_data1/oa_pdf/ec/35/srep04031.PMC3916896.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4025 | DOI: 10.1038/srep04025 4",Non-OADS,/arxiv_data1/oa_pdf/01/2a/srep04025.PMC3916898.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4034 | DOI: 10.1038/srep04034 8",Non-OADS,/arxiv_data1/oa_pdf/b9/77/srep04034.PMC3916899.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/40/srep04021.PMC3916900.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4021 | DOI: 10.1038/srep04021 5",Non-OADS,/arxiv_data1/oa_pdf/d1/40/srep04021.PMC3916900.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4196 | Page 1 of 8Video Article Regular Care and Maintenance of a Zebrafish ( Danio rerio ) Laboratory: An Introduction Avdesh Avdesh*1,2, Mengqi Chen*1,3, Mathew T. Martin-Iverson1,2,4, Alinda Mondal1,3, Daniel Ong1, Stephanie Rainey-Smith1,3, Kevin Taddei1,3, Michael Lardelli5, David M. Groth6, Giuseppe Verdile1,3, Ralph N. Martins1,2,3,7 1Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical sciences, Edith Cowan University 2Centre for Clinical Research in Neuropsychiatry, Graylands Hospital, University of Western Australia 3McCusker Alzheimer's Research foundation 4School of Medicine and Pharmacology, University of Western Australia 5Department of Molecular and Biomedical Sciences, University of Adelaide 6School of Biomedical Sciences, Curtin University of Technology 7School of Psychiatry and Clinical Neurosciences, University of Western Australia *These authors contributed equally Correspondence to: Avdesh Avdesh at chaudharyavdesh@gmail.com , Ralph N. Martins at r.martins@ecu.edu.au URL: http://www.jove.com/video/4196 DOI: doi:10.3791/4196 Keywords: Basic Protocols, Issue 69, Biology, Marine Biology, Zebrafish, Danio rerio , maintenance, breeding, feeding, raising, larvae, animal model, aquarium Date Published: 11/18/2012 Citation: Avdesh, A., Chen, M., Martin-Iverson, M.T., Mondal, A., Ong, D., Rainey-Smith, S., Taddei, K., Lardelli, M., Groth, D.M., Verdile, G., Martins, R.N.",Non-OADS,/arxiv_data1/oa_pdf/c4/01/jove-69-4196.PMC3916945.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4196/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/01/jove-69-4196.PMC3916945.pdf
"[25]  D. Andreuccetti, R. Fossi, C. Petrucci, “ An Internet resource for the  calculation of the dielectric properties of body tissues in the fr e- quency range 10 Hz - 100 GHz”, Internet document;  URL:http://niremf.ifac.cnr.it/tissprop/ .2013   [26] L. A Geddes., L. E. Baker, “ The specific resistance of biological  material a compendium of data for the biomedical engineer and  physiologist ”, Med.",OADS,/arxiv_data1/oa_pdf/bb/47/TOBEJ-8-1.PMC3917106.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/ - licenses/by -nc/3.0/) which permits unrestricted,  non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/47/TOBEJ-8-1.PMC3917106.pdf
"1 1      http://www.medsci.org  222  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 222-225. doi: 10.7150/ ijms.7382   Short Research Communication   Chymase Activities and Survival in Endotoxin -Induced  Human Chymase Transgenic Mice   Kazi Rafiq1, Yu-Yan Fan1, Shamshad J. Sherajee1, Yoshimasa Takahashi2, Junji Matsuura2, Naoki Hase2,  Hirohito Mori3, Daisuke Nakano1, Hideki Kobara3, Hirofumi Hitomi1, Tsutomu Masaki3, Hidenori Urata4,  and Akira Nishiyama1  1.",Non-OADS,/arxiv_data1/oa_pdf/ab/ec/ijmsv11p0222.PMC3917108.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ab/ec/ijmsv11p0222.PMC3917108.pdf
11     http://www.medsci.org  223  Materials and Methods   Animals   All experimental procedures were performed  according to the guidelin es for the care and use of  animals established by Kagawa University.,Non-OADS,/arxiv_data1/oa_pdf/ab/ec/ijmsv11p0222.PMC3917108.pdf
1 1      http://www.medsci.org  224    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/ab/ec/ijmsv11p0222.PMC3917108.pdf
11     http://www.medsci.org  225  References   1.,Non-OADS,/arxiv_data1/oa_pdf/ab/ec/ijmsv11p0222.PMC3917108.pdf
"1 1      http://www.medsci.org  226  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 226-233. doi: 10.7150/ ijms.7897   Research Paper   The Antinociceptive Effect of Dexmedetomidine  Modulates Spleen Cell Immunity  in Mice   Yeon Jang1, Mi-Young Yeom2, Eun -Sun Kang2, Ji-Won Kang1, Ho-Kyung Song1   1.",Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
1 1      http://www.medsci.org  227  INTRODUCTION   A complex interaction occurs between the sy m- pathetic nervous system and the immune system.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  228  Cell preparation   Mice were sacrificed by cervical dislocation after  assessing the pain behavior of formalin test .,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  229  o f  B r d U  w e r e  a d d e d  t o  e a c h  w e l l  ( 1 0  μ M  f i n a l  c o n- centration) .,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  230  lactate dehydrogenase (LDH) release (Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  231  changed  compared to control naive.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  232  not attenuate lymphocyte proliferation in a  dose -dependent manner in a bromodeoxyuridine  (BrdU ) incorporation assay [20].,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
11     http://www.medsci.org  233  13.,Non-OADS,/arxiv_data1/oa_pdf/e7/e4/ijmsv11p0226.PMC3917109.pdf
"1 1      http://www.medsci.org  234  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 234-239. doi: 10.7150/ ijms.7384   Research Paper   Three -dimensional Ultrasound Appearance of Pelvic  Floor in Nulliparous Women and  Postpartum  Women   One Week after Their First Delivery   Feifei L iu, Lian X u, Tao Y ing, Junjia Tao, and Bing  Hu   Department  of Ultrasound in Medicine,  Shanghai Jiao  Tong University  Affiliated  Sixth People’s Hospital ; Shanghai  Institute of Ultrasound  in Medicine,  Shanghai, People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
11     http://www.medsci.org  235  function are also associated with the mode of deli v- ery.,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
1 1      http://www.medsci.org  236    Figure  2.,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
11     http://www.medsci.org  237  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
11     http://www.medsci.org  238   The i ncidence of  pelvic  organ prolapse (21.28%  vs. 4.17%) and pubrectalis muscle avulsion (17.02%  vs. 0%) was significantly hi gher in V aginal delivery  group  compared to C esarean section group  (P<0.0 5).,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
11     http://www.medsci.org  239  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/80/84/ijmsv11p0234.PMC3917110.pdf
"1 1      http://www.medsci.org  240  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 240-245. doi: 10.7150/ ijms.7489   Short Research Communication   Stromal Cell -derived Factor- 1 and its Receptor CXCR4  are Upregulated Expression in Degenerated  Intervertebral Discs   Hua Zhang1* , Li Zhang*2, Linwei Chen1, Wanli Li1, Fangcai Li1, Qixin Chen1  1.",Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
11     http://www.medsci.org  241  that the types and expression of matrix  metalloproteinases (MMPs) from bovine nucleus pulposus cells were similar to those of articular chondrocytes.,Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
"11     http://www.medsci.org  242  BBC Biochemical, Seattle, WA, USA) .",Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
1 1      http://www.medsci.org  243  SDF-1 IOD in human IVDs   SDF-1 was detected in both the degeneration and  normal groups  (Figure 1E –H).,Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
1 1      http://www.medsci.org  244  CXCR4-positive cells in the rat lumbar motion  segment   CXCR4 expression in IVDs of rats was detected  not only in nucleus pulposus cells but also in endplate  chondrocytes  (Figure 2G –J).,OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
11     http://www.medsci.org  245  References   1.,Non-OADS,/arxiv_data1/oa_pdf/58/89/ijmsv11p0240.PMC3917111.pdf
"1 1      http://www.medsci.org  246  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 246.  doi: 10.7150/ ijms.8533  Retraction   Retraction: Cadmium I nduced Cell A poptosis, DNA  Damage, D ecreased DNA R epair Capacity , and  Genomic I nstability during Malignant Transformation of  Human B ronchial Epithelial Cells  Zhiheng Zhou1, Caixia Wang2, Haibai Liu1, Qinhai Huang1, Min Wang1 , Yixiong Lei1  1.",Non-OADS,/arxiv_data1/oa_pdf/45/b5/ijmsv11p0246.PMC3917112.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/b5/ijmsv11p0246.PMC3917112.pdf
"1 1      http://www.medsci.org  247  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 247-254. doi: 10.7150/ ijms.6518   Research Paper   NLS-RARα Promotes Proliferation a nd Inhibits  Differentiation in  HL-60 Cells  Xiu-Xiu Hu 1,2, Liang Zhong2, Xi Zhang 2, Yuan -Mei Gao 2, Bei-Zhong Liu 1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"11     http://www.medsci.org  248  ily [2, 3, 4 ].",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"1 1      http://www.medsci.org  249  Cell line and culture   Human HL -60 cells were purchased from the  Shanghai Institute for Biological Science  and mai n- tained in IMDM  (Gibco, MD, USA) supplemented  with  20% fetal bovine serum (FBS;  Gibco, MD, USA)  in an environment with 5% CO 2 at 37 °C.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"11     http://www.medsci.org  250  mg/ml ; Sigma, MO, USA) was added to each well  followed by incubation  for 4 h at 37° C. The medium   was then replaced with 150 μl of dimethylsulphoxide  (DMSO, Sigma, MO, USA).",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"11     http://www.medsci.org  251  mRNA and protein  expressions of  NLS -RARα was  found between HL- 60 cells and HL -60/pshRNA -NC  cells (P>0.05, Figure 2).",OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"1 1      http://www.medsci.org  252  Effect of NLS-RARα  on proliferation of HL-60  cells  MTT assay showed that, when compared with  the HL -60/pshRNA -NC cells, the proliferation of  HL-60/pshRNA -NLS -RARα cells was significantly  inhibited in a time -dependent manner  (P<0.05, Figure   4A).",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
11     http://www.medsci.org  253    Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"11     http://www.medsci.org  254  larly in hematopoietic neoplasias [ 24, 25 ].",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ijmsv11p0247.PMC3917113.pdf
"1 1      http://www.medsci.org  255  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 255-261. doi: 10.7150/ ijms.6276   Research Paper   Effect of Hemoperfusion Using Polymyxin   B-immobilized Fibers on Acute Lung Injury in a Rat  Sepsis Model   Toshiaki Iba1, Isao Nagaoka2, Atsushi Yamada1, Masataka Nagayama1, Takahiro Miki1   1.",Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
This is an open- access article distributed under  the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
11     http://www.medsci.org  256  PMX -DHP on an acute lung injury (ALI) induced by  lipopolysaccharide (LPS).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
11     http://www.medsci.org  257  observed in both the control and the PMX -DHP  groups.,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
11     http://www.medsci.org  258    Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
1 1      http://www.medsci.org  259    Fig.,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
"11     http://www.medsci.org  260  tal microscopy demonstrated the first changes ob- served examination were an increase in the adherence of leukocytes followed by platelet sticking, leading to the formation of a lining on the endothelium.",Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
11     http://www.medsci.org  261  Acknowledgements    A part of this study was presented at the 28th  International Symposium on Intensive Care and  Emergency Medicine.,Non-OADS,/arxiv_data1/oa_pdf/cf/62/ijmsv11p0255.PMC3917114.pdf
"1 1      http://www.medsci.org  262  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 262-267. doi: 10.7150/ ijms.7287   Research Paper   Up-regulated FHL1 E xpression  Maybe Involved  in the  Prognosis o f Hirschsprung’s  Disease   Li-Li Wang , Hui Gu, Yang  Fan, Yi Zhang , Di Wu, Jia-Ning Miao , Tian -Chu  Huang , Hui Li, Zheng -Wei   Yuan  Key laboratory of Health Ministry for Congenital Malformation, Shengjing Hospital , China Medical University, Shen yang, 110004 , P.R.",Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
11     http://www.medsci.org  263  although data were  emerging to s uggest that those  with constipation have a neuropathy proximal to the  aganglionic segment  [5].,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
"11     http://www.medsci.org  264  Real -time PCR amplifications were performed in  triplicates on Light Cycle (Roche, Ba sel, Switzerland)  using  the following  oligonucle otides:  FHL1 -1:5′-GTA GTCGTGCCAGGATTGT -3′; FHL1 -2:5′-GCTGTGGA GGACCAGTATTA -3′ (product size=1 42bp).",OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
1 1      http://www.medsci.org  265  FHL1  gene expression in HSCR patients   FHL1  mRNA and protein expressions were a n- alyzed in 32 HSCR patients  and 4  normal colons.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
11     http://www.medsci.org  266  participat e in intestinal dysfunction in HSCR patien ts  is not clear.,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
11     http://www.medsci.org  267  muscle cells;  FHL1: four -and-a-half LIM protein -1;  ENPs: enteric neural precursors; ENS: enteric nervous  system; ICC: interstitial cells of Cajal; PDLIM1:  PDZ   and LIM domain protein 1 ; GSN: Gelsolin ; ACTN1:  a-actin .,Non-OADS,/arxiv_data1/oa_pdf/bb/b2/ijmsv11p0262.PMC3917115.pdf
"1 1      http://www.medsci.org  268  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 268-275. doi: 10.7150/ ijms.7769   Research Paper   Role of overexpression of MACC1 and/or FAK in  predicting prognosis of hepatocellular carcinoma after  liver transplantation  Sheng Gao1,2*, Bing -Yi Lin1,2*, Zhe Yang1,2,3, Zhi -Yun Zheng1,2, Zhi-Kun Liu1,2, Li-Ming Wu1,2,3, Hai -Yang  Xie1,2,3, Lin Zhou1,2,3 and Shu -Sen Zheng1,2,3  1.",Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
11     http://www.medsci.org  269  foci before LT [6].,OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
11     http://www.medsci.org  270  survival and cumulative recurrence rates were an a- lyzed by the Kaplan –Meier method and t he diffe r- ences between groups were estimated by the log -rank  test.,OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
1 1      http://www.medsci.org  271  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
11     http://www.medsci.org  272      Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
11     http://www.medsci.org  273    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
"1 1      http://www.medsci.org  274  Cox multivariate analysis revealed  that, apart  from vascular incasion , high preoperative AFP level  (>400 ng/ml), and a larger tumor siz e (>5cm),  MACC1 overexpression in HCC, rather than FAK,  was an independent prognostic factor for predicting  tumor recurrence ( P < 0.001) and OS ( P < 0.001) in  HCC patients after LT.",Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
11     http://www.medsci.org  275  in-depth unde rstanding of the regulation and func- tions of key oncoproteins such as MACC1 in HCC  could have a profound impact on both diagnosis and treatment of this disease.,Non-OADS,/arxiv_data1/oa_pdf/d7/62/ijmsv11p0268.PMC3917116.pdf
"1 1      http://www.medsci.org  276  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 276-281. doi: 10.7150/ ijms.7627   Research Paper   Comparison of the Inhibitory Effect of Gonadotropin  Releasing Hormone  (GnRH ) Agonist, Selective Estrogen  Receptor Modulator ( SERM ), Antiprogesterone on  Myoma Cell Proliferation  In Vitro   Youn -Jee Chung1, Boah  Chae1, Se-Hyun Kwak1, Jae-Yen Song1, Ah-Won Lee2, Hyun -Hee Jo1, Young -Ok  Lew1, Jang- Heub Kim1, Mee- Ran Kim1  1.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
"11     http://www.medsci.org  277  However, given that it is the most common type of  tumor in women of reproductive age, the treatment of  uterine myomas must prioritize uterine conservation.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
"11     http://www.medsci.org  278  MTT assay   After being treated with the corresponding r e- actants  in serum -free DMEM/F12 for 48 and 72 h ours   in a 96 -well tissue culture plate, t he data were an a- lyzed at 450 nm and evaluated with  3-(4,5-dimethylthiazol -2-yl)-2,5-diphenyl -tetrazolium  bromide (MTT, Color imetric assay kit, Chemicon Inc.,  CA, USA) which is modified from the tetrazolium  based colorimetric assay.",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
"11     http://www.medsci.org  279  Effect of r aloxifene and m ifepristone on the  uterine leiomyoma cell proliferation  pretreated with leuprolide acetate    For cells pretreated with 10-9M leu prolide acetate  for 72  hours, cell viability was more significantly r e- duced when treated with raloxifene for 48 hours than  for the raloxifene single treatment group (63.6 ± 3.5%   versus 79.6 ± 2.3% , p = 0.017) .",Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
11     http://www.medsci.org  280  pristone has been shown to decrease uterine myoma  size and menstrual blood loss.,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
11     http://www.medsci.org  281  ine Leiomyoma Cells in the Absence of Comparable Effects on Myometrial  Cells.,Non-OADS,/arxiv_data1/oa_pdf/0f/f2/ijmsv11p0276.PMC3917117.pdf
"1 1      http://www.medsci.org  282  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 282-290. doi: 10.7150/ ijms.7634   Research Paper   Protective Effect of Quercetin against Oxidative Stress  and Brain Edema in an Experimental Rat Model of  Subarachnoid Hemorrhage   Yu-shu Dong1,2*, Ju-lei Wang1,3*, Da-yun Feng1, Huai -zhou Qin1, Hua Wen2, Zhong -min Yin2, Guo -dong  Gao1, Chuan Li4  1.",Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
11     http://www.medsci.org  283  outcomes post SAH remain poor.,Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
11     http://www.medsci.org  284  Experimental rat model of subarachnoid  hemorrhage  The experimental SAH model was induced by  prechias matic blood injection according to a pu b- lished procedure [17].,Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
11     http://www.medsci.org  285  cell.,Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
"11     http://www.medsci.org  286  Effects of quercetin on oxidative stress   In comparison with the sham group, CuZn- SOD  activity in the rat brain cortices was markedly d e- creased in the SAH+ vehicle group (27.65 ± 3.19 versus  48.35 ± 5.32, P < 0.01).",Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
11     http://www.medsci.org  287    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
"11     http://www.medsci.org  288  and smooth muscle, disruption of the blood –brain  barrier (BBB), and the production of strong spa s- mogens, such as prostaglandin D2 and leukotriene C4  from the lipoxygenase and cyclo -oxygenase pathways  of arachidonic acid metabolism [27].",Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
"11     http://www.medsci.org  289  Conclusions   In summary, this is the first in vivo  experiment to  demonstrate that quercetin has a protective effect  against the damage following SAH in experimental  rats.",Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
11     http://www.medsci.org  290  47.,Non-OADS,/arxiv_data1/oa_pdf/e1/50/ijmsv11p0282.PMC3917118.pdf
"1 1      http://www.medsci.org  291  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 291-297. doi: 10.7150/ ijms.5431   Research Paper   The perception of the Illness with Subsequent Outcome  Measure in More Favorable in Continuos Peritoneal  Dialysis v s Hemodialysis in the Framework of Appraisal  Model of Stress  Zbigniew Nowak1 , Krzysztof Laudański2   1.",Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
"11     http://www.medsci.org  292  If the stimulus is perceived as a benign or neutral one,  it will be ignored or even appreciated.",Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
11     http://www.medsci.org  293  interviewed at their work or home.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
11     http://www.medsci.org  294  the HD and CAPD group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
11     http://www.medsci.org  295    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
11     http://www.medsci.org  296  ysis is a passive process for patients.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
11     http://www.medsci.org  297  8.,Non-OADS,/arxiv_data1/oa_pdf/dd/2d/ijmsv11p0291.PMC3917119.pdf
"1 1      http://www.medsci.org  298  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2014;  11(3): 298-308. doi: 10.7150/ ijms.6672   Research Paper   Effects of ECM Protein Mimetics on Adhesion and  Proliferation of Chorion Derived Mesenchymal Stem  Cells  Ji-Hyun Kim1,3, Dong Wook Jekarl1, Myungshin Kim1, Eun- Jee Oh1, Yonggoo Kim1, In Yang Park2, Jong  Chul Shin2   1.",Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
"11     http://www.medsci.org  299  MSCs with age [5,6].",Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
"11     http://www.medsci.org  300  lin-strepto mycin (Gibco, Grand Island, NY, USA), and  cultured in T25 flasks (Nunc, Roskilde, Denmark) at  37 ℃ in 5% CO 2.",Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
"11     http://www.medsci.org  301  attached and the total number of cells, which are d e- termined by cell proliferation, cytotoxicity, cytopr o- tection, cell growth inhibition, and apoptosis [29 -33].",Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
11     http://www.medsci.org  302    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
"11     http://www.medsci.org  303  9, 16, 24, 36, 48 and 72 hour respectively (Figure 6A ,  C1, C2 ).",Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
11     http://www.medsci.org  304        Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
11     http://www.medsci.org  305        Figure 6.,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
1 1      http://www.medsci.org  306  Assessment of proliferation of cMSCs on ECM  protein mimetic coated surfaces using an MTS  assay   The cMSC s proliferation capabilities on ECM  protein mimetic coated surfaces were investigated  using an MTS assay.,OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
11     http://www.medsci.org  307  secretion of factors [14].,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
11     http://www.medsci.org  308  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
[Internet] http://www.kollodis.com/sub0201.html   22.,Non-OADS,/arxiv_data1/oa_pdf/fb/78/ijmsv11p0298.PMC3917120.pdf
Rambaree K. Youth Culture and Net Culture: Online Social  Practices: Ihttp://www.igi-global.com/chapter/young-people- cybersex-sexually-conservative/50699; 2011.,Non-OADS,/arxiv_data1/oa_pdf/31/6a/IJNMR-18-439.PMC3917125.pdf
Available from:  http://www.mmo.gr/pdf/news/Migration_in_the_Middle_East_ and_Mediterranean.pdf [Last retrieved 2012 May 24].,Non-OADS,/arxiv_data1/oa_pdf/9f/c4/IJNMR-18-446.PMC3917126.pdf
Available  from: http://www.aacn.nche.edu/Education/pdf/competency.,Non-OADS,/arxiv_data1/oa_pdf/9f/c4/IJNMR-18-446.PMC3917126.pdf
Available from: http://www.hrsa.gov/telehealth.,Non-OADS,/arxiv_data1/oa_pdf/5e/f6/IJNMR-18-451.PMC3917127.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/e3/13/IJNMR-18-488.PMC3917133.pdf
Available from:  http://www.sujoktherapy.com [Last accessed on 2013 May 30].,Non-OADS,/arxiv_data1/oa_pdf/4b/60/IJNMR-18-494.PMC3917134.pdf
Available from:   http://www.indiana.edu/~nsse/.22.,Non-OADS,/arxiv_data1/oa_pdf/da/fe/IJNMR-18-505.PMC3917136.pdf
Available from:  http://www.drkenhunt.com/critical.html .Teaching resourses.,Non-OADS,/arxiv_data1/oa_pdf/da/fe/IJNMR-18-505.PMC3917136.pdf
"Available from: http://archive.tehelka.com/story_main54.asp?filename=Ne131012SNAKE.asp [Last accessed on 2013 Nov 30].Table 1: Comparison of the list of antidotes in  the essential medicines lists of Bangladesh, Bhutan, India, Nepal, and Sri Lanka with the 18 th model essential medicines list of the  world health organization Antidote WHO‑EML BAN BHU IND NEP SLK Activated charcoal Yes No No Yes Yes Yes Acetyl cysteine Yes No No Yes Yes Yes Atropine Yes Yes Yes Yes Yes Yes Calcium gluconate Yes Yes Yes Yes Yes No Methylene blue Yes No No Yes Yes Yes Naloxone Yes Yes Yes Yes Yes Yes Penicillamine Yes No No Yes No Yes Prussian Blue Yes No No No Yes No Sodium nitrite Yes No No Yes Yes Yes Sodium thiosulfate Yes No Yes Yes No Yes Deferoxamine Yes No No Yes Yes Yes Dimercaprol Yes No No Yes Yes Yes Succimer Yes No No No No No Sod cal edetate Yes No No No Yes Yes Fomepizole Yes No No No No No Antisnake venom Yes Yes Yes Yes Yes Yes Pralidoxime No No Yes Yes Yes Yes Flumazenil No No Yes Yes No Yes D‑L methionine No No No No No Yes Ethanol No No No No Yes Yes Fuller’s Earth No No No No No Yes Deferiprone No No No No No Yes WHO‑EML=World health organization essential medicines list, BAN=Bangladesh, BHU=Bhutan, IND=India, NEP=Nepal, SLK=Sri Lanka.",Non-OADS,/arxiv_data1/oa_pdf/8e/31/JPP-5-1.PMC3917158.pdf
Avaialbel from: http://www.ibtimes.com/last‑call‑poor‑indians‑continue‑die‑alcohol‑poisoning‑liquor‑laced‑ industrial‑chemicals‑1434038 [Last accessed on 2013 Nov 30].,Non-OADS,/arxiv_data1/oa_pdf/8e/31/JPP-5-1.PMC3917158.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/8e/31/JPP-5-1.PMC3917158.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/8e/31/JPP-5-1.PMC3917158.pdf
Available from: http://www.rxlist.com/eliquis‑drug.htm [Last updated 2013 Oct 01].,Non-OADS,/arxiv_data1/oa_pdf/5c/84/JPP-5-12.PMC3917159.pdf
Available from:   http://www.cdsco.nic.in/.,Non-OADS,/arxiv_data1/oa_pdf/ce/0d/JPP-5-15.PMC3917160.pdf
Available from: http://www.who.int/.,Non-OADS,/arxiv_data1/oa_pdf/ce/0d/JPP-5-15.PMC3917160.pdf
Available from: http://www.cdc.gov/ncbddd/hemochromatosis/training/treatment/monitoring treatment.htm.,Non-OADS,/arxiv_data1/oa_pdf/9f/7b/JPP-5-27.PMC3917162.pdf
Downloaded from http://www.antibiotic-action.com/wp-content/uploads/  2011/07/TUN-Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
Downloaded from http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/ Current_T opics_and_Issues/Antimicrobial_Resistance/10×20/Images/ Bad%20Bugs%20no%20Drugs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
Downloaded from http://www.fda.gov/downloads/ScienceResearch/SpecialT opics/CriticalPathInitiative/CriticalPathOpportunitiesReports/UCM077254.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
"Promoting Antibiotic Discovery and Development, A California Healthcare Institute Initiative, 2012. http://www.chi.org/uploadedFiles/Industry_at_a_glance/CHI%20Antibiotic%20White%20Paper_FINAL.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
Downloaded from http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/Current_T opics_and_Issues/Antimicrobial_Resistance/10×20/Letters/T o_Congress/IDSA%20Summary%20of%20Antibiotic%20Incentives%20in%20FDASIA.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/3d/37/JPP-5-4.PMC3917165.pdf
Available from:  http://www.who.int/ mediacentre/factsheets/fs312/en/.,Non-OADS,/arxiv_data1/oa_pdf/0b/75/JPP-5-54.PMC3917168.pdf
Available from:  http://www.who.int/ mediacentre/factsheets/fs312/en/.,Non-OADS,/arxiv_data1/oa_pdf/70/b9/JPP-5-56.PMC3917169.pdf
Available from: http://emedicine.medscape.com/ article/756261‑overview   [Last cited on 2012   May   29].,Non-OADS,/arxiv_data1/oa_pdf/01/95/JPP-5-59.PMC3917170.pdf
Available from: http://www.unesco.org/new/fileadmin/MUL TIMEDIA/HQ/ CI/CI/images/GOAP/215863e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/1b/JPP-5-70.PMC3917173.pdf
Available from: http://arxiv.org/ftp/arxiv/papers/1101/1101.5260.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9e/1b/JPP-5-70.PMC3917173.pdf
Available from: http://retractionwatch.wordpress.com/2012/12/11/elsevier‑editorial‑system‑hacked‑reviews‑faked‑11‑retractions‑follow/.,Non-OADS,/arxiv_data1/oa_pdf/9e/1b/JPP-5-70.PMC3917173.pdf
E - mail:   ravi.dr.shankar@gmail.comhttp://apps.who.int/medicinedocs/en/  Essential medicines play an important role in improving  access to medicines for the majority of the world’s population.,Non-OADS,/arxiv_data1/oa_pdf/5f/d2/JPP-5-74.PMC3917174.pdf
Available from: http://www.apps.who.int/medicinedocs/en/[Last accessed on 2013 October 28].,OADS,/arxiv_data1/oa_pdf/5f/d2/JPP-5-74.PMC3917174.pdf
Available from: http://www.who.int/tb/ publications/global_report/en.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available from: http://www.nature.com/news/totally ‑ drug‑resistant‑tb‑emerges‑in‑ind ia‑1.9797.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available from: http://www.stoptb.org/global/plan.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available  from: http://www.worldlunghealth.org/confLille/images/stories/PDF_Symposias/Symposium_46.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available  from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm333695.htm.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available from: http://www.elsevierbi.com/publications/pharmasia‑news/Article #28130310001.,Non-OADS,/arxiv_data1/oa_pdf/2e/82/JPP-5-76.PMC3917175.pdf
Available at http://www.mhra.gov.uk/home/groups/pl-a/documents/websiteresources/con019461.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/76/JPP-5-8.PMC3917176.pdf
Available at http://www.edoc.co.za/modules.php?name=News and file=article and sid=2368   [Accessed on 2013 May 30].,OADS,/arxiv_data1/oa_pdf/b5/76/JPP-5-8.PMC3917176.pdf
Available at http://www.ehospice.com/india/ArticlesList/PleatoremovethebanontheanalgesicDextropropoxyphene061613064330/tabid/7185/ArticleId/5272/language/en -GB/V iew.aspx#.UcPUI1_rbIU  [Accessed on 2013 Jun 16].,Non-OADS,/arxiv_data1/oa_pdf/b5/76/JPP-5-8.PMC3917176.pdf
Available from: http://nurisngworld.org/ethicscode150.htm.,Non-OADS,/arxiv_data1/oa_pdf/8e/09/IJNMR-19-1.PMC3917177.pdf
Available from: http://www.icn.ch/ethics.htm [Last accessed  on 2012Apr6].,Non-OADS,/arxiv_data1/oa_pdf/8e/09/IJNMR-19-1.PMC3917177.pdf
Available from: http://www.helid.digicollection.org/es/d/ Jwho36e/7.4.6.html [Last accessed on 2007 Nov 21].,OADS,/arxiv_data1/oa_pdf/d3/76/IJNMR-19-11.PMC3917179.pdf
Available from: http://www.amazon.com/History-Obstetrics-Gynaecology-M-J-ODowd/dp/1850700400.,Non-OADS,/arxiv_data1/oa_pdf/d3/76/IJNMR-19-11.PMC3917179.pdf
Gach MR. Acupressure Foundations and Introduction [11/4/2011];  Available from: http://www.acupressure.com/articles/acupressure_foundations.htm.,Non-OADS,/arxiv_data1/oa_pdf/92/6f/IJNMR-19-24.PMC3917181.pdf
2011[11/4/2011]; Available from: http://www.yinyanghouse.,Non-OADS,/arxiv_data1/oa_pdf/92/6f/IJNMR-19-24.PMC3917181.pdf
acufinder.com; 2013; Available  from: https://www.acufinder.com/Acupuncture+Points/Ciliao/163.,Non-OADS,/arxiv_data1/oa_pdf/92/6f/IJNMR-19-24.PMC3917181.pdf
"Available at: http://www.ijnmr.mui.ac.ir Source of Support:  Nil, Conﬂ ict of Interest:  Nil.",Non-OADS,/arxiv_data1/oa_pdf/92/6f/IJNMR-19-24.PMC3917181.pdf
Available from: http://www.unfpa.org/rights/rights.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/0a/IJNMR-19-28.PMC3917182.pdf
Available from: http://www.who.int/reproductivehealth/topics/gender_rights/defining_sexual_health/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/08/0a/IJNMR-19-28.PMC3917182.pdf
Available from: http://www.metu.edu.tr.[Last retrieved on 2013 Jan15].,Non-OADS,/arxiv_data1/oa_pdf/08/0a/IJNMR-19-28.PMC3917182.pdf
Available  from: http://www.sage-ereference.com/view/research/n452.xml>.[Last accessed on 2013 Jan24].,OADS,/arxiv_data1/oa_pdf/08/0a/IJNMR-19-28.PMC3917182.pdf
Available from: http://www.nmha.org [Last accessed on 2013 Jun 23].,OADS,/arxiv_data1/oa_pdf/15/b1/IJNMR-19-36.PMC3917183.pdf
Available from: http://bpdanesh.ir/detailnews.asp?id=6405.,Non-OADS,/arxiv_data1/oa_pdf/a3/90/IJNMR-19-50.PMC3917185.pdf
Available  from: http://www.statcan.gc.ca/pub/82-625-x/2010002/article/11265-eng.htm [Last accessed on 2009].,OADS,/arxiv_data1/oa_pdf/a3/90/IJNMR-19-50.PMC3917185.pdf
Available from: http://www.ovsadra.com/?p=451 [Last accessed on 2010].,Non-OADS,/arxiv_data1/oa_pdf/a3/90/IJNMR-19-50.PMC3917185.pdf
Available from: http://www.ps.psychiatryonline.org.,Non-OADS,/arxiv_data1/oa_pdf/a3/90/IJNMR-19-50.PMC3917185.pdf
Available from: http://www.clinicaltrials.gov/ct2/show/NCT00841737.,Non-OADS,/arxiv_data1/oa_pdf/a3/90/IJNMR-19-50.PMC3917185.pdf
Available from: http://www.insightassessment.com/CT-Resources/Teaching-For-and-About-Critical-Thinking/Critical-Thinking-What-It-Is-and-Why-It Counts/(language)/eng-US.,Non-OADS,/arxiv_data1/oa_pdf/19/bf/IJNMR-19-70.PMC3917188.pdf
19 | Issue 1http://www.sciencedirect.com/science?-ob=ArticleURLand- udi=B6WP-SO6HOW3-and-user=2111311.,Non-OADS,/arxiv_data1/oa_pdf/a2/28/IJNMR-19-77.PMC3917189.pdf
Available from: http://sjh.umsha.ac.ir/upfile/41073Full53-4.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a2/28/IJNMR-19-77.PMC3917189.pdf
Available from: http://www.hhs.gov/news/press/2008 [Last accessed on  2012Nov20].,Non-OADS,/arxiv_data1/oa_pdf/d4/a5/IJNMR-19-82.PMC3917190.pdf
Available from: http://www.sadeghi57.persianblog.ir/post/24[Last accessed on 2009].,Non-OADS,/arxiv_data1/oa_pdf/d4/a5/IJNMR-19-82.PMC3917190.pdf
"*Corresponding author: Giulio Frontino; Email: frontino.giulio@hsr.it Submitted: 11/25/2013; Accepted: 01/09/2014http://dx.doi.org/10.4161/derm.27790Necrobiosis Lipoidica Diabeticorum A pediatric case report Clara Bonura1, Giulio Frontino1,*, andrea r igamonti1, roseila Battaglino1, Valeria Favalli1, Giusy Ferro1, Chiara r ubino1,Paolo Del  Barba1, Filippo Pesapane2, Gianluca Nazzaro2, raffaele Gianotti2, riccardo Bonfanti1, Franco Meschi1, and Giuseppe Chiumello1  1ospedale San r affaele Scientific Institute; Department of Pediatrics; Milano, Italy; 2Università degli Studi di Milano; Fondazione I rCCS Ca’ Granda o sp.",Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Diabetes Care  2007; 30:1964-7; PMID:17519431; http://dx.doi.org/10.2337/dc07-0267 3.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
N Engl J Med  2012; 366:2502; PMID:22738100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Clin Dermatol 2005; 23:601-11;  PMID:16325069; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Case Rep Dermatol 2011; 3:89-93; PMID:21577369; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Dermatology 2009; 218:136-9; PMID:19060464; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Semin Cutan Med Surg 2007; 26:87- 9; PMID:17544959; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Int J Dermatol 2010;  49:467-9; PMID:20465710; http://dx.doi.org/10.1111/j.1365-4632.2010.04149.x 12.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Br J Dermatol  2005; 152:581-2; PMID:15787840; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
Clin Exp Dermatol  2006; 31:65-7; PMID:16309486; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/9d/de-6-e27790.PMC3917223.pdf
"FDA Guidance for Industry Exposure-Response Relationships — Study Design, Data Analysis, and Regulatory Applications April 2003 <http://www.fda.gov/downloads/Drugs/Figure 8  Visual predictive check (VPC) with and without adaptive  dosing simulations.",Non-OADS,/arxiv_data1/oa_pdf/15/35/psp201371a.PMC3917320.pdf
<http://www.prnewswire.com/news-releases/final-results-of- boceprevir-phase-ii-hcv-sprint-1-study-showed-significantly-higher-svr-rates-compared- to-standard-of-care-in-treatment-naive-genotype-1-hepatitis-c-patients-61934397.html> Accessed 12 October 2013 13.,Non-OADS,/arxiv_data1/oa_pdf/15/35/psp201371a.PMC3917320.pdf
"10th Population Approach Group Conference, Basel, Switzerland, <http://www.page-meeting.org> (2001).",Non-OADS,/arxiv_data1/oa_pdf/15/35/psp201371a.PMC3917320.pdf
"To view a copy of   this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the CPT: Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/15/35/psp201371a.PMC3917320.pdf
"    Letter to the Editor                      http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7d/f4/mjiri-27-161.PMC3917481.pdf
161-162  http://mjiri.tums.ac.ir    References  1.,Non-OADS,/arxiv_data1/oa_pdf/7d/f4/mjiri-27-161.PMC3917481.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ee/21/mjiri-27-109.PMC3917482.pdf
109-112  http://mjiri.tums.ac.ir  appendiceal perforation (3).,Non-OADS,/arxiv_data1/oa_pdf/ee/21/mjiri-27-109.PMC3917482.pdf
109-112   http://mjiri.tums.ac.i rTable 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/21/mjiri-27-109.PMC3917482.pdf
"109-112  http://mjiri.tums.ac.ir  bilirubinemia (elevated total bilirubin lev- els>1 mg/dl) than those with acute simple appendicitis, but the limited number of pa-tients in this study mandates that our results should be corroborated by larger studies.",Non-OADS,/arxiv_data1/oa_pdf/ee/21/mjiri-27-109.PMC3917482.pdf
"    C a s e  R e p o r t                      http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/df/c8/mjiri-27-157.PMC3917483.pdf
157-160  http://mjiri.tums.ac.ir    Case Presentation  An eight-year-old boy was visited in endo- crinology clinic of the Kashan University of Medical Sciences.,Non-OADS,/arxiv_data1/oa_pdf/df/c8/mjiri-27-157.PMC3917483.pdf
"157-160   http://mjiri.tums.ac.i rthe United States, Europe, and Mexico.",Non-OADS,/arxiv_data1/oa_pdf/df/c8/mjiri-27-157.PMC3917483.pdf
157-160  http://mjiri.tums.ac.ir  sternum was abnormally prominent.,Non-OADS,/arxiv_data1/oa_pdf/df/c8/mjiri-27-157.PMC3917483.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
"113-118  http://mjiri.tums.ac.ir  improved functional outcomes and reduced  mortality (4,5).",Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
113-118   http://mjiri.tums.ac.i rTable1.,Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
113-118  http://mjiri.tums.ac.ir  tively.,Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
113-118   http://mjiri.tums.ac.i rand by CT (within 24 hours) in the 0- to 90- minute group (4%) and two in the 91- to 180-minute group (10%) (12).,Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
113-118  http://mjiri.tums.ac.ir  2008;359(13):1317-29.,Non-OADS,/arxiv_data1/oa_pdf/28/02/mjiri-27-113.PMC3917484.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/44/a6/mjiri-27-127.PMC3917485.pdf
"129-131  http://mjiri.tums.ac.ir   The aim of this study was to determine  the prevalence of Bocavirus in fecal speci- mens collected from gastroenteritis cases in  the Hazrat-e-Rasool Akram Hospital of Tehran, Iran and to evaluate its contribu-tion as a cause of acute gastroenteritis dis-eases.",Non-OADS,/arxiv_data1/oa_pdf/44/a6/mjiri-27-127.PMC3917485.pdf
129-131   http://mjiri.tums.ac.i rDNA.,Non-OADS,/arxiv_data1/oa_pdf/44/a6/mjiri-27-127.PMC3917485.pdf
"129-131  http://mjiri.tums.ac.ir  Conclusion  The study showed a high prevalence of  human Bocavirus in young children with  acute gastroenteritis in Iran, suggesting that  HBoV plays an important role in the path-ogenesis of gastroenteritis.",Non-OADS,/arxiv_data1/oa_pdf/44/a6/mjiri-27-127.PMC3917485.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
"101-108  http://mjiri.tums.ac.ir  tions between researchers, stakeholders and  decision makers (1).In the interactive theo-ry, researchers cooperate with stakeholders and decision makers in the research process beginning from choosing the research topic to implementing the research project.",Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
101-108   http://mjiri.tums.ac.i rresearch at different stages of the project.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
101-108  http://mjiri.tums.ac.ir  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
101-108   http://mjiri.tums.ac.i r  Fig.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
"101-108  http://mjiri.tums.ac.ir  strated that in clinical science projects, the  number of colleagues is more than those in basic science and HSR projects.",Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
101-108   http://mjiri.tums.ac.i rare of higher priority compared to other  aspects (21).,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
Available from: http://www.undp.org/conten t/undp/en/home/libraryp age/capacity-building/ capacity-for-development- new-solutions-to-old-problems-full-text.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
101-108  http://mjiri.tums.ac.ir  science and research in Iran.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
Available from: http://apps.who.int/bookorders/  anglais/detart1.jsp?codlan=1&codcol=46&codcch=29  17.,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
[cited 2007 Oct 14]Available from: http://partnership.esflive.eu/files/Assessing  Partnership Performance.pdf .,Non-OADS,/arxiv_data1/oa_pdf/59/e3/mjiri-27-101.PMC3917486.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
"147-152  http://mjiri.tums.ac.ir    Methods   Between March 2008 and March 2011, 197  children (141 female and 56 male) aged 5-15 years with history of voiding symptoms for at least three months, enuresis, urinary tract infection, and 33 healthy children (12 female and 21 male) were entered into the study after taking consent from the parents.",Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
147-152   http://mjiri.tums.ac.i rTable 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
147-152  http://mjiri.tums.ac.ir  Persian translated PLUTSS questionnaire.,Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
"147-152   http://mjiri.tums.ac.i rthat some parents respond with uncertainty;  therefore, it seems more reasonable to ask children to fill-out the questionnaire by the assistance of their parents.",Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
147-152  http://mjiri.tums.ac.ir  symptoms in pediatric population.,Non-OADS,/arxiv_data1/oa_pdf/6d/a2/mjiri-27-147.PMC3917488.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
"119-126  http://mjiri.tums.ac.ir  Considering the above definition, learning  disabilities can be divided into three main  categories: dyslexia, dyscalculia, dysgraph-ia (3).",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
119-126   http://mjiri.tums.ac.i rwork.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
"119-126  http://mjiri.tums.ac.ir  Bender-Gestalt test, he/she is brain dam- aged and the score that subject gets in Bender-Gestalt visual-motor test on the ba-sis of 30 criteria of Koppitz shows visual- motor perception development of subject.",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
119-126   http://mjiri.tums.ac.i rTable 1.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
119-126  http://mjiri.tums.ac.ir  max scores in healthy group.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
119-126   http://mjiri.tums.ac.i rand the child writes expressively what he  hears.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
"119-126  http://mjiri.tums.ac.ir   as method of administration and marking,  individual's background evaluation, and use of neural and other specialized tests (27).",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/mjiri-27-119.PMC3917489.pdf
"    Original Article                     http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
"132-140   http://mjiri.tums.ac.i rtion, many serious diseases, as well as  many cancers (6).",Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140  http://mjiri.tums.ac.ir     Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140   http://mjiri.tums.ac.i rTable1.,Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140  http://mjiri.tums.ac.ir  Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
"132-140   http://mjiri.tums.ac.i rIn these studies, the wide and sometimes  different age range of participants and ac-cumulation of the data obtained from urban and rural areas led to incongruity.",Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140  http://mjiri.tums.ac.ir  significant difference between the rates of  self-report and chemical indices of smok-ing in women (1.3% versus 6.7%) (15).,OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140   http://mjiri.tums.ac.i r1996; 23: 397-402.,Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
132-140  http://mjiri.tums.ac.ir  32.,Non-OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
Available from:  http://www.euro.who.int/document/e89842.,OADS,/arxiv_data1/oa_pdf/1f/91/mjiri-27-132.PMC3917490.pdf
"    C a s e  R e p o r t                      http://mjiri.tums.ac.ir  Medical Journal of the Islamic Republic of Iran, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5e/36/mjiri-27-153.PMC3917491.pdf
153-156  http://mjiri.tums.ac.ir  (IV) contrast revealed a giant hypodense  cystic mass of about 30x32 x43 cm located in the entire abdominopelvic cavity.,Non-OADS,/arxiv_data1/oa_pdf/5e/36/mjiri-27-153.PMC3917491.pdf
"153-156   http://mjiri.tums.ac.i rDiscussion  The human is an intermediate host in the  life cycle of Echinococcus granulosus and infection occurs after the consumption of foods contaminated by canidae feces (5,6).",Non-OADS,/arxiv_data1/oa_pdf/5e/36/mjiri-27-153.PMC3917491.pdf
153-156  http://mjiri.tums.ac.ir  recurrence and complications.,Non-OADS,/arxiv_data1/oa_pdf/5e/36/mjiri-27-153.PMC3917491.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 21–29Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  21Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S3722 0Dabrafenib for treatment of BRAF-mutant  melanoma Radhika Kainthla1 Kevin B Kim2 Gerald S Falchook3 1Department of internal Medicine,   Baylor College of Medicine,   2Department of Melanoma  Medical Oncology, 3Department of  investigational Cancer Therapeutics,   The University of Texas MD Anderson  Cancer Center, Houston, TX, USA Correspondence: Gerald S Falchook   The University of T exas MD Anderson   Cancer Center, Department of   investigational Cancer Therapeutics,   Unit 455, 1515 Holcombe Boulevard,   Houston, TX 77030, USA   Fax +1 713 792 9669   email gfalchoo@mdanderson.or gAbstract:  Melanoma has the highest mortality of all the skin cancer subtypes.",Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
"RK has no conflicts of interest to declare.Table 2  Active and recruiting clinical trials involving dabrafenib use in patients with melanoma NCT# Trial Status 01677741 The study to determine safety, tolerability, and pharmacokinetics of oral dabrafenib in   pediatric subjectsRecruiting 01584648 A Phase iii study comparing trametinib and dabrafenib combination therapy to   dabrafenib monotherapy in subjects with  BRAF -mutant melanomaActive,   not recruiting 01767454 Phase i study of dabrafenib ± trametinib in combination with ipilimumab for V600E/K    mutation positive metastatic or unresectable melanomaRecruiting 01682083 A study of the BRAF inhibitor dabrafenib in combination with the MeK inhibitor   trametinib in the adjuvant treatment of high-risk BRAF mutation-positive melanoma   after surgical resectionRecruiting 01682213 Adjuvant dabrafenib in patients with surgically resected AJCC stage iiiC melanoma   characterized by a BRAFV600E/K  mutationRecruiting 01726738 Open label Phase ii trial of dabrafenib and trametinib in unresectable stage iii and   stage iv BRAF mutant melanoma; correlation of resistance with the kinome and   functional mutationsRecruiting 01721603 A Phase ii prospective trial of dabrafenib with stereotactic radiosurgery in BRAFv600e   melanoma brain metastasesRecruiting 01597908 Dabrafenib plus trametinib vs vemurafenib alone in unresectable or metastatic BRAF   v600e/K cutaneous melanomaRecruiting 01940809 ipilimumab with and without dabrafenib, and/or trametinib in treating patients with   melanoma that is metastatic or cannot be removed by surgeryRecruiting 01701037 Dabrafenib alone and in combination with trametinib before surgery in treating   patients with locally or regionally advanced melanoma that can be removed by surgeryRecruiting Note: Trial information obtained from http://www.clinicaltrials.gov /.58 Abbreviation: NCT#,  National Clinical Trial number.",Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
Available from: http://seer.cancer.gov/ csr/1975_2009_pops09 /.,Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
"Available from:  http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ ucm354477.ht m. Accessed October 9, 2013.",Non-OADS,/arxiv_data1/oa_pdf/87/b7/pgpm-7-021.PMC3917541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 31–42Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  31Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5837 4Targeted treatment of folate receptor-positive  platinum-resistant ovarian cancer and companion  diagnostics, with specific focus on vintafolide and  etarfolatide Loredana Serpe Margherita Gallicchio Roberto Canaparo Franco Dosio Department of Drug Science and  T echnology, University of T urin, italy Correspondence: Franco Dosio   Department of Drug Science and  Technology, University of Turin, italy,   v. Pietro Giuria 9, 10125 Turin, italy   Tel +39 01 1670 7082   Fax +39 01 1236 7697   email franco.dosio@unito.i tAbstract:  Among the gynecological malignancies, ovarian cancer is the leading cause of  mortality in developed countries.",Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
"Available from: http://www.whitehouse.gov/files/documents/ostp/ PCAST/pcast_report_v2.pd f. Accessed December 19, 2013.",OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Available  from: http://clinicaltrials.gov/show/NCT0073869 9.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Available from: http://clinicaltrials.gov/show/ NCT0072259 2.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Available from: http://clinicaltrials.gov/show/ NCT0117065 0.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Available from: http://clinicaltrials.gov/show/NCT0195353 6.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Available from: http://clinicaltrials.gov/show/ NCT0168879 1.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/3b/0c/pgpm-7-031.PMC3917542.pdf
"322 http://tac.sagepub.com Ther Adv Cardiovasc Dis (2013) 7(6) 322 –342 DOI: 10.1177/  1753944713513061 © The Author(s), 2013.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Reprints and permissions:   http://www.sagepub.co.uk/ journalsPermissions.nav Therapeutic Advances in Cardiovascular Disease Introduction Chronic kidney disease (CKD) multiplies cardio-vascular risk for affected patients even beyond the risk conferred by antecedent diabetes and/or hypertension.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 323 disease is the most common cause of death for  patients with CKD or end-stage renal disease (ESRD).,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Therapeutic Advances in Cardiovascular Disease 7 (6) 324 http://tac.sagepub.com to 3.4, 3.5 to 3.9, and ≥4 mg/dL), a graded rela- tion between phosphate and death was observed after adjustment for age, race, and sex (p for trend = 0.01)’ [Tonelli et  al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Rastogi http://tac.sagepub.com 325 pathology, including the adverse effects of CKD-  and ESRD-related biochemical derangements [Santoro et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Therapeutic Advances in Cardiovascular Disease 7 (6) 326 http://tac.sagepub.com Table 1.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 327 Stage of CKD Studies and references Populations and regimens Key results  INDEPENDENT-CKD  study [Di Iorio et al.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Therapeutic Advances in Cardiovascular Disease 7 (6) 328 http://tac.sagepub.com calcification in patients with dialysis-dependent  ESRD [Asmus et  al.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 329 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Therapeutic Advances in Cardiovascular Disease 7 (6) 330 http://tac.sagepub.com Parameter Studies and  referencesPopulations and regimens Key results Anti-inflammatory, anti-endotoxin, or anti- dyslipidemic effects[Ferramosca  et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 331 Parameter Studies and  referencesPopulations and regimens Key results  [Braunlin et al.,OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Therapeutic Advances in Cardiovascular Disease 7 (6) 332 http://tac.sagepub.com Parameter Studies and  referencesPopulations and regimens Key results Antihyperuricemic Subanalysis of Treat to Goal  study [Garg et al.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 333 A possible challenge to the postulated interrela- tionship of endothelial dysfunction (e.g.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Therapeutic Advances in Cardiovascular Disease 7 (6) 334 http://tac.sagepub.com reduced circulating AGEs significantly in a study  of healthy subjects and predialysis CKD patients, showing that intestinal AGE absorption deter-mines plasma AGE concentrations [Vlassara et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 335 Reduced levels of plasma endotoxins (reflecting  reduced absorption from gut bacteria) were asso-ciated with sevelamer use in a pilot study of hemodialysis patients [Sun et al.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Therapeutic Advances in Cardiovascular Disease 7 (6) 336 http://tac.sagepub.com LDL cholesterol reduces a source of vascular  inflammation and an atherogenic substance.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 337 relatively infrequent in binder studies.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Therapeutic Advances in Cardiovascular Disease 7 (6) 338 http://tac.sagepub.com uremic toxins; and reduced blood absorption of  AGEs and endotoxin from the gut.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Rastogi http://tac.sagepub.com 339 CMPP, of Envision Scientific Solutions, which  was contracted by Sanofi (formerly Genzyme) for publication support services.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Therapeutic Advances in Cardiovascular Disease 7 (6) 340 http://tac.sagepub.com Cottone, S., Lorito, M., Riccobene, R., Nardi, E.,  Mule, G., Buscemi, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Rastogi http://tac.sagepub.com 341 erythropoiesis-stimulating agents in haemodialysis  patients.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Available  at: http://web.archive.org/web/20050117124113/http://www.hypertensiononline.org/slides2/slide01.cfm?q=endothelium&dpg=6.,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
"Therapeutic Advances in Cardiovascular Disease 7 (6) 342 http://tac.sagepub.com Santoro, D., Bellinghieri, G., Conti, G., Pazzano, D.,  Satta, E., Costantino, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
Visit SAGE journals online  http://tac.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/0a/13/10.1177_1753944713513061.PMC3917706.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/ndt-10-217.PMC3917918.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 217–223Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  217OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5668 0Baseline characteristics of depressive disorders   in Thai outpatients: findings from the Thai Study   of affective Disorders Tinakon Wongpakaran1 Nahathai Wongpakaran1 Manee Pinyopornpanish1 Usaree Srisutasanavong1 Peeraphon lueboonthavatchai2 raviwan Nivataphand2 Nattaporn apisiridej3 Donruedee Petchsuwan3 Nattha saisavoey4 Kamonporn Wannarit4 ruk ruktrakul5 Thawanrat srichan5 sirina satthapisit6 Daochompu Nakawiro7 Thanita hiranyatheb7 anakevich T emboonkiat8 Namtip T ubtimtong9 sukanya rakkhajeekul9 Boonsanong Wongtanoi10 sitthinant Tanchakvaranont11 Putipong Bookkamana12 1Faculty of Medicine, Chiang Mai University,   Chiang Mai, 2Faculty of Medicine,   Chulalongkorn University, Bangkok, 3Trang  Hospital, Trang, 4Faculty of Medicine, siriraj  Hospital, Mahidol University, Bangkok,   5Lampang Hospital, Lampang, 6KhonKaen  hospital , Khon Kaen, 7Faculty of Medicine,   ramathibodi hospital, Mahidol University,   Bangkok, 8Phramongkutklao Hospital,   Bangkok, 9Faculty of Medicine Naresuan  University, Pitsanulok, 10Srisangwal Hospital,   Mae Hong Son, 11Queen Savang Vadhana  Memorial hospital, chonburi, 12Faculty of  Science, Chiang Mai University, Chiang Mai  Kingdom of Thailand Correspondence: Tinakon Wongpakaran   Department of Psychiatry, Faculty of   Medicine, Chiang Mai University,   110 intawarorot rd, Tambon sriphum,   Amphur Muang, Chiang Mai, Thailand 50200   Tel +66 5394 5422   Fax +66 5394 5426   email tinakon.w@cmu.ac.t hBackground:  The Thai Study of Affective Disorders was a tertiary hospital-based cohort study  developed to identify treatment outcomes among depressed patients and the variables involved.",Non-OADS,/arxiv_data1/oa_pdf/16/b8/ndt-10-217.PMC3917918.pdf
Available from: http://www.dmh.go.th/downloadportal/ Morbidity/ Depress2551.pdf .,Non-OADS,/arxiv_data1/oa_pdf/16/b8/ndt-10-217.PMC3917918.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/16/b8/ndt-10-217.PMC3917918.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/b8/ndt-10-217.PMC3917918.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2014:6 19–34Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S3507 8The clinical potential of influencing Nrf2 signaling  in degenerative and immunological disorders Bifeng Gao An Doan Brooks M Hybertson Department of Medicine, Division of  Pulmonary Sciences and Critical Care  Medicine, University of Colorado  Anschutz Medical Campus, Aurora,   CO, USA Correspondence: Brooks M Hybertson   Department of Medicine, Division of  Pulmonary Sciences and Critical Care  Medicine, Box C272, 12700 east 19th  Avenue, University of Colorado Anschutz  Medical Campus, Aurora, CO 80045, USA   email b rooks.hybertson@ucdenver.ed uAbstract:  Nuclear factor (erythroid-derived 2)-like 2 (Nrf2; encoded in humans by the NFE2L2   gene) is a transcription factor that regulates the gene expression of a wide variety of cytoprotec - tive phase II detoxification and antioxidant enzymes through a promoter sequence known as the  antioxidant-responsive element (ARE).",Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
"In the present work, Nrf2 transcription factor ( NFE2L2 )  binding sites were identified in the 25 genes with the high - est fold-induction from our previous phytochemical Nrf2  activation study using Protandim® (LifeVantage, Inc., Sandy,  UT, USA; a mixture of extracts of milk thistle, bacopa, ash - wagandha, green tea, and turmeric)40 and used to generate a  sequence logo using Weblogo 3 ( http://weblogo.threeplusone.",Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
"Notes: Using  oPOSSUM 3.0 web-based software ( http://opossum.cisreg.ca/ oPOSSUM3 /) we evaluated Nrf2 binding sites in the 25 genes with the highest  fold-induction from our previous phytochemical Nrf2 activation study using  Protandim® (Lifevantage, inc., Sandy, UT, USA; a mixture of extracts of milk thistle,  bacopa, ashwagandha, green tea, and turmeric),40 examining 10,000 bases upstream  and 5,000  bases downstream of the transcription start site and aligning potential  Nrf2 binding sites.43,44 Thirty one Nrf2 binding sites were identified in 14 of the 25  genes that were upregulated by the Nrf2 activator.40  Abbreviations: Nrf2,  nuclear factor (erythroid-derived 2)-like 2; ARe, antioxidant  response element.",Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
Available  from: http://clinicaltrials.gov/show/NCT01351675.,Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/78/cpaa-6-019.PMC3917919.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/c4/imcrj-7-019.PMC3917920.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 19–22International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  19Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/ 10.2147/IMCRJ.S5889 1Disseminated intravascular coagulopathy caused  by Kikuchi–Fujimoto disease resulting in death:  first case report in T urkey emine Uslu1 sibel Gurbuz2 abdulsamet erden1 Fatma aykas1 Hatice Karagoz1 samet Karahan1 Hatice Karaman3 ali Cetinkaya1 Deniz avci1 1Internal Medicine Department,   2Infection Disease Department,   3Clinical pathology Department,   Kayseri training and Research  Hospital, Kayseri, turkey Correspondence: samet Karahan   Internal Medicine Department, Kayseri   training and Research Hospital,   Kayseri e g˘itim Araştırma   Hastanesi, I˙ç Hastalıkları   Klinig˘i, 9 Blok 3 Kat Kocasinan,   Kayseri, turkey   tel +90 506 302 0036   email doktorsamet@yahoo.co mAbstract:  Kikuchi disease, also called Kikuchi–Fujimoto disease or Kikuchi’ s histiocytic  necrotizing lymphadenitis, is a rare, benign condition of unknown cause, usually character - ized by cervical lymphadenopathy and fever.",Non-OADS,/arxiv_data1/oa_pdf/f8/c4/imcrj-7-019.PMC3917920.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/f8/c4/imcrj-7-019.PMC3917920.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/c4/imcrj-7-019.PMC3917920.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-419.PMC3917921.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 419–435International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  419OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5191 9An efficient nonviral gene-delivery vector based  on hyperbranched cationic glycogen derivatives Xuan Liang1,* Xianyue Ren2,* Zhenzhen liu1 Yingliang Liu1 Jue Wang2 Jingnan Wang2 Li-Ming Zhang1 David YB Deng2 Daping Quan1 Liqun Yang1 1Institute of Polymer Science,   School of Chemistry and Chemical  Engineering, Key Laboratory of  Designed Synthesis and Application of  Polymer Material, Key Laboratory for  Polymeric Composite and Functional  Materials of Ministry of Education,   Sun Yat-Sen University, Guangzhou,   People’s Republic of China; 2research  Center of Translational Medicine,   The First Affiliated Hospital, Sun Yat- Sen University, Guangzhou, People’s  Republic of China *Both these authors contributed  equally to this work Correspondence: Liqun Yang   School of Chemistry and   Chemical Engineering, Sun Yat-Sen   University, 135 Xingang Xi Road,   Guangzhou, Guangdong 510275,   People’s Republic of China   Tel +86 20 8411 0934   email yanglq@mail.sysu.edu.c n    Correspondence: David YB Deng   research center of Translational   Medicine, The First Affiliated Hospital,   Sun Yat-Sen University, Guangzhou   510080, People’s Republic of China   Tel 8775 5766   email dengyub@mail.sysu.edu.c nBackground:  The purpose of this study was to synthesize and evaluate hyperbranched cationic  glycogen derivatives as an efficient nonviral gene-delivery vector.",Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-419.PMC3917921.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-419.PMC3917921.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/a0/ijn-9-419.PMC3917921.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/d6/dmso-7-025.PMC3917922.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014:7 25–34Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  25Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3764 9Stress and the inflammatory process: a major  cause of pancreatic cell death in type 2 diabetes Joel Montane Lisa Cadavez Anna Novials Diabetes and Obesity Research  Laboratory, institut d’ investigacions  Biomèdiques August Pi i Sunyer  (iDiBAPS), Hospital Clínic de  Barcelona, Barcelona, Spain; Centro  de investigación Biomédica en Red de  Diabetes y enfermedades Metabólicas  Asociadas (CiBeRDeM), Barcelona,   Spain Correspondence: Anna Novials   Diabetes and Obesity Research  Laboratory, institut d’ investigacions  Biomèdiques August Pi i Sunyer ( iDiBAPS),   Hospital Clínic de Barcelona, c/Rosello,  149-153 08036, Barcelona, Spain   Tel +34 93 227 5400   Fax +34 93 312 9403   email anovials@clinic.ub.e sAbstract:  Type 2 diabetes (T2D) is a complex metabolic disorder characterized by hyperg - lycemia in the context of insulin resistance, which precedes insulin deficiency as a result of  β-cell failure.",Non-OADS,/arxiv_data1/oa_pdf/9f/d6/dmso-7-025.PMC3917922.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/9f/d6/dmso-7-025.PMC3917922.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/d6/dmso-7-025.PMC3917922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/cd/jmdh-7-093.PMC3917923.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2014:7 93–104Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  93Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S5534 5The effectiveness of hydrotherapy in the  treatment of social and behavioral aspects   of children with autism spectrum   disorders: a systematic review Rachel Mortimer Melinda Privopoulos Saravana Kumar international Centre for Allied Health  evidence, School of Health Sciences,   University of South Australia,   Adelaide, SA, Australia Correspondence: Saravana Kumar   international Centre for Allied Health  evidence (iCAHe), GPO Box 2471,  University of South Australia,   Adelaide, SA 5000, Australia   Tel +61 8 8302 2085   Fax +61 8 8302 2766   email saravana.kumar@unisa.edu.a uBackground:  Autism spectrum disorders (ASDs) are increasing in prevalence.",Non-OADS,/arxiv_data1/oa_pdf/1e/cd/jmdh-7-093.PMC3917923.pdf
"Hamilton, ON: McMaster   University; 1998. http://www.srs-mcmaster.ca/Portals/20/pdf/ebp/  quanreview.pdf.",Non-OADS,/arxiv_data1/oa_pdf/1e/cd/jmdh-7-093.PMC3917923.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/1e/cd/jmdh-7-093.PMC3917923.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/cd/jmdh-7-093.PMC3917923.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2014:6 53–61Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  53Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4060 0Decitabine in the treatment of acute myeloid  leukemia in elderly patients Priya Malik Amanda F Cashen washington University School of  Medicine, St Louis, MO, USA Correspondence: Amanda F Cashen   washington University School of  Medicine, 660 South euclid Ave,   St Louis, MO 63110, USA   Tel +1 314 454 8306   Fax +1 314 454 7551   email acashen@dom.wustl.ed uAbstract:  The majority of patients with acute myeloid leukemia (AML) are elderly and  have a poor prognosis despite induction therapy.",Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
"Available from: http://seer.cancer.gov/statfacts/html/amyl.htm l.  Accessed June 16 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ aml.pd f. Accessed June 16 , 2013.",Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/99/cmar-6-053.PMC3917925.pdf
"The impairments  Correspondence to: Azaam M Samad; Email: asamad@tpims.org Submitted: 01/16/2014; Accepted: 01/16/2014http://dx.doi.org/10.4161/adip.27914In this issue of Adipocyte Azaam M  samad torrey Pines i nstitute for Molecular s tudies; s an d iego, CA U sA Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/55/76/adip-3-1.PMC3917926.pdf
"In turn, hyperinsulinemia causes  *Correspondence to: Robert V Farese; Email: rfarese@health.usf.edu Submitted: 07/10/2013; Revised: 08/16/2013; Accepted: 08/28/2013http://dx.doi.org/10.4161/adip.26305Impairment of insulin-stimulated glucose  transport and ERK activation by adipocyte- specific knockout of PKC- λ produces a phenotype  characterized by diminished adiposity and  enhanced insulin suppression   of hepatic gluconeogenesis Mini P s ajan1,2, Michael J Jurzak3, Varman T s amuels3, Gerald I s hulman3, Ursula Braun4,5, Michael Leitges4,5,   and Robert V Farese1,2,* 1James a h aley Veterans Medical c enter; Tampa, FL U sa; 2Department of Internal Medicine; University of s outh Florida c ollege of Medicine; Tampa, FL U sa;   3Departments of Internal Medicine and c ellular and Molecular Physiology; h oward h ughes Medical Institute; Yale University s chool of Medicine; New h aven, c T Usa;   4Division of Nephrology; Department of Medicine; h annover Medical s chool; h annover, Germany; 5Biotechnology c entre of Oslo; Oslo, Norway Keywords:  adipocyte, PKC- λ, diabetes, glucose transport, ERK, insulin, liver Tissue-specific knockout (KO) of atypical protein kinase c -λ (PK c-λ) impairs insulin-stimulated glucose transport in  muscle (M) and lipid synthesis in liver (L), thereby producing insulin resistance in M λKO mice and insulin-hypersensitivity  in LλKO mice.",Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
J Biol Chem 2006 ;  281:17466 -73; PMID:16644736 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
J Clin Invest 2007 ; 117:2289 - 301; PMID:17641777 ; http://dx.doi.org/10.1172/ JCI31408 4.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
J Lipid Res 2009 ; 50:1133 - 45; PMID:19202134 ; http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
"Correction of metabolic abnormalities in a  rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic  protein kinase C- ι. Metabolism  2012 ; 61:459-69;  PMID:22225955 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Diabetologia   2009 ; 52:1197 -207; PMID:19357831 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Diabetologia  2012 ; 55:1446 -57; PMID:22349071 ;  http://dx.doi.org/10.1007/s00125-012-2477-5 9.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
J Biol Chem 2003 ;  278:33609 -12; PMID:12788932 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Protein kinase C-zeta  and phosphoinositide-dependent protein kinase-1 are required for insulin-induced activation of ERK  in rat adipocytes.. J Biol Chem 1999 ; 274:30495 - 500; PMID:10521430 ; http://dx.doi.org/10.1074/ jbc.274.43.30495 13.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Biochem Biophys Res Commun   2000 ; 274:845-51; PMID:10924365 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Am J Physiol Endocrinol Metab 2009 ;  296:E635 -46; PMID :19158325 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Cell Metab  2007 ; 6:208-16;  PMID:17767907 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Cell Metab  2006 ; 3:211- 22; PMID:16517408 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
EMBO Rep 2010 ; 11:226-32; PMID:20154642 ;  http://dx.doi.org/10.1038/embor.2010.7 19.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Diabetes  2010 ; 59:3032 -40;  PMID:20876720 ; http://dx.doi.org/10.2337/ db10-0074 20.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
J  Biol Chem  2004 ; 279:31902 -9; PMID :15131120 ;  http://dx.doi.org/10.1074/jbc.M404570200 22.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Aging Cell  2007 ; 6:827-39; PMID:18001293 ;  http://dx.doi.org/10.1111/j.1474-9726.2007.00346.x 23.,Non-OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
Nat Med   2001 ; 7:699-705; PMID:11385507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f0/31/adip-3-19.PMC3917928.pdf
"5 In the  *Correspondence to: Kostas A Triantaphyllopoulos; Email: ktrianta@aua.gr Submitted: 05/30/2013; Revised: 08/25/2013; Accepted: 09/09/2013http://dx.doi.org/10.4161/adip.26437Energy balance-dependent regulation   of ovine glucose 6-phosphate dehydrogenase  protein isoform expression Kostas A Triantaphyllopoulos*, George P Laliotis, and Iosif A Bizelis Department of Animal s cience & Aquaculture; Agricultural University of Athens; Athens, Greece Keywords:  adipose tissue, Ovis aries,  G6PD, isoform, immunoblotting Abbreviations: G6PDH, glucose-6-phosphate dehydrogenase; oG6PDA, ovine G6PDH protein isoform A; oG6PDB, ovine  G6PDH protein isoform B; WPW, week post-weaning G6PD h is the rate-limiting enzyme of the pentose phosphate pathway and one of the principal source of NADP h,  a major cellular reductant.",Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
"The protein blast ([BLASTP 2.2.28] citation http://blast.ncbi.nlm.nih.gov/Blast.cgi) for the immu - nogen peptide used for the antibody (Acris Antibodies GmbH), identified among other hits for G6PDH, the variant A (acces - sion number: ABD34655.1), and variant B (accession number: NP_001087249.1) from Ovis aries .",Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
J Biol Chem 1998; 273:10609-17; PMID:9553122 ;  http://dx.doi.org/10.1074/jbc.273.17.10609 2.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Annu Rev Nutr 2001 ; 21:121-40; PMID:11375432 ;  http://dx.doi.org/10.1146/annurev.nutr.21.1.121 7.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Mol Cell Biol   2005 ; 25:5146 -57; PMID :15923630 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Anim  Prod  1988 ; 46:387-93; http://dx.doi.org/10.1017/ S0003356100018997 9.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
J  Anim Breed Genet 1989 ; 106:51-8; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Biochem Biophys Res Commun   1978 ; 85:1318 -24; PMID:743300 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Nucleic Acids Res 1986 ; 14:2511- 22; PMID :3515319 ; http://dx.doi.org/10.1093/ nar/14.6.2511 13.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Genomics  1991 ; 10:792-800; PMID:1889820 ;  http://dx.doi.org/10.1016/0888-7543(91)90465-Q 14.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Nucleic Acids Res 1988 ; 16:7746 ;  PMID:3412913 ; http://dx.doi.org/10.1093/ nar/16.15.7746 16.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Gene  2007a ;  388:93-101; PMID:17157446 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Environ Res  1980 ;  21:366-72; PMID:7408807 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
J Anim Physiol  Anim Nutr (Berl)  2000 ; 84:73-84; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Insect Mol Biol   2006 ; 15:25- 32; PMID:16469065 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
FASEB  J 2010 ; 24:609-16; PMID:19805580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Anal  Biochem  2003 ; 318:175-80; PMID:12814619 ;  http://dx.doi.org/10.1016/S0003-2697(03)00143-X 28.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
EMBO J 2002 ; 21:4229 -39; PMID:12169625 ;  http://dx.doi.org/10.1093/emboj/cdf426 30.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
J Biol Chem  2007 ; 282:200-7; PMID:17102138 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Diabetes   2006 ; 55:2939 -49; PMID:17065329 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
Am J Physiol Lung Cell Mol Physiol 2011 ; 300:L691 - 700; http://dx.doi.org/10.1152/ajplung.00252.2010 ;  PMID:21355040 36.,Non-OADS,/arxiv_data1/oa_pdf/53/29/adip-3-30.PMC3917929.pdf
"While most *Correspondence to: Christian Wolfrum; Email: christian-wolfrum@ethz.ch Submitted: 07/08/2013; Revised: 08/20/2013; Accepted: 08/20/2013http://dx.doi.org/10.4161/adip.26232The origin and definition of brite versus white   and classical brown adipocytes Matthias Rosenwald and Christian w olfrum* Institute of Food n utrition and Health; e TH Zürich; Schwerzenbach, Switzerland Keywords:  brown adipose tissue, brown fat, brite adipocyte, beige adipocyte, non-shivering thermogenesis,  bi-directional interconversion, transdifferentiation, browning, adipocyte FACS, lineage tracing white adipose tissue stores energy while brown adipose  tissue contributes to body temperature maintenance through  non-shivering thermogenesis.",Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
N Engl J Med  2009; 360:1509-17;  PMID:19357406 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
"Diabetes 2009; 58:1526- 31; PMID:19401428 ; http://dx.doi.org/10.2337/ db09-0530 3. van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM, Drossaerts JM, Kemerink GJ, Bouvy  ND, Schrauwen P, Teule GJ.",Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
N Engl J Med 2009;  360 :1500-8 ;  PMID:19357405 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
N Engl J Med 2009; 360:1518-25; PMID:19357407 ; http://dx.doi.org/10.1056/ NEJMoa0808949 5.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
FASEB J  2009; 23:3113-20;  PMID:19417078 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Obes Rev 2009; 10:265-8;  PMID:19175509 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Diabetes Metab  J 2013; 37:22-9; PMID:23441053 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Biochim Biophys Acta 2013; 1831:1004-8; PMID:23274235 ;  http://dx.doi.org/10.1016/j.bbalip.2012.12.011 11.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Clin Invest 2012; 122:545- 52; PMID:22269323 ; http://dx.doi.org/10.1172/ JCI60433 12.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Clin Endocrinol Metab 2013; 98:E1230-4;  PMID:23783102 ; http://dx.doi.org/10.1210/ jc.2013-1348 13.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Clin Endocrinol Metab 2013; 98:E1218-23;  PMID:23780370 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Diabetologia 2013; 56:147-55;  PMID:23064293 ;  http://dx.doi.org/10.1007/s00125-012-2748-1 15.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Am J Physiol Endocrinol Metab 2012; 302:E19-31; PMID:21828341 ; http://dx.doi.org/10.1152/ ajpendo.00249.2011 17.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
FEBS Lett  1984; 167:10-4;  PMID:6698197 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell  Tissue Res 1991; 266:149-61; PMID:1747909 ;  http://dx.doi.org/10.1007/BF0067872119.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Biol Chem  2010 ; 285:7153-64 ;  PMID:20028987 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Proc Natl Acad Sci U S  A 2011; 108:143-8; PMID:21173238 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Science 2008; 321:1048-9; PMID:18719271 ;  http://dx.doi.org/10.1126/science.1164094 23.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nature 2013; 495:379-83; PMID:23485971 ;  http://dx.doi.org/10.1038/nature11943 24.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Lipid Res 2007; 48:41- 51; PMID:17041251 ; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nature 2008; 454:961- 7; PMID:18719582 ; http://dx.doi.org/10.1038/ nature07182 26.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell Metab 2010; 11:253-6; PMID:20374956 ;  http://dx.doi.org/10.1016/j.cmet.2010.03.004 27.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell  2012 ; 150 :366-76 ;  PMID:22796012 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
PLoS One 2012; 7:e49452;  PMID:23166672 ; http://dx.doi.org/10.1371/jour - nal.pone.0049452 29.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nat Med 2013; 19:635- 9; PMID :23603815 ; http://dx.doi.org/10.1038/ nm.3112 30.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nat Med  2013; 19:631-4;  PMID:23603813 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell Metab  2013; 17:798-805;  PMID:23663743 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nat Cell Biol 2013; 15:659- 67; PMID:23624403 ; http://dx.doi.org/10.1038/ ncb2740 33.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Biol Chem  2010 ; 285:7153-64 ;  PMID:20028987 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Physiol Rev 2011; 91:1447- 531; PMID:22013216 ; http://dx.doi.org/10.1152/ physrev.00031.201035.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Exp Cell Res 2010; 316:3093-9;  PMID:20580710 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell Stem Cell 2008; 3:382- 8; PMID:18940730 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Clin Invest  2012; 122:1022-36;  PMID:22307324 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nature 2012; 481:463-8; PMID:22237023 ;  http://dx.doi.org/10.1038/nature10777 40.,Non-OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Genes Dev 2012; 26:271-81;  PMID:22302939 ; http://dx.doi.org/10.1101/ gad.177857.111 41.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Eur J Biochem  2003; 270:699-705;  PMID:12581209 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Lipid Res 2012; 53:619- 29; PMID:22271685 ; http://dx.doi.org/10.1194/jlr.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell Metab 2012; 16:348-62;  PMID:22940198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Nat Cell Biol 2013; 15:302-8;  PMID:23434825 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell 2008; 135:240-9; PMID:18835024 ;  http://dx.doi.org/10.1016/j.cell.2008.09.036 46.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Cell Metab 2012; 15:480- 91; PMID:22482730 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
J Clin Invest  2006; 116:3220-8;  PMID:17143331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
Development 2007; 134:2283-92;  PMID:17507398 ; http://dx.doi.org/10.1242/ dev.002642,OADS,/arxiv_data1/oa_pdf/b0/6b/adip-3-4.PMC3917931.pdf
"This alteration of immune Keywords:  T-bet, adipose, obesity,  immune, Th1, insulin resistance, inflammation, metabolism, immu - nometabolism, IFN- γ, diabetes Submitted: 07/19/13 Revised: 08/19/13Accepted: 08/19/13http://dx.doi.org/10.4161/adip.26220 *Correspondence to: Jane K Howard;  Email: jane.k.howard@kcl.ac.uk Commentary to: Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET, Powell N, Canavan JB, Lord GM, Howard JK.",Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Cell Metab 2013; 17:520-33; PMID:23562076; http://dx.doi.org/10.1016/j.cmet.2013.02.019,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Annu Rev Physiol  2010; 72:219-46;  PMID:20148674 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Arterioscler Thromb Vasc Biol 2008; 28:1304- 10; PMID:18420999 ; http://dx.doi.org/10.1161/ ATVBAHA.108.165100 5.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Nat Med 2009; 15:930-9; PMID:19633656 ; http://dx.doi.org/10.1038/ nm.20027.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Biochem Biophys Res Commun 2009; 384:482- 5; PMID:19422792 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Nature 1998; 394:897-901;   PMID:9732873 ; http://dx.doi.org/10.1038/29795 10.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
J Clin Invest 1999; 104:1051-9; PMID:10525043 ;  http://dx.doi.org/10.1172/JCI6762 11.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Nat Med 2012; 18:363-74; PMID:22395709 ; http://dx.doi.org/10.1038/ nm.2627 12.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Blood 2008; 112:1557-69; PMID:18725574 ;  http://dx.doi.org/10.1182/blood-2008-05-078154 13.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Circ Res 2002; 91:281-91;  PMID:12193460 ; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Nat Med 2009; 15:846- 7; PMID:19661987 ; http://dx.doi.org/10.1038/ nm0809-846 16.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
PLoS One 2011; 6:e16376; PMID:21298111 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Immunity 2007; 26:241-55; PMID:17307705 ;  http://dx.doi.org/10.1016/j.immuni.2007.01.011 18.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
J Clin Invest 2007; 117:175-84; PMID:17200717 ; http://dx.doi.org/10.1172/ JCI29881 19.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Cell  2000; 100:655-69;  PMID:10761931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Science 2002;  295:338-42;  PMID:11786644 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Nat Commun 2012; 3:1268;  PMID:23232398 ; http://dx.doi.org/10.1038/ ncomms2260 22.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Mech Dev 2002; 116:157- 60; PMID:12128215 ; http://dx.doi.org/10.1016/ S0925-4773(02)00114-4 23.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Neural Syst  Circuits 2011; 1:5; PMID:22330144 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Cell Metab 2008; 7:410-20; PMID:18460332 ;  http://dx.doi.org/10.1016/j.cmet.2008.04.004 25.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
J Clin Invest 2007; 117:2621-37; PMID:17717599 ;  http://dx.doi.org/10.1172/JCI31021 26.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
Annu Rev Biochem  2008; 77:289-312;  PMID:18518822 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
J Biol Chem 2006; 281:8748-55; PMID:16431926 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d4/c4/adip-3-58.PMC3917935.pdf
